data_1ico_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ico _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -139.81 127.45 21.74 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.31 1.044 . . . . 0.0 108.766 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -85.66 130.15 34.64 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.733 0.813 . . . . 0.0 110.259 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.269 7.2 tt0 -114.39 98.28 6.82 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 101.152 -3.647 . . . . 0.0 101.152 169.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.11 120.97 43.63 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -106.95 135.38 48.6 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 125.54 1.775 . . . . 0.0 106.588 -169.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 CA--C 1.584 2.278 0 N-CA-C 101.382 -3.562 . . . . 0.0 101.382 -167.811 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -116.45 125.71 52.38 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -168.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.455 HG21 ' HE ' ' A' ' 13' ' ' ARG . 6.4 m -97.09 115.96 28.44 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -105.22 112.94 26.25 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HE ' HG21 ' A' ' 11' ' ' THR . 67.8 mtt180 -127.33 119.07 25.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 -169.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.37 -163.12 16.7 Favored Glycine 1 CA--C 1.58 4.119 0 CA-C-O 114.475 -3.403 . . . . 0.0 115.999 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -87.45 161.53 8.14 Favored 'Trans proline' 0 C--N 1.394 2.969 1 CA-C-N 126.679 5.239 . . . . 0.0 114.076 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.53 118.48 1.51 Allowed Glycine 0 N--CA 1.48 1.575 0 CA-C-O 118.021 -1.433 . . . . 0.0 110.018 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.0 m -100.74 84.46 0.47 Allowed Pre-proline 0 CA--C 1.588 2.421 0 CA-C-O 117.001 -1.476 . . . . 0.0 112.965 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -81.92 176.66 8.09 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 123.231 2.621 . . . . 0.0 112.725 168.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.29 10.0 t -98.96 157.54 16.25 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 123.791 0.836 . . . . 0.0 109.568 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 m -123.81 159.69 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 C-N-CA 124.487 1.115 . . . . 0.0 111.981 -166.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 164.2 58.8 Favored Pre-proline 0 CA--C 1.584 2.278 0 CA-C-O 115.252 -2.309 . . . . 0.0 114.686 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 C--N 1.399 3.23 0 CA-C-N 126.239 3.264 . . . . 0.0 112.945 179.576 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.8 t . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -142.58 108.31 5.12 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.263 1.3 tt -71.62 160.37 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.843 0 C-N-CA 126.972 2.109 . . . . 0.0 112.75 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -141.82 120.0 12.18 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 102.21 -3.256 . . . . 0.0 102.21 169.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.1 t -97.28 115.09 27.01 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.103 169.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 124.084 0.865 . . . . 0.0 109.126 -169.311 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -146.45 127.98 15.07 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -87.56 125.95 34.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.805 0.842 . . . . 0.0 109.804 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.271 8.3 tt0 -110.37 96.9 6.5 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 101.34 -3.578 . . . . 0.0 101.34 168.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.96 120.5 42.6 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.16 135.72 48.22 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 125.514 1.759 . . . . 0.0 106.615 -169.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 CA--C 1.584 2.276 0 N-CA-C 101.372 -3.566 . . . . 0.0 101.372 -167.68 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -114.87 125.42 53.64 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.458 HG22 ' HE ' ' A' ' 13' ' ' ARG . 6.4 m -97.27 116.25 29.14 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -105.78 112.94 26.21 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HE ' HG22 ' A' ' 11' ' ' THR . 67.6 mtt180 -127.36 120.67 29.05 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -169.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.75 -158.6 12.9 Favored Glycine 1 CA--C 1.579 4.04 0 CA-C-O 114.368 -3.462 . . . . 0.0 116.132 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -88.42 161.2 6.74 Favored 'Trans proline' 0 C--N 1.395 2.989 1 CA-C-N 126.571 5.186 . . . . 0.0 114.212 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.02 118.39 1.39 Allowed Glycine 0 N--CA 1.479 1.559 0 CA-C-O 117.981 -1.455 . . . . 0.0 110.197 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.9 m -100.69 85.71 0.59 Allowed Pre-proline 0 CA--C 1.588 2.417 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.456 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -82.4 175.45 8.94 Favored 'Trans proline' 0 C--N 1.391 2.81 0 C-N-CA 123.444 2.763 . . . . 0.0 113.739 170.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -75.71 158.13 32.7 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.727 1.211 . . . . 0.0 112.018 168.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 13.3 m -135.46 152.87 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.185 0.594 . . . . 0.0 111.609 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 167.79 32.1 Favored Pre-proline 0 CA--C 1.586 2.341 0 CA-C-O 114.998 -2.43 . . . . 0.0 113.939 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.4 3.263 0 CA-C-N 126.961 3.522 . . . . 0.0 111.349 178.88 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.501 2.077 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -140.69 109.64 6.08 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 123.3 1.524 . . . . 0.0 107.827 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.273 1.1 tt -70.54 163.4 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 109.686 -3.416 . . . . 0.0 113.192 -173.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -141.43 115.21 9.09 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 168.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.8 t -94.67 116.51 28.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 111.582 -2.553 . . . . 0.0 107.242 170.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 N--CA 1.494 1.729 0 C-N-CA 123.988 0.915 . . . . 0.0 109.774 -168.517 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -140.04 125.23 18.74 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.292 1.037 . . . . 0.0 108.58 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.35 126.08 34.09 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 124.12 0.888 . . . . 0.0 110.11 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.266 9.0 tt0 -110.76 98.91 7.94 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 100.932 -3.729 . . . . 0.0 100.932 168.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.85 107.99 16.47 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 103.763 -2.681 . . . . 0.0 103.763 -176.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -97.25 126.72 42.64 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 125.466 1.729 . . . . 0.0 106.856 -167.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mm . . . . . 0 CA--C 1.577 2.006 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 -167.137 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.2 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -94.38 127.17 40.1 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.353 1.061 . . . . 0.0 108.59 -169.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -100.8 111.28 23.47 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -103.54 119.11 38.24 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -135.62 119.19 17.0 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -170.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.04 -158.11 13.4 Favored Glycine 1 CA--C 1.579 4.048 0 CA-C-O 114.401 -3.444 . . . . 0.0 115.713 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -87.14 161.92 8.6 Favored 'Trans proline' 0 C--N 1.393 2.901 1 CA-C-N 126.597 5.198 . . . . 0.0 114.016 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.87 116.08 1.4 Allowed Glycine 0 N--CA 1.48 1.568 0 CA-C-O 118.106 -1.385 . . . . 0.0 110.381 174.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.4 m -101.46 85.78 0.68 Allowed Pre-proline 0 CA--C 1.587 2.371 0 CA-C-O 116.697 -1.62 . . . . 0.0 111.102 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -82.37 173.01 11.06 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 123.252 2.635 . . . . 0.0 113.771 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -75.61 154.78 36.45 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.575 1.15 . . . . 0.0 111.948 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.272 18.0 m -137.17 154.0 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 O-C-N 123.5 0.5 . . . . 0.0 111.856 -173.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 168.08 30.83 Favored Pre-proline 0 CA--C 1.588 2.423 0 CA-C-O 114.91 -2.471 . . . . 0.0 114.187 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 C--N 1.399 3.236 0 CA-C-N 126.982 3.529 . . . . 0.0 111.84 177.388 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.1 t . . . . . 0 N--CA 1.503 2.187 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.8 p -136.26 109.17 7.61 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 102.42 -3.178 . . . . 0.0 102.42 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.259 0.8 OUTLIER -68.79 162.33 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.858 0 C-N-CA 126.745 2.018 . . . . 0.0 113.488 -174.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -138.07 113.85 9.8 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 167.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.8 t -97.96 111.48 23.77 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.139 170.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 124.231 0.957 . . . . 0.0 109.572 -168.605 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.04 129.11 25.21 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.338 1.055 . . . . 0.0 108.92 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -85.84 131.38 34.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.654 0.782 . . . . 0.0 110.45 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.269 7.1 tt0 -116.19 98.33 6.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 100.928 -3.73 . . . . 0.0 100.928 169.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.16 121.28 44.5 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.19 135.16 49.2 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 125.511 1.757 . . . . 0.0 106.681 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.585 2.312 0 N-CA-C 101.461 -3.533 . . . . 0.0 101.461 -167.665 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -116.77 125.54 51.78 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -168.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.451 HG21 ' HE ' ' A' ' 13' ' ' ARG . 6.6 m -97.05 115.67 27.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -104.84 112.86 26.13 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.451 ' HE ' HG21 ' A' ' 11' ' ' THR . 67.4 mtt180 -127.31 118.8 24.9 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -169.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.19 -165.11 19.76 Favored Glycine 1 CA--C 1.58 4.126 0 CA-C-O 114.482 -3.399 . . . . 0.0 115.911 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -86.57 161.48 9.42 Favored 'Trans proline' 0 C--N 1.394 2.927 1 CA-C-N 126.697 5.248 . . . . 0.0 113.928 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 117.91 1.46 Allowed Glycine 0 N--CA 1.479 1.511 0 CA-C-O 117.964 -1.464 . . . . 0.0 110.057 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.8 m -100.65 84.51 0.47 Allowed Pre-proline 0 CA--C 1.587 2.389 0 CA-C-O 117.038 -1.458 . . . . 0.0 112.909 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -82.21 173.78 10.54 Favored 'Trans proline' 0 C--N 1.389 2.684 0 C-N-CA 123.16 2.573 . . . . 0.0 112.898 168.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.288 9.0 t -95.43 157.27 15.97 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 123.547 0.739 . . . . 0.0 109.288 167.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.6 m -125.68 158.55 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 124.19 0.996 . . . . 0.0 112.363 -166.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -67.76 -176.24 0.26 Allowed Pre-proline 0 CA--C 1.599 2.844 0 N-CA-C 117.662 2.468 . . . . 0.0 117.662 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 C--N 1.399 3.235 0 C-N-CA 123.866 3.044 . . . . 0.0 110.816 172.74 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -143.34 108.45 4.98 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.268 1.3 tt -71.32 161.9 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 C-N-CA 127.12 2.168 . . . . 0.0 112.82 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -141.84 122.01 13.84 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 102.21 -3.255 . . . . 0.0 102.21 168.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.8 t -97.56 115.1 27.21 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 111.813 -2.449 . . . . 0.0 107.138 169.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.246 -0.883 . . . . 0.0 108.641 -169.36 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -142.15 124.66 15.76 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.3 1.04 . . . . 0.0 108.521 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -85.14 130.94 34.51 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 117.818 -1.087 . . . . 0.0 110.672 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.276 4.9 tt0 -114.52 95.18 5.13 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 171.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.79 122.38 47.68 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -106.97 135.0 49.28 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 125.575 1.797 . . . . 0.0 106.655 -169.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 CA--C 1.586 2.352 0 N-CA-C 100.722 -3.807 . . . . 0.0 100.722 -167.877 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -116.6 125.37 51.73 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -168.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.444 HG23 ' HE ' ' A' ' 13' ' ' ARG . 7.0 m -96.98 116.91 30.04 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -104.67 112.35 25.4 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.444 ' HE ' HG23 ' A' ' 11' ' ' THR . 71.2 mtt180 -127.6 120.75 28.83 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -169.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.51 -163.58 24.79 Favored Glycine 1 CA--C 1.58 4.115 0 CA-C-O 114.521 -3.377 . . . . 0.0 116.29 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -89.98 160.86 4.94 Favored 'Trans proline' 0 C--N 1.395 2.98 1 CA-C-N 126.43 5.115 . . . . 0.0 114.455 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.14 110.44 0.69 Allowed Glycine 0 N--CA 1.483 1.797 0 CA-C-O 117.46 -1.745 . . . . 0.0 110.495 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.3 m -97.98 94.99 2.43 Favored Pre-proline 0 CA--C 1.588 2.427 0 CA-C-O 116.224 -1.846 . . . . 0.0 112.972 -169.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.29 175.65 9.49 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 123.327 2.684 . . . . 0.0 113.581 169.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -76.95 160.06 29.47 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.658 1.183 . . . . 0.0 112.128 168.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.418 HG21 ' H ' ' A' ' 26' ' ' ILE . 14.5 m -135.49 151.5 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 123.264 0.625 . . . . 0.0 111.806 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.14 166.65 38.89 Favored Pre-proline 0 CA--C 1.586 2.361 0 CA-C-O 115.094 -2.384 . . . . 0.0 113.678 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 C--N 1.399 3.187 0 CA-C-N 126.82 3.471 . . . . 0.0 111.647 178.794 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.4 t . . . . . 0 N--CA 1.502 2.132 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.1 p -130.2 105.99 8.29 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.418 ' H ' HG21 ' A' ' 20' ' ' VAL 0.263 1.9 tt -67.69 162.6 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 CA-C-N 111.95 -2.386 . . . . 0.0 114.357 -177.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -143.21 102.31 3.96 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 168.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.3 t -89.55 93.82 9.63 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 112.204 -2.271 . . . . 0.0 105.412 169.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.108 -165.544 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 CA--C 1.544 0.75 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -143.77 124.88 14.47 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -88.06 135.8 33.26 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 124.127 0.892 . . . . 0.0 110.498 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -117.99 98.87 6.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 101.076 -3.675 . . . . 0.0 101.076 170.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.53 124.05 51.48 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 m -107.91 133.32 52.43 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -169.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 CA--C 1.586 2.328 0 N-CA-C 100.925 -3.731 . . . . 0.0 100.925 -167.659 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -117.69 125.67 51.1 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -169.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -96.71 113.07 24.6 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -102.84 117.5 34.76 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -134.93 120.95 19.85 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -168.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.41 -171.88 36.25 Favored Glycine 1 CA--C 1.581 4.159 0 CA-C-O 114.721 -3.266 . . . . 0.0 116.279 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -88.73 158.45 6.24 Favored 'Trans proline' 0 C--N 1.396 3.027 1 CA-C-N 126.364 5.082 . . . . 0.0 114.295 -177.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.76 106.58 0.63 Allowed Glycine 0 N--CA 1.484 1.873 0 CA-C-O 117.196 -1.891 . . . . 0.0 110.579 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.8 m -93.48 98.49 2.58 Favored Pre-proline 0 CA--C 1.588 2.438 0 CA-C-O 116.168 -1.872 . . . . 0.0 113.008 -169.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.01 173.44 12.71 Favored 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 123.401 2.734 . . . . 0.0 113.673 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.94 159.24 31.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.483 1.113 . . . . 0.0 112.371 168.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.455 HG21 ' H ' ' A' ' 26' ' ' ILE 0.257 11.0 m -133.98 152.84 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 CA-C-O 121.422 0.63 . . . . 0.0 112.695 -169.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.24 165.47 27.96 Favored Pre-proline 0 CA--C 1.581 2.15 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--N 1.396 3.034 0 C-N-CA 123.148 2.565 . . . . 0.0 110.033 169.658 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.6 t . . . . . 0 N--CA 1.504 2.264 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.8 p -132.26 106.19 7.78 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.455 ' H ' HG21 ' A' ' 20' ' ' VAL . 2.5 tt -69.33 160.78 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.835 0 CA-C-N 111.904 -2.407 . . . . 0.0 114.023 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -139.31 102.94 4.61 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 167.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 t -98.66 113.67 25.83 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 110.87 -2.877 . . . . 0.0 105.816 170.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.297 10.2 pt-20 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -167.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.8 127.41 21.7 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.345 1.058 . . . . 0.0 108.835 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -87.42 128.41 35.21 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 124.037 0.836 . . . . 0.0 110.096 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.25 8.2 tt0 -112.34 98.38 7.25 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 100.734 -3.802 . . . . 0.0 100.734 168.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.56 120.15 41.48 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -106.98 134.74 49.67 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 125.409 1.693 . . . . 0.0 106.523 -168.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 CA--C 1.585 2.294 0 N-CA-C 101.442 -3.54 . . . . 0.0 101.442 -167.751 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -114.75 125.09 53.3 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -168.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.23 113.4 25.0 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -103.81 115.03 29.72 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -131.17 120.23 23.01 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -168.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.5 -158.52 12.61 Favored Glycine 1 CA--C 1.579 4.049 0 CA-C-O 114.361 -3.466 . . . . 0.0 115.836 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -89.04 161.37 5.87 Favored 'Trans proline' 0 C--N 1.394 2.955 1 CA-C-N 126.719 5.259 . . . . 0.0 114.294 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.15 117.19 1.33 Allowed Glycine 0 N--CA 1.479 1.563 0 CA-C-O 117.965 -1.464 . . . . 0.0 110.277 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.4 m -100.96 85.82 0.62 Allowed Pre-proline 0 CA--C 1.588 2.412 0 CA-C-O 116.697 -1.62 . . . . 0.0 111.589 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -82.86 176.13 7.97 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.378 2.719 . . . . 0.0 113.73 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -74.63 158.01 34.39 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.72 1.208 . . . . 0.0 111.941 168.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.258 15.4 m -135.62 156.08 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 C-N-CA 122.93 0.492 . . . . 0.0 112.212 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -76.95 -179.29 1.17 Allowed Pre-proline 0 CA--C 1.593 2.598 0 CA-C-O 115.543 -2.17 . . . . 0.0 115.79 -170.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 C--N 1.404 3.469 0 C-N-CA 123.902 3.068 . . . . 0.0 110.251 170.692 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.502 2.126 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.9 p -141.41 108.81 5.55 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.274 1.2 tt -69.98 164.37 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 127.046 2.138 . . . . 0.0 113.256 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -140.83 114.89 9.15 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 101.734 -3.432 . . . . 0.0 101.734 167.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.5 t -97.44 111.84 23.93 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 111.579 -2.555 . . . . 0.0 106.292 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 N--CA 1.494 1.756 0 O-C-N 124.184 0.927 . . . . 0.0 109.172 -168.709 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -148.04 124.34 10.89 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -87.06 124.61 33.41 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.933 0.893 . . . . 0.0 109.773 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.258 8.9 tt0 -109.28 97.04 6.71 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 101.382 -3.562 . . . . 0.0 101.382 168.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.9 120.79 43.28 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -107.94 131.31 54.67 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 -169.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 CA--C 1.586 2.331 0 N-CA-C 100.463 -3.903 . . . . 0.0 100.463 -167.558 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -113.15 124.75 53.28 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -168.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.0 m -96.78 113.8 25.38 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -176.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -104.09 115.2 30.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -131.19 120.98 24.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -168.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.51 -156.93 11.28 Favored Glycine 1 CA--C 1.58 4.143 0 CA-C-O 114.229 -3.54 . . . . 0.0 115.911 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.22 161.09 4.7 Favored 'Trans proline' 0 C--N 1.395 2.992 1 CA-C-N 126.799 5.299 . . . . 0.0 114.534 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.72 119.35 1.62 Allowed Glycine 0 N--CA 1.479 1.507 0 CA-C-O 118.034 -1.426 . . . . 0.0 110.33 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.2 t -98.1 87.49 0.55 Allowed Pre-proline 0 CA--C 1.591 2.524 0 CA-C-O 116.503 -1.713 . . . . 0.0 112.325 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.71 175.62 9.24 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 123.414 2.742 . . . . 0.0 113.426 169.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 p -77.62 158.24 29.87 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.638 1.175 . . . . 0.0 111.828 168.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.259 15.7 m -136.9 156.09 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 122.999 0.52 . . . . 0.0 112.23 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -76.89 -179.31 1.17 Allowed Pre-proline 0 CA--C 1.593 2.608 0 CA-C-O 115.631 -2.128 . . . . 0.0 115.742 -171.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo . . . . . 0 C--N 1.405 3.504 0 C-N-CA 123.97 3.114 . . . . 0.0 110.365 171.191 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 N--CA 1.503 2.187 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -140.87 108.89 5.72 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.265 1.3 tt -69.84 160.89 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.836 0 C-N-CA 127.036 2.134 . . . . 0.0 113.353 -177.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -139.22 109.25 6.38 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 168.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.8 m -98.11 106.91 19.27 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 110.229 -3.168 . . . . 0.0 104.679 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.736 0 C-N-CA 124.307 1.043 . . . . 0.0 111.033 -167.246 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -147.86 125.46 11.77 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -83.55 122.79 29.03 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 117.82 -1.086 . . . . 0.0 109.988 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.265 8.4 tt0 -109.25 95.94 5.96 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 102.123 -3.288 . . . . 0.0 102.123 170.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.73 120.77 43.51 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.47 130.82 54.8 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 125.423 1.702 . . . . 0.0 106.648 -169.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 CA--C 1.582 2.185 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -167.846 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.7 p . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -98.41 139.38 34.24 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 120.259 1.391 . . . . 0.0 111.155 -169.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.5 m -107.14 102.96 12.25 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 100.922 -3.733 . . . . 0.0 100.922 166.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -93.49 113.71 25.91 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -129.44 120.99 26.41 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -168.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.71 -160.81 18.88 Favored Glycine 1 CA--C 1.579 4.036 0 CA-C-O 114.522 -3.377 . . . . 0.0 116.022 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -86.74 163.37 9.17 Favored 'Trans proline' 0 C--N 1.393 2.911 1 CA-C-N 126.584 5.192 . . . . 0.0 114.023 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.18 119.87 1.79 Allowed Glycine 0 C--N 1.354 1.57 0 CA-C-O 118.01 -1.439 . . . . 0.0 110.019 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.6 t -97.86 87.87 0.57 Allowed Pre-proline 0 CA--C 1.591 2.526 0 CA-C-O 116.452 -1.737 . . . . 0.0 112.206 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -81.8 173.83 10.85 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.373 2.716 . . . . 0.0 113.504 169.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 p -79.44 158.78 27.25 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.578 1.151 . . . . 0.0 111.626 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.251 15.2 m -136.46 151.58 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.15 0.58 . . . . 0.0 111.492 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.67 166.71 40.66 Favored Pre-proline 0 CA--C 1.588 2.406 0 CA-C-O 114.949 -2.453 . . . . 0.0 114.043 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 C--N 1.4 3.275 0 CA-C-N 126.998 3.535 . . . . 0.0 111.627 -177.585 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -137.19 106.86 6.18 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.273 1.3 tt -69.24 165.55 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.955 0 CA-C-N 112.265 -2.243 . . . . 0.0 113.696 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -144.08 108.86 4.92 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 168.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 76.1 m -94.13 97.67 10.45 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 . . . . . 0 N--CA 1.491 1.615 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.808 -165.318 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -138.63 131.56 29.56 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.354 1.062 . . . . 0.0 109.058 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -85.74 136.24 33.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.644 0.778 . . . . 0.0 110.418 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.267 4.7 tt0 -120.97 98.9 6.21 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 169.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.6 122.79 47.59 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.25 135.67 48.37 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 125.671 1.857 . . . . 0.0 106.924 -169.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 CA--C 1.584 2.28 0 N-CA-C 101.271 -3.603 . . . . 0.0 101.271 -167.893 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -122.26 126.59 48.5 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -168.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.435 HG21 ' HE ' ' A' ' 13' ' ' ARG . 6.4 m -96.79 116.39 29.06 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -105.06 113.57 27.25 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.435 ' HE ' HG21 ' A' ' 11' ' ' THR . 72.0 mtt180 -128.58 122.49 31.14 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -169.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.05 -163.9 16.81 Favored Glycine 1 CA--C 1.58 4.151 0 CA-C-O 114.461 -3.41 . . . . 0.0 115.833 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -87.83 160.47 7.57 Favored 'Trans proline' 0 C--N 1.395 2.988 1 CA-C-N 126.709 5.254 . . . . 0.0 114.108 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.91 118.31 1.36 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-O 118.018 -1.435 . . . . 0.0 110.194 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -101.88 83.09 0.44 Allowed Pre-proline 0 CA--C 1.589 2.461 0 CA-C-O 117.239 -1.362 . . . . 0.0 113.263 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -84.92 172.83 8.53 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.105 2.537 . . . . 0.0 113.312 168.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.28 9.3 t -94.14 148.68 21.94 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 166.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.72 156.78 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 C-N-CA 123.343 0.657 . . . . 0.0 111.75 -165.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -8.24 145.09 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.272 0 N-CA-C 120.74 3.607 . . . . 0.0 120.74 169.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--N 1.396 3.051 0 CA-C-N 126.6 3.393 . . . . 0.0 109.557 168.599 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -125.39 106.31 9.72 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.269 1.3 tt -67.11 162.24 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 CA-C-N 112.087 -2.324 . . . . 0.0 113.322 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -140.59 124.09 16.93 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 102.264 -3.236 . . . . 0.0 102.264 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.4 t -97.43 116.08 28.96 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.776 -2.466 . . . . 0.0 107.477 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -169.485 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -147.61 125.55 12.01 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -85.63 126.93 34.3 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.89 0.876 . . . . 0.0 110.069 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.274 5.5 tt0 -111.4 97.13 6.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 101.484 -3.524 . . . . 0.0 101.484 169.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.06 121.5 45.4 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -107.68 131.68 54.14 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -169.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 CA--C 1.587 2.38 0 N-CA-C 100.302 -3.962 . . . . 0.0 100.302 -167.741 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -114.75 125.11 53.33 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -168.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -96.72 117.2 30.52 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -105.79 113.46 27.02 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -127.8 120.29 27.53 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -169.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.21 -160.1 13.91 Favored Glycine 1 CA--C 1.58 4.125 0 CA-C-O 114.349 -3.473 . . . . 0.0 116.321 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -88.68 161.32 6.37 Favored 'Trans proline' 0 C--N 1.395 2.987 1 CA-C-N 126.632 5.216 . . . . 0.0 114.276 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.62 119.8 1.65 Allowed Glycine 0 N--CA 1.48 1.603 0 CA-C-O 118.008 -1.44 . . . . 0.0 110.133 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.3 t -98.53 86.27 0.47 Allowed Pre-proline 0 CA--C 1.591 2.554 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.001 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -81.08 178.06 7.24 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.174 2.583 . . . . 0.0 112.117 166.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.299 11.2 t -103.94 158.16 16.6 Favored 'General case' 0 N--CA 1.504 2.275 0 C-N-CA 123.868 0.867 . . . . 0.0 109.818 168.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.2 m -125.91 160.05 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.56 0 C-N-CA 124.506 1.122 . . . . 0.0 111.982 -166.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 164.73 56.18 Favored Pre-proline 0 CA--C 1.585 2.304 0 CA-C-O 115.278 -2.296 . . . . 0.0 114.675 177.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--N 1.4 3.257 0 CA-C-N 126.218 3.256 . . . . 0.0 113.002 178.231 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 N--CA 1.501 2.099 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.4 p -142.8 108.96 5.23 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.264 1.4 tt -71.07 158.43 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 C-N-CA 127.033 2.133 . . . . 0.0 112.848 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -141.84 115.06 8.82 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 102.716 -3.068 . . . . 0.0 102.716 169.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 73.7 m -97.0 112.38 24.17 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 110.552 -3.022 . . . . 0.0 105.841 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.752 0 C-N-CA 124.18 0.992 . . . . 0.0 110.472 -167.853 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -139.5 128.11 23.11 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.348 1.059 . . . . 0.0 108.946 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -88.27 135.57 33.39 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 123.994 0.808 . . . . 0.0 110.471 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.266 4.2 tt0 -118.25 97.46 5.79 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 101.259 -3.608 . . . . 0.0 101.259 169.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.26 122.41 47.66 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.33 136.12 47.69 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 125.513 1.758 . . . . 0.0 106.818 -169.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.585 2.314 0 N-CA-C 101.407 -3.553 . . . . 0.0 101.407 -167.726 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -118.19 125.84 51.0 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -168.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.46 HG22 ' HE ' ' A' ' 13' ' ' ARG . 6.8 m -97.14 116.78 29.97 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -105.38 112.95 26.24 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.46 ' HE ' HG22 ' A' ' 11' ' ' THR . 74.3 mtt180 -127.63 121.36 30.27 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -169.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.15 -156.79 11.48 Favored Glycine 1 CA--C 1.579 4.077 0 CA-C-O 114.309 -3.495 . . . . 0.0 115.989 177.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -91.02 160.73 3.91 Favored 'Trans proline' 0 C--N 1.395 3.016 1 CA-C-N 126.568 5.184 . . . . 0.0 114.628 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.66 115.49 0.97 Allowed Glycine 0 N--CA 1.481 1.634 0 CA-C-O 117.799 -1.556 . . . . 0.0 110.457 174.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.6 m -100.66 87.16 0.76 Allowed Pre-proline 0 CA--C 1.589 2.467 0 CA-C-O 116.676 -1.63 . . . . 0.0 111.663 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.61 173.94 10.08 Favored 'Trans proline' 0 C--N 1.391 2.781 0 C-N-CA 123.399 2.733 . . . . 0.0 113.887 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.71 156.17 38.19 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.536 1.134 . . . . 0.0 112.426 168.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.438 HG21 ' H ' ' A' ' 26' ' ' ILE 0.268 14.1 m -135.6 155.67 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.664 0.745 . . . . 0.0 112.813 -169.193 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -69.39 165.52 39.14 Favored Pre-proline 0 CA--C 1.58 2.112 0 CA-C-O 115.64 -2.124 . . . . 0.0 116.731 -171.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo . . . . . 0 C--N 1.396 3.039 0 C-N-CA 123.772 2.981 . . . . 0.0 109.858 168.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.502 2.172 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -139.11 108.88 6.26 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 123.794 1.759 . . . . 0.0 108.187 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.438 ' H ' HG21 ' A' ' 20' ' ' VAL 0.262 2.1 tt -70.11 162.91 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.826 0 CA-C-N 109.098 -3.683 . . . . 0.0 113.739 -174.285 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -140.83 111.0 6.63 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 167.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.2 t -96.1 112.41 24.15 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 111.615 -2.539 . . . . 0.0 106.338 172.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 124.207 0.942 . . . . 0.0 110.177 -168.361 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -142.76 125.45 15.92 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.296 1.038 . . . . 0.0 108.57 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -82.83 120.62 25.87 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 117.814 -1.089 . . . . 0.0 109.622 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.278 9.7 tt0 -106.53 95.92 6.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 102.249 -3.241 . . . . 0.0 102.249 169.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.49 118.77 37.59 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.73 131.76 54.09 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -169.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 CA--C 1.585 2.324 0 N-CA-C 100.919 -3.734 . . . . 0.0 100.919 -167.596 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -111.02 124.96 53.19 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -168.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -97.06 113.36 24.91 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -104.25 114.36 28.54 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -130.09 120.07 24.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -168.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.0 -163.96 21.79 Favored Glycine 1 CA--C 1.579 4.083 0 CA-C-O 114.542 -3.365 . . . . 0.0 115.848 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -87.32 162.06 8.34 Favored 'Trans proline' 0 C--N 1.394 2.93 1 CA-C-N 126.668 5.234 . . . . 0.0 113.996 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.91 116.03 1.41 Allowed Glycine 0 N--CA 1.479 1.541 0 CA-C-O 118.07 -1.406 . . . . 0.0 110.228 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.0 m -103.63 84.16 0.74 Allowed Pre-proline 0 CA--C 1.587 2.395 0 CA-C-O 116.952 -1.499 . . . . 0.0 111.613 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -85.11 173.63 7.78 Favored 'Trans proline' 0 C--N 1.39 2.728 0 C-N-CA 123.247 2.632 . . . . 0.0 114.064 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 p -78.13 146.69 34.97 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.468 1.107 . . . . 0.0 110.216 167.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.259 30.9 m -139.47 152.65 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 O-C-N 123.6 0.562 . . . . 0.0 112.083 -172.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -17.3 146.61 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.263 0 CA-C-O 112.746 -3.502 . . . . 0.0 119.774 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 C--N 1.394 2.961 0 CA-C-N 126.667 3.417 . . . . 0.0 109.664 168.498 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.502 2.159 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.5 p -118.97 104.42 10.48 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.297 1.3 tt -66.79 165.7 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.857 0 CA-C-N 111.639 -2.528 . . . . 0.0 113.644 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -142.94 112.69 6.94 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 103.373 -2.825 . . . . 0.0 103.373 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.7 t -94.94 98.32 10.62 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 168.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 . . . . . 0 N--CA 1.493 1.705 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.241 -166.11 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -142.47 124.09 14.98 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.287 1.035 . . . . 0.0 108.286 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -83.49 121.66 27.49 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.822 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.293 9.9 tt0 -108.71 95.88 5.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 101.994 -3.335 . . . . 0.0 101.994 169.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.97 108.14 17.37 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -175.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -95.79 127.15 41.57 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 113.218 -1.81 . . . . 0.0 107.195 -167.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mm . . . . . 0 CA--C 1.58 2.108 0 N-CA-C 102.818 -3.03 . . . . 0.0 102.818 -167.491 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.24 139.92 30.0 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.494 1.117 . . . . 0.0 110.458 -170.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.469 HG21 ' HE ' ' A' ' 13' ' ' ARG . 5.0 m -111.18 110.56 21.12 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 102.788 -3.041 . . . . 0.0 102.788 169.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -99.04 115.55 29.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HE ' HG21 ' A' ' 11' ' ' THR . 65.5 mtt180 -128.13 122.16 31.31 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -173.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.68 -160.14 17.18 Favored Glycine 1 CA--C 1.578 4.012 0 CA-C-O 114.496 -3.391 . . . . 0.0 115.659 176.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -86.97 162.68 8.86 Favored 'Trans proline' 0 C--N 1.392 2.837 1 CA-C-N 126.602 5.201 . . . . 0.0 113.952 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.43 115.38 1.49 Allowed Glycine 0 N--CA 1.48 1.608 0 CA-C-O 117.943 -1.476 . . . . 0.0 110.238 174.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.9 m -102.11 85.79 0.77 Allowed Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 116.721 -1.609 . . . . 0.0 111.247 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.34 172.98 11.11 Favored 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 123.333 2.688 . . . . 0.0 113.804 171.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -76.58 155.1 33.86 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.582 1.153 . . . . 0.0 111.885 168.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.272 18.0 m -137.93 154.75 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 C-N-CA 122.968 0.507 . . . . 0.0 112.004 -174.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 168.49 27.55 Favored Pre-proline 0 CA--C 1.588 2.423 0 CA-C-O 114.945 -2.455 . . . . 0.0 114.246 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo . . . . . 0 C--N 1.399 3.22 0 CA-C-N 126.878 3.492 . . . . 0.0 111.726 176.139 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.504 2.246 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.0 p -136.59 108.88 7.29 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.28 0.8 OUTLIER -68.92 166.1 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.878 0 C-N-CA 126.782 2.033 . . . . 0.0 113.89 -173.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -140.2 110.71 6.72 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 102.717 -3.068 . . . . 0.0 102.717 168.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.6 t -96.09 98.82 10.65 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 N--CA 1.492 1.67 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.332 -165.998 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -146.25 128.3 15.57 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -87.39 126.07 34.65 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.733 0.813 . . . . 0.0 109.993 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.253 8.6 tt0 -110.44 97.84 7.19 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 101.026 -3.694 . . . . 0.0 101.026 168.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.8 120.14 41.4 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.543 -2.392 . . . . 0.0 104.543 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -107.03 134.87 49.53 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 125.46 1.725 . . . . 0.0 106.552 -169.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 CA--C 1.584 2.27 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 -167.738 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -111.0 125.23 53.51 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -168.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.24 113.42 25.03 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -103.74 114.82 29.36 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -130.85 120.44 23.68 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -168.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.08 -158.12 12.56 Favored Glycine 1 CA--C 1.579 4.067 0 CA-C-O 114.399 -3.445 . . . . 0.0 115.945 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -88.54 161.45 6.58 Favored 'Trans proline' 0 C--N 1.394 2.956 1 CA-C-N 126.61 5.205 . . . . 0.0 114.235 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.24 118.1 1.41 Allowed Glycine 0 N--CA 1.48 1.594 0 CA-C-O 117.96 -1.467 . . . . 0.0 110.162 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.4 m -100.81 85.73 0.6 Allowed Pre-proline 0 CA--C 1.587 2.396 0 CA-C-O 116.705 -1.617 . . . . 0.0 111.5 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.58 176.49 7.81 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 123.401 2.734 . . . . 0.0 113.66 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -75.38 158.74 32.3 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.717 1.207 . . . . 0.0 112.033 168.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.252 13.3 m -135.4 152.0 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 C-N-CA 123.15 0.58 . . . . 0.0 111.72 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 167.04 38.45 Favored Pre-proline 0 CA--C 1.586 2.357 0 CA-C-O 114.98 -2.438 . . . . 0.0 114.107 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 C--N 1.4 3.261 0 CA-C-N 126.968 3.524 . . . . 0.0 111.525 -177.816 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.2 p -138.98 108.46 6.16 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.275 1.2 tt -69.03 163.78 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.913 0 C-N-CA 126.885 2.074 . . . . 0.0 113.257 -177.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -141.25 115.19 9.15 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 101.753 -3.425 . . . . 0.0 101.753 168.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.6 t -94.98 116.67 28.98 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 111.6 -2.545 . . . . 0.0 107.174 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.727 0 C-N-CA 124.03 0.932 . . . . 0.0 109.815 -168.457 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -140.62 124.24 17.03 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.268 1.027 . . . . 0.0 108.534 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -85.14 124.15 31.47 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.049 0.939 . . . . 0.0 109.408 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.279 8.5 tt0 -109.44 95.95 5.96 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 101.825 -3.398 . . . . 0.0 101.825 169.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.83 120.45 42.54 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 m -107.3 131.56 54.08 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 125.128 1.517 . . . . 0.0 106.98 -168.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 CA--C 1.582 2.211 0 N-CA-C 100.87 -3.752 . . . . 0.0 100.87 -167.735 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 t . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -100.59 139.71 35.89 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 120.711 1.596 . . . . 0.0 110.99 -169.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 m -106.76 105.02 14.86 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 166.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -95.38 112.46 24.17 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -125.9 119.96 29.17 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -169.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.28 -164.62 21.06 Favored Glycine 1 CA--C 1.58 4.119 0 CA-C-O 114.495 -3.392 . . . . 0.0 116.055 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -87.14 161.44 8.59 Favored 'Trans proline' 0 C--N 1.394 2.958 1 CA-C-N 126.687 5.244 . . . . 0.0 113.998 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.48 118.34 1.48 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-O 118.078 -1.401 . . . . 0.0 110.242 174.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.7 t -99.32 86.09 0.51 Allowed Pre-proline 0 CA--C 1.588 2.416 0 CA-C-O 116.757 -1.592 . . . . 0.0 111.988 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -83.53 172.46 10.28 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 123.11 2.54 . . . . 0.0 113.458 169.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -80.3 146.29 31.69 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.244 1.017 . . . . 0.0 110.12 167.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.264 30.9 m -138.36 153.42 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 O-C-N 123.724 0.64 . . . . 0.0 112.031 -170.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -23.07 147.56 0.01 OUTLIER Pre-proline 0 CA--C 1.584 2.277 0 CA-C-O 112.937 -3.411 . . . . 0.0 119.378 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 C--N 1.394 2.945 0 CA-C-N 126.606 3.395 . . . . 0.0 109.647 168.676 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.1 t . . . . . 0 N--CA 1.501 2.116 0 N-CA-C 104.177 -2.527 . . . . 0.0 104.177 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.5 p -118.75 104.47 10.62 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 1.3 tt -68.7 159.87 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.791 0 CA-C-N 111.64 -2.527 . . . . 0.0 113.244 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.7 ttm105 -139.32 108.6 6.1 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 168.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.9 m -94.81 97.16 9.83 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 110.072 -3.24 . . . . 0.0 106.02 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 N--CA 1.495 1.776 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.768 -168.059 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -139.52 128.04 22.98 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.321 1.048 . . . . 0.0 108.898 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -85.89 141.46 29.56 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.49 0.716 . . . . 0.0 111.129 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.268 4.8 tt0 -123.01 96.23 4.93 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 101.017 -3.697 . . . . 0.0 101.017 167.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.76 121.97 44.07 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -108.15 135.8 48.88 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 125.873 1.983 . . . . 0.0 106.819 -168.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 CA--C 1.587 2.373 0 N-CA-C 100.986 -3.709 . . . . 0.0 100.986 -167.907 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.0 m . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -117.8 127.81 54.25 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -168.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.459 HG21 ' HE ' ' A' ' 13' ' ' ARG . 5.5 m -97.16 115.95 28.47 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -104.25 114.9 29.46 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.459 ' HE ' HG21 ' A' ' 11' ' ' THR . 78.9 mtt180 -128.47 119.61 25.25 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -170.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.8 171.04 39.33 Favored Glycine 1 CA--C 1.582 4.228 0 CA-C-O 115.059 -3.078 . . . . 0.0 116.948 -175.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.52 160.66 22.35 Favored 'Trans proline' 0 C--N 1.395 3.021 1 CA-C-N 125.624 4.712 . . . . 0.0 114.232 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.61 95.22 0.4 Allowed Glycine 0 N--CA 1.487 2.05 0 CA-C-O 117.315 -1.825 . . . . 0.0 111.308 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.255 4.7 p -102.8 92.05 3.26 Favored Pre-proline 0 CA--C 1.585 2.296 0 CA-C-O 116.507 -1.711 . . . . 0.0 114.403 -167.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.5 179.98 4.16 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 123.42 2.747 . . . . 0.0 113.898 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 p -68.33 148.39 50.81 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 125.114 1.366 . . . . 0.0 111.313 167.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 24.3 m -141.38 151.42 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.077 0.465 . . . . 0.0 112.02 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -12.03 145.61 0.0 OUTLIER Pre-proline 0 CA--C 1.583 2.236 0 N-CA-C 120.396 3.48 . . . . 0.0 120.396 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 C--N 1.395 2.987 0 CA-C-N 126.541 3.372 . . . . 0.0 109.406 168.178 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.1 t . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.0 p -112.75 101.34 9.44 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -172.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 tt -70.23 157.83 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.63 0 CA-C-N 111.113 -2.767 . . . . 0.0 113.596 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -136.14 106.36 6.38 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 167.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -95.59 109.35 21.6 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 111.062 -2.79 . . . . 0.0 106.127 170.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 124.629 1.206 . . . . 0.0 110.125 -168.052 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -138.96 129.89 26.42 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.297 1.039 . . . . 0.0 109.012 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -88.02 139.64 30.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.497 0.719 . . . . 0.0 110.801 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -122.55 99.92 6.66 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 101.478 -3.527 . . . . 0.0 101.478 167.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.72 122.5 47.96 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 178.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.63 133.23 52.38 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -169.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 CA--C 1.585 2.311 0 N-CA-C 100.595 -3.854 . . . . 0.0 100.595 -167.732 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.9 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -113.85 125.4 54.03 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -168.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -98.47 108.74 21.5 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -102.04 112.46 25.12 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.75 124.95 30.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -168.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.02 -154.09 9.41 Favored Glycine 1 CA--C 1.58 4.133 0 CA-C-O 114.377 -3.457 . . . . 0.0 115.239 174.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -90.35 161.65 4.56 Favored 'Trans proline' 0 C--N 1.395 3.019 1 CA-C-N 126.474 5.137 . . . . 0.0 114.533 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.05 116.02 1.05 Allowed Glycine 0 N--CA 1.481 1.648 0 CA-C-O 117.897 -1.502 . . . . 0.0 110.317 174.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.4 m -101.36 86.1 0.71 Allowed Pre-proline 0 CA--C 1.588 2.426 0 CA-C-O 116.741 -1.6 . . . . 0.0 111.609 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.66 174.35 8.76 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 123.438 2.759 . . . . 0.0 113.9 172.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.98 155.83 39.44 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.598 1.159 . . . . 0.0 112.294 168.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 13.5 m -135.83 155.21 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -169.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -56.71 153.39 22.07 Favored Pre-proline 0 CA--C 1.583 2.22 0 CA-C-O 114.25 -2.786 . . . . 0.0 116.342 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo . . . . . 0 C--N 1.397 3.103 0 CA-C-N 126.093 3.212 . . . . 0.0 109.967 168.796 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.505 2.298 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 p -136.44 107.42 6.7 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.265 2.6 tt -67.95 162.2 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 CA-C-N 112.099 -2.319 . . . . 0.0 113.713 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -138.98 112.54 8.28 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 167.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.4 t -96.33 111.57 23.61 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 111.48 -2.6 . . . . 0.0 106.247 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 124.282 0.989 . . . . 0.0 109.458 -168.328 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -141.19 125.54 17.57 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.268 1.027 . . . . 0.0 108.789 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -80.36 141.35 35.47 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 124.174 0.922 . . . . 0.0 111.439 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -124.32 98.9 5.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 100.525 -3.88 . . . . 0.0 100.525 168.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.48 122.43 47.26 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -106.83 134.87 49.31 Favored 'General case' 0 CA--C 1.55 0.981 0 O-C-N 125.653 1.846 . . . . 0.0 106.842 -169.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 CA--C 1.586 2.332 0 N-CA-C 100.532 -3.877 . . . . 0.0 100.532 -168.029 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -114.91 126.12 54.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -168.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -96.71 111.7 23.75 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -103.0 119.1 38.25 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 -139.49 125.48 19.8 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.087 -167.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.81 -156.62 10.22 Favored Glycine 1 CA--C 1.581 4.165 0 CA-C-O 114.249 -3.528 . . . . 0.0 115.755 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -87.67 163.47 7.83 Favored 'Trans proline' 0 C--N 1.395 3.011 1 CA-C-N 126.721 5.261 . . . . 0.0 114.182 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.95 131.12 4.41 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.2 m -95.79 87.01 0.37 Allowed Pre-proline 0 CA--C 1.591 2.545 0 CA-C-O 116.767 -1.587 . . . . 0.0 110.337 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.14 169.62 17.37 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 123.428 2.752 . . . . 0.0 113.689 170.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.79 156.92 24.69 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.519 1.128 . . . . 0.0 111.202 168.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.454 HG23 ' H ' ' A' ' 26' ' ' ILE 0.251 15.6 m -136.78 151.42 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.113 0.565 . . . . 0.0 111.728 -175.239 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.47 164.54 44.81 Favored Pre-proline 0 CA--C 1.584 2.264 0 CA-C-O 115.339 -2.267 . . . . 0.0 114.186 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--N 1.4 3.241 0 CA-C-N 126.251 3.268 . . . . 0.0 112.654 177.856 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.5 2.031 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.9 p -134.21 106.77 7.32 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 103.668 -2.716 . . . . 0.0 103.668 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.454 ' H ' HG23 ' A' ' 20' ' ' VAL . 2.3 tt -69.87 162.15 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 127.368 2.267 . . . . 0.0 113.466 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.8 ttm-85 -144.07 111.6 6.02 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 102.506 -3.146 . . . . 0.0 102.506 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -100.33 108.76 20.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 111.732 -2.485 . . . . 0.0 105.477 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.493 1.722 0 O-C-N 124.479 1.112 . . . . 0.0 109.502 -168.454 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.34 128.05 40.6 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -84.73 126.33 33.31 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.116 0.966 . . . . 0.0 109.842 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.264 5.1 tt0 -121.22 92.05 3.66 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 171.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.27 130.99 55.15 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 171.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 m -108.2 128.03 54.35 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 112.479 -2.146 . . . . 0.0 106.625 -169.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 CA--C 1.582 2.201 0 N-CA-C 100.428 -3.915 . . . . 0.0 100.428 -168.56 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.8 m . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -99.02 138.57 35.93 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 120.55 1.523 . . . . 0.0 111.022 -169.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.7 m -106.12 104.0 13.61 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 100.994 -3.706 . . . . 0.0 100.994 166.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -92.17 98.3 11.44 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -113.32 121.27 43.88 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -170.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.73 -166.26 28.42 Favored Glycine 1 CA--C 1.58 4.104 0 CA-C-O 114.495 -3.392 . . . . 0.0 116.519 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -88.0 160.3 7.32 Favored 'Trans proline' 0 C--N 1.395 2.974 1 CA-C-N 126.737 5.269 . . . . 0.0 114.211 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.03 116.8 1.28 Allowed Glycine 0 N--CA 1.479 1.534 0 CA-C-O 118.194 -1.337 . . . . 0.0 110.602 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 t -97.03 90.67 0.82 Allowed Pre-proline 0 CA--C 1.587 2.392 0 CA-C-O 116.394 -1.765 . . . . 0.0 111.68 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.85 170.47 13.97 Favored 'Trans proline' 0 C--N 1.39 2.711 0 CA-C-N 124.287 2.567 . . . . 0.0 113.431 169.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -82.57 143.85 30.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.354 1.062 . . . . 0.0 109.806 168.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.302 19.0 m -140.53 161.56 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.052 0 CA-C-O 121.328 0.585 . . . . 0.0 111.896 -176.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.9 175.72 0.52 Allowed Pre-proline 0 CA--C 1.591 2.526 0 N-CA-C 118.786 2.884 . . . . 0.0 118.786 -168.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo . . . . . 0 C--N 1.404 3.471 0 CA-C-N 125.614 3.041 . . . . 0.0 110.635 173.254 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 N--CA 1.499 1.993 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.4 p -125.44 106.34 9.74 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 tt -66.48 160.32 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.835 0 CA-C-N 111.956 -2.384 . . . . 0.0 113.049 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -136.85 107.97 6.77 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.2 m -94.92 109.55 21.54 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 109.764 -3.38 . . . . 0.0 105.425 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.737 0 C-N-CA 124.217 1.007 . . . . 0.0 111.033 -167.332 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -136.53 140.98 43.37 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.316 1.046 . . . . 0.0 110.086 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -87.63 143.99 26.9 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.564 0.746 . . . . 0.0 111.643 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -126.23 96.8 4.84 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 100.269 -3.975 . . . . 0.0 100.269 166.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.94 122.46 46.33 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.1 m -108.16 135.78 48.92 Favored 'General case' 0 CA--C 1.552 1.035 0 O-C-N 125.79 1.931 . . . . 0.0 106.685 -169.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.586 2.329 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 -167.84 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -118.53 127.26 53.45 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -168.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 m -97.51 112.49 24.32 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -102.85 119.65 39.21 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.3 mtm-85 -138.25 123.01 18.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -168.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.92 177.15 42.31 Favored Glycine 1 CA--C 1.581 4.198 0 CA-C-O 115.054 -3.081 . . . . 0.0 116.555 -178.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.88 160.07 21.22 Favored 'Trans proline' 0 C--N 1.395 2.999 1 CA-C-N 126.019 4.91 . . . . 0.0 113.97 -175.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.94 96.66 0.4 Allowed Glycine 0 N--CA 1.487 2.074 0 CA-C-O 117.315 -1.825 . . . . 0.0 111.174 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.252 4.0 p -102.3 95.43 5.87 Favored Pre-proline 0 CA--C 1.584 2.275 0 CA-C-O 115.978 -1.963 . . . . 0.0 114.192 -167.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -85.54 179.51 3.9 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 123.442 2.761 . . . . 0.0 114.006 173.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 p -61.68 161.81 9.43 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 125.616 1.566 . . . . 0.0 113.857 169.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.252 14.2 m -135.29 154.27 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 C-N-CA 122.983 0.513 . . . . 0.0 112.229 178.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.259 50.7 pttt -75.14 -172.2 0.25 Allowed Pre-proline 0 CA--C 1.601 2.919 0 CA-C-O 114.688 -2.577 . . . . 0.0 116.46 -176.069 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 C--N 1.4 3.263 0 CA-C-N 126.539 3.371 . . . . 0.0 110.806 173.993 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.5 2.03 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -137.4 106.87 6.12 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 -177.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.53 162.91 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 CA-C-N 112.173 -2.285 . . . . 0.0 113.584 -178.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -137.93 108.63 6.62 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 101.87 -3.382 . . . . 0.0 101.87 166.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.1 t -98.07 109.34 22.11 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 111.558 -2.565 . . . . 0.0 105.673 171.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 124.601 1.188 . . . . 0.0 110.1 -167.824 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -139.57 137.46 35.4 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 124.4 1.08 . . . . 0.0 109.882 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -84.85 121.84 28.3 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 117.404 -1.284 . . . . 0.0 109.517 -179.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -109.17 98.56 7.98 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 170.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.93 120.26 41.8 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.4 m -107.38 130.71 54.77 Favored 'General case' 0 CA--C 1.554 1.108 0 O-C-N 125.314 1.634 . . . . 0.0 106.817 -168.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 CA--C 1.582 2.195 0 N-CA-C 100.522 -3.881 . . . . 0.0 100.522 -167.996 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -98.6 140.66 32.49 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 120.443 1.474 . . . . 0.0 111.102 -169.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.0 m -107.02 100.19 9.7 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 101.058 -3.682 . . . . 0.0 101.058 167.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -94.14 110.72 22.42 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -175.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.46 116.59 20.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -167.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.98 -172.21 28.0 Favored Glycine 1 CA--C 1.583 4.286 0 CA-C-O 114.613 -3.326 . . . . 0.0 115.059 177.487 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -86.48 162.81 9.57 Favored 'Trans proline' 0 C--N 1.394 2.933 1 CA-C-N 126.892 5.346 . . . . 0.0 114.332 -175.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.32 113.81 1.38 Allowed Glycine 0 N--CA 1.481 1.649 0 CA-C-O 117.643 -1.643 . . . . 0.0 110.089 176.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.3 m -102.56 85.62 0.8 Allowed Pre-proline 0 CA--C 1.588 2.439 0 CA-C-O 117.021 -1.466 . . . . 0.0 111.942 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.02 173.41 9.07 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 123.258 2.638 . . . . 0.0 113.791 169.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -77.44 147.71 35.81 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.443 1.097 . . . . 0.0 110.358 167.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 31.2 m -139.08 152.21 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.828 0 O-C-N 123.556 0.535 . . . . 0.0 112.052 -173.173 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -17.45 146.57 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.265 0 CA-C-O 112.784 -3.484 . . . . 0.0 119.713 170.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 C--N 1.395 2.991 0 CA-C-N 126.614 3.398 . . . . 0.0 109.616 168.505 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.0 t . . . . . 0 N--CA 1.502 2.156 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.2 p -118.56 104.14 10.38 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 -174.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.282 1.3 tt -67.3 167.55 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 111.455 -2.611 . . . . 0.0 113.66 179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -144.65 112.19 6.14 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 168.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.4 t -95.82 98.05 10.14 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 168.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 N--CA 1.492 1.668 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.349 -165.963 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -139.46 125.64 20.04 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.264 1.026 . . . . 0.0 108.862 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -112.61 145.09 41.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 124.185 0.928 . . . . 0.0 112.201 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.27 3.2 tt0 -126.04 95.04 4.27 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 102.176 -3.268 . . . . 0.0 102.176 168.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -111.12 124.7 52.72 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.3 m -109.59 134.43 51.94 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 125.495 1.747 . . . . 0.0 106.528 -168.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 CA--C 1.585 2.293 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 -167.852 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -120.64 127.51 52.15 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -168.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.445 HG21 ' HE ' ' A' ' 13' ' ' ARG . 6.3 m -96.96 117.46 31.2 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 178.276 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -106.5 113.02 26.29 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.445 ' HE ' HG21 ' A' ' 11' ' ' THR . 82.5 mtt180 -127.02 121.46 31.68 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -169.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.18 -160.31 13.28 Favored Glycine 1 CA--C 1.58 4.123 0 CA-C-O 114.466 -3.408 . . . . 0.0 116.297 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -90.71 156.86 4.21 Favored 'Trans proline' 0 C--N 1.397 3.096 1 CA-C-N 126.271 5.035 . . . . 0.0 114.487 -176.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.22 109.99 0.51 Allowed Glycine 0 N--CA 1.482 1.703 0 CA-C-O 117.954 -1.47 . . . . 0.0 111.261 174.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.323 1.3 p -108.38 82.37 1.6 Allowed Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 116.69 -1.624 . . . . 0.0 112.197 -171.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.84 -178.8 3.39 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 123.619 2.879 . . . . 0.0 113.684 172.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 p -61.79 158.31 16.09 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.446 1.498 . . . . 0.0 113.937 169.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.25 12.7 m -132.92 154.86 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.858 0 C-N-CA 123.358 0.663 . . . . 0.0 111.752 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 163.95 58.06 Favored Pre-proline 0 CA--C 1.583 2.248 0 CA-C-O 115.338 -2.267 . . . . 0.0 114.659 -179.447 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo . . . . . 0 C--N 1.4 3.245 0 CA-C-N 126.058 3.199 . . . . 0.0 112.661 179.845 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.2 p -139.14 108.51 6.13 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 102.907 -2.997 . . . . 0.0 102.907 -178.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 tt -70.06 163.2 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 C-N-CA 126.918 2.087 . . . . 0.0 113.685 -174.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -119.64 134.85 55.06 Favored 'General case' 0 CA--C 1.543 0.677 1 N-CA-C 97.397 -5.038 . . . . 0.0 97.397 163.205 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.0 t -106.17 65.0 0.68 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.689 1.233 . . . . 0.0 108.001 162.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.327 10.3 pt-20 . . . . . 0 N--CA 1.493 1.697 0 C-N-CA 126.08 1.752 . . . . 0.0 107.798 -170.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -146.29 128.28 15.52 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.15 128.24 35.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.542 0.737 . . . . 0.0 110.351 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.279 9.4 tt0 -112.92 96.83 6.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 101.216 -3.624 . . . . 0.0 101.216 168.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.4 109.93 19.84 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 -176.303 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 m -96.39 127.75 42.68 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.243 -167.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mm . . . . . 0 CA--C 1.58 2.112 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 -167.506 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.52 139.41 30.56 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.582 1.153 . . . . 0.0 110.356 -170.148 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.468 HG22 ' HE ' ' A' ' 13' ' ' ARG . 5.0 m -110.93 110.47 21.06 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 102.782 -3.044 . . . . 0.0 102.782 169.059 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -98.94 115.75 29.6 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.31 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.468 ' HE ' HG22 ' A' ' 11' ' ' THR . 65.2 mtt180 -128.22 122.61 32.19 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -173.028 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.53 -155.71 11.1 Favored Glycine 0 CA--C 1.578 3.982 0 CA-C-O 114.452 -3.416 . . . . 0.0 115.856 176.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -87.94 161.58 7.44 Favored 'Trans proline' 0 C--N 1.394 2.942 1 CA-C-N 126.393 5.096 . . . . 0.0 114.024 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.64 117.02 1.42 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-O 118.235 -1.314 . . . . 0.0 110.481 173.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.5 m -102.46 84.47 0.63 Allowed Pre-proline 0 CA--C 1.588 2.407 0 CA-C-O 116.766 -1.588 . . . . 0.0 111.129 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.91 174.07 9.73 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 123.399 2.732 . . . . 0.0 113.958 171.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.51 155.4 36.17 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.556 1.143 . . . . 0.0 112.05 168.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.268 13.4 m -137.08 156.63 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -169.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -63.64 165.59 11.67 Favored Pre-proline 0 CA--C 1.58 2.132 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--N 1.396 3.052 0 C-N-CA 123.149 2.566 . . . . 0.0 109.944 169.53 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t . . . . . 0 N--CA 1.506 2.353 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -137.76 108.78 6.74 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 -178.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.264 1.1 tt -69.49 164.36 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 C-N-CA 126.91 2.084 . . . . 0.0 113.718 -174.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -139.35 113.76 9.03 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 167.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.4 t -95.78 115.91 28.12 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 111.606 -2.543 . . . . 0.0 106.943 171.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.493 1.686 0 C-N-CA 124.162 0.985 . . . . 0.0 110.098 -168.221 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -140.78 124.2 16.78 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.301 1.04 . . . . 0.0 108.4 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -86.16 128.07 34.83 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 124.088 0.868 . . . . 0.0 110.33 -179.405 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.259 7.1 tt0 -112.0 97.86 6.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 100.855 -3.757 . . . . 0.0 100.855 168.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.48 108.18 16.85 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -177.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 m -96.36 126.17 41.37 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 113.369 -1.741 . . . . 0.0 106.817 -167.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 mm . . . . . 0 CA--C 1.579 2.088 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 -166.897 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.74 119.52 36.95 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -169.245 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 m -96.58 120.81 37.6 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 -171.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -112.38 118.37 35.01 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -138.37 116.88 12.07 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -168.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.63 -155.34 9.92 Favored Glycine 1 CA--C 1.579 4.054 0 CA-C-O 114.345 -3.475 . . . . 0.0 115.373 178.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -88.12 161.63 7.17 Favored 'Trans proline' 0 C--N 1.394 2.935 1 CA-C-N 126.728 5.264 . . . . 0.0 114.131 -178.394 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.28 115.72 1.47 Allowed Glycine 0 N--CA 1.479 1.519 0 CA-C-O 118.058 -1.412 . . . . 0.0 110.443 174.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.2 m -101.56 85.7 0.68 Allowed Pre-proline 0 CA--C 1.587 2.376 0 CA-C-O 116.716 -1.611 . . . . 0.0 111.295 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.48 173.51 10.54 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 123.31 2.673 . . . . 0.0 113.827 171.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -75.48 155.3 36.35 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.557 1.143 . . . . 0.0 111.963 168.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.27 19.4 m -136.96 153.3 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 123.503 0.502 . . . . 0.0 111.98 -173.175 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.98 48.41 Favored Pre-proline 0 CA--C 1.585 2.292 0 CA-C-O 115.241 -2.314 . . . . 0.0 114.688 -179.441 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo . . . . . 0 C--N 1.4 3.249 0 CA-C-N 126.34 3.3 . . . . 0.0 113.006 177.916 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t . . . . . 0 N--CA 1.503 2.191 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 p -137.36 109.18 7.08 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 0.9 OUTLIER -68.8 164.5 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 C-N-CA 126.84 2.056 . . . . 0.0 113.685 -174.959 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -141.03 113.11 7.84 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 167.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.1 t -97.81 114.15 26.12 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 111.524 -2.58 . . . . 0.0 106.411 170.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 124.055 0.847 . . . . 0.0 110.005 -168.695 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.93 139.75 38.1 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 124.265 1.026 . . . . 0.0 109.672 179.44 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -80.0 139.54 36.94 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 117.338 -1.315 . . . . 0.0 111.78 -177.067 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -121.22 97.58 5.58 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 102.503 -3.147 . . . . 0.0 102.503 168.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.58 119.63 39.8 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 -178.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -107.13 130.03 54.75 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 125.652 1.845 . . . . 0.0 106.174 -168.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 mp . . . . . 0 CA--C 1.586 2.335 0 N-CA-C 100.469 -3.901 . . . . 0.0 100.469 -167.871 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -113.52 125.55 54.33 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -168.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -97.92 108.35 21.04 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 -173.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -101.86 112.08 24.57 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -176.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.75 121.24 26.48 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -168.541 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.03 170.8 42.69 Favored Glycine 1 CA--C 1.581 4.218 0 CA-C-O 115.102 -3.054 . . . . 0.0 116.325 -177.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.46 162.76 22.07 Favored 'Trans proline' 0 C--N 1.394 2.938 1 CA-C-N 125.805 4.802 . . . . 0.0 114.153 -176.294 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.08 91.54 0.81 Allowed Glycine 0 N--CA 1.486 2.003 0 CA-C-O 117.379 -1.79 . . . . 0.0 110.38 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.9 m -85.7 102.49 2.63 Favored Pre-proline 0 CA--C 1.589 2.472 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -166.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -79.68 179.37 6.37 Favored 'Trans proline' 0 CA--C 1.58 2.796 0 C-N-CA 123.199 2.599 . . . . 0.0 112.158 166.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.303 9.9 t -105.24 155.97 18.57 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 123.841 0.856 . . . . 0.0 109.025 167.091 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.0 m -120.31 155.42 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 C-N-CA 124.22 1.008 . . . . 0.0 112.151 -165.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 179.79 1.58 Allowed Pre-proline 0 CA--C 1.6 2.869 0 CA-C-O 116.232 -1.842 . . . . 0.0 112.935 -179.342 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo . . . . . 0 C--N 1.394 2.951 0 C-N-CA 123.654 2.903 . . . . 0.0 111.088 177.391 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.501 2.108 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.9 p -141.4 106.09 4.9 Favored 'General case' 0 CA--C 1.558 1.272 0 N-CA-C 104.54 -2.392 . . . . 0.0 104.54 -176.042 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.253 1.6 tt -72.91 159.95 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.741 0 C-N-CA 127.14 2.176 . . . . 0.0 113.653 -178.203 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -145.42 103.53 3.83 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 105.896 -1.891 . . . . 0.0 105.896 168.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.9 t -91.89 98.02 11.33 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 111.951 -2.386 . . . . 0.0 104.729 169.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 . . . . . 0 N--CA 1.492 1.647 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.983 -165.51 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -136.25 141.04 43.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 124.312 1.045 . . . . 0.0 110.148 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -88.75 142.84 27.33 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.559 0.744 . . . . 0.0 111.404 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.251 4.0 tt0 -125.49 96.93 4.98 Favored 'General case' 0 N--CA 1.487 1.387 1 N-CA-C 100.15 -4.018 . . . . 0.0 100.15 166.704 . . . . . . . . 3 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.89 124.2 50.02 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 m -106.56 132.26 52.77 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 125.576 1.797 . . . . 0.0 107.357 -168.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.582 2.179 0 N-CA-C 100.998 -3.704 . . . . 0.0 100.998 -168.679 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -101.73 141.25 34.87 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.612 1.551 . . . . 0.0 111.231 -169.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -104.51 102.84 12.46 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 165.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -92.42 115.23 27.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -178.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -131.54 122.32 25.93 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -168.261 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.22 172.21 42.76 Favored Glycine 1 CA--C 1.58 4.12 0 CA-C-O 115.139 -3.034 . . . . 0.0 116.542 -177.402 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.12 159.69 23.62 Favored 'Trans proline' 0 C--N 1.395 3.009 1 CA-C-N 125.896 4.848 . . . . 0.0 113.962 -175.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.99 97.11 0.39 Allowed Glycine 0 N--CA 1.488 2.103 0 CA-C-O 117.346 -1.808 . . . . 0.0 111.151 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.253 4.0 p -101.44 95.93 5.62 Favored Pre-proline 0 CA--C 1.583 2.241 0 CA-C-O 115.932 -1.985 . . . . 0.0 114.02 -167.459 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -84.03 178.52 5.27 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 123.497 2.798 . . . . 0.0 113.88 173.447 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -63.72 161.23 15.47 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 125.454 1.502 . . . . 0.0 114.095 169.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.418 HG21 ' H ' ' A' ' 26' ' ' ILE . 12.3 m -134.1 152.78 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 C-N-CA 123.42 0.688 . . . . 0.0 111.682 -179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.28 164.54 49.53 Favored Pre-proline 0 CA--C 1.585 2.289 0 CA-C-O 115.305 -2.283 . . . . 0.0 114.219 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo . . . . . 0 C--N 1.398 3.179 0 CA-C-N 126.203 3.251 . . . . 0.0 112.503 177.626 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.6 t . . . . . 0 N--CA 1.502 2.146 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.6 p -135.92 106.22 6.4 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 -176.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.418 ' H ' HG21 ' A' ' 20' ' ' VAL . 1.2 tt -71.46 164.06 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.829 0 CA-C-N 111.983 -2.371 . . . . 0.0 113.54 -178.335 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -139.0 108.0 6.01 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 101.776 -3.416 . . . . 0.0 101.776 165.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.6 t -98.02 108.98 21.8 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 111.664 -2.517 . . . . 0.0 105.637 172.227 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 124.67 1.231 . . . . 0.0 110.164 -167.774 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -138.5 136.6 36.3 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.349 1.06 . . . . 0.0 109.664 179.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -87.65 142.02 28.16 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.45 0.7 . . . . 0.0 111.4 -178.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.254 4.2 tt0 -124.72 96.87 5.05 Favored 'General case' 0 N--CA 1.488 1.43 1 N-CA-C 100.185 -4.005 . . . . 0.0 100.185 166.639 . . . . . . . . 3 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.24 123.67 49.42 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -106.57 131.71 53.42 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 113.23 -1.805 . . . . 0.0 107.194 -168.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.581 2.172 0 N-CA-C 101.002 -3.703 . . . . 0.0 101.002 -168.507 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.7 m . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -101.41 141.09 34.8 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 120.622 1.555 . . . . 0.0 111.247 -169.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -104.6 102.65 12.25 Favored 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 100.928 -3.731 . . . . 0.0 100.928 165.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -92.68 115.0 27.71 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 -178.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -131.22 122.03 25.83 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -168.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.2 171.8 42.61 Favored Glycine 1 CA--C 1.58 4.132 0 CA-C-O 115.102 -3.054 . . . . 0.0 116.694 -177.149 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.96 159.64 24.11 Favored 'Trans proline' 0 C--N 1.394 2.965 1 CA-C-N 125.775 4.787 . . . . 0.0 113.958 -175.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.8 96.89 0.38 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-O 117.324 -1.82 . . . . 0.0 111.107 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.253 3.8 p -101.44 95.97 5.66 Favored Pre-proline 0 CA--C 1.582 2.209 0 CA-C-O 115.893 -2.003 . . . . 0.0 114.048 -167.504 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -83.93 178.0 5.69 Favored 'Trans proline' 0 C--N 1.394 2.95 0 C-N-CA 123.479 2.786 . . . . 0.0 113.912 173.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -63.9 161.11 16.21 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 125.35 1.46 . . . . 0.0 114.062 169.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.443 HG23 ' H ' ' A' ' 26' ' ' ILE . 13.1 m -134.84 152.55 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 123.353 0.661 . . . . 0.0 111.589 -179.636 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 164.73 49.69 Favored Pre-proline 0 CA--C 1.583 2.243 0 CA-C-O 115.341 -2.266 . . . . 0.0 114.225 179.644 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo . . . . . 0 C--N 1.399 3.226 0 CA-C-N 126.179 3.243 . . . . 0.0 112.373 177.331 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 N--CA 1.502 2.151 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -137.42 106.03 5.85 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 123.724 1.726 . . . . 0.0 108.528 -178.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.443 ' H ' HG23 ' A' ' 20' ' ' VAL . 1.3 tt -70.9 162.29 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 CA-C-N 109.109 -3.678 . . . . 0.0 113.663 -176.045 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -138.01 107.67 6.23 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 101.934 -3.358 . . . . 0.0 101.934 165.499 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -97.97 107.51 20.0 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 111.469 -2.605 . . . . 0.0 105.617 171.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 124.657 1.223 . . . . 0.0 109.947 -167.91 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -141.4 122.86 14.99 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -82.46 123.5 29.21 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 117.535 -1.222 . . . . 0.0 110.0 -175.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -108.66 95.96 6.01 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 170.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.56 119.24 38.86 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 179.346 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.0 m -107.52 130.15 54.89 Favored 'General case' 0 CA--C 1.554 1.132 0 O-C-N 125.323 1.639 . . . . 0.0 106.66 -168.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 CA--C 1.582 2.184 0 N-CA-C 100.572 -3.862 . . . . 0.0 100.572 -167.819 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -96.58 139.71 32.27 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 120.621 1.555 . . . . 0.0 111.03 -169.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 m -107.93 99.86 9.27 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 101.098 -3.667 . . . . 0.0 101.098 167.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -94.11 110.93 22.61 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -176.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.27 116.82 20.45 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -167.805 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.01 -164.63 20.8 Favored Glycine 1 CA--C 1.582 4.231 0 CA-C-O 114.687 -3.285 . . . . 0.0 115.464 177.528 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -88.01 162.65 7.35 Favored 'Trans proline' 0 C--N 1.394 2.945 1 CA-C-N 126.554 5.177 . . . . 0.0 114.204 -177.075 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.82 114.95 1.55 Allowed Glycine 0 N--CA 1.48 1.569 0 CA-C-O 117.861 -1.522 . . . . 0.0 110.097 174.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.2 t -101.23 85.92 0.67 Allowed Pre-proline 0 CA--C 1.588 2.411 0 CA-C-O 116.864 -1.541 . . . . 0.0 112.432 -175.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.12 171.72 11.28 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 123.134 2.556 . . . . 0.0 113.33 168.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.81 147.13 31.92 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.195 0.998 . . . . 0.0 110.467 167.816 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.266 29.8 m -138.09 154.42 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 O-C-N 123.743 0.652 . . . . 0.0 111.934 -169.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -28.0 148.52 0.03 OUTLIER Pre-proline 0 CA--C 1.585 2.298 0 CA-C-O 113.145 -3.312 . . . . 0.0 118.884 174.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 C--N 1.395 3.014 0 CA-C-N 126.546 3.374 . . . . 0.0 109.828 168.98 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 N--CA 1.502 2.136 0 N-CA-C 103.84 -2.652 . . . . 0.0 103.84 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.6 p -115.37 102.42 9.82 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -173.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.263 1.7 tt -68.28 163.05 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-N 111.159 -2.746 . . . . 0.0 114.026 -179.173 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -145.14 106.23 4.17 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 167.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 81.2 m -92.43 91.35 7.6 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 111.362 -2.654 . . . . 0.0 104.769 172.426 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 . . . . . 0 N--CA 1.493 1.677 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.79 -165.383 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.2 p . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -140.44 123.9 16.96 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 118.056 -0.974 . . . . 0.0 108.783 178.154 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -89.81 135.86 33.38 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 124.391 1.057 . . . . 0.0 110.23 174.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.287 3.4 tt0 -119.32 95.71 4.91 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 102.626 -3.101 . . . . 0.0 102.626 169.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.38 123.71 50.15 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -176.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -105.75 134.22 49.23 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 125.489 1.743 . . . . 0.0 107.679 -168.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 CA--C 1.583 2.22 0 N-CA-C 100.961 -3.718 . . . . 0.0 100.961 -168.514 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -103.41 141.54 35.79 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 120.173 1.351 . . . . 0.0 111.082 -169.533 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 m -105.05 105.74 15.92 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 100.995 -3.706 . . . . 0.0 100.995 166.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -93.5 110.44 22.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -122.45 116.6 24.24 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -169.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.89 164.97 36.76 Favored Glycine 1 CA--C 1.58 4.096 0 CA-C-O 114.975 -3.125 . . . . 0.0 116.693 -174.187 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.79 159.16 21.52 Favored 'Trans proline' 0 C--N 1.395 3.008 1 CA-C-N 125.739 4.77 . . . . 0.0 114.303 -174.173 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.72 95.17 0.41 Allowed Glycine 0 N--CA 1.487 2.071 0 CA-C-O 117.144 -1.92 . . . . 0.0 111.375 177.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.4 m -74.09 108.12 4.57 Favored Pre-proline 0 CA--C 1.586 2.358 0 CA-C-O 115.662 -2.113 . . . . 0.0 114.818 -167.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.73 169.44 18.22 Favored 'Trans proline' 0 C--N 1.39 2.727 0 CA-C-N 124.683 2.708 . . . . 0.0 113.663 169.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.88 149.88 26.07 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.127 0.971 . . . . 0.0 110.519 168.635 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.71 148.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 123.712 0.805 . . . . 0.0 111.491 -169.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 166.68 33.96 Favored Pre-proline 0 CA--C 1.586 2.345 0 CA-C-O 115.097 -2.383 . . . . 0.0 113.176 175.66 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--N 1.4 3.249 0 CA-C-N 127.032 3.547 . . . . 0.0 111.341 -177.967 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -136.53 107.28 6.6 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 123.767 1.746 . . . . 0.0 108.261 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 tt -70.88 160.12 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 CA-C-N 109.124 -3.671 . . . . 0.0 114.042 -172.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -135.45 94.73 3.15 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 166.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.0 t -93.17 117.55 30.2 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 111.16 -2.745 . . . . 0.0 106.596 170.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.29 14.3 pt-20 . . . . . 0 N--CA 1.497 1.911 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -166.8 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.97 130.24 33.35 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.159 0.983 . . . . 0.0 109.064 176.519 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -87.82 140.29 29.66 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.979 0.799 . . . . 0.0 110.333 174.32 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.54 100.94 6.89 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 101.916 -3.365 . . . . 0.0 101.916 169.018 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -113.97 123.75 50.49 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.411 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -107.08 131.33 54.23 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 125.38 1.675 . . . . 0.0 107.124 -168.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 CA--C 1.582 2.198 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 -168.187 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -100.15 139.87 35.21 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 120.657 1.571 . . . . 0.0 111.054 -169.63 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.1 m -105.57 102.29 11.76 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 100.906 -3.739 . . . . 0.0 100.906 166.212 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -92.42 117.84 30.33 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -178.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -136.22 123.28 21.56 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -167.776 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.36 -156.53 12.57 Favored Glycine 1 CA--C 1.579 4.091 0 CA-C-O 114.501 -3.388 . . . . 0.0 115.698 176.573 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -88.95 161.93 5.98 Favored 'Trans proline' 0 C--N 1.395 2.984 1 CA-C-N 126.268 5.034 . . . . 0.0 114.339 -178.965 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.42 113.71 0.76 Allowed Glycine 0 N--CA 1.481 1.637 0 CA-C-O 117.656 -1.636 . . . . 0.0 110.597 173.358 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.4 m -98.78 89.3 0.84 Allowed Pre-proline 0 CA--C 1.587 2.401 0 CA-C-O 116.554 -1.688 . . . . 0.0 111.906 -175.448 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.04 172.72 12.66 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.298 2.665 . . . . 0.0 113.632 169.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.05 156.54 37.38 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.581 1.152 . . . . 0.0 112.394 168.786 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 26' ' ' ILE 0.26 13.3 m -134.45 154.64 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.841 0 O-C-N 123.685 0.615 . . . . 0.0 112.225 -170.347 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -64.94 164.59 20.54 Favored Pre-proline 0 CA--C 1.581 2.135 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 -178.418 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--N 1.396 3.05 0 C-N-CA 123.199 2.6 . . . . 0.0 110.034 169.9 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.504 2.241 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.7 p -135.8 106.98 6.75 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 -176.333 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.43 ' H ' HG22 ' A' ' 20' ' ' VAL 0.253 1.9 tt -69.17 163.51 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.87 0 CA-C-N 111.932 -2.394 . . . . 0.0 113.465 -179.314 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -139.53 108.03 5.87 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 103.048 -2.945 . . . . 0.0 103.048 167.624 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 17.5 t -98.35 123.92 42.72 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 111.019 -2.809 . . . . 0.0 106.735 169.643 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.285 14.8 pt-20 . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -167.82 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -140.12 131.31 26.51 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.155 0.982 . . . . 0.0 109.697 179.395 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -84.08 135.65 34.32 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 124.543 1.152 . . . . 0.0 110.523 179.197 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.268 8.0 tt0 -119.81 99.14 6.46 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 100.999 -3.704 . . . . 0.0 100.999 170.285 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.69 123.62 49.27 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 177.077 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 m -107.84 131.09 54.86 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -169.442 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 CA--C 1.586 2.349 0 N-CA-C 100.42 -3.918 . . . . 0.0 100.42 -167.765 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -115.83 125.27 52.46 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -169.065 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.425 HG23 ' HE ' ' A' ' 13' ' ' ARG . 5.9 m -95.97 116.4 28.88 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 -177.654 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -105.57 113.89 27.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.735 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.425 ' HE ' HG23 ' A' ' 11' ' ' THR . 66.6 mtt180 -128.34 117.54 21.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -169.828 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.22 -166.24 20.64 Favored Glycine 1 CA--C 1.582 4.266 0 CA-C-O 114.199 -3.556 . . . . 0.0 115.986 179.445 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -89.47 163.04 5.43 Favored 'Trans proline' 0 C--N 1.395 3.019 1 CA-C-N 127.293 5.547 . . . . 0.0 114.601 -177.816 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.27 128.32 4.08 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 m -98.48 84.17 0.33 Allowed Pre-proline 0 CA--C 1.591 2.557 0 CA-C-O 117.296 -1.335 . . . . 0.0 112.244 177.917 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -80.71 174.92 10.56 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.124 2.55 . . . . 0.0 112.482 167.761 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.299 8.8 t -106.47 153.8 21.76 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 167.735 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 m -121.96 159.79 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 C-N-CA 124.389 1.076 . . . . 0.0 111.958 -165.732 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 163.42 65.28 Favored Pre-proline 0 CA--C 1.585 2.321 0 CA-C-O 115.28 -2.295 . . . . 0.0 114.782 176.406 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo . . . . . 0 C--N 1.399 3.203 0 CA-C-N 126.162 3.236 . . . . 0.0 113.503 -179.532 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.3 t . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -142.53 108.44 5.16 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 103.428 -2.805 . . . . 0.0 103.428 -178.212 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.256 3.3 tt -70.93 160.92 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 C-N-CA 127.233 2.213 . . . . 0.0 113.027 -179.275 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -145.97 115.07 7.01 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 102.565 -3.124 . . . . 0.0 102.565 169.12 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.48 110.21 22.7 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 111.977 -2.374 . . . . 0.0 106.23 169.646 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 124.472 1.108 . . . . 0.0 109.389 -168.666 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.43 130.61 17.45 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.757 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -84.47 137.15 33.52 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.874 178.16 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.25 8.2 tt0 -121.05 99.61 6.6 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 100.965 -3.717 . . . . 0.0 100.965 169.038 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.24 122.92 46.4 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.093 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.29 136.14 47.6 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 125.67 1.856 . . . . 0.0 106.926 -169.267 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 CA--C 1.585 2.299 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 -167.829 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -119.97 126.08 49.97 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -169.073 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 m -97.07 112.01 23.98 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -177.2 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -103.38 118.62 37.18 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -178.921 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -139.57 124.82 18.95 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -168.013 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.54 -156.15 9.76 Favored Glycine 1 CA--C 1.578 4.022 0 CA-C-O 114.478 -3.401 . . . . 0.0 115.734 177.241 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.58 161.07 9.4 Favored 'Trans proline' 0 C--N 1.394 2.969 1 CA-C-N 126.429 5.114 . . . . 0.0 113.833 -178.421 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.91 118.51 1.37 Allowed Glycine 0 N--CA 1.479 1.516 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.093 176.571 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -100.2 84.56 0.45 Allowed Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 117.036 -1.459 . . . . 0.0 112.702 -179.021 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.99 172.29 12.1 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 123.116 2.544 . . . . 0.0 112.953 168.585 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.289 9.5 t -93.45 157.85 16.01 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 123.457 0.703 . . . . 0.0 109.281 167.775 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.5 m -126.61 158.97 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 C-N-CA 124.131 0.972 . . . . 0.0 112.244 -166.277 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -73.99 -176.07 0.47 Allowed Pre-proline 0 CA--C 1.609 3.226 0 CA-C-O 115.142 -2.361 . . . . 0.0 113.717 -179.495 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--N 1.394 2.955 0 CA-C-N 126.606 3.395 . . . . 0.0 111.476 -178.634 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 N--CA 1.502 2.126 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.8 p -141.75 107.23 5.04 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 103.656 -2.72 . . . . 0.0 103.656 -176.619 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.266 1.4 tt -71.34 162.61 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 C-N-CA 127.255 2.222 . . . . 0.0 112.7 -179.077 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -142.65 123.94 14.67 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 169.019 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.8 t -95.31 123.76 38.99 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 111.789 -2.46 . . . . 0.0 108.391 169.536 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 . . . . . 0 N--CA 1.492 1.629 0 C-N-CA 124.176 0.991 . . . . 0.0 109.663 -169.269 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -147.52 127.28 13.44 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 178.696 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -86.4 140.45 29.99 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.118 0.567 . . . . 0.0 111.086 178.52 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.258 8.2 tt0 -124.56 96.46 4.91 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 100.665 -3.828 . . . . 0.0 100.665 166.785 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.99 123.33 46.65 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -177.016 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -107.77 135.72 48.71 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 125.853 1.97 . . . . 0.0 106.928 -169.143 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 CA--C 1.585 2.314 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 -167.956 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -118.36 126.9 53.06 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -168.852 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -97.01 112.41 24.18 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 -178.284 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -103.59 119.26 38.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -179.671 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -138.57 120.43 15.39 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -168.485 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.11 178.75 42.18 Favored Glycine 1 CA--C 1.582 4.22 0 CA-C-O 115.054 -3.081 . . . . 0.0 116.866 -177.406 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.31 159.45 17.46 Favored 'Trans proline' 0 C--N 1.395 2.992 1 CA-C-N 125.877 4.839 . . . . 0.0 114.088 -174.994 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.03 96.37 0.41 Allowed Glycine 0 N--CA 1.488 2.127 0 CA-C-O 117.322 -1.821 . . . . 0.0 111.163 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.25 3.1 p -100.57 96.02 4.93 Favored Pre-proline 0 CA--C 1.583 2.234 0 CA-C-O 115.949 -1.977 . . . . 0.0 113.948 -167.414 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -83.5 178.81 5.38 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 123.516 2.81 . . . . 0.0 113.796 173.149 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 p -64.57 160.57 19.27 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.291 1.437 . . . . 0.0 113.817 169.554 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.44 HG21 ' H ' ' A' ' 26' ' ' ILE . 12.4 m -134.29 152.23 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 123.334 0.654 . . . . 0.0 111.73 -178.262 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.71 164.09 48.58 Favored Pre-proline 0 CA--C 1.583 2.227 0 CA-C-O 115.336 -2.269 . . . . 0.0 114.213 178.952 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 C--N 1.399 3.223 0 CA-C-N 126.216 3.256 . . . . 0.0 112.686 178.575 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.499 2.024 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.4 p -133.81 105.85 7.01 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -176.72 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.44 ' H ' HG21 ' A' ' 20' ' ' VAL . 1.4 tt -71.58 160.98 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.775 0 CA-C-N 112.009 -2.36 . . . . 0.0 113.471 -177.411 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -136.45 105.21 5.85 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 102.392 -3.188 . . . . 0.0 102.392 165.409 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.4 t -94.9 112.97 24.65 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 111.258 -2.701 . . . . 0.0 106.102 173.239 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 124.621 1.201 . . . . 0.0 111.228 -167.428 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -140.47 125.94 18.96 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.292 1.037 . . . . 0.0 108.767 179.722 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -88.2 139.92 30.01 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 124.005 0.816 . . . . 0.0 111.184 179.211 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -123.56 98.52 5.87 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 101.996 -3.335 . . . . 0.0 101.996 168.356 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.05 122.68 48.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 178.747 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -106.96 130.66 54.58 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 125.353 1.658 . . . . 0.0 107.029 -168.718 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 CA--C 1.582 2.182 0 N-CA-C 100.635 -3.839 . . . . 0.0 100.635 -168.271 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -100.31 141.14 33.57 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.417 1.462 . . . . 0.0 111.068 -169.607 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.8 m -106.09 100.46 10.0 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 166.926 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -93.46 109.9 21.48 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 -175.599 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.93 118.5 25.54 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -168.146 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.9 169.02 40.61 Favored Glycine 1 CA--C 1.582 4.22 0 CA-C-O 115.097 -3.057 . . . . 0.0 116.35 -176.343 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.45 160.89 22.53 Favored 'Trans proline' 0 C--N 1.395 2.987 1 CA-C-N 125.834 4.817 . . . . 0.0 114.29 -174.092 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.36 95.8 0.37 Allowed Glycine 0 N--CA 1.487 2.062 0 CA-C-O 116.921 -2.044 . . . . 0.0 111.465 178.017 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.8 m -78.98 106.59 4.59 Favored Pre-proline 0 CA--C 1.587 2.368 0 CA-C-O 115.755 -2.069 . . . . 0.0 113.943 -167.639 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -80.07 171.38 15.29 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 123.428 2.752 . . . . 0.0 113.828 170.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.82 153.69 28.95 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.358 1.063 . . . . 0.0 110.746 168.008 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.45 HG23 ' H ' ' A' ' 26' ' ' ILE 0.25 11.4 m -129.55 152.21 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 123.211 0.604 . . . . 0.0 112.497 -168.845 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.13 165.63 31.47 Favored Pre-proline 0 CA--C 1.581 2.16 0 CA-C-O 115.814 -2.041 . . . . 0.0 116.332 -179.611 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 C--N 1.395 3.017 0 C-N-CA 123.12 2.547 . . . . 0.0 109.958 169.73 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.3 t . . . . . 0 N--CA 1.504 2.234 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 p -131.7 106.27 8.04 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 -176.482 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.45 ' H ' HG23 ' A' ' 20' ' ' VAL . 1.9 tt -69.66 162.16 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.827 0 CA-C-N 111.863 -2.426 . . . . 0.0 113.871 -179.071 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -138.17 102.31 4.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 166.162 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.0 t -96.1 105.14 17.14 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 111.138 -2.755 . . . . 0.0 105.818 171.776 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 N--CA 1.491 1.597 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.582 -167.677 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.6 p . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -141.29 124.22 16.23 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 124.285 1.034 . . . . 0.0 108.481 179.72 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -84.57 129.7 34.82 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 117.83 -1.081 . . . . 0.0 110.574 -177.207 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.276 5.3 tt0 -114.55 94.44 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 102.639 -3.097 . . . . 0.0 102.639 172.685 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.19 123.31 48.55 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.473 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 m -108.08 132.53 53.47 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -169.736 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 CA--C 1.586 2.351 0 N-CA-C 100.602 -3.851 . . . . 0.0 100.602 -167.661 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 94.7 p . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -113.57 125.67 54.44 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -168.768 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.456 HG21 ' HE ' ' A' ' 13' ' ' ARG . 7.0 m -97.12 116.41 29.28 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 -179.709 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -104.23 112.92 26.13 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 -179.993 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.456 ' HE ' HG21 ' A' ' 11' ' ' THR . 67.4 mtt180 -128.2 119.42 25.18 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -169.961 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.58 -161.71 20.48 Favored Glycine 1 CA--C 1.579 4.078 0 CA-C-O 114.362 -3.466 . . . . 0.0 115.821 177.663 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.8 160.96 4.12 Favored 'Trans proline' 0 C--N 1.394 2.928 1 CA-C-N 126.748 5.274 . . . . 0.0 114.533 -179.458 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.31 113.51 0.87 Allowed Glycine 0 N--CA 1.482 1.719 0 CA-C-O 117.576 -1.68 . . . . 0.0 110.489 172.671 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -96.1 94.89 1.69 Allowed Pre-proline 0 CA--C 1.591 2.525 0 CA-C-O 116.211 -1.852 . . . . 0.0 113.628 -170.996 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -82.11 174.79 9.75 Favored 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 123.309 2.673 . . . . 0.0 113.624 169.283 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.94 158.89 27.92 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.431 1.093 . . . . 0.0 111.958 168.351 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 26' ' ' ILE 0.253 10.5 m -135.98 153.73 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -169.74 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -62.3 158.69 45.54 Favored Pre-proline 0 CA--C 1.587 2.366 0 CA-C-O 114.613 -2.613 . . . . 0.0 115.823 179.216 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 C--N 1.398 3.134 0 CA-C-N 126.105 3.216 . . . . 0.0 109.783 168.764 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.505 2.316 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 p -132.08 105.52 7.44 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 -174.672 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.429 ' H ' HG22 ' A' ' 20' ' ' VAL 0.267 2.6 tt -67.74 161.91 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.828 0 CA-C-N 111.65 -2.523 . . . . 0.0 114.446 -178.753 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -143.44 100.69 3.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 124.664 2.173 . . . . 0.0 106.49 167.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.7 m -94.89 91.95 6.67 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 110.792 -2.913 . . . . 0.0 104.128 173.571 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 N--CA 1.493 1.721 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.53 -165.161 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -142.24 132.59 24.99 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.346 1.059 . . . . 0.0 109.17 -179.774 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -83.13 135.2 34.9 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 117.343 -1.313 . . . . 0.0 111.211 -178.551 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -120.58 96.89 5.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 102.368 -3.197 . . . . 0.0 102.368 167.918 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.26 122.76 46.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.038 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -107.0 131.35 54.16 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 125.73 1.894 . . . . 0.0 107.068 -168.559 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 CA--C 1.581 2.17 0 N-CA-C 100.521 -3.881 . . . . 0.0 100.521 -168.435 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.6 p . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -99.54 141.31 32.5 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 120.401 1.455 . . . . 0.0 111.297 -169.614 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 m -105.94 101.64 11.13 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 101.004 -3.702 . . . . 0.0 101.004 166.762 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -94.36 110.32 22.1 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 -176.248 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.03 121.34 29.52 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -168.342 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.61 171.8 42.85 Favored Glycine 1 CA--C 1.581 4.175 0 CA-C-O 115.16 -3.022 . . . . 0.0 116.45 -177.549 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.21 160.39 23.29 Favored 'Trans proline' 0 C--N 1.396 3.031 1 CA-C-N 125.767 4.784 . . . . 0.0 114.064 -175.565 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.78 95.46 0.62 Allowed Glycine 0 N--CA 1.486 1.986 0 CA-C-O 117.603 -1.665 . . . . 0.0 110.863 -179.503 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.257 4.7 p -105.2 90.75 4.01 Favored Pre-proline 0 CA--C 1.583 2.248 0 CA-C-O 116.474 -1.727 . . . . 0.0 113.432 -167.645 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -83.73 178.6 5.39 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 123.409 2.74 . . . . 0.0 113.721 171.847 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 p -69.33 146.98 51.73 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.89 1.276 . . . . 0.0 111.871 168.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.31 30.8 m -138.94 168.56 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.112 0 CA-C-O 121.455 0.645 . . . . 0.0 111.607 -179.335 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.08 161.98 3.29 Favored Pre-proline 0 CA--C 1.58 2.1 0 N-CA-C 118.863 2.912 . . . . 0.0 118.863 -170.146 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 C--N 1.396 3.031 0 C-N-CA 123.111 2.541 . . . . 0.0 110.227 169.886 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.9 t . . . . . 0 N--CA 1.503 2.175 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.7 p -117.07 101.93 8.89 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -172.732 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.47 163.74 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 CA-C-N 111.023 -2.808 . . . . 0.0 113.934 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -140.18 105.53 5.06 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 166.968 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.13 97.29 10.19 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 169.023 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.492 1.671 0 CA-C-N 113.71 -1.587 . . . . 0.0 111.424 -165.491 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -138.87 129.1 25.54 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.332 1.053 . . . . 0.0 108.929 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -86.13 133.15 33.89 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.665 179.829 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -116.69 100.12 7.6 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 100.888 -3.745 . . . . 0.0 100.888 168.865 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.77 123.15 49.64 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 177.69 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -107.51 133.23 52.29 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 125.303 1.627 . . . . 0.0 106.633 -169.213 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 CA--C 1.585 2.317 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -167.686 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -116.71 125.4 51.65 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -169.053 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 m -96.28 113.34 24.93 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -177.976 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -103.16 115.76 31.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -179.493 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -132.5 120.91 22.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -168.686 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.6 -162.19 16.28 Favored Glycine 1 CA--C 1.581 4.157 0 CA-C-O 114.496 -3.391 . . . . 0.0 115.887 178.47 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -87.61 161.53 7.92 Favored 'Trans proline' 0 C--N 1.395 3.004 1 CA-C-N 126.617 5.209 . . . . 0.0 114.062 -178.084 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.33 117.84 1.41 Allowed Glycine 0 N--CA 1.48 1.598 0 CA-C-O 117.932 -1.482 . . . . 0.0 110.044 176.929 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.5 m -100.72 84.6 0.48 Allowed Pre-proline 0 CA--C 1.588 2.408 0 CA-C-O 116.979 -1.486 . . . . 0.0 112.957 -177.304 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.99 174.11 10.44 Favored 'Trans proline' 0 C--N 1.389 2.701 0 C-N-CA 123.17 2.58 . . . . 0.0 112.923 168.559 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.288 9.6 t -95.57 157.72 15.77 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 123.619 0.768 . . . . 0.0 109.406 167.886 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 m -125.93 159.43 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 124.306 1.042 . . . . 0.0 112.069 -166.445 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -73.58 -176.2 0.46 Allowed Pre-proline 0 CA--C 1.609 3.22 0 CA-C-O 115.096 -2.383 . . . . 0.0 113.843 -179.111 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 C--N 1.394 2.956 0 CA-C-N 126.685 3.423 . . . . 0.0 111.579 -178.482 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.8 t . . . . . 0 N--CA 1.503 2.186 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.5 p -142.73 108.07 5.02 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 -176.799 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.272 1.8 tt -70.8 161.64 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 C-N-CA 127.248 2.219 . . . . 0.0 112.711 -179.049 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -141.79 121.21 13.2 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 102.348 -3.204 . . . . 0.0 102.348 169.409 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.8 t -97.0 116.04 28.51 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 111.601 -2.545 . . . . 0.0 107.208 169.497 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.267 -0.873 . . . . 0.0 108.828 -169.367 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.28 124.61 19.14 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.164 0.986 . . . . 0.0 108.779 178.863 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -85.55 127.9 34.58 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 124.395 1.059 . . . . 0.0 110.252 -179.071 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.252 9.1 tt0 -109.9 97.68 7.15 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 169.127 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.67 122.08 45.98 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 177.545 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 m -108.17 130.46 55.13 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -169.248 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 CA--C 1.586 2.336 0 N-CA-C 100.291 -3.966 . . . . 0.0 100.291 -167.602 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -111.86 124.35 52.17 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -168.884 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -96.25 113.61 25.22 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -176.471 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -103.72 114.38 28.6 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 -179.544 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -131.25 119.66 22.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 -169.029 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.58 -161.37 19.87 Favored Glycine 1 CA--C 1.58 4.101 0 CA-C-O 114.379 -3.456 . . . . 0.0 116.134 178.455 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -90.66 160.53 4.26 Favored 'Trans proline' 0 C--N 1.394 2.964 1 CA-C-N 126.768 5.284 . . . . 0.0 114.595 -178.477 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.17 113.62 0.73 Allowed Glycine 0 N--CA 1.481 1.681 0 CA-C-O 117.451 -1.749 . . . . 0.0 110.615 173.614 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.7 t -94.28 95.18 1.31 Allowed Pre-proline 0 CA--C 1.589 2.458 0 CA-C-O 116.132 -1.89 . . . . 0.0 113.471 -173.294 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -81.02 174.35 10.97 Favored 'Trans proline' 0 C--N 1.392 2.839 0 CA-C-N 124.559 2.664 . . . . 0.0 113.225 168.806 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -79.12 157.65 27.91 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.412 1.085 . . . . 0.0 111.508 168.403 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.262 16.5 m -135.07 152.58 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 C-N-CA 123.118 0.567 . . . . 0.0 111.559 -177.905 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 167.56 34.62 Favored Pre-proline 0 CA--C 1.588 2.411 0 CA-C-O 115.006 -2.426 . . . . 0.0 114.032 179.331 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.4 3.237 0 CA-C-N 126.883 3.494 . . . . 0.0 111.572 177.861 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.3 t . . . . . 0 N--CA 1.502 2.167 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -139.77 111.29 7.18 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 123.682 1.706 . . . . 0.0 107.722 177.763 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.255 1.8 tt -70.76 158.98 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 CA-C-N 109.26 -3.609 . . . . 0.0 113.632 -172.441 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -139.78 103.93 4.78 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 167.905 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.7 m -97.57 98.48 9.94 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 109.879 -3.328 . . . . 0.0 105.01 175.307 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.493 1.715 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.282 -167.418 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.6 t . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -135.91 140.95 44.45 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 124.272 1.029 . . . . 0.0 110.191 179.049 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -86.37 136.92 32.94 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.645 0.778 . . . . 0.0 110.226 174.173 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.253 4.3 tt0 -123.55 100.31 6.74 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 101.352 -3.573 . . . . 0.0 101.352 170.099 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.15 124.41 51.42 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 179.127 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -106.51 132.07 52.94 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 125.406 1.691 . . . . 0.0 107.465 -168.536 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 CA--C 1.583 2.224 0 N-CA-C 100.761 -3.792 . . . . 0.0 100.761 -168.325 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.7 p . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -101.31 140.65 35.31 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 120.342 1.428 . . . . 0.0 110.985 -169.612 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m -105.03 102.95 12.42 Favored 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 100.939 -3.726 . . . . 0.0 100.939 166.137 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -92.47 116.57 29.1 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 -179.38 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -132.39 119.42 20.66 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -168.186 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.89 -169.37 25.13 Favored Glycine 1 CA--C 1.582 4.26 0 CA-C-O 114.482 -3.399 . . . . 0.0 115.585 179.04 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -86.83 160.96 9.03 Favored 'Trans proline' 0 C--N 1.394 2.957 1 CA-C-N 126.898 5.349 . . . . 0.0 114.186 -176.27 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.33 117.71 1.4 Allowed Glycine 0 N--CA 1.479 1.552 0 CA-C-O 117.83 -1.539 . . . . 0.0 110.084 177.68 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.8 m -100.65 83.93 0.43 Allowed Pre-proline 0 CA--C 1.589 2.48 0 CA-C-O 117.275 -1.345 . . . . 0.0 113.717 -177.623 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.31 171.53 10.03 Favored 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 123.123 2.548 . . . . 0.0 113.117 168.157 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.282 9.5 t -93.98 149.43 21.24 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.669 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.62 156.66 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.644 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.788 -165.616 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -7.69 145.01 0.0 OUTLIER Pre-proline 0 CA--C 1.585 2.296 0 N-CA-C 120.752 3.612 . . . . 0.0 120.752 169.405 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--N 1.395 3.02 0 CA-C-N 126.571 3.382 . . . . 0.0 109.464 168.533 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t . . . . . 0 N--CA 1.502 2.141 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.8 p -127.23 107.31 9.89 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 -178.498 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 1.3 tt -65.1 162.69 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 C-N-CA 127.456 2.302 . . . . 0.0 113.349 177.806 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -139.18 118.56 12.83 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 102.918 -2.993 . . . . 0.0 102.918 169.805 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 14.3 t -100.79 128.97 46.62 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.001 -2.818 . . . . 0.0 107.474 168.422 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.283 14.8 pt-20 . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -168.729 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -136.17 137.49 40.98 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 124.183 0.993 . . . . 0.0 110.422 -179.364 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -92.75 135.21 34.31 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.189 0.93 . . . . 0.0 110.215 -178.08 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -115.83 99.82 7.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 100.87 -3.752 . . . . 0.0 100.87 169.318 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.43 122.65 46.44 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -179.922 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.44 134.53 50.35 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 125.652 1.845 . . . . 0.0 106.485 -169.132 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 CA--C 1.585 2.301 0 N-CA-C 101.136 -3.653 . . . . 0.0 101.136 -167.842 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -119.21 126.5 51.69 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -168.904 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m -97.1 113.45 25.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 -179.293 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -103.43 116.07 31.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -179.657 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -133.22 122.73 24.39 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -168.622 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.86 -178.17 40.73 Favored Glycine 1 CA--C 1.58 4.149 0 CA-C-O 114.977 -3.124 . . . . 0.0 116.529 -179.632 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -84.28 158.75 13.03 Favored 'Trans proline' 0 C--N 1.395 3.005 1 CA-C-N 125.929 4.865 . . . . 0.0 113.798 -177.418 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.18 107.33 0.42 Allowed Glycine 0 N--CA 1.483 1.789 0 CA-C-O 116.902 -2.054 . . . . 0.0 110.828 177.071 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.3 m -90.54 98.82 1.65 Allowed Pre-proline 0 CA--C 1.587 2.381 0 CA-C-O 116.121 -1.895 . . . . 0.0 112.4 -169.645 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.79 170.14 18.54 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 123.43 2.754 . . . . 0.0 113.688 169.911 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.16 149.24 29.2 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.078 0.951 . . . . 0.0 111.083 169.388 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.5 m -104.06 147.11 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 124.049 0.939 . . . . 0.0 112.241 -168.064 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HZ3' HG21 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -83.64 163.03 51.18 Favored Pre-proline 0 CA--C 1.588 2.417 0 CA-C-O 115.159 -2.353 . . . . 0.0 112.205 168.95 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.396 3.058 0 CA-C-N 126.948 3.517 . . . . 0.0 113.678 -169.571 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.454 HG21 ' HZ3' ' A' ' 21' ' ' LYS . 87.8 t . . . . . 0 CA--C 1.569 1.701 0 N-CA-C 101.164 -3.643 . . . . 0.0 101.164 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.6 p -129.96 105.12 7.76 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -177.442 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 tt -72.15 161.79 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 112.25 -2.25 . . . . 0.0 113.861 -177.851 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -142.46 104.48 4.41 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 165.835 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.1 t -95.97 108.82 21.25 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 111.58 -2.554 . . . . 0.0 105.923 171.365 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 124.619 1.199 . . . . 0.0 110.598 -167.609 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -139.11 128.29 23.96 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.331 1.053 . . . . 0.0 108.966 179.698 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -87.52 133.8 33.71 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.964 0.79 . . . . 0.0 110.177 179.785 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.98 102.02 8.72 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 101.325 -3.583 . . . . 0.0 101.325 168.257 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.21 121.22 44.31 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 178.036 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -107.17 130.91 54.65 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 125.128 1.517 . . . . 0.0 107.037 -168.767 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 CA--C 1.582 2.176 0 N-CA-C 100.743 -3.799 . . . . 0.0 100.743 -167.928 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -99.73 139.57 35.2 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 120.737 1.608 . . . . 0.0 110.971 -169.571 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.2 m -106.11 102.35 11.78 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 100.962 -3.718 . . . . 0.0 100.962 166.483 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -93.27 116.67 29.23 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 -179.559 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -132.82 121.94 23.71 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -167.838 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.4 -162.57 19.47 Favored Glycine 1 CA--C 1.58 4.108 0 CA-C-O 114.675 -3.291 . . . . 0.0 115.822 178.009 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -86.22 161.92 9.94 Favored 'Trans proline' 0 C--N 1.394 2.93 1 CA-C-N 126.354 5.077 . . . . 0.0 113.868 -177.832 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.61 117.22 1.22 Allowed Glycine 0 N--CA 1.479 1.52 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.295 174.292 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -101.7 84.58 0.56 Allowed Pre-proline 0 CA--C 1.588 2.416 0 CA-C-O 116.913 -1.518 . . . . 0.0 111.621 -179.169 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.18 174.03 7.43 Favored 'Trans proline' 0 C--N 1.39 2.733 0 C-N-CA 123.253 2.635 . . . . 0.0 114.116 171.2 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 p -77.95 147.11 35.11 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.484 1.113 . . . . 0.0 110.056 167.223 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 30.1 m -139.64 151.66 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 123.526 0.516 . . . . 0.0 112.07 -174.2 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -14.46 146.18 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.272 0 CA-C-O 112.685 -3.531 . . . . 0.0 119.939 169.904 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 C--N 1.394 2.969 0 CA-C-N 126.624 3.401 . . . . 0.0 109.473 168.413 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.502 2.149 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 p -121.85 105.35 10.28 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 -175.756 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.27 1.5 tt -68.11 163.75 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 CA-C-N 111.774 -2.466 . . . . 0.0 113.202 -179.797 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -139.75 118.04 12.03 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 168.697 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.2 t -97.6 114.52 26.46 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 111.416 -2.629 . . . . 0.0 106.776 169.499 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.493 1.72 0 C-N-CA 123.825 0.85 . . . . 0.0 109.052 -169.039 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -139.81 127.45 21.74 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.31 1.044 . . . . 0.0 108.766 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -85.66 130.15 34.64 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.733 0.813 . . . . 0.0 110.259 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.269 7.2 tt0 -114.39 98.28 6.82 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 101.152 -3.647 . . . . 0.0 101.152 169.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.11 120.97 43.63 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -106.95 135.38 48.6 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 125.54 1.775 . . . . 0.0 106.588 -169.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.17 98.69 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.278 0 N-CA-C 101.382 -3.562 . . . . 0.0 101.382 -167.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t -118.66 7.5 11.72 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -116.45 125.71 52.38 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -168.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.455 HG21 ' HE ' ' A' ' 13' ' ' ARG . 6.4 m -97.09 115.96 28.44 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -105.22 112.94 26.25 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HE ' HG21 ' A' ' 11' ' ' THR . 67.8 mtt180 -127.33 119.07 25.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 -169.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.37 -163.12 16.7 Favored Glycine 1 CA--C 1.58 4.119 0 CA-C-O 114.475 -3.403 . . . . 0.0 115.999 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -87.45 161.53 8.14 Favored 'Trans proline' 0 C--N 1.394 2.969 1 CA-C-N 126.679 5.239 . . . . 0.0 114.076 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.53 118.48 1.51 Allowed Glycine 0 N--CA 1.48 1.575 0 CA-C-O 118.021 -1.433 . . . . 0.0 110.018 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.0 m -100.74 84.46 0.47 Allowed Pre-proline 0 CA--C 1.588 2.421 0 CA-C-O 117.001 -1.476 . . . . 0.0 112.965 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -81.92 176.66 8.09 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 123.231 2.621 . . . . 0.0 112.725 168.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.29 10.0 t -98.96 157.54 16.25 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 123.791 0.836 . . . . 0.0 109.568 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 m -123.81 159.69 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 C-N-CA 124.487 1.115 . . . . 0.0 111.981 -166.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 164.2 58.8 Favored Pre-proline 0 CA--C 1.584 2.278 0 CA-C-O 115.252 -2.309 . . . . 0.0 114.686 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -63.85 129.02 23.45 Favored 'Trans proline' 0 C--N 1.399 3.23 0 CA-C-N 126.239 3.264 . . . . 0.0 112.945 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.8 t -78.08 138.41 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -142.58 108.31 5.12 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.263 1.3 tt -71.62 160.37 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.843 0 C-N-CA 126.972 2.109 . . . . 0.0 112.75 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -141.82 120.0 12.18 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 102.21 -3.256 . . . . 0.0 102.21 169.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.1 t -97.28 115.09 27.01 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.103 169.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 124.084 0.865 . . . . 0.0 109.126 -169.311 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -146.45 127.98 15.07 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -87.56 125.95 34.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.805 0.842 . . . . 0.0 109.804 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.271 8.3 tt0 -110.37 96.9 6.5 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 101.34 -3.578 . . . . 0.0 101.34 168.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.96 120.5 42.6 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.16 135.72 48.22 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 125.514 1.759 . . . . 0.0 106.615 -169.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.56 98.65 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.276 0 N-CA-C 101.372 -3.566 . . . . 0.0 101.372 -167.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.6 t -119.24 6.38 11.22 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -114.87 125.42 53.64 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.458 HG22 ' HE ' ' A' ' 13' ' ' ARG . 6.4 m -97.27 116.25 29.14 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -105.78 112.94 26.21 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HE ' HG22 ' A' ' 11' ' ' THR . 67.6 mtt180 -127.36 120.67 29.05 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -169.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.75 -158.6 12.9 Favored Glycine 1 CA--C 1.579 4.04 0 CA-C-O 114.368 -3.462 . . . . 0.0 116.132 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -88.42 161.2 6.74 Favored 'Trans proline' 0 C--N 1.395 2.989 1 CA-C-N 126.571 5.186 . . . . 0.0 114.212 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.02 118.39 1.39 Allowed Glycine 0 N--CA 1.479 1.559 0 CA-C-O 117.981 -1.455 . . . . 0.0 110.197 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.9 m -100.69 85.71 0.59 Allowed Pre-proline 0 CA--C 1.588 2.417 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.456 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -82.4 175.45 8.94 Favored 'Trans proline' 0 C--N 1.391 2.81 0 C-N-CA 123.444 2.763 . . . . 0.0 113.739 170.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -75.71 158.13 32.7 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.727 1.211 . . . . 0.0 112.018 168.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 13.3 m -135.46 152.87 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.185 0.594 . . . . 0.0 111.609 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 167.79 32.1 Favored Pre-proline 0 CA--C 1.586 2.341 0 CA-C-O 114.998 -2.43 . . . . 0.0 113.939 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.84 126.59 13.43 Favored 'Trans proline' 0 C--N 1.4 3.263 0 CA-C-N 126.961 3.522 . . . . 0.0 111.349 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.67 130.01 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 174.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -140.69 109.64 6.08 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 123.3 1.524 . . . . 0.0 107.827 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.273 1.1 tt -70.54 163.4 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 109.686 -3.416 . . . . 0.0 113.192 -173.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -141.43 115.21 9.09 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 168.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.8 t -94.67 116.51 28.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 111.582 -2.553 . . . . 0.0 107.242 170.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 N--CA 1.494 1.729 0 C-N-CA 123.988 0.915 . . . . 0.0 109.774 -168.517 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -140.04 125.23 18.74 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.292 1.037 . . . . 0.0 108.58 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.35 126.08 34.09 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 124.12 0.888 . . . . 0.0 110.11 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.266 9.0 tt0 -110.76 98.91 7.94 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 100.932 -3.729 . . . . 0.0 100.932 168.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.85 107.99 16.47 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 103.763 -2.681 . . . . 0.0 103.763 -176.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -97.25 126.72 42.64 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 125.466 1.729 . . . . 0.0 106.856 -167.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mm -113.43 88.9 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 -167.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.2 p -121.54 -6.86 9.2 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.588 -1.187 . . . . 0.0 114.098 169.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -94.38 127.17 40.1 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.353 1.061 . . . . 0.0 108.59 -169.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -100.8 111.28 23.47 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -103.54 119.11 38.24 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -135.62 119.19 17.0 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -170.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.04 -158.11 13.4 Favored Glycine 1 CA--C 1.579 4.048 0 CA-C-O 114.401 -3.444 . . . . 0.0 115.713 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -87.14 161.92 8.6 Favored 'Trans proline' 0 C--N 1.393 2.901 1 CA-C-N 126.597 5.198 . . . . 0.0 114.016 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.87 116.08 1.4 Allowed Glycine 0 N--CA 1.48 1.568 0 CA-C-O 118.106 -1.385 . . . . 0.0 110.381 174.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.4 m -101.46 85.78 0.68 Allowed Pre-proline 0 CA--C 1.587 2.371 0 CA-C-O 116.697 -1.62 . . . . 0.0 111.102 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -82.37 173.01 11.06 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 123.252 2.635 . . . . 0.0 113.771 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -75.61 154.78 36.45 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.575 1.15 . . . . 0.0 111.948 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.272 18.0 m -137.17 154.0 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 O-C-N 123.5 0.5 . . . . 0.0 111.856 -173.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 168.08 30.83 Favored Pre-proline 0 CA--C 1.588 2.423 0 CA-C-O 114.91 -2.471 . . . . 0.0 114.187 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.2 130.78 18.09 Favored 'Trans proline' 0 C--N 1.399 3.236 0 CA-C-N 126.982 3.529 . . . . 0.0 111.84 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.1 t -77.21 121.99 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 170.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.8 p -136.26 109.17 7.61 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 102.42 -3.178 . . . . 0.0 102.42 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.259 0.8 OUTLIER -68.79 162.33 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.858 0 C-N-CA 126.745 2.018 . . . . 0.0 113.488 -174.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -138.07 113.85 9.8 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 167.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.8 t -97.96 111.48 23.77 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.139 170.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 124.231 0.957 . . . . 0.0 109.572 -168.605 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.04 129.11 25.21 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.338 1.055 . . . . 0.0 108.92 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -85.84 131.38 34.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.654 0.782 . . . . 0.0 110.45 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.269 7.1 tt0 -116.19 98.33 6.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 100.928 -3.73 . . . . 0.0 100.928 169.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.16 121.28 44.5 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.19 135.16 49.2 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 125.511 1.757 . . . . 0.0 106.681 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.2 98.72 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.312 0 N-CA-C 101.461 -3.533 . . . . 0.0 101.461 -167.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t -118.37 7.94 12.07 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -116.77 125.54 51.78 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -168.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.451 HG21 ' HE ' ' A' ' 13' ' ' ARG . 6.6 m -97.05 115.67 27.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -104.84 112.86 26.13 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' HE ' HG21 ' A' ' 11' ' ' THR . 67.4 mtt180 -127.31 118.8 24.9 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -169.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.19 -165.11 19.76 Favored Glycine 1 CA--C 1.58 4.126 0 CA-C-O 114.482 -3.399 . . . . 0.0 115.911 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -86.57 161.48 9.42 Favored 'Trans proline' 0 C--N 1.394 2.927 1 CA-C-N 126.697 5.248 . . . . 0.0 113.928 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 117.91 1.46 Allowed Glycine 0 N--CA 1.479 1.511 0 CA-C-O 117.964 -1.464 . . . . 0.0 110.057 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.8 m -100.65 84.51 0.47 Allowed Pre-proline 0 CA--C 1.587 2.389 0 CA-C-O 117.038 -1.458 . . . . 0.0 112.909 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -82.21 173.78 10.54 Favored 'Trans proline' 0 C--N 1.389 2.684 0 C-N-CA 123.16 2.573 . . . . 0.0 112.898 168.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.288 9.0 t -95.43 157.27 15.97 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 123.547 0.739 . . . . 0.0 109.288 167.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.6 m -125.68 158.55 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 124.19 0.996 . . . . 0.0 112.363 -166.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -67.76 -176.24 0.26 Allowed Pre-proline 0 CA--C 1.599 2.844 0 N-CA-C 117.662 2.468 . . . . 0.0 117.662 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -77.51 124.84 7.25 Favored 'Trans proline' 0 C--N 1.399 3.235 0 C-N-CA 123.866 3.044 . . . . 0.0 110.816 172.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.85 140.61 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -143.34 108.45 4.98 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.268 1.3 tt -71.32 161.9 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 C-N-CA 127.12 2.168 . . . . 0.0 112.82 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -141.84 122.01 13.84 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 102.21 -3.255 . . . . 0.0 102.21 168.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.8 t -97.56 115.1 27.21 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 111.813 -2.449 . . . . 0.0 107.138 169.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.246 -0.883 . . . . 0.0 108.641 -169.36 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -142.15 124.66 15.76 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.3 1.04 . . . . 0.0 108.521 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -85.14 130.94 34.51 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 117.818 -1.087 . . . . 0.0 110.672 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.276 4.9 tt0 -114.52 95.18 5.13 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 171.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.79 122.38 47.68 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -106.97 135.0 49.28 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 125.575 1.797 . . . . 0.0 106.655 -169.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.17 98.08 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.352 0 N-CA-C 100.722 -3.807 . . . . 0.0 100.722 -167.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t -119.69 6.88 10.98 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 169.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -116.6 125.37 51.73 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -168.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.444 HG23 ' HE ' ' A' ' 13' ' ' ARG . 7.0 m -96.98 116.91 30.04 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -104.67 112.35 25.4 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' HE ' HG23 ' A' ' 11' ' ' THR . 71.2 mtt180 -127.6 120.75 28.83 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -169.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.51 -163.58 24.79 Favored Glycine 1 CA--C 1.58 4.115 0 CA-C-O 114.521 -3.377 . . . . 0.0 116.29 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -89.98 160.86 4.94 Favored 'Trans proline' 0 C--N 1.395 2.98 1 CA-C-N 126.43 5.115 . . . . 0.0 114.455 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.14 110.44 0.69 Allowed Glycine 0 N--CA 1.483 1.797 0 CA-C-O 117.46 -1.745 . . . . 0.0 110.495 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.3 m -97.98 94.99 2.43 Favored Pre-proline 0 CA--C 1.588 2.427 0 CA-C-O 116.224 -1.846 . . . . 0.0 112.972 -169.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.29 175.65 9.49 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 123.327 2.684 . . . . 0.0 113.581 169.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -76.95 160.06 29.47 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.658 1.183 . . . . 0.0 112.128 168.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.418 HG21 ' H ' ' A' ' 26' ' ' ILE . 14.5 m -135.49 151.5 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 123.264 0.625 . . . . 0.0 111.806 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.14 166.65 38.89 Favored Pre-proline 0 CA--C 1.586 2.361 0 CA-C-O 115.094 -2.384 . . . . 0.0 113.678 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.93 128.84 15.47 Favored 'Trans proline' 0 C--N 1.399 3.187 0 CA-C-N 126.82 3.471 . . . . 0.0 111.647 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.4 t -80.27 120.22 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 174.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.1 p -130.2 105.99 8.29 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.418 ' H ' HG21 ' A' ' 20' ' ' VAL 0.263 1.9 tt -67.69 162.6 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 CA-C-N 111.95 -2.386 . . . . 0.0 114.357 -177.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -143.21 102.31 3.96 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 168.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.3 t -89.55 93.82 9.63 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 112.204 -2.271 . . . . 0.0 105.412 169.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.108 -165.544 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 CA--C 1.544 0.75 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -143.77 124.88 14.47 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -88.06 135.8 33.26 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 124.127 0.892 . . . . 0.0 110.498 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -117.99 98.87 6.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 101.076 -3.675 . . . . 0.0 101.076 170.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.53 124.05 51.48 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 m -107.91 133.32 52.43 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -169.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mp -131.0 97.81 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.328 0 N-CA-C 100.925 -3.731 . . . . 0.0 100.925 -167.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -118.71 8.85 11.96 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -117.69 125.67 51.1 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -169.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -96.71 113.07 24.6 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -102.84 117.5 34.76 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -134.93 120.95 19.85 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -168.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.41 -171.88 36.25 Favored Glycine 1 CA--C 1.581 4.159 0 CA-C-O 114.721 -3.266 . . . . 0.0 116.279 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -88.73 158.45 6.24 Favored 'Trans proline' 0 C--N 1.396 3.027 1 CA-C-N 126.364 5.082 . . . . 0.0 114.295 -177.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.76 106.58 0.63 Allowed Glycine 0 N--CA 1.484 1.873 0 CA-C-O 117.196 -1.891 . . . . 0.0 110.579 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.8 m -93.48 98.49 2.58 Favored Pre-proline 0 CA--C 1.588 2.438 0 CA-C-O 116.168 -1.872 . . . . 0.0 113.008 -169.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.01 173.44 12.71 Favored 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 123.401 2.734 . . . . 0.0 113.673 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.94 159.24 31.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.483 1.113 . . . . 0.0 112.371 168.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.455 HG21 ' H ' ' A' ' 26' ' ' ILE 0.257 11.0 m -133.98 152.84 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 CA-C-O 121.422 0.63 . . . . 0.0 112.695 -169.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.24 165.47 27.96 Favored Pre-proline 0 CA--C 1.581 2.15 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.97 108.26 2.55 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 123.148 2.565 . . . . 0.0 110.033 169.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.6 t -77.11 122.07 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.8 p -132.26 106.19 7.78 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.455 ' H ' HG21 ' A' ' 20' ' ' VAL . 2.5 tt -69.33 160.78 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.835 0 CA-C-N 111.904 -2.407 . . . . 0.0 114.023 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -139.31 102.94 4.61 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 167.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 t -98.66 113.67 25.83 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 110.87 -2.877 . . . . 0.0 105.816 170.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.297 10.2 pt-20 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -167.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.8 127.41 21.7 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.345 1.058 . . . . 0.0 108.835 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -87.42 128.41 35.21 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 124.037 0.836 . . . . 0.0 110.096 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.25 8.2 tt0 -112.34 98.38 7.25 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 100.734 -3.802 . . . . 0.0 100.734 168.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.56 120.15 41.48 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -106.98 134.74 49.67 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 125.409 1.693 . . . . 0.0 106.523 -168.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.97 98.57 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.294 0 N-CA-C 101.442 -3.54 . . . . 0.0 101.442 -167.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t -119.36 6.85 11.15 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -114.75 125.09 53.3 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -168.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.23 113.4 25.0 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -103.81 115.03 29.72 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -131.17 120.23 23.01 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -168.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.5 -158.52 12.61 Favored Glycine 1 CA--C 1.579 4.049 0 CA-C-O 114.361 -3.466 . . . . 0.0 115.836 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -89.04 161.37 5.87 Favored 'Trans proline' 0 C--N 1.394 2.955 1 CA-C-N 126.719 5.259 . . . . 0.0 114.294 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.15 117.19 1.33 Allowed Glycine 0 N--CA 1.479 1.563 0 CA-C-O 117.965 -1.464 . . . . 0.0 110.277 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.4 m -100.96 85.82 0.62 Allowed Pre-proline 0 CA--C 1.588 2.412 0 CA-C-O 116.697 -1.62 . . . . 0.0 111.589 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -82.86 176.13 7.97 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.378 2.719 . . . . 0.0 113.73 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -74.63 158.01 34.39 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.72 1.208 . . . . 0.0 111.941 168.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.258 15.4 m -135.62 156.08 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 C-N-CA 122.93 0.492 . . . . 0.0 112.212 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -76.95 -179.29 1.17 Allowed Pre-proline 0 CA--C 1.593 2.598 0 CA-C-O 115.543 -2.17 . . . . 0.0 115.79 -170.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.08 114.25 3.99 Favored 'Trans proline' 0 C--N 1.404 3.469 0 C-N-CA 123.902 3.068 . . . . 0.0 110.251 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -77.7 135.03 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.9 p -141.41 108.81 5.55 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.274 1.2 tt -69.98 164.37 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 127.046 2.138 . . . . 0.0 113.256 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -140.83 114.89 9.15 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 101.734 -3.432 . . . . 0.0 101.734 167.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.5 t -97.44 111.84 23.93 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 111.579 -2.555 . . . . 0.0 106.292 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 N--CA 1.494 1.756 0 O-C-N 124.184 0.927 . . . . 0.0 109.172 -168.709 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -148.04 124.34 10.89 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -87.06 124.61 33.41 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.933 0.893 . . . . 0.0 109.773 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.258 8.9 tt0 -109.28 97.04 6.71 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 101.382 -3.562 . . . . 0.0 101.382 168.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.9 120.79 43.28 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -107.94 131.31 54.67 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 -169.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mp -128.66 97.11 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.331 0 N-CA-C 100.463 -3.903 . . . . 0.0 100.463 -167.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 t -120.67 5.43 10.55 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -113.15 124.75 53.28 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -168.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.0 m -96.78 113.8 25.38 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -176.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -104.09 115.2 30.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -131.19 120.98 24.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -168.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.51 -156.93 11.28 Favored Glycine 1 CA--C 1.58 4.143 0 CA-C-O 114.229 -3.54 . . . . 0.0 115.911 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.22 161.09 4.7 Favored 'Trans proline' 0 C--N 1.395 2.992 1 CA-C-N 126.799 5.299 . . . . 0.0 114.534 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.72 119.35 1.62 Allowed Glycine 0 N--CA 1.479 1.507 0 CA-C-O 118.034 -1.426 . . . . 0.0 110.33 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.2 t -98.1 87.49 0.55 Allowed Pre-proline 0 CA--C 1.591 2.524 0 CA-C-O 116.503 -1.713 . . . . 0.0 112.325 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.71 175.62 9.24 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 123.414 2.742 . . . . 0.0 113.426 169.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 p -77.62 158.24 29.87 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.638 1.175 . . . . 0.0 111.828 168.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.259 15.7 m -136.9 156.09 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 122.999 0.52 . . . . 0.0 112.23 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -76.89 -179.31 1.17 Allowed Pre-proline 0 CA--C 1.593 2.608 0 CA-C-O 115.631 -2.128 . . . . 0.0 115.742 -171.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.99 116.69 4.82 Favored 'Trans proline' 0 C--N 1.405 3.504 0 C-N-CA 123.97 3.114 . . . . 0.0 110.365 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.7 t -77.22 132.35 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -140.87 108.89 5.72 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.265 1.3 tt -69.84 160.89 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.836 0 C-N-CA 127.036 2.134 . . . . 0.0 113.353 -177.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -139.22 109.25 6.38 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 168.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.8 m -98.11 106.91 19.27 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 110.229 -3.168 . . . . 0.0 104.679 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.736 0 C-N-CA 124.307 1.043 . . . . 0.0 111.033 -167.246 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -147.86 125.46 11.77 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -83.55 122.79 29.03 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 117.82 -1.086 . . . . 0.0 109.988 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.265 8.4 tt0 -109.25 95.94 5.96 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 102.123 -3.288 . . . . 0.0 102.123 170.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.73 120.77 43.51 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.47 130.82 54.8 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 125.423 1.702 . . . . 0.0 106.648 -169.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.88 96.18 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.185 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -167.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.7 p -78.46 -18.17 55.25 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 169.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -98.41 139.38 34.24 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 120.259 1.391 . . . . 0.0 111.155 -169.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.5 m -107.14 102.96 12.25 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 100.922 -3.733 . . . . 0.0 100.922 166.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -93.49 113.71 25.91 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -129.44 120.99 26.41 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -168.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.71 -160.81 18.88 Favored Glycine 1 CA--C 1.579 4.036 0 CA-C-O 114.522 -3.377 . . . . 0.0 116.022 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -86.74 163.37 9.17 Favored 'Trans proline' 0 C--N 1.393 2.911 1 CA-C-N 126.584 5.192 . . . . 0.0 114.023 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.18 119.87 1.79 Allowed Glycine 0 C--N 1.354 1.57 0 CA-C-O 118.01 -1.439 . . . . 0.0 110.019 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.6 t -97.86 87.87 0.57 Allowed Pre-proline 0 CA--C 1.591 2.526 0 CA-C-O 116.452 -1.737 . . . . 0.0 112.206 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -81.8 173.83 10.85 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.373 2.716 . . . . 0.0 113.504 169.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 p -79.44 158.78 27.25 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.578 1.151 . . . . 0.0 111.626 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.251 15.2 m -136.46 151.58 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.15 0.58 . . . . 0.0 111.492 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.67 166.71 40.66 Favored Pre-proline 0 CA--C 1.588 2.406 0 CA-C-O 114.949 -2.453 . . . . 0.0 114.043 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.09 130.29 17.48 Favored 'Trans proline' 0 C--N 1.4 3.275 0 CA-C-N 126.998 3.535 . . . . 0.0 111.627 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t -78.72 128.13 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 173.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -137.19 106.86 6.18 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.273 1.3 tt -69.24 165.55 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.955 0 CA-C-N 112.265 -2.243 . . . . 0.0 113.696 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -144.08 108.86 4.92 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 168.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 76.1 m -94.13 97.67 10.45 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 . . . . . 0 N--CA 1.491 1.615 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.808 -165.318 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -138.63 131.56 29.56 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.354 1.062 . . . . 0.0 109.058 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -85.74 136.24 33.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.644 0.778 . . . . 0.0 110.418 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.267 4.7 tt0 -120.97 98.9 6.21 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 169.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.6 122.79 47.59 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.25 135.67 48.37 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 125.671 1.857 . . . . 0.0 106.924 -169.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.75 98.51 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.28 0 N-CA-C 101.271 -3.603 . . . . 0.0 101.271 -167.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 t -116.64 11.85 14.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 169.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -122.26 126.59 48.5 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -168.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.435 HG21 ' HE ' ' A' ' 13' ' ' ARG . 6.4 m -96.79 116.39 29.06 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -105.06 113.57 27.25 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.435 ' HE ' HG21 ' A' ' 11' ' ' THR . 72.0 mtt180 -128.58 122.49 31.14 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -169.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.05 -163.9 16.81 Favored Glycine 1 CA--C 1.58 4.151 0 CA-C-O 114.461 -3.41 . . . . 0.0 115.833 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -87.83 160.47 7.57 Favored 'Trans proline' 0 C--N 1.395 2.988 1 CA-C-N 126.709 5.254 . . . . 0.0 114.108 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.91 118.31 1.36 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-O 118.018 -1.435 . . . . 0.0 110.194 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -101.88 83.09 0.44 Allowed Pre-proline 0 CA--C 1.589 2.461 0 CA-C-O 117.239 -1.362 . . . . 0.0 113.263 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -84.92 172.83 8.53 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.105 2.537 . . . . 0.0 113.312 168.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.28 9.3 t -94.14 148.68 21.94 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 166.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.72 156.78 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 C-N-CA 123.343 0.657 . . . . 0.0 111.75 -165.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -8.24 145.09 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.272 0 N-CA-C 120.74 3.607 . . . . 0.0 120.74 169.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.93 116.57 4.63 Favored 'Trans proline' 0 C--N 1.396 3.051 0 CA-C-N 126.6 3.393 . . . . 0.0 109.557 168.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.83 118.87 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -125.39 106.31 9.72 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.269 1.3 tt -67.11 162.24 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 CA-C-N 112.087 -2.324 . . . . 0.0 113.322 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -140.59 124.09 16.93 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 102.264 -3.236 . . . . 0.0 102.264 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.4 t -97.43 116.08 28.96 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.776 -2.466 . . . . 0.0 107.477 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -169.485 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -147.61 125.55 12.01 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -85.63 126.93 34.3 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.89 0.876 . . . . 0.0 110.069 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.274 5.5 tt0 -111.4 97.13 6.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 101.484 -3.524 . . . . 0.0 101.484 169.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.06 121.5 45.4 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -107.68 131.68 54.14 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -169.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 mp -127.94 97.23 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.38 0 N-CA-C 100.302 -3.962 . . . . 0.0 100.302 -167.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t -120.63 5.99 10.55 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 170.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -114.75 125.11 53.33 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -168.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -96.72 117.2 30.52 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -105.79 113.46 27.02 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -127.8 120.29 27.53 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -169.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.21 -160.1 13.91 Favored Glycine 1 CA--C 1.58 4.125 0 CA-C-O 114.349 -3.473 . . . . 0.0 116.321 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -88.68 161.32 6.37 Favored 'Trans proline' 0 C--N 1.395 2.987 1 CA-C-N 126.632 5.216 . . . . 0.0 114.276 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.62 119.8 1.65 Allowed Glycine 0 N--CA 1.48 1.603 0 CA-C-O 118.008 -1.44 . . . . 0.0 110.133 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.3 t -98.53 86.27 0.47 Allowed Pre-proline 0 CA--C 1.591 2.554 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.001 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -81.08 178.06 7.24 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.174 2.583 . . . . 0.0 112.117 166.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.299 11.2 t -103.94 158.16 16.6 Favored 'General case' 0 N--CA 1.504 2.275 0 C-N-CA 123.868 0.867 . . . . 0.0 109.818 168.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.2 m -125.91 160.05 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.56 0 C-N-CA 124.506 1.122 . . . . 0.0 111.982 -166.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 164.73 56.18 Favored Pre-proline 0 CA--C 1.585 2.304 0 CA-C-O 115.278 -2.296 . . . . 0.0 114.675 177.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -64.05 129.88 25.75 Favored 'Trans proline' 0 C--N 1.4 3.257 0 CA-C-N 126.218 3.256 . . . . 0.0 113.002 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.0 t -77.2 135.62 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.4 p -142.8 108.96 5.23 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.264 1.4 tt -71.07 158.43 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 C-N-CA 127.033 2.133 . . . . 0.0 112.848 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -141.84 115.06 8.82 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 102.716 -3.068 . . . . 0.0 102.716 169.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 73.7 m -97.0 112.38 24.17 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 110.552 -3.022 . . . . 0.0 105.841 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.752 0 C-N-CA 124.18 0.992 . . . . 0.0 110.472 -167.853 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -139.5 128.11 23.11 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.348 1.059 . . . . 0.0 108.946 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -88.27 135.57 33.39 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 123.994 0.808 . . . . 0.0 110.471 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.266 4.2 tt0 -118.25 97.46 5.79 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 101.259 -3.608 . . . . 0.0 101.259 169.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.26 122.41 47.66 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.33 136.12 47.69 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 125.513 1.758 . . . . 0.0 106.818 -169.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.71 98.78 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.314 0 N-CA-C 101.407 -3.553 . . . . 0.0 101.407 -167.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.7 t -117.97 8.65 12.59 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -118.19 125.84 51.0 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -168.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.46 HG22 ' HE ' ' A' ' 13' ' ' ARG . 6.8 m -97.14 116.78 29.97 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -105.38 112.95 26.24 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.46 ' HE ' HG22 ' A' ' 11' ' ' THR . 74.3 mtt180 -127.63 121.36 30.27 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -169.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.15 -156.79 11.48 Favored Glycine 1 CA--C 1.579 4.077 0 CA-C-O 114.309 -3.495 . . . . 0.0 115.989 177.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -91.02 160.73 3.91 Favored 'Trans proline' 0 C--N 1.395 3.016 1 CA-C-N 126.568 5.184 . . . . 0.0 114.628 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.66 115.49 0.97 Allowed Glycine 0 N--CA 1.481 1.634 0 CA-C-O 117.799 -1.556 . . . . 0.0 110.457 174.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.6 m -100.66 87.16 0.76 Allowed Pre-proline 0 CA--C 1.589 2.467 0 CA-C-O 116.676 -1.63 . . . . 0.0 111.663 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.61 173.94 10.08 Favored 'Trans proline' 0 C--N 1.391 2.781 0 C-N-CA 123.399 2.733 . . . . 0.0 113.887 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.71 156.17 38.19 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.536 1.134 . . . . 0.0 112.426 168.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.438 HG21 ' H ' ' A' ' 26' ' ' ILE 0.268 14.1 m -135.6 155.67 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.664 0.745 . . . . 0.0 112.813 -169.193 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -69.39 165.52 39.14 Favored Pre-proline 0 CA--C 1.58 2.112 0 CA-C-O 115.64 -2.124 . . . . 0.0 116.731 -171.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -68.6 102.72 0.88 Allowed 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 123.772 2.981 . . . . 0.0 109.858 168.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.9 129.03 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -139.11 108.88 6.26 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 123.794 1.759 . . . . 0.0 108.187 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.438 ' H ' HG21 ' A' ' 20' ' ' VAL 0.262 2.1 tt -70.11 162.91 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.826 0 CA-C-N 109.098 -3.683 . . . . 0.0 113.739 -174.285 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -140.83 111.0 6.63 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 167.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.2 t -96.1 112.41 24.15 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 111.615 -2.539 . . . . 0.0 106.338 172.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 124.207 0.942 . . . . 0.0 110.177 -168.361 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -142.76 125.45 15.92 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.296 1.038 . . . . 0.0 108.57 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -82.83 120.62 25.87 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 117.814 -1.089 . . . . 0.0 109.622 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.278 9.7 tt0 -106.53 95.92 6.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 102.249 -3.241 . . . . 0.0 102.249 169.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.49 118.77 37.59 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.73 131.76 54.09 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -169.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.59 98.09 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.324 0 N-CA-C 100.919 -3.734 . . . . 0.0 100.919 -167.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -120.31 3.48 10.83 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 169.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -111.02 124.96 53.19 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -168.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -97.06 113.36 24.91 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -104.25 114.36 28.54 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -130.09 120.07 24.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -168.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.0 -163.96 21.79 Favored Glycine 1 CA--C 1.579 4.083 0 CA-C-O 114.542 -3.365 . . . . 0.0 115.848 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -87.32 162.06 8.34 Favored 'Trans proline' 0 C--N 1.394 2.93 1 CA-C-N 126.668 5.234 . . . . 0.0 113.996 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.91 116.03 1.41 Allowed Glycine 0 N--CA 1.479 1.541 0 CA-C-O 118.07 -1.406 . . . . 0.0 110.228 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.0 m -103.63 84.16 0.74 Allowed Pre-proline 0 CA--C 1.587 2.395 0 CA-C-O 116.952 -1.499 . . . . 0.0 111.613 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -85.11 173.63 7.78 Favored 'Trans proline' 0 C--N 1.39 2.728 0 C-N-CA 123.247 2.632 . . . . 0.0 114.064 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 p -78.13 146.69 34.97 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.468 1.107 . . . . 0.0 110.216 167.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.259 30.9 m -139.47 152.65 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 O-C-N 123.6 0.562 . . . . 0.0 112.083 -172.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -17.3 146.61 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.263 0 CA-C-O 112.746 -3.502 . . . . 0.0 119.774 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.03 117.31 4.64 Favored 'Trans proline' 0 C--N 1.394 2.961 0 CA-C-N 126.667 3.417 . . . . 0.0 109.664 168.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.68 115.8 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.5 p -118.97 104.42 10.48 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.297 1.3 tt -66.79 165.7 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.857 0 CA-C-N 111.639 -2.528 . . . . 0.0 113.644 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -142.94 112.69 6.94 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 103.373 -2.825 . . . . 0.0 103.373 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.7 t -94.94 98.32 10.62 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 168.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 . . . . . 0 N--CA 1.493 1.705 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.241 -166.11 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -142.47 124.09 14.98 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.287 1.035 . . . . 0.0 108.286 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -83.49 121.66 27.49 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.822 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.293 9.9 tt0 -108.71 95.88 5.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 101.994 -3.335 . . . . 0.0 101.994 169.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.97 108.14 17.37 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -175.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -95.79 127.15 41.57 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 113.218 -1.81 . . . . 0.0 107.195 -167.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mm -118.6 87.28 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.108 0 N-CA-C 102.818 -3.03 . . . . 0.0 102.818 -167.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -89.19 -16.71 30.7 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 169.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.24 139.92 30.0 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.494 1.117 . . . . 0.0 110.458 -170.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.469 HG21 ' HE ' ' A' ' 13' ' ' ARG . 5.0 m -111.18 110.56 21.12 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 102.788 -3.041 . . . . 0.0 102.788 169.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -99.04 115.55 29.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HE ' HG21 ' A' ' 11' ' ' THR . 65.5 mtt180 -128.13 122.16 31.31 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -173.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.68 -160.14 17.18 Favored Glycine 1 CA--C 1.578 4.012 0 CA-C-O 114.496 -3.391 . . . . 0.0 115.659 176.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -86.97 162.68 8.86 Favored 'Trans proline' 0 C--N 1.392 2.837 1 CA-C-N 126.602 5.201 . . . . 0.0 113.952 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.43 115.38 1.49 Allowed Glycine 0 N--CA 1.48 1.608 0 CA-C-O 117.943 -1.476 . . . . 0.0 110.238 174.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.9 m -102.11 85.79 0.77 Allowed Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 116.721 -1.609 . . . . 0.0 111.247 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.34 172.98 11.11 Favored 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 123.333 2.688 . . . . 0.0 113.804 171.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -76.58 155.1 33.86 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.582 1.153 . . . . 0.0 111.885 168.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.272 18.0 m -137.93 154.75 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 C-N-CA 122.968 0.507 . . . . 0.0 112.004 -174.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 168.49 27.55 Favored Pre-proline 0 CA--C 1.588 2.423 0 CA-C-O 114.945 -2.455 . . . . 0.0 114.246 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.35 130.74 17.86 Favored 'Trans proline' 0 C--N 1.399 3.22 0 CA-C-N 126.878 3.492 . . . . 0.0 111.726 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.1 t -77.34 122.62 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 170.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.0 p -136.59 108.88 7.29 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.28 0.8 OUTLIER -68.92 166.1 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.878 0 C-N-CA 126.782 2.033 . . . . 0.0 113.89 -173.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -140.2 110.71 6.72 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 102.717 -3.068 . . . . 0.0 102.717 168.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.6 t -96.09 98.82 10.65 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 N--CA 1.492 1.67 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.332 -165.998 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -146.25 128.3 15.57 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -87.39 126.07 34.65 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.733 0.813 . . . . 0.0 109.993 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.253 8.6 tt0 -110.44 97.84 7.19 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 101.026 -3.694 . . . . 0.0 101.026 168.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.8 120.14 41.4 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.543 -2.392 . . . . 0.0 104.543 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -107.03 134.87 49.53 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 125.46 1.725 . . . . 0.0 106.552 -169.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.48 98.25 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.27 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 -167.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m -120.66 3.41 10.66 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -111.0 125.23 53.51 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -168.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.24 113.42 25.03 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -103.74 114.82 29.36 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -130.85 120.44 23.68 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -168.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.08 -158.12 12.56 Favored Glycine 1 CA--C 1.579 4.067 0 CA-C-O 114.399 -3.445 . . . . 0.0 115.945 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -88.54 161.45 6.58 Favored 'Trans proline' 0 C--N 1.394 2.956 1 CA-C-N 126.61 5.205 . . . . 0.0 114.235 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.24 118.1 1.41 Allowed Glycine 0 N--CA 1.48 1.594 0 CA-C-O 117.96 -1.467 . . . . 0.0 110.162 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.4 m -100.81 85.73 0.6 Allowed Pre-proline 0 CA--C 1.587 2.396 0 CA-C-O 116.705 -1.617 . . . . 0.0 111.5 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.58 176.49 7.81 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 123.401 2.734 . . . . 0.0 113.66 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -75.38 158.74 32.3 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.717 1.207 . . . . 0.0 112.033 168.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.252 13.3 m -135.4 152.0 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 C-N-CA 123.15 0.58 . . . . 0.0 111.72 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 167.04 38.45 Favored Pre-proline 0 CA--C 1.586 2.357 0 CA-C-O 114.98 -2.438 . . . . 0.0 114.107 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.13 129.59 16.38 Favored 'Trans proline' 0 C--N 1.4 3.261 0 CA-C-N 126.968 3.524 . . . . 0.0 111.525 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.54 128.86 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 173.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.2 p -138.98 108.46 6.16 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.275 1.2 tt -69.03 163.78 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.913 0 C-N-CA 126.885 2.074 . . . . 0.0 113.257 -177.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -141.25 115.19 9.15 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 101.753 -3.425 . . . . 0.0 101.753 168.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.6 t -94.98 116.67 28.98 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 111.6 -2.545 . . . . 0.0 107.174 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.727 0 C-N-CA 124.03 0.932 . . . . 0.0 109.815 -168.457 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -140.62 124.24 17.03 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.268 1.027 . . . . 0.0 108.534 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -85.14 124.15 31.47 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.049 0.939 . . . . 0.0 109.408 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.279 8.5 tt0 -109.44 95.95 5.96 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 101.825 -3.398 . . . . 0.0 101.825 169.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.83 120.45 42.54 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 m -107.3 131.56 54.08 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 125.128 1.517 . . . . 0.0 106.98 -168.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mp -136.53 96.0 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.211 0 N-CA-C 100.87 -3.752 . . . . 0.0 100.87 -167.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 t -80.13 -15.95 55.99 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 170.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -100.59 139.71 35.89 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 120.711 1.596 . . . . 0.0 110.99 -169.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 m -106.76 105.02 14.86 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 166.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -95.38 112.46 24.17 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -125.9 119.96 29.17 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -169.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.28 -164.62 21.06 Favored Glycine 1 CA--C 1.58 4.119 0 CA-C-O 114.495 -3.392 . . . . 0.0 116.055 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -87.14 161.44 8.59 Favored 'Trans proline' 0 C--N 1.394 2.958 1 CA-C-N 126.687 5.244 . . . . 0.0 113.998 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.48 118.34 1.48 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-O 118.078 -1.401 . . . . 0.0 110.242 174.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.7 t -99.32 86.09 0.51 Allowed Pre-proline 0 CA--C 1.588 2.416 0 CA-C-O 116.757 -1.592 . . . . 0.0 111.988 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -83.53 172.46 10.28 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 123.11 2.54 . . . . 0.0 113.458 169.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -80.3 146.29 31.69 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.244 1.017 . . . . 0.0 110.12 167.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.264 30.9 m -138.36 153.42 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 O-C-N 123.724 0.64 . . . . 0.0 112.031 -170.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -23.07 147.56 0.01 OUTLIER Pre-proline 0 CA--C 1.584 2.277 0 CA-C-O 112.937 -3.411 . . . . 0.0 119.378 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.26 116.92 4.68 Favored 'Trans proline' 0 C--N 1.394 2.945 0 CA-C-N 126.606 3.395 . . . . 0.0 109.647 168.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.1 t -78.45 114.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 104.177 -2.527 . . . . 0.0 104.177 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.5 p -118.75 104.47 10.62 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 1.3 tt -68.7 159.87 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.791 0 CA-C-N 111.64 -2.527 . . . . 0.0 113.244 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.7 ttm105 -139.32 108.6 6.1 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 168.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.9 m -94.81 97.16 9.83 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 110.072 -3.24 . . . . 0.0 106.02 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 N--CA 1.495 1.776 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.768 -168.059 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -139.52 128.04 22.98 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.321 1.048 . . . . 0.0 108.898 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -85.89 141.46 29.56 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.49 0.716 . . . . 0.0 111.129 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.268 4.8 tt0 -123.01 96.23 4.93 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 101.017 -3.697 . . . . 0.0 101.017 167.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.76 121.97 44.07 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -108.15 135.8 48.88 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 125.873 1.983 . . . . 0.0 106.819 -168.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.78 98.71 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.373 0 N-CA-C 100.986 -3.709 . . . . 0.0 100.986 -167.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.0 m -117.55 6.95 12.56 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 169.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -117.8 127.81 54.25 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -168.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.459 HG21 ' HE ' ' A' ' 13' ' ' ARG . 5.5 m -97.16 115.95 28.47 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -104.25 114.9 29.46 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.459 ' HE ' HG21 ' A' ' 11' ' ' THR . 78.9 mtt180 -128.47 119.61 25.25 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -170.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.8 171.04 39.33 Favored Glycine 1 CA--C 1.582 4.228 0 CA-C-O 115.059 -3.078 . . . . 0.0 116.948 -175.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.52 160.66 22.35 Favored 'Trans proline' 0 C--N 1.395 3.021 1 CA-C-N 125.624 4.712 . . . . 0.0 114.232 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.61 95.22 0.4 Allowed Glycine 0 N--CA 1.487 2.05 0 CA-C-O 117.315 -1.825 . . . . 0.0 111.308 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.255 4.7 p -102.8 92.05 3.26 Favored Pre-proline 0 CA--C 1.585 2.296 0 CA-C-O 116.507 -1.711 . . . . 0.0 114.403 -167.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.5 179.98 4.16 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 123.42 2.747 . . . . 0.0 113.898 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 p -68.33 148.39 50.81 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 125.114 1.366 . . . . 0.0 111.313 167.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 24.3 m -141.38 151.42 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.077 0.465 . . . . 0.0 112.02 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -12.03 145.61 0.0 OUTLIER Pre-proline 0 CA--C 1.583 2.236 0 N-CA-C 120.396 3.48 . . . . 0.0 120.396 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.56 117.6 4.61 Favored 'Trans proline' 0 C--N 1.395 2.987 0 CA-C-N 126.541 3.372 . . . . 0.0 109.406 168.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.1 t -79.24 107.34 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.0 p -112.75 101.34 9.44 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -172.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 tt -70.23 157.83 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.63 0 CA-C-N 111.113 -2.767 . . . . 0.0 113.596 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -136.14 106.36 6.38 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 167.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -95.59 109.35 21.6 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 111.062 -2.79 . . . . 0.0 106.127 170.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 124.629 1.206 . . . . 0.0 110.125 -168.052 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -138.96 129.89 26.42 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.297 1.039 . . . . 0.0 109.012 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -88.02 139.64 30.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.497 0.719 . . . . 0.0 110.801 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -122.55 99.92 6.66 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 101.478 -3.527 . . . . 0.0 101.478 167.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.72 122.5 47.96 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 178.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.63 133.23 52.38 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -169.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.0 mp -130.47 97.42 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.311 0 N-CA-C 100.595 -3.854 . . . . 0.0 100.595 -167.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.9 p -119.52 5.62 11.09 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 169.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -113.85 125.4 54.03 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -168.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -98.47 108.74 21.5 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -102.04 112.46 25.12 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.75 124.95 30.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -168.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.02 -154.09 9.41 Favored Glycine 1 CA--C 1.58 4.133 0 CA-C-O 114.377 -3.457 . . . . 0.0 115.239 174.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -90.35 161.65 4.56 Favored 'Trans proline' 0 C--N 1.395 3.019 1 CA-C-N 126.474 5.137 . . . . 0.0 114.533 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.05 116.02 1.05 Allowed Glycine 0 N--CA 1.481 1.648 0 CA-C-O 117.897 -1.502 . . . . 0.0 110.317 174.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.4 m -101.36 86.1 0.71 Allowed Pre-proline 0 CA--C 1.588 2.426 0 CA-C-O 116.741 -1.6 . . . . 0.0 111.609 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.66 174.35 8.76 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 123.438 2.759 . . . . 0.0 113.9 172.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.98 155.83 39.44 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.598 1.159 . . . . 0.0 112.294 168.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 13.5 m -135.83 155.21 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -169.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -56.71 153.39 22.07 Favored Pre-proline 0 CA--C 1.583 2.22 0 CA-C-O 114.25 -2.786 . . . . 0.0 116.342 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -66.99 109.27 1.66 Allowed 'Trans proline' 0 C--N 1.397 3.103 0 CA-C-N 126.093 3.212 . . . . 0.0 109.967 168.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.74 126.24 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 p -136.44 107.42 6.7 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.265 2.6 tt -67.95 162.2 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 CA-C-N 112.099 -2.319 . . . . 0.0 113.713 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -138.98 112.54 8.28 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 167.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.4 t -96.33 111.57 23.61 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 111.48 -2.6 . . . . 0.0 106.247 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 124.282 0.989 . . . . 0.0 109.458 -168.328 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -141.19 125.54 17.57 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.268 1.027 . . . . 0.0 108.789 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -80.36 141.35 35.47 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 124.174 0.922 . . . . 0.0 111.439 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -124.32 98.9 5.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 100.525 -3.88 . . . . 0.0 100.525 168.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.48 122.43 47.26 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -106.83 134.87 49.31 Favored 'General case' 0 CA--C 1.55 0.981 0 O-C-N 125.653 1.846 . . . . 0.0 106.842 -169.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mp -130.73 97.41 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.332 0 N-CA-C 100.532 -3.877 . . . . 0.0 100.532 -168.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -120.77 5.73 10.49 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 169.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -114.91 126.12 54.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -168.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -96.71 111.7 23.75 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -103.0 119.1 38.25 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 -139.49 125.48 19.8 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.087 -167.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.81 -156.62 10.22 Favored Glycine 1 CA--C 1.581 4.165 0 CA-C-O 114.249 -3.528 . . . . 0.0 115.755 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -87.67 163.47 7.83 Favored 'Trans proline' 0 C--N 1.395 3.011 1 CA-C-N 126.721 5.261 . . . . 0.0 114.182 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.95 131.12 4.41 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.2 m -95.79 87.01 0.37 Allowed Pre-proline 0 CA--C 1.591 2.545 0 CA-C-O 116.767 -1.587 . . . . 0.0 110.337 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.14 169.62 17.37 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 123.428 2.752 . . . . 0.0 113.689 170.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.79 156.92 24.69 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.519 1.128 . . . . 0.0 111.202 168.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.454 HG23 ' H ' ' A' ' 26' ' ' ILE 0.251 15.6 m -136.78 151.42 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.113 0.565 . . . . 0.0 111.728 -175.239 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.47 164.54 44.81 Favored Pre-proline 0 CA--C 1.584 2.264 0 CA-C-O 115.339 -2.267 . . . . 0.0 114.186 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -63.33 126.59 18.07 Favored 'Trans proline' 0 C--N 1.4 3.241 0 CA-C-N 126.251 3.268 . . . . 0.0 112.654 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t -80.96 123.67 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.9 p -134.21 106.77 7.32 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 103.668 -2.716 . . . . 0.0 103.668 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.454 ' H ' HG23 ' A' ' 20' ' ' VAL . 2.3 tt -69.87 162.15 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 127.368 2.267 . . . . 0.0 113.466 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.8 ttm-85 -144.07 111.6 6.02 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 102.506 -3.146 . . . . 0.0 102.506 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -100.33 108.76 20.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 111.732 -2.485 . . . . 0.0 105.477 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.493 1.722 0 O-C-N 124.479 1.112 . . . . 0.0 109.502 -168.454 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.34 128.05 40.6 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -84.73 126.33 33.31 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.116 0.966 . . . . 0.0 109.842 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.264 5.1 tt0 -121.22 92.05 3.66 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 171.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.27 130.99 55.15 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 171.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 m -108.2 128.03 54.35 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 112.479 -2.146 . . . . 0.0 106.625 -169.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.2 95.06 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.201 0 N-CA-C 100.428 -3.915 . . . . 0.0 100.428 -168.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.8 m -78.19 -18.96 54.82 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 169.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -99.02 138.57 35.93 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 120.55 1.523 . . . . 0.0 111.022 -169.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.7 m -106.12 104.0 13.61 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 100.994 -3.706 . . . . 0.0 100.994 166.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -92.17 98.3 11.44 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -113.32 121.27 43.88 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -170.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.73 -166.26 28.42 Favored Glycine 1 CA--C 1.58 4.104 0 CA-C-O 114.495 -3.392 . . . . 0.0 116.519 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -88.0 160.3 7.32 Favored 'Trans proline' 0 C--N 1.395 2.974 1 CA-C-N 126.737 5.269 . . . . 0.0 114.211 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.03 116.8 1.28 Allowed Glycine 0 N--CA 1.479 1.534 0 CA-C-O 118.194 -1.337 . . . . 0.0 110.602 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 t -97.03 90.67 0.82 Allowed Pre-proline 0 CA--C 1.587 2.392 0 CA-C-O 116.394 -1.765 . . . . 0.0 111.68 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.85 170.47 13.97 Favored 'Trans proline' 0 C--N 1.39 2.711 0 CA-C-N 124.287 2.567 . . . . 0.0 113.431 169.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -82.57 143.85 30.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.354 1.062 . . . . 0.0 109.806 168.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.302 19.0 m -140.53 161.56 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.052 0 CA-C-O 121.328 0.585 . . . . 0.0 111.896 -176.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.9 175.72 0.52 Allowed Pre-proline 0 CA--C 1.591 2.526 0 N-CA-C 118.786 2.884 . . . . 0.0 118.786 -168.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -80.9 122.73 4.41 Favored 'Trans proline' 0 C--N 1.404 3.471 0 CA-C-N 125.614 3.041 . . . . 0.0 110.635 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.7 t -78.71 115.86 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 174.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.4 p -125.44 106.34 9.74 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 tt -66.48 160.32 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.835 0 CA-C-N 111.956 -2.384 . . . . 0.0 113.049 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -136.85 107.97 6.77 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.2 m -94.92 109.55 21.54 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 109.764 -3.38 . . . . 0.0 105.425 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.737 0 C-N-CA 124.217 1.007 . . . . 0.0 111.033 -167.332 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -136.53 140.98 43.37 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.316 1.046 . . . . 0.0 110.086 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -87.63 143.99 26.9 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.564 0.746 . . . . 0.0 111.643 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -126.23 96.8 4.84 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 100.269 -3.975 . . . . 0.0 100.269 166.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.94 122.46 46.33 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.1 m -108.16 135.78 48.92 Favored 'General case' 0 CA--C 1.552 1.035 0 O-C-N 125.79 1.931 . . . . 0.0 106.685 -169.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.8 mp -132.23 98.94 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.329 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 -167.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m -117.69 8.49 12.8 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -118.53 127.26 53.45 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -168.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 m -97.51 112.49 24.32 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -102.85 119.65 39.21 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.3 mtm-85 -138.25 123.01 18.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -168.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.92 177.15 42.31 Favored Glycine 1 CA--C 1.581 4.198 0 CA-C-O 115.054 -3.081 . . . . 0.0 116.555 -178.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.88 160.07 21.22 Favored 'Trans proline' 0 C--N 1.395 2.999 1 CA-C-N 126.019 4.91 . . . . 0.0 113.97 -175.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.94 96.66 0.4 Allowed Glycine 0 N--CA 1.487 2.074 0 CA-C-O 117.315 -1.825 . . . . 0.0 111.174 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.252 4.0 p -102.3 95.43 5.87 Favored Pre-proline 0 CA--C 1.584 2.275 0 CA-C-O 115.978 -1.963 . . . . 0.0 114.192 -167.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -85.54 179.51 3.9 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 123.442 2.761 . . . . 0.0 114.006 173.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 p -61.68 161.81 9.43 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 125.616 1.566 . . . . 0.0 113.857 169.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.252 14.2 m -135.29 154.27 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 C-N-CA 122.983 0.513 . . . . 0.0 112.229 178.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.259 50.7 pttt -75.14 -172.2 0.25 Allowed Pre-proline 0 CA--C 1.601 2.919 0 CA-C-O 114.688 -2.577 . . . . 0.0 116.46 -176.069 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.79 122.16 3.4 Favored 'Trans proline' 0 C--N 1.4 3.263 0 CA-C-N 126.539 3.371 . . . . 0.0 110.806 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.64 131.98 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 179.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -137.4 106.87 6.12 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 -177.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.53 162.91 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 CA-C-N 112.173 -2.285 . . . . 0.0 113.584 -178.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -137.93 108.63 6.62 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 101.87 -3.382 . . . . 0.0 101.87 166.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.1 t -98.07 109.34 22.11 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 111.558 -2.565 . . . . 0.0 105.673 171.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 124.601 1.188 . . . . 0.0 110.1 -167.824 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -139.57 137.46 35.4 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 124.4 1.08 . . . . 0.0 109.882 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -84.85 121.84 28.3 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 117.404 -1.284 . . . . 0.0 109.517 -179.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -109.17 98.56 7.98 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 170.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.93 120.26 41.8 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.4 m -107.38 130.71 54.77 Favored 'General case' 0 CA--C 1.554 1.108 0 O-C-N 125.314 1.634 . . . . 0.0 106.817 -168.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.73 96.35 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.195 0 N-CA-C 100.522 -3.881 . . . . 0.0 100.522 -167.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.8 p -78.16 -19.07 54.72 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 169.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -98.6 140.66 32.49 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 120.443 1.474 . . . . 0.0 111.102 -169.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.0 m -107.02 100.19 9.7 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 101.058 -3.682 . . . . 0.0 101.058 167.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -94.14 110.72 22.42 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -175.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.46 116.59 20.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -167.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.98 -172.21 28.0 Favored Glycine 1 CA--C 1.583 4.286 0 CA-C-O 114.613 -3.326 . . . . 0.0 115.059 177.487 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -86.48 162.81 9.57 Favored 'Trans proline' 0 C--N 1.394 2.933 1 CA-C-N 126.892 5.346 . . . . 0.0 114.332 -175.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.32 113.81 1.38 Allowed Glycine 0 N--CA 1.481 1.649 0 CA-C-O 117.643 -1.643 . . . . 0.0 110.089 176.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.3 m -102.56 85.62 0.8 Allowed Pre-proline 0 CA--C 1.588 2.439 0 CA-C-O 117.021 -1.466 . . . . 0.0 111.942 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.02 173.41 9.07 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 123.258 2.638 . . . . 0.0 113.791 169.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -77.44 147.71 35.81 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.443 1.097 . . . . 0.0 110.358 167.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 31.2 m -139.08 152.21 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.828 0 O-C-N 123.556 0.535 . . . . 0.0 112.052 -173.173 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -17.45 146.57 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.265 0 CA-C-O 112.784 -3.484 . . . . 0.0 119.713 170.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.98 116.57 4.44 Favored 'Trans proline' 0 C--N 1.395 2.991 0 CA-C-N 126.614 3.398 . . . . 0.0 109.616 168.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.0 t -77.72 115.78 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 176.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.2 p -118.56 104.14 10.38 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 -174.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.282 1.3 tt -67.3 167.55 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 111.455 -2.611 . . . . 0.0 113.66 179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -144.65 112.19 6.14 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 168.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.4 t -95.82 98.05 10.14 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 168.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 N--CA 1.492 1.668 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.349 -165.963 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -139.46 125.64 20.04 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.264 1.026 . . . . 0.0 108.862 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -112.61 145.09 41.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 124.185 0.928 . . . . 0.0 112.201 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.27 3.2 tt0 -126.04 95.04 4.27 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 102.176 -3.268 . . . . 0.0 102.176 168.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -111.12 124.7 52.72 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.3 m -109.59 134.43 51.94 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 125.495 1.747 . . . . 0.0 106.528 -168.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.97 99.04 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.293 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 -167.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.5 m -115.68 9.66 15.29 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 169.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -120.64 127.51 52.15 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -168.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.445 HG21 ' HE ' ' A' ' 13' ' ' ARG . 6.3 m -96.96 117.46 31.2 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 178.276 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -106.5 113.02 26.29 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.445 ' HE ' HG21 ' A' ' 11' ' ' THR . 82.5 mtt180 -127.02 121.46 31.68 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -169.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.18 -160.31 13.28 Favored Glycine 1 CA--C 1.58 4.123 0 CA-C-O 114.466 -3.408 . . . . 0.0 116.297 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -90.71 156.86 4.21 Favored 'Trans proline' 0 C--N 1.397 3.096 1 CA-C-N 126.271 5.035 . . . . 0.0 114.487 -176.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.22 109.99 0.51 Allowed Glycine 0 N--CA 1.482 1.703 0 CA-C-O 117.954 -1.47 . . . . 0.0 111.261 174.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.323 1.3 p -108.38 82.37 1.6 Allowed Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 116.69 -1.624 . . . . 0.0 112.197 -171.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.84 -178.8 3.39 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 123.619 2.879 . . . . 0.0 113.684 172.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 p -61.79 158.31 16.09 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.446 1.498 . . . . 0.0 113.937 169.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.25 12.7 m -132.92 154.86 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.858 0 C-N-CA 123.358 0.663 . . . . 0.0 111.752 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 163.95 58.06 Favored Pre-proline 0 CA--C 1.583 2.248 0 CA-C-O 115.338 -2.267 . . . . 0.0 114.659 -179.447 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -64.81 128.35 20.72 Favored 'Trans proline' 0 C--N 1.4 3.245 0 CA-C-N 126.058 3.199 . . . . 0.0 112.661 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.25 130.1 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 175.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.2 p -139.14 108.51 6.13 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 102.907 -2.997 . . . . 0.0 102.907 -178.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 tt -70.06 163.2 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 C-N-CA 126.918 2.087 . . . . 0.0 113.685 -174.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -119.64 134.85 55.06 Favored 'General case' 0 CA--C 1.543 0.677 1 N-CA-C 97.397 -5.038 . . . . 0.0 97.397 163.205 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.0 t -106.17 65.0 0.68 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.689 1.233 . . . . 0.0 108.001 162.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.327 10.3 pt-20 . . . . . 0 N--CA 1.493 1.697 0 C-N-CA 126.08 1.752 . . . . 0.0 107.798 -170.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -146.29 128.28 15.52 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.15 128.24 35.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.542 0.737 . . . . 0.0 110.351 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.279 9.4 tt0 -112.92 96.83 6.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 101.216 -3.624 . . . . 0.0 101.216 168.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.4 109.93 19.84 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 -176.303 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 m -96.39 127.75 42.68 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.243 -167.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mm -119.12 86.82 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.112 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 -167.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.6 p -88.42 -16.06 33.87 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 168.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.52 139.41 30.56 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.582 1.153 . . . . 0.0 110.356 -170.148 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.468 HG22 ' HE ' ' A' ' 13' ' ' ARG . 5.0 m -110.93 110.47 21.06 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 102.782 -3.044 . . . . 0.0 102.782 169.059 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -98.94 115.75 29.6 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.31 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.468 ' HE ' HG22 ' A' ' 11' ' ' THR . 65.2 mtt180 -128.22 122.61 32.19 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -173.028 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.53 -155.71 11.1 Favored Glycine 0 CA--C 1.578 3.982 0 CA-C-O 114.452 -3.416 . . . . 0.0 115.856 176.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -87.94 161.58 7.44 Favored 'Trans proline' 0 C--N 1.394 2.942 1 CA-C-N 126.393 5.096 . . . . 0.0 114.024 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.64 117.02 1.42 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-O 118.235 -1.314 . . . . 0.0 110.481 173.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.5 m -102.46 84.47 0.63 Allowed Pre-proline 0 CA--C 1.588 2.407 0 CA-C-O 116.766 -1.588 . . . . 0.0 111.129 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.91 174.07 9.73 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 123.399 2.732 . . . . 0.0 113.958 171.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.51 155.4 36.17 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.556 1.143 . . . . 0.0 112.05 168.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.268 13.4 m -137.08 156.63 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -169.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -63.64 165.59 11.67 Favored Pre-proline 0 CA--C 1.58 2.132 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.67 111.32 3.27 Favored 'Trans proline' 0 C--N 1.396 3.052 0 C-N-CA 123.149 2.566 . . . . 0.0 109.944 169.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -74.64 124.11 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 172.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -137.76 108.78 6.74 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 -178.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.264 1.1 tt -69.49 164.36 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 C-N-CA 126.91 2.084 . . . . 0.0 113.718 -174.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -139.35 113.76 9.03 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 167.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.4 t -95.78 115.91 28.12 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 111.606 -2.543 . . . . 0.0 106.943 171.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.493 1.686 0 C-N-CA 124.162 0.985 . . . . 0.0 110.098 -168.221 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -140.78 124.2 16.78 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.301 1.04 . . . . 0.0 108.4 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -86.16 128.07 34.83 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 124.088 0.868 . . . . 0.0 110.33 -179.405 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.259 7.1 tt0 -112.0 97.86 6.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 100.855 -3.757 . . . . 0.0 100.855 168.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.48 108.18 16.85 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -177.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 m -96.36 126.17 41.37 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 113.369 -1.741 . . . . 0.0 106.817 -167.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 mm -115.16 90.96 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.088 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 -166.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.7 m -125.64 4.74 7.5 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.495 169.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.74 119.52 36.95 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -169.245 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 m -96.58 120.81 37.6 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 -171.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -112.38 118.37 35.01 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -138.37 116.88 12.07 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -168.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.63 -155.34 9.92 Favored Glycine 1 CA--C 1.579 4.054 0 CA-C-O 114.345 -3.475 . . . . 0.0 115.373 178.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -88.12 161.63 7.17 Favored 'Trans proline' 0 C--N 1.394 2.935 1 CA-C-N 126.728 5.264 . . . . 0.0 114.131 -178.394 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.28 115.72 1.47 Allowed Glycine 0 N--CA 1.479 1.519 0 CA-C-O 118.058 -1.412 . . . . 0.0 110.443 174.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.2 m -101.56 85.7 0.68 Allowed Pre-proline 0 CA--C 1.587 2.376 0 CA-C-O 116.716 -1.611 . . . . 0.0 111.295 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.48 173.51 10.54 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 123.31 2.673 . . . . 0.0 113.827 171.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -75.48 155.3 36.35 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.557 1.143 . . . . 0.0 111.963 168.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.27 19.4 m -136.96 153.3 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 123.503 0.502 . . . . 0.0 111.98 -173.175 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.98 48.41 Favored Pre-proline 0 CA--C 1.585 2.292 0 CA-C-O 115.241 -2.314 . . . . 0.0 114.688 -179.441 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -63.68 130.21 27.29 Favored 'Trans proline' 0 C--N 1.4 3.249 0 CA-C-N 126.34 3.3 . . . . 0.0 113.006 177.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -77.99 122.7 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 171.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 p -137.36 109.18 7.08 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 0.9 OUTLIER -68.8 164.5 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 C-N-CA 126.84 2.056 . . . . 0.0 113.685 -174.959 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -141.03 113.11 7.84 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 167.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.1 t -97.81 114.15 26.12 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 111.524 -2.58 . . . . 0.0 106.411 170.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 124.055 0.847 . . . . 0.0 110.005 -168.695 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.93 139.75 38.1 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 124.265 1.026 . . . . 0.0 109.672 179.44 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -80.0 139.54 36.94 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 117.338 -1.315 . . . . 0.0 111.78 -177.067 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -121.22 97.58 5.58 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 102.503 -3.147 . . . . 0.0 102.503 168.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.58 119.63 39.8 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 -178.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -107.13 130.03 54.75 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 125.652 1.845 . . . . 0.0 106.174 -168.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.03 97.6 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.335 0 N-CA-C 100.469 -3.901 . . . . 0.0 100.469 -167.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m -121.35 5.14 10.22 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -113.52 125.55 54.33 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -168.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -97.92 108.35 21.04 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 -173.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -101.86 112.08 24.57 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -176.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.75 121.24 26.48 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -168.541 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.03 170.8 42.69 Favored Glycine 1 CA--C 1.581 4.218 0 CA-C-O 115.102 -3.054 . . . . 0.0 116.325 -177.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.46 162.76 22.07 Favored 'Trans proline' 0 C--N 1.394 2.938 1 CA-C-N 125.805 4.802 . . . . 0.0 114.153 -176.294 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.08 91.54 0.81 Allowed Glycine 0 N--CA 1.486 2.003 0 CA-C-O 117.379 -1.79 . . . . 0.0 110.38 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.9 m -85.7 102.49 2.63 Favored Pre-proline 0 CA--C 1.589 2.472 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -166.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -79.68 179.37 6.37 Favored 'Trans proline' 0 CA--C 1.58 2.796 0 C-N-CA 123.199 2.599 . . . . 0.0 112.158 166.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.303 9.9 t -105.24 155.97 18.57 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 123.841 0.856 . . . . 0.0 109.025 167.091 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.0 m -120.31 155.42 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 C-N-CA 124.22 1.008 . . . . 0.0 112.151 -165.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 179.79 1.58 Allowed Pre-proline 0 CA--C 1.6 2.869 0 CA-C-O 116.232 -1.842 . . . . 0.0 112.935 -179.342 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -75.23 125.6 9.28 Favored 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 123.654 2.903 . . . . 0.0 111.088 177.391 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.7 t -77.31 138.85 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.9 p -141.4 106.09 4.9 Favored 'General case' 0 CA--C 1.558 1.272 0 N-CA-C 104.54 -2.392 . . . . 0.0 104.54 -176.042 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.253 1.6 tt -72.91 159.95 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.741 0 C-N-CA 127.14 2.176 . . . . 0.0 113.653 -178.203 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -145.42 103.53 3.83 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 105.896 -1.891 . . . . 0.0 105.896 168.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.9 t -91.89 98.02 11.33 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 111.951 -2.386 . . . . 0.0 104.729 169.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 . . . . . 0 N--CA 1.492 1.647 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.983 -165.51 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -136.25 141.04 43.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 124.312 1.045 . . . . 0.0 110.148 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -88.75 142.84 27.33 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.559 0.744 . . . . 0.0 111.404 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.251 4.0 tt0 -125.49 96.93 4.98 Favored 'General case' 0 N--CA 1.487 1.387 1 N-CA-C 100.15 -4.018 . . . . 0.0 100.15 166.704 . . . . . . . . 3 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.89 124.2 50.02 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 m -106.56 132.26 52.77 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 125.576 1.797 . . . . 0.0 107.357 -168.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.8 mp -136.32 95.83 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.179 0 N-CA-C 100.998 -3.704 . . . . 0.0 100.998 -168.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.6 m -78.51 -17.92 55.52 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 169.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -101.73 141.25 34.87 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.612 1.551 . . . . 0.0 111.231 -169.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -104.51 102.84 12.46 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 165.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -92.42 115.23 27.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -178.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -131.54 122.32 25.93 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -168.261 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.22 172.21 42.76 Favored Glycine 1 CA--C 1.58 4.12 0 CA-C-O 115.139 -3.034 . . . . 0.0 116.542 -177.402 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.12 159.69 23.62 Favored 'Trans proline' 0 C--N 1.395 3.009 1 CA-C-N 125.896 4.848 . . . . 0.0 113.962 -175.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.99 97.11 0.39 Allowed Glycine 0 N--CA 1.488 2.103 0 CA-C-O 117.346 -1.808 . . . . 0.0 111.151 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.253 4.0 p -101.44 95.93 5.62 Favored Pre-proline 0 CA--C 1.583 2.241 0 CA-C-O 115.932 -1.985 . . . . 0.0 114.02 -167.459 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -84.03 178.52 5.27 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 123.497 2.798 . . . . 0.0 113.88 173.447 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -63.72 161.23 15.47 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 125.454 1.502 . . . . 0.0 114.095 169.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.418 HG21 ' H ' ' A' ' 26' ' ' ILE . 12.3 m -134.1 152.78 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 C-N-CA 123.42 0.688 . . . . 0.0 111.682 -179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.28 164.54 49.53 Favored Pre-proline 0 CA--C 1.585 2.289 0 CA-C-O 115.305 -2.283 . . . . 0.0 114.219 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -64.28 126.5 17.17 Favored 'Trans proline' 0 C--N 1.398 3.179 0 CA-C-N 126.203 3.251 . . . . 0.0 112.503 177.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.6 t -79.73 127.73 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 176.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.6 p -135.92 106.22 6.4 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 -176.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.418 ' H ' HG21 ' A' ' 20' ' ' VAL . 1.2 tt -71.46 164.06 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.829 0 CA-C-N 111.983 -2.371 . . . . 0.0 113.54 -178.335 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -139.0 108.0 6.01 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 101.776 -3.416 . . . . 0.0 101.776 165.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.6 t -98.02 108.98 21.8 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 111.664 -2.517 . . . . 0.0 105.637 172.227 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 124.67 1.231 . . . . 0.0 110.164 -167.774 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -138.5 136.6 36.3 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.349 1.06 . . . . 0.0 109.664 179.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -87.65 142.02 28.16 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.45 0.7 . . . . 0.0 111.4 -178.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.254 4.2 tt0 -124.72 96.87 5.05 Favored 'General case' 0 N--CA 1.488 1.43 1 N-CA-C 100.185 -4.005 . . . . 0.0 100.185 166.639 . . . . . . . . 3 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.24 123.67 49.42 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -106.57 131.71 53.42 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 113.23 -1.805 . . . . 0.0 107.194 -168.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.24 95.9 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.172 0 N-CA-C 101.002 -3.703 . . . . 0.0 101.002 -168.507 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.7 m -78.57 -18.1 55.12 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 169.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -101.41 141.09 34.8 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 120.622 1.555 . . . . 0.0 111.247 -169.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -104.6 102.65 12.25 Favored 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 100.928 -3.731 . . . . 0.0 100.928 165.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -92.68 115.0 27.71 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 -178.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -131.22 122.03 25.83 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -168.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.2 171.8 42.61 Favored Glycine 1 CA--C 1.58 4.132 0 CA-C-O 115.102 -3.054 . . . . 0.0 116.694 -177.149 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.96 159.64 24.11 Favored 'Trans proline' 0 C--N 1.394 2.965 1 CA-C-N 125.775 4.787 . . . . 0.0 113.958 -175.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.8 96.89 0.38 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-O 117.324 -1.82 . . . . 0.0 111.107 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.253 3.8 p -101.44 95.97 5.66 Favored Pre-proline 0 CA--C 1.582 2.209 0 CA-C-O 115.893 -2.003 . . . . 0.0 114.048 -167.504 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -83.93 178.0 5.69 Favored 'Trans proline' 0 C--N 1.394 2.95 0 C-N-CA 123.479 2.786 . . . . 0.0 113.912 173.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -63.9 161.11 16.21 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 125.35 1.46 . . . . 0.0 114.062 169.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.443 HG23 ' H ' ' A' ' 26' ' ' ILE . 13.1 m -134.84 152.55 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 123.353 0.661 . . . . 0.0 111.589 -179.636 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 164.73 49.69 Favored Pre-proline 0 CA--C 1.583 2.243 0 CA-C-O 115.341 -2.266 . . . . 0.0 114.225 179.644 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -64.34 126.09 16.34 Favored 'Trans proline' 0 C--N 1.399 3.226 0 CA-C-N 126.179 3.243 . . . . 0.0 112.373 177.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.4 t -79.48 127.82 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 176.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -137.42 106.03 5.85 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 123.724 1.726 . . . . 0.0 108.528 -178.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.443 ' H ' HG23 ' A' ' 20' ' ' VAL . 1.3 tt -70.9 162.29 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 CA-C-N 109.109 -3.678 . . . . 0.0 113.663 -176.045 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -138.01 107.67 6.23 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 101.934 -3.358 . . . . 0.0 101.934 165.499 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -97.97 107.51 20.0 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 111.469 -2.605 . . . . 0.0 105.617 171.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 124.657 1.223 . . . . 0.0 109.947 -167.91 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -141.4 122.86 14.99 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -82.46 123.5 29.21 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 117.535 -1.222 . . . . 0.0 110.0 -175.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -108.66 95.96 6.01 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 170.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.56 119.24 38.86 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 179.346 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.0 m -107.52 130.15 54.89 Favored 'General case' 0 CA--C 1.554 1.132 0 O-C-N 125.323 1.639 . . . . 0.0 106.66 -168.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.37 96.34 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.184 0 N-CA-C 100.572 -3.862 . . . . 0.0 100.572 -167.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.6 m -78.79 -19.06 53.07 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 169.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -96.58 139.71 32.27 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 120.621 1.555 . . . . 0.0 111.03 -169.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 m -107.93 99.86 9.27 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 101.098 -3.667 . . . . 0.0 101.098 167.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -94.11 110.93 22.61 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -176.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.27 116.82 20.45 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -167.805 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.01 -164.63 20.8 Favored Glycine 1 CA--C 1.582 4.231 0 CA-C-O 114.687 -3.285 . . . . 0.0 115.464 177.528 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -88.01 162.65 7.35 Favored 'Trans proline' 0 C--N 1.394 2.945 1 CA-C-N 126.554 5.177 . . . . 0.0 114.204 -177.075 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.82 114.95 1.55 Allowed Glycine 0 N--CA 1.48 1.569 0 CA-C-O 117.861 -1.522 . . . . 0.0 110.097 174.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.2 t -101.23 85.92 0.67 Allowed Pre-proline 0 CA--C 1.588 2.411 0 CA-C-O 116.864 -1.541 . . . . 0.0 112.432 -175.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.12 171.72 11.28 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 123.134 2.556 . . . . 0.0 113.33 168.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.81 147.13 31.92 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.195 0.998 . . . . 0.0 110.467 167.816 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.266 29.8 m -138.09 154.42 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 O-C-N 123.743 0.652 . . . . 0.0 111.934 -169.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -28.0 148.52 0.03 OUTLIER Pre-proline 0 CA--C 1.585 2.298 0 CA-C-O 113.145 -3.312 . . . . 0.0 118.884 174.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.74 116.83 4.72 Favored 'Trans proline' 0 C--N 1.395 3.014 0 CA-C-N 126.546 3.374 . . . . 0.0 109.828 168.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.9 t -80.23 112.58 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 103.84 -2.652 . . . . 0.0 103.84 177.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.6 p -115.37 102.42 9.82 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -173.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.263 1.7 tt -68.28 163.05 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-N 111.159 -2.746 . . . . 0.0 114.026 -179.173 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -145.14 106.23 4.17 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 167.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 81.2 m -92.43 91.35 7.6 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 111.362 -2.654 . . . . 0.0 104.769 172.426 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 . . . . . 0 N--CA 1.493 1.677 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.79 -165.383 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.2 p . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -140.44 123.9 16.96 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 118.056 -0.974 . . . . 0.0 108.783 178.154 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -89.81 135.86 33.38 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 124.391 1.057 . . . . 0.0 110.23 174.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.287 3.4 tt0 -119.32 95.71 4.91 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 102.626 -3.101 . . . . 0.0 102.626 169.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.38 123.71 50.15 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -176.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -105.75 134.22 49.23 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 125.489 1.743 . . . . 0.0 107.679 -168.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp -137.75 95.25 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 N-CA-C 100.961 -3.718 . . . . 0.0 100.961 -168.514 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.9 p -78.41 -16.66 57.37 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 169.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -103.41 141.54 35.79 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 120.173 1.351 . . . . 0.0 111.082 -169.533 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 m -105.05 105.74 15.92 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 100.995 -3.706 . . . . 0.0 100.995 166.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -93.5 110.44 22.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -122.45 116.6 24.24 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -169.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.89 164.97 36.76 Favored Glycine 1 CA--C 1.58 4.096 0 CA-C-O 114.975 -3.125 . . . . 0.0 116.693 -174.187 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.79 159.16 21.52 Favored 'Trans proline' 0 C--N 1.395 3.008 1 CA-C-N 125.739 4.77 . . . . 0.0 114.303 -174.173 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.72 95.17 0.41 Allowed Glycine 0 N--CA 1.487 2.071 0 CA-C-O 117.144 -1.92 . . . . 0.0 111.375 177.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.4 m -74.09 108.12 4.57 Favored Pre-proline 0 CA--C 1.586 2.358 0 CA-C-O 115.662 -2.113 . . . . 0.0 114.818 -167.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.73 169.44 18.22 Favored 'Trans proline' 0 C--N 1.39 2.727 0 CA-C-N 124.683 2.708 . . . . 0.0 113.663 169.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.88 149.88 26.07 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.127 0.971 . . . . 0.0 110.519 168.635 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.71 148.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 123.712 0.805 . . . . 0.0 111.491 -169.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 166.68 33.96 Favored Pre-proline 0 CA--C 1.586 2.345 0 CA-C-O 115.097 -2.383 . . . . 0.0 113.176 175.66 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.74 125.72 11.93 Favored 'Trans proline' 0 C--N 1.4 3.249 0 CA-C-N 127.032 3.547 . . . . 0.0 111.341 -177.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.64 129.14 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.625 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -136.53 107.28 6.6 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 123.767 1.746 . . . . 0.0 108.261 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 tt -70.88 160.12 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 CA-C-N 109.124 -3.671 . . . . 0.0 114.042 -172.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -135.45 94.73 3.15 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 166.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.0 t -93.17 117.55 30.2 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 111.16 -2.745 . . . . 0.0 106.596 170.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.29 14.3 pt-20 . . . . . 0 N--CA 1.497 1.911 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -166.8 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.97 130.24 33.35 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.159 0.983 . . . . 0.0 109.064 176.519 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -87.82 140.29 29.66 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.979 0.799 . . . . 0.0 110.333 174.32 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.54 100.94 6.89 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 101.916 -3.365 . . . . 0.0 101.916 169.018 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -113.97 123.75 50.49 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.411 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -107.08 131.33 54.23 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 125.38 1.675 . . . . 0.0 107.124 -168.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.32 95.89 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.198 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 -168.187 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.6 m -78.78 -17.69 55.35 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 169.921 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -100.15 139.87 35.21 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 120.657 1.571 . . . . 0.0 111.054 -169.63 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.1 m -105.57 102.29 11.76 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 100.906 -3.739 . . . . 0.0 100.906 166.212 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -92.42 117.84 30.33 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -178.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -136.22 123.28 21.56 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -167.776 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.36 -156.53 12.57 Favored Glycine 1 CA--C 1.579 4.091 0 CA-C-O 114.501 -3.388 . . . . 0.0 115.698 176.573 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -88.95 161.93 5.98 Favored 'Trans proline' 0 C--N 1.395 2.984 1 CA-C-N 126.268 5.034 . . . . 0.0 114.339 -178.965 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.42 113.71 0.76 Allowed Glycine 0 N--CA 1.481 1.637 0 CA-C-O 117.656 -1.636 . . . . 0.0 110.597 173.358 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.4 m -98.78 89.3 0.84 Allowed Pre-proline 0 CA--C 1.587 2.401 0 CA-C-O 116.554 -1.688 . . . . 0.0 111.906 -175.448 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.04 172.72 12.66 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.298 2.665 . . . . 0.0 113.632 169.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.05 156.54 37.38 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.581 1.152 . . . . 0.0 112.394 168.786 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 26' ' ' ILE 0.26 13.3 m -134.45 154.64 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.841 0 O-C-N 123.685 0.615 . . . . 0.0 112.225 -170.347 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -64.94 164.59 20.54 Favored Pre-proline 0 CA--C 1.581 2.135 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 -178.418 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.58 107.98 2.43 Favored 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 123.199 2.6 . . . . 0.0 110.034 169.9 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.61 126.27 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 176.454 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.7 p -135.8 106.98 6.75 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 -176.333 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.43 ' H ' HG22 ' A' ' 20' ' ' VAL 0.253 1.9 tt -69.17 163.51 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.87 0 CA-C-N 111.932 -2.394 . . . . 0.0 113.465 -179.314 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -139.53 108.03 5.87 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 103.048 -2.945 . . . . 0.0 103.048 167.624 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 17.5 t -98.35 123.92 42.72 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 111.019 -2.809 . . . . 0.0 106.735 169.643 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.285 14.8 pt-20 . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -167.82 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -140.12 131.31 26.51 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.155 0.982 . . . . 0.0 109.697 179.395 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -84.08 135.65 34.32 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 124.543 1.152 . . . . 0.0 110.523 179.197 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.268 8.0 tt0 -119.81 99.14 6.46 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 100.999 -3.704 . . . . 0.0 100.999 170.285 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.69 123.62 49.27 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 177.077 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 m -107.84 131.09 54.86 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -169.442 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 mp -127.85 96.9 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.349 0 N-CA-C 100.42 -3.918 . . . . 0.0 100.42 -167.765 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m -120.35 7.17 10.66 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 170.101 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -115.83 125.27 52.46 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -169.065 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.425 HG23 ' HE ' ' A' ' 13' ' ' ARG . 5.9 m -95.97 116.4 28.88 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 -177.654 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -105.57 113.89 27.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.735 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.425 ' HE ' HG23 ' A' ' 11' ' ' THR . 66.6 mtt180 -128.34 117.54 21.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -169.828 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.22 -166.24 20.64 Favored Glycine 1 CA--C 1.582 4.266 0 CA-C-O 114.199 -3.556 . . . . 0.0 115.986 179.445 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -89.47 163.04 5.43 Favored 'Trans proline' 0 C--N 1.395 3.019 1 CA-C-N 127.293 5.547 . . . . 0.0 114.601 -177.816 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.27 128.32 4.08 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 m -98.48 84.17 0.33 Allowed Pre-proline 0 CA--C 1.591 2.557 0 CA-C-O 117.296 -1.335 . . . . 0.0 112.244 177.917 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -80.71 174.92 10.56 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.124 2.55 . . . . 0.0 112.482 167.761 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.299 8.8 t -106.47 153.8 21.76 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 167.735 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 m -121.96 159.79 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 C-N-CA 124.389 1.076 . . . . 0.0 111.958 -165.732 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 163.42 65.28 Favored Pre-proline 0 CA--C 1.585 2.321 0 CA-C-O 115.28 -2.295 . . . . 0.0 114.782 176.406 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -64.31 134.02 40.21 Favored 'Trans proline' 0 C--N 1.399 3.203 0 CA-C-N 126.162 3.236 . . . . 0.0 113.503 -179.532 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.3 t -77.04 133.53 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.676 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -142.53 108.44 5.16 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 103.428 -2.805 . . . . 0.0 103.428 -178.212 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.256 3.3 tt -70.93 160.92 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 C-N-CA 127.233 2.213 . . . . 0.0 113.027 -179.275 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -145.97 115.07 7.01 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 102.565 -3.124 . . . . 0.0 102.565 169.12 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.48 110.21 22.7 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 111.977 -2.374 . . . . 0.0 106.23 169.646 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 124.472 1.108 . . . . 0.0 109.389 -168.666 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.43 130.61 17.45 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.757 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -84.47 137.15 33.52 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.874 178.16 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.25 8.2 tt0 -121.05 99.61 6.6 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 100.965 -3.717 . . . . 0.0 100.965 169.038 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.24 122.92 46.4 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.093 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.29 136.14 47.6 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 125.67 1.856 . . . . 0.0 106.926 -169.267 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.2 mp -133.08 98.28 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.299 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 -167.829 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t -119.05 10.65 12.21 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 169.815 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -119.97 126.08 49.97 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -169.073 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 m -97.07 112.01 23.98 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -177.2 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -103.38 118.62 37.18 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -178.921 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -139.57 124.82 18.95 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -168.013 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.54 -156.15 9.76 Favored Glycine 1 CA--C 1.578 4.022 0 CA-C-O 114.478 -3.401 . . . . 0.0 115.734 177.241 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.58 161.07 9.4 Favored 'Trans proline' 0 C--N 1.394 2.969 1 CA-C-N 126.429 5.114 . . . . 0.0 113.833 -178.421 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.91 118.51 1.37 Allowed Glycine 0 N--CA 1.479 1.516 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.093 176.571 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -100.2 84.56 0.45 Allowed Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 117.036 -1.459 . . . . 0.0 112.702 -179.021 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.99 172.29 12.1 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 123.116 2.544 . . . . 0.0 112.953 168.585 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.289 9.5 t -93.45 157.85 16.01 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 123.457 0.703 . . . . 0.0 109.281 167.775 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.5 m -126.61 158.97 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 C-N-CA 124.131 0.972 . . . . 0.0 112.244 -166.277 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -73.99 -176.07 0.47 Allowed Pre-proline 0 CA--C 1.609 3.226 0 CA-C-O 115.142 -2.361 . . . . 0.0 113.717 -179.495 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -84.02 129.54 4.65 Favored 'Trans proline' 0 C--N 1.394 2.955 0 CA-C-N 126.606 3.395 . . . . 0.0 111.476 -178.634 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.12 133.96 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 175.443 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.8 p -141.75 107.23 5.04 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 103.656 -2.72 . . . . 0.0 103.656 -176.619 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.266 1.4 tt -71.34 162.61 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 C-N-CA 127.255 2.222 . . . . 0.0 112.7 -179.077 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -142.65 123.94 14.67 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 169.019 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.8 t -95.31 123.76 38.99 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 111.789 -2.46 . . . . 0.0 108.391 169.536 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 . . . . . 0 N--CA 1.492 1.629 0 C-N-CA 124.176 0.991 . . . . 0.0 109.663 -169.269 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -147.52 127.28 13.44 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 178.696 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -86.4 140.45 29.99 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.118 0.567 . . . . 0.0 111.086 178.52 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.258 8.2 tt0 -124.56 96.46 4.91 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 100.665 -3.828 . . . . 0.0 100.665 166.785 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.99 123.33 46.65 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -177.016 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -107.77 135.72 48.71 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 125.853 1.97 . . . . 0.0 106.928 -169.143 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.45 98.39 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.314 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 -167.956 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.5 m -118.5 8.64 12.11 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 169.825 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -118.36 126.9 53.06 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -168.852 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -97.01 112.41 24.18 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 -178.284 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -103.59 119.26 38.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -179.671 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -138.57 120.43 15.39 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -168.485 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.11 178.75 42.18 Favored Glycine 1 CA--C 1.582 4.22 0 CA-C-O 115.054 -3.081 . . . . 0.0 116.866 -177.406 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.31 159.45 17.46 Favored 'Trans proline' 0 C--N 1.395 2.992 1 CA-C-N 125.877 4.839 . . . . 0.0 114.088 -174.994 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.03 96.37 0.41 Allowed Glycine 0 N--CA 1.488 2.127 0 CA-C-O 117.322 -1.821 . . . . 0.0 111.163 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.25 3.1 p -100.57 96.02 4.93 Favored Pre-proline 0 CA--C 1.583 2.234 0 CA-C-O 115.949 -1.977 . . . . 0.0 113.948 -167.414 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -83.5 178.81 5.38 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 123.516 2.81 . . . . 0.0 113.796 173.149 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 p -64.57 160.57 19.27 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.291 1.437 . . . . 0.0 113.817 169.554 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.44 HG21 ' H ' ' A' ' 26' ' ' ILE . 12.4 m -134.29 152.23 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 123.334 0.654 . . . . 0.0 111.73 -178.262 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.71 164.09 48.58 Favored Pre-proline 0 CA--C 1.583 2.227 0 CA-C-O 115.336 -2.269 . . . . 0.0 114.213 178.952 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -63.74 126.87 18.32 Favored 'Trans proline' 0 C--N 1.399 3.223 0 CA-C-N 126.216 3.256 . . . . 0.0 112.686 178.575 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t -81.01 124.6 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 176.648 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.4 p -133.81 105.85 7.01 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -176.72 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.44 ' H ' HG21 ' A' ' 20' ' ' VAL . 1.4 tt -71.58 160.98 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.775 0 CA-C-N 112.009 -2.36 . . . . 0.0 113.471 -177.411 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -136.45 105.21 5.85 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 102.392 -3.188 . . . . 0.0 102.392 165.409 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.4 t -94.9 112.97 24.65 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 111.258 -2.701 . . . . 0.0 106.102 173.239 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 124.621 1.201 . . . . 0.0 111.228 -167.428 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -140.47 125.94 18.96 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.292 1.037 . . . . 0.0 108.767 179.722 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -88.2 139.92 30.01 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 124.005 0.816 . . . . 0.0 111.184 179.211 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -123.56 98.52 5.87 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 101.996 -3.335 . . . . 0.0 101.996 168.356 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.05 122.68 48.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 178.747 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -106.96 130.66 54.58 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 125.353 1.658 . . . . 0.0 107.029 -168.718 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp -136.12 96.22 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.182 0 N-CA-C 100.635 -3.839 . . . . 0.0 100.635 -168.271 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.8 p -77.97 -18.87 55.5 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 169.84 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -100.31 141.14 33.57 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.417 1.462 . . . . 0.0 111.068 -169.607 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.8 m -106.09 100.46 10.0 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 166.926 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -93.46 109.9 21.48 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 -175.599 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.93 118.5 25.54 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -168.146 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.9 169.02 40.61 Favored Glycine 1 CA--C 1.582 4.22 0 CA-C-O 115.097 -3.057 . . . . 0.0 116.35 -176.343 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.45 160.89 22.53 Favored 'Trans proline' 0 C--N 1.395 2.987 1 CA-C-N 125.834 4.817 . . . . 0.0 114.29 -174.092 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.36 95.8 0.37 Allowed Glycine 0 N--CA 1.487 2.062 0 CA-C-O 116.921 -2.044 . . . . 0.0 111.465 178.017 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.8 m -78.98 106.59 4.59 Favored Pre-proline 0 CA--C 1.587 2.368 0 CA-C-O 115.755 -2.069 . . . . 0.0 113.943 -167.639 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -80.07 171.38 15.29 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 123.428 2.752 . . . . 0.0 113.828 170.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.82 153.69 28.95 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.358 1.063 . . . . 0.0 110.746 168.008 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.45 HG23 ' H ' ' A' ' 26' ' ' ILE 0.25 11.4 m -129.55 152.21 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 123.211 0.604 . . . . 0.0 112.497 -168.845 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.13 165.63 31.47 Favored Pre-proline 0 CA--C 1.581 2.16 0 CA-C-O 115.814 -2.041 . . . . 0.0 116.332 -179.611 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.69 106.91 2.2 Favored 'Trans proline' 0 C--N 1.395 3.017 0 C-N-CA 123.12 2.547 . . . . 0.0 109.958 169.73 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.3 t -76.79 122.86 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 176.936 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 p -131.7 106.27 8.04 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 -176.482 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.45 ' H ' HG23 ' A' ' 20' ' ' VAL . 1.9 tt -69.66 162.16 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.827 0 CA-C-N 111.863 -2.426 . . . . 0.0 113.871 -179.071 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -138.17 102.31 4.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 166.162 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.0 t -96.1 105.14 17.14 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 111.138 -2.755 . . . . 0.0 105.818 171.776 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 N--CA 1.491 1.597 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.582 -167.677 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.6 p . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -141.29 124.22 16.23 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 124.285 1.034 . . . . 0.0 108.481 179.72 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -84.57 129.7 34.82 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 117.83 -1.081 . . . . 0.0 110.574 -177.207 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.276 5.3 tt0 -114.55 94.44 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 102.639 -3.097 . . . . 0.0 102.639 172.685 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.19 123.31 48.55 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.473 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 m -108.08 132.53 53.47 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -169.736 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 mp -129.82 97.8 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.351 0 N-CA-C 100.602 -3.851 . . . . 0.0 100.602 -167.661 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 94.7 p -118.72 3.91 11.63 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 169.8 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -113.57 125.67 54.44 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -168.768 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.456 HG21 ' HE ' ' A' ' 13' ' ' ARG . 7.0 m -97.12 116.41 29.28 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 -179.709 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -104.23 112.92 26.13 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 -179.993 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.456 ' HE ' HG21 ' A' ' 11' ' ' THR . 67.4 mtt180 -128.2 119.42 25.18 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -169.961 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.58 -161.71 20.48 Favored Glycine 1 CA--C 1.579 4.078 0 CA-C-O 114.362 -3.466 . . . . 0.0 115.821 177.663 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.8 160.96 4.12 Favored 'Trans proline' 0 C--N 1.394 2.928 1 CA-C-N 126.748 5.274 . . . . 0.0 114.533 -179.458 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.31 113.51 0.87 Allowed Glycine 0 N--CA 1.482 1.719 0 CA-C-O 117.576 -1.68 . . . . 0.0 110.489 172.671 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -96.1 94.89 1.69 Allowed Pre-proline 0 CA--C 1.591 2.525 0 CA-C-O 116.211 -1.852 . . . . 0.0 113.628 -170.996 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -82.11 174.79 9.75 Favored 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 123.309 2.673 . . . . 0.0 113.624 169.283 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.94 158.89 27.92 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.431 1.093 . . . . 0.0 111.958 168.351 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 26' ' ' ILE 0.253 10.5 m -135.98 153.73 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -169.74 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -62.3 158.69 45.54 Favored Pre-proline 0 CA--C 1.587 2.366 0 CA-C-O 114.613 -2.613 . . . . 0.0 115.823 179.216 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.82 108.95 2.4 Favored 'Trans proline' 0 C--N 1.398 3.134 0 CA-C-N 126.105 3.216 . . . . 0.0 109.783 168.764 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.3 t -75.14 121.93 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 174.5 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 p -132.08 105.52 7.44 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 -174.672 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.429 ' H ' HG22 ' A' ' 20' ' ' VAL 0.267 2.6 tt -67.74 161.91 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.828 0 CA-C-N 111.65 -2.523 . . . . 0.0 114.446 -178.753 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -143.44 100.69 3.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 124.664 2.173 . . . . 0.0 106.49 167.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.7 m -94.89 91.95 6.67 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 110.792 -2.913 . . . . 0.0 104.128 173.571 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 N--CA 1.493 1.721 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.53 -165.161 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -142.24 132.59 24.99 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.346 1.059 . . . . 0.0 109.17 -179.774 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -83.13 135.2 34.9 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 117.343 -1.313 . . . . 0.0 111.211 -178.551 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -120.58 96.89 5.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 102.368 -3.197 . . . . 0.0 102.368 167.918 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.26 122.76 46.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.038 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -107.0 131.35 54.16 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 125.73 1.894 . . . . 0.0 107.068 -168.559 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.93 96.33 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.17 0 N-CA-C 100.521 -3.881 . . . . 0.0 100.521 -168.435 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.6 p -78.28 -19.06 54.42 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 169.789 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -99.54 141.31 32.5 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 120.401 1.455 . . . . 0.0 111.297 -169.614 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 m -105.94 101.64 11.13 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 101.004 -3.702 . . . . 0.0 101.004 166.762 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -94.36 110.32 22.1 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 -176.248 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.03 121.34 29.52 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -168.342 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.61 171.8 42.85 Favored Glycine 1 CA--C 1.581 4.175 0 CA-C-O 115.16 -3.022 . . . . 0.0 116.45 -177.549 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.21 160.39 23.29 Favored 'Trans proline' 0 C--N 1.396 3.031 1 CA-C-N 125.767 4.784 . . . . 0.0 114.064 -175.565 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.78 95.46 0.62 Allowed Glycine 0 N--CA 1.486 1.986 0 CA-C-O 117.603 -1.665 . . . . 0.0 110.863 -179.503 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.257 4.7 p -105.2 90.75 4.01 Favored Pre-proline 0 CA--C 1.583 2.248 0 CA-C-O 116.474 -1.727 . . . . 0.0 113.432 -167.645 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -83.73 178.6 5.39 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 123.409 2.74 . . . . 0.0 113.721 171.847 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 p -69.33 146.98 51.73 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.89 1.276 . . . . 0.0 111.871 168.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.31 30.8 m -138.94 168.56 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.112 0 CA-C-O 121.455 0.645 . . . . 0.0 111.607 -179.335 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.08 161.98 3.29 Favored Pre-proline 0 CA--C 1.58 2.1 0 N-CA-C 118.863 2.912 . . . . 0.0 118.863 -170.146 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.32 114.88 4.09 Favored 'Trans proline' 0 C--N 1.396 3.031 0 C-N-CA 123.111 2.541 . . . . 0.0 110.227 169.886 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.9 t -78.36 112.58 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 176.275 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.7 p -117.07 101.93 8.89 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -172.732 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.47 163.74 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 CA-C-N 111.023 -2.808 . . . . 0.0 113.934 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -140.18 105.53 5.06 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 166.968 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.13 97.29 10.19 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 169.023 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.492 1.671 0 CA-C-N 113.71 -1.587 . . . . 0.0 111.424 -165.491 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -138.87 129.1 25.54 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.332 1.053 . . . . 0.0 108.929 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -86.13 133.15 33.89 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.665 179.829 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -116.69 100.12 7.6 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 100.888 -3.745 . . . . 0.0 100.888 168.865 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.77 123.15 49.64 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 177.69 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -107.51 133.23 52.29 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 125.303 1.627 . . . . 0.0 106.633 -169.213 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.38 97.4 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.317 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -167.686 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -119.59 8.01 11.19 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 169.931 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -116.71 125.4 51.65 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -169.053 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 m -96.28 113.34 24.93 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -177.976 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -103.16 115.76 31.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -179.493 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -132.5 120.91 22.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -168.686 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.6 -162.19 16.28 Favored Glycine 1 CA--C 1.581 4.157 0 CA-C-O 114.496 -3.391 . . . . 0.0 115.887 178.47 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -87.61 161.53 7.92 Favored 'Trans proline' 0 C--N 1.395 3.004 1 CA-C-N 126.617 5.209 . . . . 0.0 114.062 -178.084 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.33 117.84 1.41 Allowed Glycine 0 N--CA 1.48 1.598 0 CA-C-O 117.932 -1.482 . . . . 0.0 110.044 176.929 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.5 m -100.72 84.6 0.48 Allowed Pre-proline 0 CA--C 1.588 2.408 0 CA-C-O 116.979 -1.486 . . . . 0.0 112.957 -177.304 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.99 174.11 10.44 Favored 'Trans proline' 0 C--N 1.389 2.701 0 C-N-CA 123.17 2.58 . . . . 0.0 112.923 168.559 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.288 9.6 t -95.57 157.72 15.77 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 123.619 0.768 . . . . 0.0 109.406 167.886 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 m -125.93 159.43 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 124.306 1.042 . . . . 0.0 112.069 -166.445 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -73.58 -176.2 0.46 Allowed Pre-proline 0 CA--C 1.609 3.22 0 CA-C-O 115.096 -2.383 . . . . 0.0 113.843 -179.111 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -83.66 129.84 4.99 Favored 'Trans proline' 0 C--N 1.394 2.956 0 CA-C-N 126.685 3.423 . . . . 0.0 111.579 -178.482 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.8 t -76.53 134.52 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 174.901 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.5 p -142.73 108.07 5.02 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 -176.799 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.272 1.8 tt -70.8 161.64 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 C-N-CA 127.248 2.219 . . . . 0.0 112.711 -179.049 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -141.79 121.21 13.2 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 102.348 -3.204 . . . . 0.0 102.348 169.409 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.8 t -97.0 116.04 28.51 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 111.601 -2.545 . . . . 0.0 107.208 169.497 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.267 -0.873 . . . . 0.0 108.828 -169.367 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.28 124.61 19.14 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.164 0.986 . . . . 0.0 108.779 178.863 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -85.55 127.9 34.58 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 124.395 1.059 . . . . 0.0 110.252 -179.071 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.252 9.1 tt0 -109.9 97.68 7.15 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 169.127 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.67 122.08 45.98 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 177.545 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 m -108.17 130.46 55.13 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -169.248 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp -127.67 96.81 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.336 0 N-CA-C 100.291 -3.966 . . . . 0.0 100.291 -167.602 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.2 m -121.71 3.83 10.07 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 170.197 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -111.86 124.35 52.17 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -168.884 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -96.25 113.61 25.22 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -176.471 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -103.72 114.38 28.6 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 -179.544 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -131.25 119.66 22.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 -169.029 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.58 -161.37 19.87 Favored Glycine 1 CA--C 1.58 4.101 0 CA-C-O 114.379 -3.456 . . . . 0.0 116.134 178.455 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -90.66 160.53 4.26 Favored 'Trans proline' 0 C--N 1.394 2.964 1 CA-C-N 126.768 5.284 . . . . 0.0 114.595 -178.477 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.17 113.62 0.73 Allowed Glycine 0 N--CA 1.481 1.681 0 CA-C-O 117.451 -1.749 . . . . 0.0 110.615 173.614 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.7 t -94.28 95.18 1.31 Allowed Pre-proline 0 CA--C 1.589 2.458 0 CA-C-O 116.132 -1.89 . . . . 0.0 113.471 -173.294 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -81.02 174.35 10.97 Favored 'Trans proline' 0 C--N 1.392 2.839 0 CA-C-N 124.559 2.664 . . . . 0.0 113.225 168.806 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -79.12 157.65 27.91 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.412 1.085 . . . . 0.0 111.508 168.403 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.262 16.5 m -135.07 152.58 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 C-N-CA 123.118 0.567 . . . . 0.0 111.559 -177.905 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 167.56 34.62 Favored Pre-proline 0 CA--C 1.588 2.411 0 CA-C-O 115.006 -2.426 . . . . 0.0 114.032 179.331 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.3 129.19 16.62 Favored 'Trans proline' 0 C--N 1.4 3.237 0 CA-C-N 126.883 3.494 . . . . 0.0 111.572 177.861 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.3 t -78.93 125.86 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 171.993 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -139.77 111.29 7.18 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 123.682 1.706 . . . . 0.0 107.722 177.763 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.255 1.8 tt -70.76 158.98 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 CA-C-N 109.26 -3.609 . . . . 0.0 113.632 -172.441 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -139.78 103.93 4.78 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 167.905 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.7 m -97.57 98.48 9.94 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 109.879 -3.328 . . . . 0.0 105.01 175.307 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.493 1.715 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.282 -167.418 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.6 t . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -135.91 140.95 44.45 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 124.272 1.029 . . . . 0.0 110.191 179.049 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -86.37 136.92 32.94 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.645 0.778 . . . . 0.0 110.226 174.173 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.253 4.3 tt0 -123.55 100.31 6.74 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 101.352 -3.573 . . . . 0.0 101.352 170.099 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.15 124.41 51.42 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 179.127 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -106.51 132.07 52.94 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 125.406 1.691 . . . . 0.0 107.465 -168.536 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp -136.47 94.95 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.583 2.224 0 N-CA-C 100.761 -3.792 . . . . 0.0 100.761 -168.325 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.7 p -78.16 -17.31 56.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 169.76 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -101.31 140.65 35.31 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 120.342 1.428 . . . . 0.0 110.985 -169.612 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m -105.03 102.95 12.42 Favored 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 100.939 -3.726 . . . . 0.0 100.939 166.137 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -92.47 116.57 29.1 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 -179.38 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -132.39 119.42 20.66 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -168.186 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.89 -169.37 25.13 Favored Glycine 1 CA--C 1.582 4.26 0 CA-C-O 114.482 -3.399 . . . . 0.0 115.585 179.04 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -86.83 160.96 9.03 Favored 'Trans proline' 0 C--N 1.394 2.957 1 CA-C-N 126.898 5.349 . . . . 0.0 114.186 -176.27 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.33 117.71 1.4 Allowed Glycine 0 N--CA 1.479 1.552 0 CA-C-O 117.83 -1.539 . . . . 0.0 110.084 177.68 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.8 m -100.65 83.93 0.43 Allowed Pre-proline 0 CA--C 1.589 2.48 0 CA-C-O 117.275 -1.345 . . . . 0.0 113.717 -177.623 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.31 171.53 10.03 Favored 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 123.123 2.548 . . . . 0.0 113.117 168.157 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.282 9.5 t -93.98 149.43 21.24 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.669 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.62 156.66 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.644 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.788 -165.616 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -7.69 145.01 0.0 OUTLIER Pre-proline 0 CA--C 1.585 2.296 0 N-CA-C 120.752 3.612 . . . . 0.0 120.752 169.405 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.92 115.37 4.27 Favored 'Trans proline' 0 C--N 1.395 3.02 0 CA-C-N 126.571 3.382 . . . . 0.0 109.464 168.533 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -77.25 122.27 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 174.508 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.8 p -127.23 107.31 9.89 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 -178.498 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 1.3 tt -65.1 162.69 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 C-N-CA 127.456 2.302 . . . . 0.0 113.349 177.806 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -139.18 118.56 12.83 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 102.918 -2.993 . . . . 0.0 102.918 169.805 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 14.3 t -100.79 128.97 46.62 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.001 -2.818 . . . . 0.0 107.474 168.422 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.283 14.8 pt-20 . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -168.729 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -136.17 137.49 40.98 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 124.183 0.993 . . . . 0.0 110.422 -179.364 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -92.75 135.21 34.31 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.189 0.93 . . . . 0.0 110.215 -178.08 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -115.83 99.82 7.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 100.87 -3.752 . . . . 0.0 100.87 169.318 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.43 122.65 46.44 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -179.922 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.44 134.53 50.35 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 125.652 1.845 . . . . 0.0 106.485 -169.132 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.35 98.52 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.301 0 N-CA-C 101.136 -3.653 . . . . 0.0 101.136 -167.842 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 t -117.81 9.64 13.01 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 169.861 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -119.21 126.5 51.69 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -168.904 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m -97.1 113.45 25.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 -179.293 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -103.43 116.07 31.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -179.657 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -133.22 122.73 24.39 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -168.622 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.86 -178.17 40.73 Favored Glycine 1 CA--C 1.58 4.149 0 CA-C-O 114.977 -3.124 . . . . 0.0 116.529 -179.632 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -84.28 158.75 13.03 Favored 'Trans proline' 0 C--N 1.395 3.005 1 CA-C-N 125.929 4.865 . . . . 0.0 113.798 -177.418 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.18 107.33 0.42 Allowed Glycine 0 N--CA 1.483 1.789 0 CA-C-O 116.902 -2.054 . . . . 0.0 110.828 177.071 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.3 m -90.54 98.82 1.65 Allowed Pre-proline 0 CA--C 1.587 2.381 0 CA-C-O 116.121 -1.895 . . . . 0.0 112.4 -169.645 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.79 170.14 18.54 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 123.43 2.754 . . . . 0.0 113.688 169.911 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.16 149.24 29.2 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.078 0.951 . . . . 0.0 111.083 169.388 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.5 m -104.06 147.11 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 124.049 0.939 . . . . 0.0 112.241 -168.064 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HZ3' HG21 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -83.64 163.03 51.18 Favored Pre-proline 0 CA--C 1.588 2.417 0 CA-C-O 115.159 -2.353 . . . . 0.0 112.205 168.95 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.62 140.24 35.61 Favored 'Trans proline' 0 C--N 1.396 3.058 0 CA-C-N 126.948 3.517 . . . . 0.0 113.678 -169.571 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.454 HG21 ' HZ3' ' A' ' 21' ' ' LYS . 87.8 t -143.41 129.21 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 N-CA-C 101.164 -3.643 . . . . 0.0 101.164 -176.542 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.6 p -129.96 105.12 7.76 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -177.442 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 tt -72.15 161.79 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 112.25 -2.25 . . . . 0.0 113.861 -177.851 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -142.46 104.48 4.41 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 165.835 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.1 t -95.97 108.82 21.25 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 111.58 -2.554 . . . . 0.0 105.923 171.365 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 124.619 1.199 . . . . 0.0 110.598 -167.609 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -139.11 128.29 23.96 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.331 1.053 . . . . 0.0 108.966 179.698 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -87.52 133.8 33.71 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.964 0.79 . . . . 0.0 110.177 179.785 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.98 102.02 8.72 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 101.325 -3.583 . . . . 0.0 101.325 168.257 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.21 121.22 44.31 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 178.036 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -107.17 130.91 54.65 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 125.128 1.517 . . . . 0.0 107.037 -168.767 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.76 95.65 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.176 0 N-CA-C 100.743 -3.799 . . . . 0.0 100.743 -167.928 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.1 t -79.23 -16.71 56.08 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 170.069 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -99.73 139.57 35.2 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 120.737 1.608 . . . . 0.0 110.971 -169.571 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.2 m -106.11 102.35 11.78 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 100.962 -3.718 . . . . 0.0 100.962 166.483 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -93.27 116.67 29.23 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 -179.559 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -132.82 121.94 23.71 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -167.838 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.4 -162.57 19.47 Favored Glycine 1 CA--C 1.58 4.108 0 CA-C-O 114.675 -3.291 . . . . 0.0 115.822 178.009 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -86.22 161.92 9.94 Favored 'Trans proline' 0 C--N 1.394 2.93 1 CA-C-N 126.354 5.077 . . . . 0.0 113.868 -177.832 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.61 117.22 1.22 Allowed Glycine 0 N--CA 1.479 1.52 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.295 174.292 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -101.7 84.58 0.56 Allowed Pre-proline 0 CA--C 1.588 2.416 0 CA-C-O 116.913 -1.518 . . . . 0.0 111.621 -179.169 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.18 174.03 7.43 Favored 'Trans proline' 0 C--N 1.39 2.733 0 C-N-CA 123.253 2.635 . . . . 0.0 114.116 171.2 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 p -77.95 147.11 35.11 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.484 1.113 . . . . 0.0 110.056 167.223 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 30.1 m -139.64 151.66 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 123.526 0.516 . . . . 0.0 112.07 -174.2 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -14.46 146.18 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.272 0 CA-C-O 112.685 -3.531 . . . . 0.0 119.939 169.904 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.14 116.8 4.46 Favored 'Trans proline' 0 C--N 1.394 2.969 0 CA-C-N 126.624 3.401 . . . . 0.0 109.473 168.413 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t -76.87 117.5 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 175.428 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 p -121.85 105.35 10.28 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 -175.756 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.27 1.5 tt -68.11 163.75 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 CA-C-N 111.774 -2.466 . . . . 0.0 113.202 -179.797 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -139.75 118.04 12.03 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 168.697 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.2 t -97.6 114.52 26.46 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 111.416 -2.629 . . . . 0.0 106.776 169.499 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.493 1.72 0 C-N-CA 123.825 0.85 . . . . 0.0 109.052 -169.039 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -139.81 127.45 21.74 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.31 1.044 . . . . 0.0 108.766 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -85.66 130.15 34.64 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.733 0.813 . . . . 0.0 110.259 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.269 7.2 tt0 -114.39 98.28 6.82 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 101.152 -3.647 . . . . 0.0 101.152 169.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.11 120.97 43.63 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -106.95 135.38 48.6 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 125.54 1.775 . . . . 0.0 106.588 -169.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mp . . . . . 0 CA--C 1.584 2.278 0 N-CA-C 101.382 -3.562 . . . . 0.0 101.382 -167.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -116.45 125.71 52.38 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -168.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.09 115.96 28.44 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.424 ' CD1' HD13 ' A' ' 7' ' ' ILE . 91.3 m-85 -105.22 112.94 26.25 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -127.33 119.07 25.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 -169.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.37 -163.12 16.7 Favored Glycine 1 CA--C 1.58 4.119 0 CA-C-O 114.475 -3.403 . . . . 0.0 115.999 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -87.45 161.53 8.14 Favored 'Trans proline' 0 C--N 1.394 2.969 1 CA-C-N 126.679 5.239 . . . . 0.0 114.076 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.53 118.48 1.51 Allowed Glycine 0 N--CA 1.48 1.575 0 CA-C-O 118.021 -1.433 . . . . 0.0 110.018 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.0 m -100.74 84.46 0.47 Allowed Pre-proline 0 CA--C 1.588 2.421 0 CA-C-O 117.001 -1.476 . . . . 0.0 112.965 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -81.92 176.66 8.09 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 123.231 2.621 . . . . 0.0 112.725 168.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.29 10.0 t -98.96 157.54 16.25 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 123.791 0.836 . . . . 0.0 109.568 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 m -123.81 159.69 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 C-N-CA 124.487 1.115 . . . . 0.0 111.981 -166.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 164.2 58.8 Favored Pre-proline 0 CA--C 1.584 2.278 0 CA-C-O 115.252 -2.309 . . . . 0.0 114.686 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 C--N 1.399 3.23 0 CA-C-N 126.239 3.264 . . . . 0.0 112.945 179.576 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.8 t . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -142.58 108.31 5.12 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.263 1.3 tt -71.62 160.37 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.843 0 C-N-CA 126.972 2.109 . . . . 0.0 112.75 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -141.82 120.0 12.18 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 102.21 -3.256 . . . . 0.0 102.21 169.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.1 t -97.28 115.09 27.01 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.103 169.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 124.084 0.865 . . . . 0.0 109.126 -169.311 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -146.45 127.98 15.07 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -87.56 125.95 34.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.805 0.842 . . . . 0.0 109.804 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.271 8.3 tt0 -110.37 96.9 6.5 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 101.34 -3.578 . . . . 0.0 101.34 168.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.96 120.5 42.6 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.16 135.72 48.22 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 125.514 1.759 . . . . 0.0 106.615 -169.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mp . . . . . 0 CA--C 1.584 2.276 0 N-CA-C 101.372 -3.566 . . . . 0.0 101.372 -167.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -114.87 125.42 53.64 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.27 116.25 29.14 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.421 ' CD1' HD13 ' A' ' 7' ' ' ILE . 93.0 m-85 -105.78 112.94 26.21 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -127.36 120.67 29.05 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -169.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.75 -158.6 12.9 Favored Glycine 1 CA--C 1.579 4.04 0 CA-C-O 114.368 -3.462 . . . . 0.0 116.132 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -88.42 161.2 6.74 Favored 'Trans proline' 0 C--N 1.395 2.989 1 CA-C-N 126.571 5.186 . . . . 0.0 114.212 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.02 118.39 1.39 Allowed Glycine 0 N--CA 1.479 1.559 0 CA-C-O 117.981 -1.455 . . . . 0.0 110.197 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.9 m -100.69 85.71 0.59 Allowed Pre-proline 0 CA--C 1.588 2.417 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.456 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -82.4 175.45 8.94 Favored 'Trans proline' 0 C--N 1.391 2.81 0 C-N-CA 123.444 2.763 . . . . 0.0 113.739 170.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -75.71 158.13 32.7 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.727 1.211 . . . . 0.0 112.018 168.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 13.3 m -135.46 152.87 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.185 0.594 . . . . 0.0 111.609 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 167.79 32.1 Favored Pre-proline 0 CA--C 1.586 2.341 0 CA-C-O 114.998 -2.43 . . . . 0.0 113.939 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.4 3.263 0 CA-C-N 126.961 3.522 . . . . 0.0 111.349 178.88 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.501 2.077 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -140.69 109.64 6.08 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 123.3 1.524 . . . . 0.0 107.827 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.273 1.1 tt -70.54 163.4 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 109.686 -3.416 . . . . 0.0 113.192 -173.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -141.43 115.21 9.09 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 168.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.8 t -94.67 116.51 28.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 111.582 -2.553 . . . . 0.0 107.242 170.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 N--CA 1.494 1.729 0 C-N-CA 123.988 0.915 . . . . 0.0 109.774 -168.517 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -140.04 125.23 18.74 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.292 1.037 . . . . 0.0 108.58 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.35 126.08 34.09 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 124.12 0.888 . . . . 0.0 110.11 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.266 9.0 tt0 -110.76 98.91 7.94 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 100.932 -3.729 . . . . 0.0 100.932 168.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.85 107.99 16.47 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 103.763 -2.681 . . . . 0.0 103.763 -176.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -97.25 126.72 42.64 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 125.466 1.729 . . . . 0.0 106.856 -167.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mm . . . . . 0 CA--C 1.577 2.006 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 -167.137 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.2 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -94.38 127.17 40.1 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.353 1.061 . . . . 0.0 108.59 -169.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -100.8 111.28 23.47 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -103.54 119.11 38.24 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -135.62 119.19 17.0 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -170.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.04 -158.11 13.4 Favored Glycine 1 CA--C 1.579 4.048 0 CA-C-O 114.401 -3.444 . . . . 0.0 115.713 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -87.14 161.92 8.6 Favored 'Trans proline' 0 C--N 1.393 2.901 1 CA-C-N 126.597 5.198 . . . . 0.0 114.016 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.87 116.08 1.4 Allowed Glycine 0 N--CA 1.48 1.568 0 CA-C-O 118.106 -1.385 . . . . 0.0 110.381 174.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.4 m -101.46 85.78 0.68 Allowed Pre-proline 0 CA--C 1.587 2.371 0 CA-C-O 116.697 -1.62 . . . . 0.0 111.102 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -82.37 173.01 11.06 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 123.252 2.635 . . . . 0.0 113.771 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -75.61 154.78 36.45 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.575 1.15 . . . . 0.0 111.948 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.272 18.0 m -137.17 154.0 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 O-C-N 123.5 0.5 . . . . 0.0 111.856 -173.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 168.08 30.83 Favored Pre-proline 0 CA--C 1.588 2.423 0 CA-C-O 114.91 -2.471 . . . . 0.0 114.187 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 C--N 1.399 3.236 0 CA-C-N 126.982 3.529 . . . . 0.0 111.84 177.388 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.1 t . . . . . 0 N--CA 1.503 2.187 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.8 p -136.26 109.17 7.61 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 102.42 -3.178 . . . . 0.0 102.42 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.259 0.8 OUTLIER -68.79 162.33 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.858 0 C-N-CA 126.745 2.018 . . . . 0.0 113.488 -174.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -138.07 113.85 9.8 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 167.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.8 t -97.96 111.48 23.77 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.139 170.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 124.231 0.957 . . . . 0.0 109.572 -168.605 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.04 129.11 25.21 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.338 1.055 . . . . 0.0 108.92 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -85.84 131.38 34.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.654 0.782 . . . . 0.0 110.45 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.269 7.1 tt0 -116.19 98.33 6.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 100.928 -3.73 . . . . 0.0 100.928 169.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.16 121.28 44.5 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.19 135.16 49.2 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 125.511 1.757 . . . . 0.0 106.681 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.411 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.7 mp . . . . . 0 CA--C 1.585 2.312 0 N-CA-C 101.461 -3.533 . . . . 0.0 101.461 -167.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -116.77 125.54 51.78 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -168.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -97.05 115.67 27.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.411 ' CD1' HD13 ' A' ' 7' ' ' ILE . 90.2 m-85 -104.84 112.86 26.13 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -127.31 118.8 24.9 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -169.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.19 -165.11 19.76 Favored Glycine 1 CA--C 1.58 4.126 0 CA-C-O 114.482 -3.399 . . . . 0.0 115.911 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -86.57 161.48 9.42 Favored 'Trans proline' 0 C--N 1.394 2.927 1 CA-C-N 126.697 5.248 . . . . 0.0 113.928 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 117.91 1.46 Allowed Glycine 0 N--CA 1.479 1.511 0 CA-C-O 117.964 -1.464 . . . . 0.0 110.057 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.8 m -100.65 84.51 0.47 Allowed Pre-proline 0 CA--C 1.587 2.389 0 CA-C-O 117.038 -1.458 . . . . 0.0 112.909 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -82.21 173.78 10.54 Favored 'Trans proline' 0 C--N 1.389 2.684 0 C-N-CA 123.16 2.573 . . . . 0.0 112.898 168.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.288 9.0 t -95.43 157.27 15.97 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 123.547 0.739 . . . . 0.0 109.288 167.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.6 m -125.68 158.55 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 124.19 0.996 . . . . 0.0 112.363 -166.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -67.76 -176.24 0.26 Allowed Pre-proline 0 CA--C 1.599 2.844 0 N-CA-C 117.662 2.468 . . . . 0.0 117.662 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 C--N 1.399 3.235 0 C-N-CA 123.866 3.044 . . . . 0.0 110.816 172.74 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -143.34 108.45 4.98 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.268 1.3 tt -71.32 161.9 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 C-N-CA 127.12 2.168 . . . . 0.0 112.82 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -141.84 122.01 13.84 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 102.21 -3.255 . . . . 0.0 102.21 168.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.8 t -97.56 115.1 27.21 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 111.813 -2.449 . . . . 0.0 107.138 169.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.246 -0.883 . . . . 0.0 108.641 -169.36 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -142.15 124.66 15.76 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.3 1.04 . . . . 0.0 108.521 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -85.14 130.94 34.51 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 117.818 -1.087 . . . . 0.0 110.672 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.276 4.9 tt0 -114.52 95.18 5.13 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 171.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.79 122.38 47.68 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -106.97 135.0 49.28 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 125.575 1.797 . . . . 0.0 106.655 -169.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.51 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.6 mp . . . . . 0 CA--C 1.586 2.352 0 N-CA-C 100.722 -3.807 . . . . 0.0 100.722 -167.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -116.6 125.37 51.73 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -168.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -96.98 116.91 30.04 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.51 ' CD1' HD13 ' A' ' 7' ' ' ILE . 83.9 m-85 -104.67 112.35 25.4 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -127.6 120.75 28.83 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -169.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.51 -163.58 24.79 Favored Glycine 1 CA--C 1.58 4.115 0 CA-C-O 114.521 -3.377 . . . . 0.0 116.29 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -89.98 160.86 4.94 Favored 'Trans proline' 0 C--N 1.395 2.98 1 CA-C-N 126.43 5.115 . . . . 0.0 114.455 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.14 110.44 0.69 Allowed Glycine 0 N--CA 1.483 1.797 0 CA-C-O 117.46 -1.745 . . . . 0.0 110.495 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.3 m -97.98 94.99 2.43 Favored Pre-proline 0 CA--C 1.588 2.427 0 CA-C-O 116.224 -1.846 . . . . 0.0 112.972 -169.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.29 175.65 9.49 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 123.327 2.684 . . . . 0.0 113.581 169.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -76.95 160.06 29.47 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.658 1.183 . . . . 0.0 112.128 168.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.5 m -135.49 151.5 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 123.264 0.625 . . . . 0.0 111.806 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.14 166.65 38.89 Favored Pre-proline 0 CA--C 1.586 2.361 0 CA-C-O 115.094 -2.384 . . . . 0.0 113.678 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 C--N 1.399 3.187 0 CA-C-N 126.82 3.471 . . . . 0.0 111.647 178.794 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.4 t . . . . . 0 N--CA 1.502 2.132 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.1 p -130.2 105.99 8.29 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.263 1.9 tt -67.69 162.6 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 CA-C-N 111.95 -2.386 . . . . 0.0 114.357 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -143.21 102.31 3.96 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 168.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.3 t -89.55 93.82 9.63 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 112.204 -2.271 . . . . 0.0 105.412 169.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.108 -165.544 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 CA--C 1.544 0.75 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -143.77 124.88 14.47 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -88.06 135.8 33.26 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 124.127 0.892 . . . . 0.0 110.498 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -117.99 98.87 6.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 101.076 -3.675 . . . . 0.0 101.076 170.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.53 124.05 51.48 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 m -107.91 133.32 52.43 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -169.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.437 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.9 mp . . . . . 0 CA--C 1.586 2.328 0 N-CA-C 100.925 -3.731 . . . . 0.0 100.925 -167.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -117.69 125.67 51.1 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -169.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -96.71 113.07 24.6 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.437 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.8 m-85 -102.84 117.5 34.76 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -134.93 120.95 19.85 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -168.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.41 -171.88 36.25 Favored Glycine 1 CA--C 1.581 4.159 0 CA-C-O 114.721 -3.266 . . . . 0.0 116.279 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -88.73 158.45 6.24 Favored 'Trans proline' 0 C--N 1.396 3.027 1 CA-C-N 126.364 5.082 . . . . 0.0 114.295 -177.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.76 106.58 0.63 Allowed Glycine 0 N--CA 1.484 1.873 0 CA-C-O 117.196 -1.891 . . . . 0.0 110.579 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.8 m -93.48 98.49 2.58 Favored Pre-proline 0 CA--C 1.588 2.438 0 CA-C-O 116.168 -1.872 . . . . 0.0 113.008 -169.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.01 173.44 12.71 Favored 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 123.401 2.734 . . . . 0.0 113.673 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.94 159.24 31.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.483 1.113 . . . . 0.0 112.371 168.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 11.0 m -133.98 152.84 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 CA-C-O 121.422 0.63 . . . . 0.0 112.695 -169.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.24 165.47 27.96 Favored Pre-proline 0 CA--C 1.581 2.15 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--N 1.396 3.034 0 C-N-CA 123.148 2.565 . . . . 0.0 110.033 169.658 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.6 t . . . . . 0 N--CA 1.504 2.264 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.8 p -132.26 106.19 7.78 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.5 tt -69.33 160.78 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.835 0 CA-C-N 111.904 -2.407 . . . . 0.0 114.023 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -139.31 102.94 4.61 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 167.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 t -98.66 113.67 25.83 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 110.87 -2.877 . . . . 0.0 105.816 170.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.297 10.2 pt-20 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -167.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.8 127.41 21.7 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.345 1.058 . . . . 0.0 108.835 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -87.42 128.41 35.21 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 124.037 0.836 . . . . 0.0 110.096 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.25 8.2 tt0 -112.34 98.38 7.25 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 100.734 -3.802 . . . . 0.0 100.734 168.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.56 120.15 41.48 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -106.98 134.74 49.67 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 125.409 1.693 . . . . 0.0 106.523 -168.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.414 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.6 mp . . . . . 0 CA--C 1.585 2.294 0 N-CA-C 101.442 -3.54 . . . . 0.0 101.442 -167.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -114.75 125.09 53.3 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -168.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.23 113.4 25.0 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.414 ' CD1' HD13 ' A' ' 7' ' ' ILE . 93.2 m-85 -103.81 115.03 29.72 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -131.17 120.23 23.01 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -168.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.5 -158.52 12.61 Favored Glycine 1 CA--C 1.579 4.049 0 CA-C-O 114.361 -3.466 . . . . 0.0 115.836 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -89.04 161.37 5.87 Favored 'Trans proline' 0 C--N 1.394 2.955 1 CA-C-N 126.719 5.259 . . . . 0.0 114.294 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.15 117.19 1.33 Allowed Glycine 0 N--CA 1.479 1.563 0 CA-C-O 117.965 -1.464 . . . . 0.0 110.277 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.4 m -100.96 85.82 0.62 Allowed Pre-proline 0 CA--C 1.588 2.412 0 CA-C-O 116.697 -1.62 . . . . 0.0 111.589 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -82.86 176.13 7.97 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.378 2.719 . . . . 0.0 113.73 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -74.63 158.01 34.39 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.72 1.208 . . . . 0.0 111.941 168.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.258 15.4 m -135.62 156.08 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 C-N-CA 122.93 0.492 . . . . 0.0 112.212 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -76.95 -179.29 1.17 Allowed Pre-proline 0 CA--C 1.593 2.598 0 CA-C-O 115.543 -2.17 . . . . 0.0 115.79 -170.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 C--N 1.404 3.469 0 C-N-CA 123.902 3.068 . . . . 0.0 110.251 170.692 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.502 2.126 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.9 p -141.41 108.81 5.55 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.274 1.2 tt -69.98 164.37 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 127.046 2.138 . . . . 0.0 113.256 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -140.83 114.89 9.15 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 101.734 -3.432 . . . . 0.0 101.734 167.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.5 t -97.44 111.84 23.93 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 111.579 -2.555 . . . . 0.0 106.292 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 N--CA 1.494 1.756 0 O-C-N 124.184 0.927 . . . . 0.0 109.172 -168.709 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -148.04 124.34 10.89 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -87.06 124.61 33.41 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.933 0.893 . . . . 0.0 109.773 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.258 8.9 tt0 -109.28 97.04 6.71 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 101.382 -3.562 . . . . 0.0 101.382 168.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.465 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.9 120.79 43.28 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 178.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -107.94 131.31 54.67 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 -169.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.489 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.2 mp . . . . . 0 CA--C 1.586 2.331 0 N-CA-C 100.463 -3.903 . . . . 0.0 100.463 -167.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -113.15 124.75 53.28 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -168.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.0 m -96.78 113.8 25.38 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -176.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.489 ' CD1' HD13 ' A' ' 7' ' ' ILE . 87.1 m-85 -104.09 115.2 30.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -131.19 120.98 24.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -168.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.51 -156.93 11.28 Favored Glycine 1 CA--C 1.58 4.143 0 CA-C-O 114.229 -3.54 . . . . 0.0 115.911 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.22 161.09 4.7 Favored 'Trans proline' 0 C--N 1.395 2.992 1 CA-C-N 126.799 5.299 . . . . 0.0 114.534 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.72 119.35 1.62 Allowed Glycine 0 N--CA 1.479 1.507 0 CA-C-O 118.034 -1.426 . . . . 0.0 110.33 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.2 t -98.1 87.49 0.55 Allowed Pre-proline 0 CA--C 1.591 2.524 0 CA-C-O 116.503 -1.713 . . . . 0.0 112.325 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.71 175.62 9.24 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 123.414 2.742 . . . . 0.0 113.426 169.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 p -77.62 158.24 29.87 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.638 1.175 . . . . 0.0 111.828 168.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.259 15.7 m -136.9 156.09 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 122.999 0.52 . . . . 0.0 112.23 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -76.89 -179.31 1.17 Allowed Pre-proline 0 CA--C 1.593 2.608 0 CA-C-O 115.631 -2.128 . . . . 0.0 115.742 -171.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo . . . . . 0 C--N 1.405 3.504 0 C-N-CA 123.97 3.114 . . . . 0.0 110.365 171.191 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 N--CA 1.503 2.187 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -140.87 108.89 5.72 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.265 1.3 tt -69.84 160.89 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.836 0 C-N-CA 127.036 2.134 . . . . 0.0 113.353 -177.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -139.22 109.25 6.38 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 168.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.8 m -98.11 106.91 19.27 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 110.229 -3.168 . . . . 0.0 104.679 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.736 0 C-N-CA 124.307 1.043 . . . . 0.0 111.033 -167.246 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -147.86 125.46 11.77 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -83.55 122.79 29.03 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 117.82 -1.086 . . . . 0.0 109.988 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.265 8.4 tt0 -109.25 95.94 5.96 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 102.123 -3.288 . . . . 0.0 102.123 170.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.529 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -109.73 120.77 43.51 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.406 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.47 130.82 54.8 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 125.423 1.702 . . . . 0.0 106.648 -169.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.529 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.3 mp . . . . . 0 CA--C 1.582 2.185 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -167.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.7 p . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -98.41 139.38 34.24 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 120.259 1.391 . . . . 0.0 111.155 -169.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.5 m -107.14 102.96 12.25 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 100.922 -3.733 . . . . 0.0 100.922 166.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -93.49 113.71 25.91 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -129.44 120.99 26.41 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -168.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.71 -160.81 18.88 Favored Glycine 1 CA--C 1.579 4.036 0 CA-C-O 114.522 -3.377 . . . . 0.0 116.022 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -86.74 163.37 9.17 Favored 'Trans proline' 0 C--N 1.393 2.911 1 CA-C-N 126.584 5.192 . . . . 0.0 114.023 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.18 119.87 1.79 Allowed Glycine 0 C--N 1.354 1.57 0 CA-C-O 118.01 -1.439 . . . . 0.0 110.019 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.6 t -97.86 87.87 0.57 Allowed Pre-proline 0 CA--C 1.591 2.526 0 CA-C-O 116.452 -1.737 . . . . 0.0 112.206 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -81.8 173.83 10.85 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.373 2.716 . . . . 0.0 113.504 169.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 p -79.44 158.78 27.25 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.578 1.151 . . . . 0.0 111.626 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.251 15.2 m -136.46 151.58 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.15 0.58 . . . . 0.0 111.492 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.67 166.71 40.66 Favored Pre-proline 0 CA--C 1.588 2.406 0 CA-C-O 114.949 -2.453 . . . . 0.0 114.043 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 C--N 1.4 3.275 0 CA-C-N 126.998 3.535 . . . . 0.0 111.627 -177.585 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -137.19 106.86 6.18 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.273 1.3 tt -69.24 165.55 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.955 0 CA-C-N 112.265 -2.243 . . . . 0.0 113.696 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -144.08 108.86 4.92 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 168.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 76.1 m -94.13 97.67 10.45 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 . . . . . 0 N--CA 1.491 1.615 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.808 -165.318 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -138.63 131.56 29.56 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.354 1.062 . . . . 0.0 109.058 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -85.74 136.24 33.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.644 0.778 . . . . 0.0 110.418 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.267 4.7 tt0 -120.97 98.9 6.21 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 169.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.6 122.79 47.59 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.25 135.67 48.37 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 125.671 1.857 . . . . 0.0 106.924 -169.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.431 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.6 mp . . . . . 0 CA--C 1.584 2.28 0 N-CA-C 101.271 -3.603 . . . . 0.0 101.271 -167.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -122.26 126.59 48.5 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -168.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -96.79 116.39 29.06 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.431 ' CD1' HD13 ' A' ' 7' ' ' ILE . 82.4 m-85 -105.06 113.57 27.25 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -128.58 122.49 31.14 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -169.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.05 -163.9 16.81 Favored Glycine 1 CA--C 1.58 4.151 0 CA-C-O 114.461 -3.41 . . . . 0.0 115.833 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -87.83 160.47 7.57 Favored 'Trans proline' 0 C--N 1.395 2.988 1 CA-C-N 126.709 5.254 . . . . 0.0 114.108 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.91 118.31 1.36 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-O 118.018 -1.435 . . . . 0.0 110.194 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -101.88 83.09 0.44 Allowed Pre-proline 0 CA--C 1.589 2.461 0 CA-C-O 117.239 -1.362 . . . . 0.0 113.263 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -84.92 172.83 8.53 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.105 2.537 . . . . 0.0 113.312 168.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.28 9.3 t -94.14 148.68 21.94 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 166.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.72 156.78 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 C-N-CA 123.343 0.657 . . . . 0.0 111.75 -165.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -8.24 145.09 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.272 0 N-CA-C 120.74 3.607 . . . . 0.0 120.74 169.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--N 1.396 3.051 0 CA-C-N 126.6 3.393 . . . . 0.0 109.557 168.599 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -125.39 106.31 9.72 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.269 1.3 tt -67.11 162.24 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 CA-C-N 112.087 -2.324 . . . . 0.0 113.322 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -140.59 124.09 16.93 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 102.264 -3.236 . . . . 0.0 102.264 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.4 t -97.43 116.08 28.96 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.776 -2.466 . . . . 0.0 107.477 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -169.485 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -147.61 125.55 12.01 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -85.63 126.93 34.3 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.89 0.876 . . . . 0.0 110.069 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.274 5.5 tt0 -111.4 97.13 6.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 101.484 -3.524 . . . . 0.0 101.484 169.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.444 ' CE2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -110.06 121.5 45.4 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 179.533 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -107.68 131.68 54.14 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -169.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.511 HD13 ' CD1' ' A' ' 12' ' ' PHE . 2.9 mp . . . . . 0 CA--C 1.587 2.38 0 N-CA-C 100.302 -3.962 . . . . 0.0 100.302 -167.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -114.75 125.11 53.33 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -168.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -96.72 117.2 30.52 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.511 ' CD1' HD13 ' A' ' 7' ' ' ILE . 82.5 m-85 -105.79 113.46 27.02 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -127.8 120.29 27.53 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -169.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.21 -160.1 13.91 Favored Glycine 1 CA--C 1.58 4.125 0 CA-C-O 114.349 -3.473 . . . . 0.0 116.321 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -88.68 161.32 6.37 Favored 'Trans proline' 0 C--N 1.395 2.987 1 CA-C-N 126.632 5.216 . . . . 0.0 114.276 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.62 119.8 1.65 Allowed Glycine 0 N--CA 1.48 1.603 0 CA-C-O 118.008 -1.44 . . . . 0.0 110.133 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.3 t -98.53 86.27 0.47 Allowed Pre-proline 0 CA--C 1.591 2.554 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.001 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -81.08 178.06 7.24 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.174 2.583 . . . . 0.0 112.117 166.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.299 11.2 t -103.94 158.16 16.6 Favored 'General case' 0 N--CA 1.504 2.275 0 C-N-CA 123.868 0.867 . . . . 0.0 109.818 168.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.2 m -125.91 160.05 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.56 0 C-N-CA 124.506 1.122 . . . . 0.0 111.982 -166.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 164.73 56.18 Favored Pre-proline 0 CA--C 1.585 2.304 0 CA-C-O 115.278 -2.296 . . . . 0.0 114.675 177.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--N 1.4 3.257 0 CA-C-N 126.218 3.256 . . . . 0.0 113.002 178.231 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 N--CA 1.501 2.099 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.4 p -142.8 108.96 5.23 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.264 1.4 tt -71.07 158.43 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 C-N-CA 127.033 2.133 . . . . 0.0 112.848 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -141.84 115.06 8.82 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 102.716 -3.068 . . . . 0.0 102.716 169.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 73.7 m -97.0 112.38 24.17 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 110.552 -3.022 . . . . 0.0 105.841 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.752 0 C-N-CA 124.18 0.992 . . . . 0.0 110.472 -167.853 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -139.5 128.11 23.11 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.348 1.059 . . . . 0.0 108.946 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -88.27 135.57 33.39 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 123.994 0.808 . . . . 0.0 110.471 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.266 4.2 tt0 -118.25 97.46 5.79 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 101.259 -3.608 . . . . 0.0 101.259 169.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.26 122.41 47.66 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.33 136.12 47.69 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 125.513 1.758 . . . . 0.0 106.818 -169.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.419 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.7 mp . . . . . 0 CA--C 1.585 2.314 0 N-CA-C 101.407 -3.553 . . . . 0.0 101.407 -167.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -118.19 125.84 51.0 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -168.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.8 m -97.14 116.78 29.97 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.419 ' CD1' HD13 ' A' ' 7' ' ' ILE . 87.9 m-85 -105.38 112.95 26.24 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -127.63 121.36 30.27 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -169.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.15 -156.79 11.48 Favored Glycine 1 CA--C 1.579 4.077 0 CA-C-O 114.309 -3.495 . . . . 0.0 115.989 177.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -91.02 160.73 3.91 Favored 'Trans proline' 0 C--N 1.395 3.016 1 CA-C-N 126.568 5.184 . . . . 0.0 114.628 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.66 115.49 0.97 Allowed Glycine 0 N--CA 1.481 1.634 0 CA-C-O 117.799 -1.556 . . . . 0.0 110.457 174.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.6 m -100.66 87.16 0.76 Allowed Pre-proline 0 CA--C 1.589 2.467 0 CA-C-O 116.676 -1.63 . . . . 0.0 111.663 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.61 173.94 10.08 Favored 'Trans proline' 0 C--N 1.391 2.781 0 C-N-CA 123.399 2.733 . . . . 0.0 113.887 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.71 156.17 38.19 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.536 1.134 . . . . 0.0 112.426 168.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.268 14.1 m -135.6 155.67 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.664 0.745 . . . . 0.0 112.813 -169.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -69.39 165.52 39.14 Favored Pre-proline 0 CA--C 1.58 2.112 0 CA-C-O 115.64 -2.124 . . . . 0.0 116.731 -171.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo . . . . . 0 C--N 1.396 3.039 0 C-N-CA 123.772 2.981 . . . . 0.0 109.858 168.994 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.502 2.172 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -139.11 108.88 6.26 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 123.794 1.759 . . . . 0.0 108.187 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.262 2.1 tt -70.11 162.91 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.826 0 CA-C-N 109.098 -3.683 . . . . 0.0 113.739 -174.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -140.83 111.0 6.63 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 167.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.2 t -96.1 112.41 24.15 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 111.615 -2.539 . . . . 0.0 106.338 172.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 124.207 0.942 . . . . 0.0 110.177 -168.361 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -142.76 125.45 15.92 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.296 1.038 . . . . 0.0 108.57 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -82.83 120.62 25.87 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 117.814 -1.089 . . . . 0.0 109.622 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.278 9.7 tt0 -106.53 95.92 6.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 102.249 -3.241 . . . . 0.0 102.249 169.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.452 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.49 118.77 37.59 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.636 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.73 131.76 54.09 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -169.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.452 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.1 mp . . . . . 0 CA--C 1.585 2.324 0 N-CA-C 100.919 -3.734 . . . . 0.0 100.919 -167.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -111.02 124.96 53.19 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -168.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -97.06 113.36 24.91 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.406 ' CD1' HD13 ' A' ' 7' ' ' ILE . 91.9 m-85 -104.25 114.36 28.54 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -130.09 120.07 24.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -168.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.0 -163.96 21.79 Favored Glycine 1 CA--C 1.579 4.083 0 CA-C-O 114.542 -3.365 . . . . 0.0 115.848 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -87.32 162.06 8.34 Favored 'Trans proline' 0 C--N 1.394 2.93 1 CA-C-N 126.668 5.234 . . . . 0.0 113.996 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.91 116.03 1.41 Allowed Glycine 0 N--CA 1.479 1.541 0 CA-C-O 118.07 -1.406 . . . . 0.0 110.228 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.0 m -103.63 84.16 0.74 Allowed Pre-proline 0 CA--C 1.587 2.395 0 CA-C-O 116.952 -1.499 . . . . 0.0 111.613 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -85.11 173.63 7.78 Favored 'Trans proline' 0 C--N 1.39 2.728 0 C-N-CA 123.247 2.632 . . . . 0.0 114.064 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 p -78.13 146.69 34.97 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.468 1.107 . . . . 0.0 110.216 167.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.259 30.9 m -139.47 152.65 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 O-C-N 123.6 0.562 . . . . 0.0 112.083 -172.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -17.3 146.61 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.263 0 CA-C-O 112.746 -3.502 . . . . 0.0 119.774 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 C--N 1.394 2.961 0 CA-C-N 126.667 3.417 . . . . 0.0 109.664 168.498 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.502 2.159 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.5 p -118.97 104.42 10.48 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.297 1.3 tt -66.79 165.7 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.857 0 CA-C-N 111.639 -2.528 . . . . 0.0 113.644 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -142.94 112.69 6.94 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 103.373 -2.825 . . . . 0.0 103.373 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.7 t -94.94 98.32 10.62 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 168.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 . . . . . 0 N--CA 1.493 1.705 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.241 -166.11 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -142.47 124.09 14.98 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.287 1.035 . . . . 0.0 108.286 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -83.49 121.66 27.49 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.822 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.293 9.9 tt0 -108.71 95.88 5.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 101.994 -3.335 . . . . 0.0 101.994 169.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.97 108.14 17.37 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -175.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -95.79 127.15 41.57 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 113.218 -1.81 . . . . 0.0 107.195 -167.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mm . . . . . 0 CA--C 1.58 2.108 0 N-CA-C 102.818 -3.03 . . . . 0.0 102.818 -167.491 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.24 139.92 30.0 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.494 1.117 . . . . 0.0 110.458 -170.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -111.18 110.56 21.12 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 102.788 -3.041 . . . . 0.0 102.788 169.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -99.04 115.55 29.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -128.13 122.16 31.31 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -173.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.68 -160.14 17.18 Favored Glycine 1 CA--C 1.578 4.012 0 CA-C-O 114.496 -3.391 . . . . 0.0 115.659 176.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -86.97 162.68 8.86 Favored 'Trans proline' 0 C--N 1.392 2.837 1 CA-C-N 126.602 5.201 . . . . 0.0 113.952 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.43 115.38 1.49 Allowed Glycine 0 N--CA 1.48 1.608 0 CA-C-O 117.943 -1.476 . . . . 0.0 110.238 174.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.9 m -102.11 85.79 0.77 Allowed Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 116.721 -1.609 . . . . 0.0 111.247 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.34 172.98 11.11 Favored 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 123.333 2.688 . . . . 0.0 113.804 171.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -76.58 155.1 33.86 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.582 1.153 . . . . 0.0 111.885 168.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.272 18.0 m -137.93 154.75 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 C-N-CA 122.968 0.507 . . . . 0.0 112.004 -174.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 168.49 27.55 Favored Pre-proline 0 CA--C 1.588 2.423 0 CA-C-O 114.945 -2.455 . . . . 0.0 114.246 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo . . . . . 0 C--N 1.399 3.22 0 CA-C-N 126.878 3.492 . . . . 0.0 111.726 176.139 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.504 2.246 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.0 p -136.59 108.88 7.29 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.28 0.8 OUTLIER -68.92 166.1 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.878 0 C-N-CA 126.782 2.033 . . . . 0.0 113.89 -173.694 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -140.2 110.71 6.72 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 102.717 -3.068 . . . . 0.0 102.717 168.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.6 t -96.09 98.82 10.65 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 N--CA 1.492 1.67 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.332 -165.998 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -146.25 128.3 15.57 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -87.39 126.07 34.65 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.733 0.813 . . . . 0.0 109.993 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.253 8.6 tt0 -110.44 97.84 7.19 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 101.026 -3.694 . . . . 0.0 101.026 168.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.8 120.14 41.4 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.543 -2.392 . . . . 0.0 104.543 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -107.03 134.87 49.53 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 125.46 1.725 . . . . 0.0 106.552 -169.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.425 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.4 mp . . . . . 0 CA--C 1.584 2.27 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 -167.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -111.0 125.23 53.51 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -168.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.24 113.42 25.03 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CD1' HD13 ' A' ' 7' ' ' ILE . 93.4 m-85 -103.74 114.82 29.36 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -130.85 120.44 23.68 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -168.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.08 -158.12 12.56 Favored Glycine 1 CA--C 1.579 4.067 0 CA-C-O 114.399 -3.445 . . . . 0.0 115.945 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -88.54 161.45 6.58 Favored 'Trans proline' 0 C--N 1.394 2.956 1 CA-C-N 126.61 5.205 . . . . 0.0 114.235 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.24 118.1 1.41 Allowed Glycine 0 N--CA 1.48 1.594 0 CA-C-O 117.96 -1.467 . . . . 0.0 110.162 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.4 m -100.81 85.73 0.6 Allowed Pre-proline 0 CA--C 1.587 2.396 0 CA-C-O 116.705 -1.617 . . . . 0.0 111.5 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.58 176.49 7.81 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 123.401 2.734 . . . . 0.0 113.66 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -75.38 158.74 32.3 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.717 1.207 . . . . 0.0 112.033 168.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.252 13.3 m -135.4 152.0 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 C-N-CA 123.15 0.58 . . . . 0.0 111.72 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 167.04 38.45 Favored Pre-proline 0 CA--C 1.586 2.357 0 CA-C-O 114.98 -2.438 . . . . 0.0 114.107 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 C--N 1.4 3.261 0 CA-C-N 126.968 3.524 . . . . 0.0 111.525 -177.816 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.2 p -138.98 108.46 6.16 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.275 1.2 tt -69.03 163.78 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.913 0 C-N-CA 126.885 2.074 . . . . 0.0 113.257 -177.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -141.25 115.19 9.15 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 101.753 -3.425 . . . . 0.0 101.753 168.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.6 t -94.98 116.67 28.98 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 111.6 -2.545 . . . . 0.0 107.174 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.727 0 C-N-CA 124.03 0.932 . . . . 0.0 109.815 -168.457 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -140.62 124.24 17.03 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.268 1.027 . . . . 0.0 108.534 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -85.14 124.15 31.47 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.049 0.939 . . . . 0.0 109.408 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.279 8.5 tt0 -109.44 95.95 5.96 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 101.825 -3.398 . . . . 0.0 101.825 169.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.528 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -108.83 120.45 42.54 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 m -107.3 131.56 54.08 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 125.128 1.517 . . . . 0.0 106.98 -168.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.528 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.3 mp . . . . . 0 CA--C 1.582 2.211 0 N-CA-C 100.87 -3.752 . . . . 0.0 100.87 -167.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 t . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -100.59 139.71 35.89 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 120.711 1.596 . . . . 0.0 110.99 -169.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 m -106.76 105.02 14.86 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 166.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -95.38 112.46 24.17 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -125.9 119.96 29.17 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -169.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.28 -164.62 21.06 Favored Glycine 1 CA--C 1.58 4.119 0 CA-C-O 114.495 -3.392 . . . . 0.0 116.055 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -87.14 161.44 8.59 Favored 'Trans proline' 0 C--N 1.394 2.958 1 CA-C-N 126.687 5.244 . . . . 0.0 113.998 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.48 118.34 1.48 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-O 118.078 -1.401 . . . . 0.0 110.242 174.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.7 t -99.32 86.09 0.51 Allowed Pre-proline 0 CA--C 1.588 2.416 0 CA-C-O 116.757 -1.592 . . . . 0.0 111.988 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -83.53 172.46 10.28 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 123.11 2.54 . . . . 0.0 113.458 169.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -80.3 146.29 31.69 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.244 1.017 . . . . 0.0 110.12 167.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.264 30.9 m -138.36 153.42 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 O-C-N 123.724 0.64 . . . . 0.0 112.031 -170.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -23.07 147.56 0.01 OUTLIER Pre-proline 0 CA--C 1.584 2.277 0 CA-C-O 112.937 -3.411 . . . . 0.0 119.378 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 C--N 1.394 2.945 0 CA-C-N 126.606 3.395 . . . . 0.0 109.647 168.676 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.1 t . . . . . 0 N--CA 1.501 2.116 0 N-CA-C 104.177 -2.527 . . . . 0.0 104.177 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.5 p -118.75 104.47 10.62 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 1.3 tt -68.7 159.87 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.791 0 CA-C-N 111.64 -2.527 . . . . 0.0 113.244 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.7 ttm105 -139.32 108.6 6.1 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 168.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.9 m -94.81 97.16 9.83 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 110.072 -3.24 . . . . 0.0 106.02 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 N--CA 1.495 1.776 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.768 -168.059 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -139.52 128.04 22.98 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.321 1.048 . . . . 0.0 108.898 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -85.89 141.46 29.56 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.49 0.716 . . . . 0.0 111.129 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.268 4.8 tt0 -123.01 96.23 4.93 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 101.017 -3.697 . . . . 0.0 101.017 167.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.76 121.97 44.07 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -108.15 135.8 48.88 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 125.873 1.983 . . . . 0.0 106.819 -168.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.427 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mp . . . . . 0 CA--C 1.587 2.373 0 N-CA-C 100.986 -3.709 . . . . 0.0 100.986 -167.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.0 m . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -117.8 127.81 54.25 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -168.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 m -97.16 115.95 28.47 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.427 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.9 m-85 -104.25 114.9 29.46 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -128.47 119.61 25.25 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -170.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.8 171.04 39.33 Favored Glycine 1 CA--C 1.582 4.228 0 CA-C-O 115.059 -3.078 . . . . 0.0 116.948 -175.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.52 160.66 22.35 Favored 'Trans proline' 0 C--N 1.395 3.021 1 CA-C-N 125.624 4.712 . . . . 0.0 114.232 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.61 95.22 0.4 Allowed Glycine 0 N--CA 1.487 2.05 0 CA-C-O 117.315 -1.825 . . . . 0.0 111.308 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.255 4.7 p -102.8 92.05 3.26 Favored Pre-proline 0 CA--C 1.585 2.296 0 CA-C-O 116.507 -1.711 . . . . 0.0 114.403 -167.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.5 179.98 4.16 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 123.42 2.747 . . . . 0.0 113.898 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 p -68.33 148.39 50.81 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 125.114 1.366 . . . . 0.0 111.313 167.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 24.3 m -141.38 151.42 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.077 0.465 . . . . 0.0 112.02 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -12.03 145.61 0.0 OUTLIER Pre-proline 0 CA--C 1.583 2.236 0 N-CA-C 120.396 3.48 . . . . 0.0 120.396 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 C--N 1.395 2.987 0 CA-C-N 126.541 3.372 . . . . 0.0 109.406 168.178 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.1 t . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.0 p -112.75 101.34 9.44 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -172.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 tt -70.23 157.83 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.63 0 CA-C-N 111.113 -2.767 . . . . 0.0 113.596 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -136.14 106.36 6.38 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 167.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -95.59 109.35 21.6 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 111.062 -2.79 . . . . 0.0 106.127 170.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 124.629 1.206 . . . . 0.0 110.125 -168.052 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -138.96 129.89 26.42 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.297 1.039 . . . . 0.0 109.012 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -88.02 139.64 30.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.497 0.719 . . . . 0.0 110.801 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -122.55 99.92 6.66 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 101.478 -3.527 . . . . 0.0 101.478 167.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.72 122.5 47.96 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 178.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.63 133.23 52.38 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -169.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.449 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.0 mp . . . . . 0 CA--C 1.585 2.311 0 N-CA-C 100.595 -3.854 . . . . 0.0 100.595 -167.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.9 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -113.85 125.4 54.03 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -168.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -98.47 108.74 21.5 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.449 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.6 m-85 -102.04 112.46 25.12 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.75 124.95 30.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -168.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.02 -154.09 9.41 Favored Glycine 1 CA--C 1.58 4.133 0 CA-C-O 114.377 -3.457 . . . . 0.0 115.239 174.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -90.35 161.65 4.56 Favored 'Trans proline' 0 C--N 1.395 3.019 1 CA-C-N 126.474 5.137 . . . . 0.0 114.533 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.05 116.02 1.05 Allowed Glycine 0 N--CA 1.481 1.648 0 CA-C-O 117.897 -1.502 . . . . 0.0 110.317 174.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.4 m -101.36 86.1 0.71 Allowed Pre-proline 0 CA--C 1.588 2.426 0 CA-C-O 116.741 -1.6 . . . . 0.0 111.609 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.66 174.35 8.76 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 123.438 2.759 . . . . 0.0 113.9 172.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.98 155.83 39.44 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.598 1.159 . . . . 0.0 112.294 168.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 13.5 m -135.83 155.21 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -169.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -56.71 153.39 22.07 Favored Pre-proline 0 CA--C 1.583 2.22 0 CA-C-O 114.25 -2.786 . . . . 0.0 116.342 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo . . . . . 0 C--N 1.397 3.103 0 CA-C-N 126.093 3.212 . . . . 0.0 109.967 168.796 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.505 2.298 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 p -136.44 107.42 6.7 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.265 2.6 tt -67.95 162.2 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 CA-C-N 112.099 -2.319 . . . . 0.0 113.713 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -138.98 112.54 8.28 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 167.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.4 t -96.33 111.57 23.61 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 111.48 -2.6 . . . . 0.0 106.247 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 124.282 0.989 . . . . 0.0 109.458 -168.328 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -141.19 125.54 17.57 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.268 1.027 . . . . 0.0 108.789 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -80.36 141.35 35.47 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 124.174 0.922 . . . . 0.0 111.439 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -124.32 98.9 5.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 100.525 -3.88 . . . . 0.0 100.525 168.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.48 122.43 47.26 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -106.83 134.87 49.31 Favored 'General case' 0 CA--C 1.55 0.981 0 O-C-N 125.653 1.846 . . . . 0.0 106.842 -169.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.494 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.7 mp . . . . . 0 CA--C 1.586 2.332 0 N-CA-C 100.532 -3.877 . . . . 0.0 100.532 -168.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -114.91 126.12 54.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -168.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -96.71 111.7 23.75 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.494 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.1 m-85 -103.0 119.1 38.25 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 -139.49 125.48 19.8 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.087 -167.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.81 -156.62 10.22 Favored Glycine 1 CA--C 1.581 4.165 0 CA-C-O 114.249 -3.528 . . . . 0.0 115.755 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -87.67 163.47 7.83 Favored 'Trans proline' 0 C--N 1.395 3.011 1 CA-C-N 126.721 5.261 . . . . 0.0 114.182 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.95 131.12 4.41 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.2 m -95.79 87.01 0.37 Allowed Pre-proline 0 CA--C 1.591 2.545 0 CA-C-O 116.767 -1.587 . . . . 0.0 110.337 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.14 169.62 17.37 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 123.428 2.752 . . . . 0.0 113.689 170.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.79 156.92 24.69 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.519 1.128 . . . . 0.0 111.202 168.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.251 15.6 m -136.78 151.42 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.113 0.565 . . . . 0.0 111.728 -175.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.47 164.54 44.81 Favored Pre-proline 0 CA--C 1.584 2.264 0 CA-C-O 115.339 -2.267 . . . . 0.0 114.186 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--N 1.4 3.241 0 CA-C-N 126.251 3.268 . . . . 0.0 112.654 177.856 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.5 2.031 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.9 p -134.21 106.77 7.32 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 103.668 -2.716 . . . . 0.0 103.668 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 tt -69.87 162.15 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 127.368 2.267 . . . . 0.0 113.466 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.8 ttm-85 -144.07 111.6 6.02 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 102.506 -3.146 . . . . 0.0 102.506 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -100.33 108.76 20.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 111.732 -2.485 . . . . 0.0 105.477 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.493 1.722 0 O-C-N 124.479 1.112 . . . . 0.0 109.502 -168.454 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.34 128.05 40.6 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -84.73 126.33 33.31 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.116 0.966 . . . . 0.0 109.842 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.264 5.1 tt0 -121.22 92.05 3.66 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 171.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.27 130.99 55.15 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 171.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 m -108.2 128.03 54.35 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 112.479 -2.146 . . . . 0.0 106.625 -169.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 CA--C 1.582 2.201 0 N-CA-C 100.428 -3.915 . . . . 0.0 100.428 -168.56 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.8 m . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -99.02 138.57 35.93 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 120.55 1.523 . . . . 0.0 111.022 -169.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.7 m -106.12 104.0 13.61 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 100.994 -3.706 . . . . 0.0 100.994 166.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -92.17 98.3 11.44 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -113.32 121.27 43.88 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -170.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.73 -166.26 28.42 Favored Glycine 1 CA--C 1.58 4.104 0 CA-C-O 114.495 -3.392 . . . . 0.0 116.519 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -88.0 160.3 7.32 Favored 'Trans proline' 0 C--N 1.395 2.974 1 CA-C-N 126.737 5.269 . . . . 0.0 114.211 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.03 116.8 1.28 Allowed Glycine 0 N--CA 1.479 1.534 0 CA-C-O 118.194 -1.337 . . . . 0.0 110.602 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 t -97.03 90.67 0.82 Allowed Pre-proline 0 CA--C 1.587 2.392 0 CA-C-O 116.394 -1.765 . . . . 0.0 111.68 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.85 170.47 13.97 Favored 'Trans proline' 0 C--N 1.39 2.711 0 CA-C-N 124.287 2.567 . . . . 0.0 113.431 169.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -82.57 143.85 30.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.354 1.062 . . . . 0.0 109.806 168.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.302 19.0 m -140.53 161.56 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.052 0 CA-C-O 121.328 0.585 . . . . 0.0 111.896 -176.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.9 175.72 0.52 Allowed Pre-proline 0 CA--C 1.591 2.526 0 N-CA-C 118.786 2.884 . . . . 0.0 118.786 -168.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo . . . . . 0 C--N 1.404 3.471 0 CA-C-N 125.614 3.041 . . . . 0.0 110.635 173.254 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 N--CA 1.499 1.993 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.4 p -125.44 106.34 9.74 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 tt -66.48 160.32 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.835 0 CA-C-N 111.956 -2.384 . . . . 0.0 113.049 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -136.85 107.97 6.77 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.2 m -94.92 109.55 21.54 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 109.764 -3.38 . . . . 0.0 105.425 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.737 0 C-N-CA 124.217 1.007 . . . . 0.0 111.033 -167.332 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -136.53 140.98 43.37 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.316 1.046 . . . . 0.0 110.086 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -87.63 143.99 26.9 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.564 0.746 . . . . 0.0 111.643 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -126.23 96.8 4.84 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 100.269 -3.975 . . . . 0.0 100.269 166.557 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.94 122.46 46.33 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.1 m -108.16 135.78 48.92 Favored 'General case' 0 CA--C 1.552 1.035 0 O-C-N 125.79 1.931 . . . . 0.0 106.685 -169.016 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.409 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.8 mp . . . . . 0 CA--C 1.586 2.329 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 -167.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -118.53 127.26 53.45 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -168.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 m -97.51 112.49 24.32 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.409 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.1 m-85 -102.85 119.65 39.21 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.3 mtm-85 -138.25 123.01 18.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -168.233 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.92 177.15 42.31 Favored Glycine 1 CA--C 1.581 4.198 0 CA-C-O 115.054 -3.081 . . . . 0.0 116.555 -178.38 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.88 160.07 21.22 Favored 'Trans proline' 0 C--N 1.395 2.999 1 CA-C-N 126.019 4.91 . . . . 0.0 113.97 -175.639 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.94 96.66 0.4 Allowed Glycine 0 N--CA 1.487 2.074 0 CA-C-O 117.315 -1.825 . . . . 0.0 111.174 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.252 4.0 p -102.3 95.43 5.87 Favored Pre-proline 0 CA--C 1.584 2.275 0 CA-C-O 115.978 -1.963 . . . . 0.0 114.192 -167.326 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -85.54 179.51 3.9 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 123.442 2.761 . . . . 0.0 114.006 173.236 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 p -61.68 161.81 9.43 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 125.616 1.566 . . . . 0.0 113.857 169.322 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.252 14.2 m -135.29 154.27 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 C-N-CA 122.983 0.513 . . . . 0.0 112.229 178.308 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.259 50.7 pttt -75.14 -172.2 0.25 Allowed Pre-proline 0 CA--C 1.601 2.919 0 CA-C-O 114.688 -2.577 . . . . 0.0 116.46 -176.069 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 C--N 1.4 3.263 0 CA-C-N 126.539 3.371 . . . . 0.0 110.806 173.993 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.5 2.03 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -137.4 106.87 6.12 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 -177.042 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.53 162.91 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 CA-C-N 112.173 -2.285 . . . . 0.0 113.584 -178.52 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -137.93 108.63 6.62 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 101.87 -3.382 . . . . 0.0 101.87 166.009 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.1 t -98.07 109.34 22.11 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 111.558 -2.565 . . . . 0.0 105.673 171.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 124.601 1.188 . . . . 0.0 110.1 -167.824 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -139.57 137.46 35.4 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 124.4 1.08 . . . . 0.0 109.882 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -84.85 121.84 28.3 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 117.404 -1.284 . . . . 0.0 109.517 -179.037 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -109.17 98.56 7.98 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 170.261 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -110.93 120.26 41.8 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 179.897 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.4 m -107.38 130.71 54.77 Favored 'General case' 0 CA--C 1.554 1.108 0 O-C-N 125.314 1.634 . . . . 0.0 106.817 -168.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.492 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.3 mp . . . . . 0 CA--C 1.582 2.195 0 N-CA-C 100.522 -3.881 . . . . 0.0 100.522 -167.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -98.6 140.66 32.49 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 120.443 1.474 . . . . 0.0 111.102 -169.656 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.0 m -107.02 100.19 9.7 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 101.058 -3.682 . . . . 0.0 101.058 167.227 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -94.14 110.72 22.42 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -175.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.46 116.59 20.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -167.817 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.98 -172.21 28.0 Favored Glycine 1 CA--C 1.583 4.286 0 CA-C-O 114.613 -3.326 . . . . 0.0 115.059 177.487 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -86.48 162.81 9.57 Favored 'Trans proline' 0 C--N 1.394 2.933 1 CA-C-N 126.892 5.346 . . . . 0.0 114.332 -175.657 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.32 113.81 1.38 Allowed Glycine 0 N--CA 1.481 1.649 0 CA-C-O 117.643 -1.643 . . . . 0.0 110.089 176.013 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.3 m -102.56 85.62 0.8 Allowed Pre-proline 0 CA--C 1.588 2.439 0 CA-C-O 117.021 -1.466 . . . . 0.0 111.942 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.02 173.41 9.07 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 123.258 2.638 . . . . 0.0 113.791 169.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -77.44 147.71 35.81 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.443 1.097 . . . . 0.0 110.358 167.652 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 31.2 m -139.08 152.21 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.828 0 O-C-N 123.556 0.535 . . . . 0.0 112.052 -173.173 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -17.45 146.57 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.265 0 CA-C-O 112.784 -3.484 . . . . 0.0 119.713 170.597 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 C--N 1.395 2.991 0 CA-C-N 126.614 3.398 . . . . 0.0 109.616 168.505 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.0 t . . . . . 0 N--CA 1.502 2.156 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.2 p -118.56 104.14 10.38 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 -174.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.282 1.3 tt -67.3 167.55 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 111.455 -2.611 . . . . 0.0 113.66 179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -144.65 112.19 6.14 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 168.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.4 t -95.82 98.05 10.14 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 168.315 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 N--CA 1.492 1.668 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.349 -165.963 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -139.46 125.64 20.04 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.264 1.026 . . . . 0.0 108.862 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -112.61 145.09 41.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 124.185 0.928 . . . . 0.0 112.201 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.27 3.2 tt0 -126.04 95.04 4.27 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 102.176 -3.268 . . . . 0.0 102.176 168.525 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -111.12 124.7 52.72 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.3 m -109.59 134.43 51.94 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 125.495 1.747 . . . . 0.0 106.528 -168.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 CA--C 1.585 2.293 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 -167.852 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -120.64 127.51 52.15 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -168.726 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m -96.96 117.46 31.2 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 178.276 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -106.5 113.02 26.29 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -127.02 121.46 31.68 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -169.638 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.18 -160.31 13.28 Favored Glycine 1 CA--C 1.58 4.123 0 CA-C-O 114.466 -3.408 . . . . 0.0 116.297 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -90.71 156.86 4.21 Favored 'Trans proline' 0 C--N 1.397 3.096 1 CA-C-N 126.271 5.035 . . . . 0.0 114.487 -176.739 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.22 109.99 0.51 Allowed Glycine 0 N--CA 1.482 1.703 0 CA-C-O 117.954 -1.47 . . . . 0.0 111.261 174.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.323 1.3 p -108.38 82.37 1.6 Allowed Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 116.69 -1.624 . . . . 0.0 112.197 -171.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.84 -178.8 3.39 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 123.619 2.879 . . . . 0.0 113.684 172.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 p -61.79 158.31 16.09 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.446 1.498 . . . . 0.0 113.937 169.594 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.25 12.7 m -132.92 154.86 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.858 0 C-N-CA 123.358 0.663 . . . . 0.0 111.752 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 163.95 58.06 Favored Pre-proline 0 CA--C 1.583 2.248 0 CA-C-O 115.338 -2.267 . . . . 0.0 114.659 -179.447 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo . . . . . 0 C--N 1.4 3.245 0 CA-C-N 126.058 3.199 . . . . 0.0 112.661 179.845 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.2 p -139.14 108.51 6.13 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 102.907 -2.997 . . . . 0.0 102.907 -178.625 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 tt -70.06 163.2 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 C-N-CA 126.918 2.087 . . . . 0.0 113.685 -174.558 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -119.64 134.85 55.06 Favored 'General case' 0 CA--C 1.543 0.677 1 N-CA-C 97.397 -5.038 . . . . 0.0 97.397 163.205 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.0 t -106.17 65.0 0.68 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.689 1.233 . . . . 0.0 108.001 162.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.327 10.3 pt-20 . . . . . 0 N--CA 1.493 1.697 0 C-N-CA 126.08 1.752 . . . . 0.0 107.798 -170.061 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -146.29 128.28 15.52 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.15 128.24 35.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.542 0.737 . . . . 0.0 110.351 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.279 9.4 tt0 -112.92 96.83 6.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 101.216 -3.624 . . . . 0.0 101.216 168.555 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.4 109.93 19.84 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 -176.303 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 m -96.39 127.75 42.68 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.243 -167.221 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mm . . . . . 0 CA--C 1.58 2.112 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 -167.506 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.52 139.41 30.56 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.582 1.153 . . . . 0.0 110.356 -170.148 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -110.93 110.47 21.06 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 102.782 -3.044 . . . . 0.0 102.782 169.059 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -98.94 115.75 29.6 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.31 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -128.22 122.61 32.19 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -173.028 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.53 -155.71 11.1 Favored Glycine 0 CA--C 1.578 3.982 0 CA-C-O 114.452 -3.416 . . . . 0.0 115.856 176.236 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -87.94 161.58 7.44 Favored 'Trans proline' 0 C--N 1.394 2.942 1 CA-C-N 126.393 5.096 . . . . 0.0 114.024 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.64 117.02 1.42 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-O 118.235 -1.314 . . . . 0.0 110.481 173.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.5 m -102.46 84.47 0.63 Allowed Pre-proline 0 CA--C 1.588 2.407 0 CA-C-O 116.766 -1.588 . . . . 0.0 111.129 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.91 174.07 9.73 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 123.399 2.732 . . . . 0.0 113.958 171.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.51 155.4 36.17 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.556 1.143 . . . . 0.0 112.05 168.61 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.268 13.4 m -137.08 156.63 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -169.512 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -63.64 165.59 11.67 Favored Pre-proline 0 CA--C 1.58 2.132 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--N 1.396 3.052 0 C-N-CA 123.149 2.566 . . . . 0.0 109.944 169.53 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t . . . . . 0 N--CA 1.506 2.353 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -137.76 108.78 6.74 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 -178.287 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.264 1.1 tt -69.49 164.36 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 C-N-CA 126.91 2.084 . . . . 0.0 113.718 -174.712 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -139.35 113.76 9.03 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 167.019 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.4 t -95.78 115.91 28.12 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 111.606 -2.543 . . . . 0.0 106.943 171.504 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.493 1.686 0 C-N-CA 124.162 0.985 . . . . 0.0 110.098 -168.221 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -140.78 124.2 16.78 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.301 1.04 . . . . 0.0 108.4 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -86.16 128.07 34.83 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 124.088 0.868 . . . . 0.0 110.33 -179.405 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.259 7.1 tt0 -112.0 97.86 6.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 100.855 -3.757 . . . . 0.0 100.855 168.734 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.48 108.18 16.85 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -177.181 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 m -96.36 126.17 41.37 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 113.369 -1.741 . . . . 0.0 106.817 -167.213 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 mm . . . . . 0 CA--C 1.579 2.088 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 -166.897 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.74 119.52 36.95 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -169.245 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 m -96.58 120.81 37.6 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 -171.578 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -112.38 118.37 35.01 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -138.37 116.88 12.07 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -168.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.63 -155.34 9.92 Favored Glycine 1 CA--C 1.579 4.054 0 CA-C-O 114.345 -3.475 . . . . 0.0 115.373 178.472 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -88.12 161.63 7.17 Favored 'Trans proline' 0 C--N 1.394 2.935 1 CA-C-N 126.728 5.264 . . . . 0.0 114.131 -178.394 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.28 115.72 1.47 Allowed Glycine 0 N--CA 1.479 1.519 0 CA-C-O 118.058 -1.412 . . . . 0.0 110.443 174.357 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.2 m -101.56 85.7 0.68 Allowed Pre-proline 0 CA--C 1.587 2.376 0 CA-C-O 116.716 -1.611 . . . . 0.0 111.295 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.48 173.51 10.54 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 123.31 2.673 . . . . 0.0 113.827 171.046 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -75.48 155.3 36.35 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.557 1.143 . . . . 0.0 111.963 168.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.27 19.4 m -136.96 153.3 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 123.503 0.502 . . . . 0.0 111.98 -173.175 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.98 48.41 Favored Pre-proline 0 CA--C 1.585 2.292 0 CA-C-O 115.241 -2.314 . . . . 0.0 114.688 -179.441 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo . . . . . 0 C--N 1.4 3.249 0 CA-C-N 126.34 3.3 . . . . 0.0 113.006 177.916 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t . . . . . 0 N--CA 1.503 2.191 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 p -137.36 109.18 7.08 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 0.9 OUTLIER -68.8 164.5 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 C-N-CA 126.84 2.056 . . . . 0.0 113.685 -174.959 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -141.03 113.11 7.84 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 167.131 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.1 t -97.81 114.15 26.12 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 111.524 -2.58 . . . . 0.0 106.411 170.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 124.055 0.847 . . . . 0.0 110.005 -168.695 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.93 139.75 38.1 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 124.265 1.026 . . . . 0.0 109.672 179.44 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -80.0 139.54 36.94 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 117.338 -1.315 . . . . 0.0 111.78 -177.067 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -121.22 97.58 5.58 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 102.503 -3.147 . . . . 0.0 102.503 168.697 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.58 119.63 39.8 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 -178.705 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -107.13 130.03 54.75 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 125.652 1.845 . . . . 0.0 106.174 -168.892 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.8 mp . . . . . 0 CA--C 1.586 2.335 0 N-CA-C 100.469 -3.901 . . . . 0.0 100.469 -167.871 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -113.52 125.55 54.33 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -168.882 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -97.92 108.35 21.04 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 -173.988 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.471 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.5 m-85 -101.86 112.08 24.57 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -176.67 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.75 121.24 26.48 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -168.541 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.03 170.8 42.69 Favored Glycine 1 CA--C 1.581 4.218 0 CA-C-O 115.102 -3.054 . . . . 0.0 116.325 -177.705 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.46 162.76 22.07 Favored 'Trans proline' 0 C--N 1.394 2.938 1 CA-C-N 125.805 4.802 . . . . 0.0 114.153 -176.294 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.08 91.54 0.81 Allowed Glycine 0 N--CA 1.486 2.003 0 CA-C-O 117.379 -1.79 . . . . 0.0 110.38 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.9 m -85.7 102.49 2.63 Favored Pre-proline 0 CA--C 1.589 2.472 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -166.895 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -79.68 179.37 6.37 Favored 'Trans proline' 0 CA--C 1.58 2.796 0 C-N-CA 123.199 2.599 . . . . 0.0 112.158 166.709 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.303 9.9 t -105.24 155.97 18.57 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 123.841 0.856 . . . . 0.0 109.025 167.091 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.0 m -120.31 155.42 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 C-N-CA 124.22 1.008 . . . . 0.0 112.151 -165.695 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 179.79 1.58 Allowed Pre-proline 0 CA--C 1.6 2.869 0 CA-C-O 116.232 -1.842 . . . . 0.0 112.935 -179.342 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo . . . . . 0 C--N 1.394 2.951 0 C-N-CA 123.654 2.903 . . . . 0.0 111.088 177.391 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.501 2.108 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.9 p -141.4 106.09 4.9 Favored 'General case' 0 CA--C 1.558 1.272 0 N-CA-C 104.54 -2.392 . . . . 0.0 104.54 -176.042 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.253 1.6 tt -72.91 159.95 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.741 0 C-N-CA 127.14 2.176 . . . . 0.0 113.653 -178.203 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -145.42 103.53 3.83 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 105.896 -1.891 . . . . 0.0 105.896 168.711 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.9 t -91.89 98.02 11.33 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 111.951 -2.386 . . . . 0.0 104.729 169.507 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 . . . . . 0 N--CA 1.492 1.647 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.983 -165.51 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -136.25 141.04 43.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 124.312 1.045 . . . . 0.0 110.148 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -88.75 142.84 27.33 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.559 0.744 . . . . 0.0 111.404 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.251 4.0 tt0 -125.49 96.93 4.98 Favored 'General case' 0 N--CA 1.487 1.387 1 N-CA-C 100.15 -4.018 . . . . 0.0 100.15 166.704 . . . . . . . . 3 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.89 124.2 50.02 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 m -106.56 132.26 52.77 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 125.576 1.797 . . . . 0.0 107.357 -168.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.582 2.179 0 N-CA-C 100.998 -3.704 . . . . 0.0 100.998 -168.679 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -101.73 141.25 34.87 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.612 1.551 . . . . 0.0 111.231 -169.55 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -104.51 102.84 12.46 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 165.828 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -92.42 115.23 27.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -178.916 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -131.54 122.32 25.93 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -168.261 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.22 172.21 42.76 Favored Glycine 1 CA--C 1.58 4.12 0 CA-C-O 115.139 -3.034 . . . . 0.0 116.542 -177.402 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.12 159.69 23.62 Favored 'Trans proline' 0 C--N 1.395 3.009 1 CA-C-N 125.896 4.848 . . . . 0.0 113.962 -175.838 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.99 97.11 0.39 Allowed Glycine 0 N--CA 1.488 2.103 0 CA-C-O 117.346 -1.808 . . . . 0.0 111.151 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.253 4.0 p -101.44 95.93 5.62 Favored Pre-proline 0 CA--C 1.583 2.241 0 CA-C-O 115.932 -1.985 . . . . 0.0 114.02 -167.459 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -84.03 178.52 5.27 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 123.497 2.798 . . . . 0.0 113.88 173.447 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -63.72 161.23 15.47 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 125.454 1.502 . . . . 0.0 114.095 169.792 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.3 m -134.1 152.78 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 C-N-CA 123.42 0.688 . . . . 0.0 111.682 -179.694 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.28 164.54 49.53 Favored Pre-proline 0 CA--C 1.585 2.289 0 CA-C-O 115.305 -2.283 . . . . 0.0 114.219 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo . . . . . 0 C--N 1.398 3.179 0 CA-C-N 126.203 3.251 . . . . 0.0 112.503 177.626 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.6 t . . . . . 0 N--CA 1.502 2.146 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.6 p -135.92 106.22 6.4 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 -176.394 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 tt -71.46 164.06 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.829 0 CA-C-N 111.983 -2.371 . . . . 0.0 113.54 -178.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -139.0 108.0 6.01 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 101.776 -3.416 . . . . 0.0 101.776 165.351 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.6 t -98.02 108.98 21.8 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 111.664 -2.517 . . . . 0.0 105.637 172.227 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 124.67 1.231 . . . . 0.0 110.164 -167.774 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -138.5 136.6 36.3 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.349 1.06 . . . . 0.0 109.664 179.646 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -87.65 142.02 28.16 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.45 0.7 . . . . 0.0 111.4 -178.01 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.254 4.2 tt0 -124.72 96.87 5.05 Favored 'General case' 0 N--CA 1.488 1.43 1 N-CA-C 100.185 -4.005 . . . . 0.0 100.185 166.639 . . . . . . . . 3 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.24 123.67 49.42 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -106.57 131.71 53.42 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 113.23 -1.805 . . . . 0.0 107.194 -168.482 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.581 2.172 0 N-CA-C 101.002 -3.703 . . . . 0.0 101.002 -168.507 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.7 m . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -101.41 141.09 34.8 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 120.622 1.555 . . . . 0.0 111.247 -169.556 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -104.6 102.65 12.25 Favored 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 100.928 -3.731 . . . . 0.0 100.928 165.744 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -92.68 115.0 27.71 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 -178.764 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -131.22 122.03 25.83 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -168.29 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.2 171.8 42.61 Favored Glycine 1 CA--C 1.58 4.132 0 CA-C-O 115.102 -3.054 . . . . 0.0 116.694 -177.149 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.96 159.64 24.11 Favored 'Trans proline' 0 C--N 1.394 2.965 1 CA-C-N 125.775 4.787 . . . . 0.0 113.958 -175.884 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.8 96.89 0.38 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-O 117.324 -1.82 . . . . 0.0 111.107 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.253 3.8 p -101.44 95.97 5.66 Favored Pre-proline 0 CA--C 1.582 2.209 0 CA-C-O 115.893 -2.003 . . . . 0.0 114.048 -167.504 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -83.93 178.0 5.69 Favored 'Trans proline' 0 C--N 1.394 2.95 0 C-N-CA 123.479 2.786 . . . . 0.0 113.912 173.493 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -63.9 161.11 16.21 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 125.35 1.46 . . . . 0.0 114.062 169.818 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 m -134.84 152.55 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 123.353 0.661 . . . . 0.0 111.589 -179.636 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 164.73 49.69 Favored Pre-proline 0 CA--C 1.583 2.243 0 CA-C-O 115.341 -2.266 . . . . 0.0 114.225 179.644 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo . . . . . 0 C--N 1.399 3.226 0 CA-C-N 126.179 3.243 . . . . 0.0 112.373 177.331 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 N--CA 1.502 2.151 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -137.42 106.03 5.85 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 123.724 1.726 . . . . 0.0 108.528 -178.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 tt -70.9 162.29 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 CA-C-N 109.109 -3.678 . . . . 0.0 113.663 -176.045 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -138.01 107.67 6.23 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 101.934 -3.358 . . . . 0.0 101.934 165.499 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -97.97 107.51 20.0 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 111.469 -2.605 . . . . 0.0 105.617 171.697 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 124.657 1.223 . . . . 0.0 109.947 -167.91 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -141.4 122.86 14.99 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -82.46 123.5 29.21 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 117.535 -1.222 . . . . 0.0 110.0 -175.92 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -108.66 95.96 6.01 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 170.532 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.527 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.56 119.24 38.86 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 179.346 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.0 m -107.52 130.15 54.89 Favored 'General case' 0 CA--C 1.554 1.132 0 O-C-N 125.323 1.639 . . . . 0.0 106.66 -168.913 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.527 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.3 mp . . . . . 0 CA--C 1.582 2.184 0 N-CA-C 100.572 -3.862 . . . . 0.0 100.572 -167.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -96.58 139.71 32.27 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 120.621 1.555 . . . . 0.0 111.03 -169.677 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 m -107.93 99.86 9.27 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 101.098 -3.667 . . . . 0.0 101.098 167.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -94.11 110.93 22.61 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -176.029 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.27 116.82 20.45 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -167.805 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.01 -164.63 20.8 Favored Glycine 1 CA--C 1.582 4.231 0 CA-C-O 114.687 -3.285 . . . . 0.0 115.464 177.528 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -88.01 162.65 7.35 Favored 'Trans proline' 0 C--N 1.394 2.945 1 CA-C-N 126.554 5.177 . . . . 0.0 114.204 -177.075 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.82 114.95 1.55 Allowed Glycine 0 N--CA 1.48 1.569 0 CA-C-O 117.861 -1.522 . . . . 0.0 110.097 174.016 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.2 t -101.23 85.92 0.67 Allowed Pre-proline 0 CA--C 1.588 2.411 0 CA-C-O 116.864 -1.541 . . . . 0.0 112.432 -175.577 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.12 171.72 11.28 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 123.134 2.556 . . . . 0.0 113.33 168.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.81 147.13 31.92 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.195 0.998 . . . . 0.0 110.467 167.816 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.266 29.8 m -138.09 154.42 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 O-C-N 123.743 0.652 . . . . 0.0 111.934 -169.941 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -28.0 148.52 0.03 OUTLIER Pre-proline 0 CA--C 1.585 2.298 0 CA-C-O 113.145 -3.312 . . . . 0.0 118.884 174.759 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 C--N 1.395 3.014 0 CA-C-N 126.546 3.374 . . . . 0.0 109.828 168.98 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 N--CA 1.502 2.136 0 N-CA-C 103.84 -2.652 . . . . 0.0 103.84 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.6 p -115.37 102.42 9.82 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -173.225 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.263 1.7 tt -68.28 163.05 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-N 111.159 -2.746 . . . . 0.0 114.026 -179.173 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -145.14 106.23 4.17 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 167.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 81.2 m -92.43 91.35 7.6 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 111.362 -2.654 . . . . 0.0 104.769 172.426 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 . . . . . 0 N--CA 1.493 1.677 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.79 -165.383 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.2 p . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -140.44 123.9 16.96 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 118.056 -0.974 . . . . 0.0 108.783 178.154 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -89.81 135.86 33.38 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 124.391 1.057 . . . . 0.0 110.23 174.433 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.287 3.4 tt0 -119.32 95.71 4.91 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 102.626 -3.101 . . . . 0.0 102.626 169.889 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.38 123.71 50.15 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -176.787 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -105.75 134.22 49.23 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 125.489 1.743 . . . . 0.0 107.679 -168.515 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 CA--C 1.583 2.22 0 N-CA-C 100.961 -3.718 . . . . 0.0 100.961 -168.514 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -103.41 141.54 35.79 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 120.173 1.351 . . . . 0.0 111.082 -169.533 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 m -105.05 105.74 15.92 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 100.995 -3.706 . . . . 0.0 100.995 166.2 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -93.5 110.44 22.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -122.45 116.6 24.24 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -169.883 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.89 164.97 36.76 Favored Glycine 1 CA--C 1.58 4.096 0 CA-C-O 114.975 -3.125 . . . . 0.0 116.693 -174.187 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.79 159.16 21.52 Favored 'Trans proline' 0 C--N 1.395 3.008 1 CA-C-N 125.739 4.77 . . . . 0.0 114.303 -174.173 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.72 95.17 0.41 Allowed Glycine 0 N--CA 1.487 2.071 0 CA-C-O 117.144 -1.92 . . . . 0.0 111.375 177.093 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.4 m -74.09 108.12 4.57 Favored Pre-proline 0 CA--C 1.586 2.358 0 CA-C-O 115.662 -2.113 . . . . 0.0 114.818 -167.314 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.73 169.44 18.22 Favored 'Trans proline' 0 C--N 1.39 2.727 0 CA-C-N 124.683 2.708 . . . . 0.0 113.663 169.916 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.88 149.88 26.07 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.127 0.971 . . . . 0.0 110.519 168.635 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.71 148.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 123.712 0.805 . . . . 0.0 111.491 -169.161 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 166.68 33.96 Favored Pre-proline 0 CA--C 1.586 2.345 0 CA-C-O 115.097 -2.383 . . . . 0.0 113.176 175.66 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--N 1.4 3.249 0 CA-C-N 127.032 3.547 . . . . 0.0 111.341 -177.967 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -136.53 107.28 6.6 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 123.767 1.746 . . . . 0.0 108.261 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 tt -70.88 160.12 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 CA-C-N 109.124 -3.671 . . . . 0.0 114.042 -172.843 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -135.45 94.73 3.15 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 166.593 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.0 t -93.17 117.55 30.2 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 111.16 -2.745 . . . . 0.0 106.596 170.094 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.29 14.3 pt-20 . . . . . 0 N--CA 1.497 1.911 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -166.8 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.97 130.24 33.35 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.159 0.983 . . . . 0.0 109.064 176.519 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -87.82 140.29 29.66 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.979 0.799 . . . . 0.0 110.333 174.32 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.54 100.94 6.89 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 101.916 -3.365 . . . . 0.0 101.916 169.018 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.433 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -113.97 123.75 50.49 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.411 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -107.08 131.33 54.23 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 125.38 1.675 . . . . 0.0 107.124 -168.825 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.433 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.5 mp . . . . . 0 CA--C 1.582 2.198 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 -168.187 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -100.15 139.87 35.21 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 120.657 1.571 . . . . 0.0 111.054 -169.63 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.1 m -105.57 102.29 11.76 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 100.906 -3.739 . . . . 0.0 100.906 166.212 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -92.42 117.84 30.33 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -178.988 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -136.22 123.28 21.56 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -167.776 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.36 -156.53 12.57 Favored Glycine 1 CA--C 1.579 4.091 0 CA-C-O 114.501 -3.388 . . . . 0.0 115.698 176.573 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -88.95 161.93 5.98 Favored 'Trans proline' 0 C--N 1.395 2.984 1 CA-C-N 126.268 5.034 . . . . 0.0 114.339 -178.965 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.42 113.71 0.76 Allowed Glycine 0 N--CA 1.481 1.637 0 CA-C-O 117.656 -1.636 . . . . 0.0 110.597 173.358 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.4 m -98.78 89.3 0.84 Allowed Pre-proline 0 CA--C 1.587 2.401 0 CA-C-O 116.554 -1.688 . . . . 0.0 111.906 -175.448 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.04 172.72 12.66 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.298 2.665 . . . . 0.0 113.632 169.951 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.05 156.54 37.38 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.581 1.152 . . . . 0.0 112.394 168.786 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.26 13.3 m -134.45 154.64 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.841 0 O-C-N 123.685 0.615 . . . . 0.0 112.225 -170.347 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -64.94 164.59 20.54 Favored Pre-proline 0 CA--C 1.581 2.135 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 -178.418 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--N 1.396 3.05 0 C-N-CA 123.199 2.6 . . . . 0.0 110.034 169.9 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.504 2.241 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.7 p -135.8 106.98 6.75 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 -176.333 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.253 1.9 tt -69.17 163.51 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.87 0 CA-C-N 111.932 -2.394 . . . . 0.0 113.465 -179.314 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -139.53 108.03 5.87 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 103.048 -2.945 . . . . 0.0 103.048 167.624 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 17.5 t -98.35 123.92 42.72 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 111.019 -2.809 . . . . 0.0 106.735 169.643 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.285 14.8 pt-20 . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -167.82 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -140.12 131.31 26.51 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.155 0.982 . . . . 0.0 109.697 179.395 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -84.08 135.65 34.32 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 124.543 1.152 . . . . 0.0 110.523 179.197 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.268 8.0 tt0 -119.81 99.14 6.46 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 100.999 -3.704 . . . . 0.0 100.999 170.285 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.479 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -108.69 123.62 49.27 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 177.077 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 m -107.84 131.09 54.86 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -169.442 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.482 HD13 ' CD1' ' A' ' 12' ' ' PHE . 2.9 mp . . . . . 0 CA--C 1.586 2.349 0 N-CA-C 100.42 -3.918 . . . . 0.0 100.42 -167.765 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -115.83 125.27 52.46 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -169.065 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -95.97 116.4 28.88 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 -177.654 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.482 ' CD1' HD13 ' A' ' 7' ' ' ILE . 83.2 m-85 -105.57 113.89 27.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -128.34 117.54 21.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -169.828 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.22 -166.24 20.64 Favored Glycine 1 CA--C 1.582 4.266 0 CA-C-O 114.199 -3.556 . . . . 0.0 115.986 179.445 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -89.47 163.04 5.43 Favored 'Trans proline' 0 C--N 1.395 3.019 1 CA-C-N 127.293 5.547 . . . . 0.0 114.601 -177.816 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.27 128.32 4.08 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 m -98.48 84.17 0.33 Allowed Pre-proline 0 CA--C 1.591 2.557 0 CA-C-O 117.296 -1.335 . . . . 0.0 112.244 177.917 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -80.71 174.92 10.56 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.124 2.55 . . . . 0.0 112.482 167.761 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.299 8.8 t -106.47 153.8 21.76 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 167.735 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 m -121.96 159.79 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 C-N-CA 124.389 1.076 . . . . 0.0 111.958 -165.732 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 163.42 65.28 Favored Pre-proline 0 CA--C 1.585 2.321 0 CA-C-O 115.28 -2.295 . . . . 0.0 114.782 176.406 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo . . . . . 0 C--N 1.399 3.203 0 CA-C-N 126.162 3.236 . . . . 0.0 113.503 -179.532 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.3 t . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -142.53 108.44 5.16 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 103.428 -2.805 . . . . 0.0 103.428 -178.212 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.256 3.3 tt -70.93 160.92 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 C-N-CA 127.233 2.213 . . . . 0.0 113.027 -179.275 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -145.97 115.07 7.01 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 102.565 -3.124 . . . . 0.0 102.565 169.12 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.48 110.21 22.7 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 111.977 -2.374 . . . . 0.0 106.23 169.646 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 124.472 1.108 . . . . 0.0 109.389 -168.666 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.43 130.61 17.45 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.757 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -84.47 137.15 33.52 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.874 178.16 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.25 8.2 tt0 -121.05 99.61 6.6 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 100.965 -3.717 . . . . 0.0 100.965 169.038 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.24 122.92 46.4 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.093 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.29 136.14 47.6 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 125.67 1.856 . . . . 0.0 106.926 -169.267 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.469 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.2 mp . . . . . 0 CA--C 1.585 2.299 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 -167.829 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -119.97 126.08 49.97 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -169.073 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 m -97.07 112.01 23.98 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -177.2 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.469 ' CD1' HD13 ' A' ' 7' ' ' ILE . 83.3 m-85 -103.38 118.62 37.18 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -178.921 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -139.57 124.82 18.95 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -168.013 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.54 -156.15 9.76 Favored Glycine 1 CA--C 1.578 4.022 0 CA-C-O 114.478 -3.401 . . . . 0.0 115.734 177.241 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.58 161.07 9.4 Favored 'Trans proline' 0 C--N 1.394 2.969 1 CA-C-N 126.429 5.114 . . . . 0.0 113.833 -178.421 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.91 118.51 1.37 Allowed Glycine 0 N--CA 1.479 1.516 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.093 176.571 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -100.2 84.56 0.45 Allowed Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 117.036 -1.459 . . . . 0.0 112.702 -179.021 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.99 172.29 12.1 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 123.116 2.544 . . . . 0.0 112.953 168.585 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.289 9.5 t -93.45 157.85 16.01 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 123.457 0.703 . . . . 0.0 109.281 167.775 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.5 m -126.61 158.97 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 C-N-CA 124.131 0.972 . . . . 0.0 112.244 -166.277 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -73.99 -176.07 0.47 Allowed Pre-proline 0 CA--C 1.609 3.226 0 CA-C-O 115.142 -2.361 . . . . 0.0 113.717 -179.495 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--N 1.394 2.955 0 CA-C-N 126.606 3.395 . . . . 0.0 111.476 -178.634 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 N--CA 1.502 2.126 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.8 p -141.75 107.23 5.04 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 103.656 -2.72 . . . . 0.0 103.656 -176.619 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.266 1.4 tt -71.34 162.61 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 C-N-CA 127.255 2.222 . . . . 0.0 112.7 -179.077 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -142.65 123.94 14.67 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 169.019 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.8 t -95.31 123.76 38.99 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 111.789 -2.46 . . . . 0.0 108.391 169.536 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 . . . . . 0 N--CA 1.492 1.629 0 C-N-CA 124.176 0.991 . . . . 0.0 109.663 -169.269 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -147.52 127.28 13.44 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 178.696 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -86.4 140.45 29.99 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.118 0.567 . . . . 0.0 111.086 178.52 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.258 8.2 tt0 -124.56 96.46 4.91 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 100.665 -3.828 . . . . 0.0 100.665 166.785 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.99 123.33 46.65 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -177.016 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -107.77 135.72 48.71 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 125.853 1.97 . . . . 0.0 106.928 -169.143 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.438 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.6 mp . . . . . 0 CA--C 1.585 2.314 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 -167.956 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -118.36 126.9 53.06 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -168.852 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -97.01 112.41 24.18 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 -178.284 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.438 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.0 m-85 -103.59 119.26 38.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -179.671 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -138.57 120.43 15.39 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -168.485 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.11 178.75 42.18 Favored Glycine 1 CA--C 1.582 4.22 0 CA-C-O 115.054 -3.081 . . . . 0.0 116.866 -177.406 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.31 159.45 17.46 Favored 'Trans proline' 0 C--N 1.395 2.992 1 CA-C-N 125.877 4.839 . . . . 0.0 114.088 -174.994 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.03 96.37 0.41 Allowed Glycine 0 N--CA 1.488 2.127 0 CA-C-O 117.322 -1.821 . . . . 0.0 111.163 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.25 3.1 p -100.57 96.02 4.93 Favored Pre-proline 0 CA--C 1.583 2.234 0 CA-C-O 115.949 -1.977 . . . . 0.0 113.948 -167.414 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -83.5 178.81 5.38 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 123.516 2.81 . . . . 0.0 113.796 173.149 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 p -64.57 160.57 19.27 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.291 1.437 . . . . 0.0 113.817 169.554 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 m -134.29 152.23 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 123.334 0.654 . . . . 0.0 111.73 -178.262 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.71 164.09 48.58 Favored Pre-proline 0 CA--C 1.583 2.227 0 CA-C-O 115.336 -2.269 . . . . 0.0 114.213 178.952 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 C--N 1.399 3.223 0 CA-C-N 126.216 3.256 . . . . 0.0 112.686 178.575 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.499 2.024 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.4 p -133.81 105.85 7.01 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -176.72 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.4 tt -71.58 160.98 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.775 0 CA-C-N 112.009 -2.36 . . . . 0.0 113.471 -177.411 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -136.45 105.21 5.85 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 102.392 -3.188 . . . . 0.0 102.392 165.409 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.4 t -94.9 112.97 24.65 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 111.258 -2.701 . . . . 0.0 106.102 173.239 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 124.621 1.201 . . . . 0.0 111.228 -167.428 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -140.47 125.94 18.96 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.292 1.037 . . . . 0.0 108.767 179.722 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -88.2 139.92 30.01 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 124.005 0.816 . . . . 0.0 111.184 179.211 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -123.56 98.52 5.87 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 101.996 -3.335 . . . . 0.0 101.996 168.356 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.47 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -112.05 122.68 48.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 178.747 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -106.96 130.66 54.58 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 125.353 1.658 . . . . 0.0 107.029 -168.718 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.47 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.4 mp . . . . . 0 CA--C 1.582 2.182 0 N-CA-C 100.635 -3.839 . . . . 0.0 100.635 -168.271 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -100.31 141.14 33.57 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.417 1.462 . . . . 0.0 111.068 -169.607 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.8 m -106.09 100.46 10.0 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 166.926 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -93.46 109.9 21.48 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 -175.599 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.93 118.5 25.54 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -168.146 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.9 169.02 40.61 Favored Glycine 1 CA--C 1.582 4.22 0 CA-C-O 115.097 -3.057 . . . . 0.0 116.35 -176.343 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.45 160.89 22.53 Favored 'Trans proline' 0 C--N 1.395 2.987 1 CA-C-N 125.834 4.817 . . . . 0.0 114.29 -174.092 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.36 95.8 0.37 Allowed Glycine 0 N--CA 1.487 2.062 0 CA-C-O 116.921 -2.044 . . . . 0.0 111.465 178.017 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.8 m -78.98 106.59 4.59 Favored Pre-proline 0 CA--C 1.587 2.368 0 CA-C-O 115.755 -2.069 . . . . 0.0 113.943 -167.639 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -80.07 171.38 15.29 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 123.428 2.752 . . . . 0.0 113.828 170.7 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.82 153.69 28.95 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.358 1.063 . . . . 0.0 110.746 168.008 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.25 11.4 m -129.55 152.21 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 123.211 0.604 . . . . 0.0 112.497 -168.845 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.13 165.63 31.47 Favored Pre-proline 0 CA--C 1.581 2.16 0 CA-C-O 115.814 -2.041 . . . . 0.0 116.332 -179.611 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 C--N 1.395 3.017 0 C-N-CA 123.12 2.547 . . . . 0.0 109.958 169.73 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.3 t . . . . . 0 N--CA 1.504 2.234 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 p -131.7 106.27 8.04 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 -176.482 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 tt -69.66 162.16 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.827 0 CA-C-N 111.863 -2.426 . . . . 0.0 113.871 -179.071 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -138.17 102.31 4.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 166.162 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.0 t -96.1 105.14 17.14 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 111.138 -2.755 . . . . 0.0 105.818 171.776 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 N--CA 1.491 1.597 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.582 -167.677 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.6 p . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -141.29 124.22 16.23 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 124.285 1.034 . . . . 0.0 108.481 179.72 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -84.57 129.7 34.82 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 117.83 -1.081 . . . . 0.0 110.574 -177.207 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.276 5.3 tt0 -114.55 94.44 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 102.639 -3.097 . . . . 0.0 102.639 172.685 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.491 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -108.19 123.31 48.55 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.473 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 m -108.08 132.53 53.47 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -169.736 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.491 HD11 ' CD2' ' A' ' 5' ' ' TYR . 3.6 mp . . . . . 0 CA--C 1.586 2.351 0 N-CA-C 100.602 -3.851 . . . . 0.0 100.602 -167.661 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 94.7 p . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -113.57 125.67 54.44 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -168.768 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -97.12 116.41 29.28 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 -179.709 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.436 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.3 m-85 -104.23 112.92 26.13 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -128.2 119.42 25.18 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -169.961 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.58 -161.71 20.48 Favored Glycine 1 CA--C 1.579 4.078 0 CA-C-O 114.362 -3.466 . . . . 0.0 115.821 177.663 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.8 160.96 4.12 Favored 'Trans proline' 0 C--N 1.394 2.928 1 CA-C-N 126.748 5.274 . . . . 0.0 114.533 -179.458 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.31 113.51 0.87 Allowed Glycine 0 N--CA 1.482 1.719 0 CA-C-O 117.576 -1.68 . . . . 0.0 110.489 172.671 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -96.1 94.89 1.69 Allowed Pre-proline 0 CA--C 1.591 2.525 0 CA-C-O 116.211 -1.852 . . . . 0.0 113.628 -170.996 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -82.11 174.79 9.75 Favored 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 123.309 2.673 . . . . 0.0 113.624 169.283 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.94 158.89 27.92 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.431 1.093 . . . . 0.0 111.958 168.351 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.253 10.5 m -135.98 153.73 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -169.74 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -62.3 158.69 45.54 Favored Pre-proline 0 CA--C 1.587 2.366 0 CA-C-O 114.613 -2.613 . . . . 0.0 115.823 179.216 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 C--N 1.398 3.134 0 CA-C-N 126.105 3.216 . . . . 0.0 109.783 168.764 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.505 2.316 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 p -132.08 105.52 7.44 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 -174.672 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.267 2.6 tt -67.74 161.91 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.828 0 CA-C-N 111.65 -2.523 . . . . 0.0 114.446 -178.753 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -143.44 100.69 3.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 124.664 2.173 . . . . 0.0 106.49 167.852 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.7 m -94.89 91.95 6.67 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 110.792 -2.913 . . . . 0.0 104.128 173.571 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 N--CA 1.493 1.721 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.53 -165.161 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -142.24 132.59 24.99 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.346 1.059 . . . . 0.0 109.17 -179.774 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -83.13 135.2 34.9 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 117.343 -1.313 . . . . 0.0 111.211 -178.551 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -120.58 96.89 5.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 102.368 -3.197 . . . . 0.0 102.368 167.918 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.26 122.76 46.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.038 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -107.0 131.35 54.16 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 125.73 1.894 . . . . 0.0 107.068 -168.559 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 CA--C 1.581 2.17 0 N-CA-C 100.521 -3.881 . . . . 0.0 100.521 -168.435 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.6 p . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -99.54 141.31 32.5 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 120.401 1.455 . . . . 0.0 111.297 -169.614 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 m -105.94 101.64 11.13 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 101.004 -3.702 . . . . 0.0 101.004 166.762 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -94.36 110.32 22.1 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 -176.248 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.03 121.34 29.52 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -168.342 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.61 171.8 42.85 Favored Glycine 1 CA--C 1.581 4.175 0 CA-C-O 115.16 -3.022 . . . . 0.0 116.45 -177.549 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.21 160.39 23.29 Favored 'Trans proline' 0 C--N 1.396 3.031 1 CA-C-N 125.767 4.784 . . . . 0.0 114.064 -175.565 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.78 95.46 0.62 Allowed Glycine 0 N--CA 1.486 1.986 0 CA-C-O 117.603 -1.665 . . . . 0.0 110.863 -179.503 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.257 4.7 p -105.2 90.75 4.01 Favored Pre-proline 0 CA--C 1.583 2.248 0 CA-C-O 116.474 -1.727 . . . . 0.0 113.432 -167.645 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -83.73 178.6 5.39 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 123.409 2.74 . . . . 0.0 113.721 171.847 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 p -69.33 146.98 51.73 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.89 1.276 . . . . 0.0 111.871 168.911 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.31 30.8 m -138.94 168.56 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.112 0 CA-C-O 121.455 0.645 . . . . 0.0 111.607 -179.335 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.08 161.98 3.29 Favored Pre-proline 0 CA--C 1.58 2.1 0 N-CA-C 118.863 2.912 . . . . 0.0 118.863 -170.146 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 C--N 1.396 3.031 0 C-N-CA 123.111 2.541 . . . . 0.0 110.227 169.886 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.9 t . . . . . 0 N--CA 1.503 2.175 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.7 p -117.07 101.93 8.89 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -172.732 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.47 163.74 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 CA-C-N 111.023 -2.808 . . . . 0.0 113.934 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -140.18 105.53 5.06 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 166.968 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.13 97.29 10.19 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 169.023 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.492 1.671 0 CA-C-N 113.71 -1.587 . . . . 0.0 111.424 -165.491 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -138.87 129.1 25.54 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.332 1.053 . . . . 0.0 108.929 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -86.13 133.15 33.89 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.665 179.829 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -116.69 100.12 7.6 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 100.888 -3.745 . . . . 0.0 100.888 168.865 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.77 123.15 49.64 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 177.69 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -107.51 133.23 52.29 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 125.303 1.627 . . . . 0.0 106.633 -169.213 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.485 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.6 mp . . . . . 0 CA--C 1.585 2.317 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -167.686 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -116.71 125.4 51.65 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -169.053 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 m -96.28 113.34 24.93 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -177.976 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.485 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.8 m-85 -103.16 115.76 31.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -179.493 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -132.5 120.91 22.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -168.686 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.6 -162.19 16.28 Favored Glycine 1 CA--C 1.581 4.157 0 CA-C-O 114.496 -3.391 . . . . 0.0 115.887 178.47 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -87.61 161.53 7.92 Favored 'Trans proline' 0 C--N 1.395 3.004 1 CA-C-N 126.617 5.209 . . . . 0.0 114.062 -178.084 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.33 117.84 1.41 Allowed Glycine 0 N--CA 1.48 1.598 0 CA-C-O 117.932 -1.482 . . . . 0.0 110.044 176.929 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.5 m -100.72 84.6 0.48 Allowed Pre-proline 0 CA--C 1.588 2.408 0 CA-C-O 116.979 -1.486 . . . . 0.0 112.957 -177.304 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.99 174.11 10.44 Favored 'Trans proline' 0 C--N 1.389 2.701 0 C-N-CA 123.17 2.58 . . . . 0.0 112.923 168.559 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.288 9.6 t -95.57 157.72 15.77 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 123.619 0.768 . . . . 0.0 109.406 167.886 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 m -125.93 159.43 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 124.306 1.042 . . . . 0.0 112.069 -166.445 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -73.58 -176.2 0.46 Allowed Pre-proline 0 CA--C 1.609 3.22 0 CA-C-O 115.096 -2.383 . . . . 0.0 113.843 -179.111 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 C--N 1.394 2.956 0 CA-C-N 126.685 3.423 . . . . 0.0 111.579 -178.482 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.8 t . . . . . 0 N--CA 1.503 2.186 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.5 p -142.73 108.07 5.02 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 -176.799 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.272 1.8 tt -70.8 161.64 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 C-N-CA 127.248 2.219 . . . . 0.0 112.711 -179.049 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -141.79 121.21 13.2 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 102.348 -3.204 . . . . 0.0 102.348 169.409 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.8 t -97.0 116.04 28.51 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 111.601 -2.545 . . . . 0.0 107.208 169.497 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.267 -0.873 . . . . 0.0 108.828 -169.367 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.28 124.61 19.14 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.164 0.986 . . . . 0.0 108.779 178.863 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -85.55 127.9 34.58 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 124.395 1.059 . . . . 0.0 110.252 -179.071 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.252 9.1 tt0 -109.9 97.68 7.15 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 169.127 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.67 122.08 45.98 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 177.545 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 m -108.17 130.46 55.13 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -169.248 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.5 HD13 ' CD1' ' A' ' 12' ' ' PHE . 2.6 mp . . . . . 0 CA--C 1.586 2.336 0 N-CA-C 100.291 -3.966 . . . . 0.0 100.291 -167.602 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -111.86 124.35 52.17 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -168.884 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -96.25 113.61 25.22 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -176.471 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.5 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.0 m-85 -103.72 114.38 28.6 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 -179.544 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -131.25 119.66 22.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 -169.029 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.58 -161.37 19.87 Favored Glycine 1 CA--C 1.58 4.101 0 CA-C-O 114.379 -3.456 . . . . 0.0 116.134 178.455 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -90.66 160.53 4.26 Favored 'Trans proline' 0 C--N 1.394 2.964 1 CA-C-N 126.768 5.284 . . . . 0.0 114.595 -178.477 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.17 113.62 0.73 Allowed Glycine 0 N--CA 1.481 1.681 0 CA-C-O 117.451 -1.749 . . . . 0.0 110.615 173.614 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.7 t -94.28 95.18 1.31 Allowed Pre-proline 0 CA--C 1.589 2.458 0 CA-C-O 116.132 -1.89 . . . . 0.0 113.471 -173.294 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -81.02 174.35 10.97 Favored 'Trans proline' 0 C--N 1.392 2.839 0 CA-C-N 124.559 2.664 . . . . 0.0 113.225 168.806 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -79.12 157.65 27.91 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.412 1.085 . . . . 0.0 111.508 168.403 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.262 16.5 m -135.07 152.58 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 C-N-CA 123.118 0.567 . . . . 0.0 111.559 -177.905 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 167.56 34.62 Favored Pre-proline 0 CA--C 1.588 2.411 0 CA-C-O 115.006 -2.426 . . . . 0.0 114.032 179.331 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.4 3.237 0 CA-C-N 126.883 3.494 . . . . 0.0 111.572 177.861 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.3 t . . . . . 0 N--CA 1.502 2.167 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -139.77 111.29 7.18 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 123.682 1.706 . . . . 0.0 107.722 177.763 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.255 1.8 tt -70.76 158.98 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 CA-C-N 109.26 -3.609 . . . . 0.0 113.632 -172.441 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -139.78 103.93 4.78 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 167.905 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.7 m -97.57 98.48 9.94 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 109.879 -3.328 . . . . 0.0 105.01 175.307 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.493 1.715 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.282 -167.418 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.6 t . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -135.91 140.95 44.45 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 124.272 1.029 . . . . 0.0 110.191 179.049 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -86.37 136.92 32.94 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.645 0.778 . . . . 0.0 110.226 174.173 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.253 4.3 tt0 -123.55 100.31 6.74 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 101.352 -3.573 . . . . 0.0 101.352 170.099 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.15 124.41 51.42 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 179.127 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -106.51 132.07 52.94 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 125.406 1.691 . . . . 0.0 107.465 -168.536 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 CA--C 1.583 2.224 0 N-CA-C 100.761 -3.792 . . . . 0.0 100.761 -168.325 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.7 p . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -101.31 140.65 35.31 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 120.342 1.428 . . . . 0.0 110.985 -169.612 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m -105.03 102.95 12.42 Favored 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 100.939 -3.726 . . . . 0.0 100.939 166.137 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -92.47 116.57 29.1 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 -179.38 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -132.39 119.42 20.66 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -168.186 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.89 -169.37 25.13 Favored Glycine 1 CA--C 1.582 4.26 0 CA-C-O 114.482 -3.399 . . . . 0.0 115.585 179.04 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -86.83 160.96 9.03 Favored 'Trans proline' 0 C--N 1.394 2.957 1 CA-C-N 126.898 5.349 . . . . 0.0 114.186 -176.27 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.33 117.71 1.4 Allowed Glycine 0 N--CA 1.479 1.552 0 CA-C-O 117.83 -1.539 . . . . 0.0 110.084 177.68 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.8 m -100.65 83.93 0.43 Allowed Pre-proline 0 CA--C 1.589 2.48 0 CA-C-O 117.275 -1.345 . . . . 0.0 113.717 -177.623 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.31 171.53 10.03 Favored 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 123.123 2.548 . . . . 0.0 113.117 168.157 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.282 9.5 t -93.98 149.43 21.24 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.669 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.62 156.66 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.644 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.788 -165.616 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -7.69 145.01 0.0 OUTLIER Pre-proline 0 CA--C 1.585 2.296 0 N-CA-C 120.752 3.612 . . . . 0.0 120.752 169.405 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--N 1.395 3.02 0 CA-C-N 126.571 3.382 . . . . 0.0 109.464 168.533 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t . . . . . 0 N--CA 1.502 2.141 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.8 p -127.23 107.31 9.89 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 -178.498 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 1.3 tt -65.1 162.69 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 C-N-CA 127.456 2.302 . . . . 0.0 113.349 177.806 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -139.18 118.56 12.83 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 102.918 -2.993 . . . . 0.0 102.918 169.805 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 14.3 t -100.79 128.97 46.62 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.001 -2.818 . . . . 0.0 107.474 168.422 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.283 14.8 pt-20 . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -168.729 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -136.17 137.49 40.98 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 124.183 0.993 . . . . 0.0 110.422 -179.364 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -92.75 135.21 34.31 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.189 0.93 . . . . 0.0 110.215 -178.08 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -115.83 99.82 7.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 100.87 -3.752 . . . . 0.0 100.87 169.318 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.43 122.65 46.44 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -179.922 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.44 134.53 50.35 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 125.652 1.845 . . . . 0.0 106.485 -169.132 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.426 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mp . . . . . 0 CA--C 1.585 2.301 0 N-CA-C 101.136 -3.653 . . . . 0.0 101.136 -167.842 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -119.21 126.5 51.69 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -168.904 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m -97.1 113.45 25.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 -179.293 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.426 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.6 m-85 -103.43 116.07 31.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -179.657 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -133.22 122.73 24.39 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -168.622 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.86 -178.17 40.73 Favored Glycine 1 CA--C 1.58 4.149 0 CA-C-O 114.977 -3.124 . . . . 0.0 116.529 -179.632 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -84.28 158.75 13.03 Favored 'Trans proline' 0 C--N 1.395 3.005 1 CA-C-N 125.929 4.865 . . . . 0.0 113.798 -177.418 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.18 107.33 0.42 Allowed Glycine 0 N--CA 1.483 1.789 0 CA-C-O 116.902 -2.054 . . . . 0.0 110.828 177.071 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.3 m -90.54 98.82 1.65 Allowed Pre-proline 0 CA--C 1.587 2.381 0 CA-C-O 116.121 -1.895 . . . . 0.0 112.4 -169.645 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.79 170.14 18.54 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 123.43 2.754 . . . . 0.0 113.688 169.911 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.16 149.24 29.2 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.078 0.951 . . . . 0.0 111.083 169.388 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.5 m -104.06 147.11 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 124.049 0.939 . . . . 0.0 112.241 -168.064 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.64 163.03 51.18 Favored Pre-proline 0 CA--C 1.588 2.417 0 CA-C-O 115.159 -2.353 . . . . 0.0 112.205 168.95 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.396 3.058 0 CA-C-N 126.948 3.517 . . . . 0.0 113.678 -169.571 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.8 t . . . . . 0 CA--C 1.569 1.701 0 N-CA-C 101.164 -3.643 . . . . 0.0 101.164 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.6 p -129.96 105.12 7.76 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -177.442 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 tt -72.15 161.79 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 112.25 -2.25 . . . . 0.0 113.861 -177.851 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -142.46 104.48 4.41 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 165.835 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.1 t -95.97 108.82 21.25 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 111.58 -2.554 . . . . 0.0 105.923 171.365 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 124.619 1.199 . . . . 0.0 110.598 -167.609 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -139.11 128.29 23.96 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.331 1.053 . . . . 0.0 108.966 179.698 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -87.52 133.8 33.71 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.964 0.79 . . . . 0.0 110.177 179.785 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.98 102.02 8.72 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 101.325 -3.583 . . . . 0.0 101.325 168.257 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.493 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -112.21 121.22 44.31 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 178.036 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -107.17 130.91 54.65 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 125.128 1.517 . . . . 0.0 107.037 -168.767 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.4 mp . . . . . 0 CA--C 1.582 2.176 0 N-CA-C 100.743 -3.799 . . . . 0.0 100.743 -167.928 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -99.73 139.57 35.2 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 120.737 1.608 . . . . 0.0 110.971 -169.571 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.2 m -106.11 102.35 11.78 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 100.962 -3.718 . . . . 0.0 100.962 166.483 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -93.27 116.67 29.23 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 -179.559 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -132.82 121.94 23.71 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -167.838 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.4 -162.57 19.47 Favored Glycine 1 CA--C 1.58 4.108 0 CA-C-O 114.675 -3.291 . . . . 0.0 115.822 178.009 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -86.22 161.92 9.94 Favored 'Trans proline' 0 C--N 1.394 2.93 1 CA-C-N 126.354 5.077 . . . . 0.0 113.868 -177.832 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.61 117.22 1.22 Allowed Glycine 0 N--CA 1.479 1.52 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.295 174.292 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -101.7 84.58 0.56 Allowed Pre-proline 0 CA--C 1.588 2.416 0 CA-C-O 116.913 -1.518 . . . . 0.0 111.621 -179.169 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.18 174.03 7.43 Favored 'Trans proline' 0 C--N 1.39 2.733 0 C-N-CA 123.253 2.635 . . . . 0.0 114.116 171.2 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 p -77.95 147.11 35.11 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.484 1.113 . . . . 0.0 110.056 167.223 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 30.1 m -139.64 151.66 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 123.526 0.516 . . . . 0.0 112.07 -174.2 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -14.46 146.18 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.272 0 CA-C-O 112.685 -3.531 . . . . 0.0 119.939 169.904 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 C--N 1.394 2.969 0 CA-C-N 126.624 3.401 . . . . 0.0 109.473 168.413 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.502 2.149 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 p -121.85 105.35 10.28 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 -175.756 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.27 1.5 tt -68.11 163.75 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 CA-C-N 111.774 -2.466 . . . . 0.0 113.202 -179.797 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -139.75 118.04 12.03 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 168.697 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.2 t -97.6 114.52 26.46 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 111.416 -2.629 . . . . 0.0 106.776 169.499 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.493 1.72 0 C-N-CA 123.825 0.85 . . . . 0.0 109.052 -169.039 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -139.81 127.45 21.74 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.31 1.044 . . . . 0.0 108.766 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -85.66 130.15 34.64 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.733 0.813 . . . . 0.0 110.259 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.269 7.2 tt0 -114.39 98.28 6.82 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 101.152 -3.647 . . . . 0.0 101.152 169.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.11 120.97 43.63 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -106.95 135.38 48.6 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 125.54 1.775 . . . . 0.0 106.588 -169.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mp -133.17 98.69 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.278 0 N-CA-C 101.382 -3.562 . . . . 0.0 101.382 -167.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t -118.66 7.5 11.72 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -116.45 125.71 52.38 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -168.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.09 115.96 28.44 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.424 ' CD1' HD13 ' A' ' 7' ' ' ILE . 91.3 m-85 -105.22 112.94 26.25 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -127.33 119.07 25.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 -169.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.37 -163.12 16.7 Favored Glycine 1 CA--C 1.58 4.119 0 CA-C-O 114.475 -3.403 . . . . 0.0 115.999 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -87.45 161.53 8.14 Favored 'Trans proline' 0 C--N 1.394 2.969 1 CA-C-N 126.679 5.239 . . . . 0.0 114.076 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.53 118.48 1.51 Allowed Glycine 0 N--CA 1.48 1.575 0 CA-C-O 118.021 -1.433 . . . . 0.0 110.018 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.0 m -100.74 84.46 0.47 Allowed Pre-proline 0 CA--C 1.588 2.421 0 CA-C-O 117.001 -1.476 . . . . 0.0 112.965 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -81.92 176.66 8.09 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 123.231 2.621 . . . . 0.0 112.725 168.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.29 10.0 t -98.96 157.54 16.25 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 123.791 0.836 . . . . 0.0 109.568 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 m -123.81 159.69 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 C-N-CA 124.487 1.115 . . . . 0.0 111.981 -166.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 164.2 58.8 Favored Pre-proline 0 CA--C 1.584 2.278 0 CA-C-O 115.252 -2.309 . . . . 0.0 114.686 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -63.85 129.02 23.45 Favored 'Trans proline' 0 C--N 1.399 3.23 0 CA-C-N 126.239 3.264 . . . . 0.0 112.945 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.8 t -78.08 138.41 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -142.58 108.31 5.12 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.263 1.3 tt -71.62 160.37 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.843 0 C-N-CA 126.972 2.109 . . . . 0.0 112.75 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -141.82 120.0 12.18 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 102.21 -3.256 . . . . 0.0 102.21 169.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.1 t -97.28 115.09 27.01 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.103 169.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 124.084 0.865 . . . . 0.0 109.126 -169.311 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -146.45 127.98 15.07 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -87.56 125.95 34.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.805 0.842 . . . . 0.0 109.804 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.271 8.3 tt0 -110.37 96.9 6.5 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 101.34 -3.578 . . . . 0.0 101.34 168.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.96 120.5 42.6 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.16 135.72 48.22 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 125.514 1.759 . . . . 0.0 106.615 -169.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mp -133.56 98.65 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.276 0 N-CA-C 101.372 -3.566 . . . . 0.0 101.372 -167.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.6 t -119.24 6.38 11.22 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -114.87 125.42 53.64 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.27 116.25 29.14 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.421 ' CD1' HD13 ' A' ' 7' ' ' ILE . 93.0 m-85 -105.78 112.94 26.21 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -127.36 120.67 29.05 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -169.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.75 -158.6 12.9 Favored Glycine 1 CA--C 1.579 4.04 0 CA-C-O 114.368 -3.462 . . . . 0.0 116.132 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -88.42 161.2 6.74 Favored 'Trans proline' 0 C--N 1.395 2.989 1 CA-C-N 126.571 5.186 . . . . 0.0 114.212 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.02 118.39 1.39 Allowed Glycine 0 N--CA 1.479 1.559 0 CA-C-O 117.981 -1.455 . . . . 0.0 110.197 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.9 m -100.69 85.71 0.59 Allowed Pre-proline 0 CA--C 1.588 2.417 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.456 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -82.4 175.45 8.94 Favored 'Trans proline' 0 C--N 1.391 2.81 0 C-N-CA 123.444 2.763 . . . . 0.0 113.739 170.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -75.71 158.13 32.7 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.727 1.211 . . . . 0.0 112.018 168.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 13.3 m -135.46 152.87 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.185 0.594 . . . . 0.0 111.609 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 167.79 32.1 Favored Pre-proline 0 CA--C 1.586 2.341 0 CA-C-O 114.998 -2.43 . . . . 0.0 113.939 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.84 126.59 13.43 Favored 'Trans proline' 0 C--N 1.4 3.263 0 CA-C-N 126.961 3.522 . . . . 0.0 111.349 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.67 130.01 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 174.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -140.69 109.64 6.08 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 123.3 1.524 . . . . 0.0 107.827 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.273 1.1 tt -70.54 163.4 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 109.686 -3.416 . . . . 0.0 113.192 -173.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -141.43 115.21 9.09 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 168.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.8 t -94.67 116.51 28.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 111.582 -2.553 . . . . 0.0 107.242 170.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 N--CA 1.494 1.729 0 C-N-CA 123.988 0.915 . . . . 0.0 109.774 -168.517 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -140.04 125.23 18.74 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.292 1.037 . . . . 0.0 108.58 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.35 126.08 34.09 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 124.12 0.888 . . . . 0.0 110.11 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.266 9.0 tt0 -110.76 98.91 7.94 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 100.932 -3.729 . . . . 0.0 100.932 168.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.85 107.99 16.47 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 103.763 -2.681 . . . . 0.0 103.763 -176.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -97.25 126.72 42.64 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 125.466 1.729 . . . . 0.0 106.856 -167.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mm -113.43 88.9 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 -167.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.2 p -121.54 -6.86 9.2 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.588 -1.187 . . . . 0.0 114.098 169.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -94.38 127.17 40.1 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.353 1.061 . . . . 0.0 108.59 -169.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -100.8 111.28 23.47 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -103.54 119.11 38.24 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -135.62 119.19 17.0 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -170.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.04 -158.11 13.4 Favored Glycine 1 CA--C 1.579 4.048 0 CA-C-O 114.401 -3.444 . . . . 0.0 115.713 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -87.14 161.92 8.6 Favored 'Trans proline' 0 C--N 1.393 2.901 1 CA-C-N 126.597 5.198 . . . . 0.0 114.016 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.87 116.08 1.4 Allowed Glycine 0 N--CA 1.48 1.568 0 CA-C-O 118.106 -1.385 . . . . 0.0 110.381 174.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.4 m -101.46 85.78 0.68 Allowed Pre-proline 0 CA--C 1.587 2.371 0 CA-C-O 116.697 -1.62 . . . . 0.0 111.102 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -82.37 173.01 11.06 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 123.252 2.635 . . . . 0.0 113.771 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -75.61 154.78 36.45 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.575 1.15 . . . . 0.0 111.948 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.272 18.0 m -137.17 154.0 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 O-C-N 123.5 0.5 . . . . 0.0 111.856 -173.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 168.08 30.83 Favored Pre-proline 0 CA--C 1.588 2.423 0 CA-C-O 114.91 -2.471 . . . . 0.0 114.187 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.2 130.78 18.09 Favored 'Trans proline' 0 C--N 1.399 3.236 0 CA-C-N 126.982 3.529 . . . . 0.0 111.84 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.1 t -77.21 121.99 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 170.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.8 p -136.26 109.17 7.61 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 102.42 -3.178 . . . . 0.0 102.42 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.259 0.8 OUTLIER -68.79 162.33 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.858 0 C-N-CA 126.745 2.018 . . . . 0.0 113.488 -174.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -138.07 113.85 9.8 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 167.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.8 t -97.96 111.48 23.77 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.139 170.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 124.231 0.957 . . . . 0.0 109.572 -168.605 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.04 129.11 25.21 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.338 1.055 . . . . 0.0 108.92 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -85.84 131.38 34.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.654 0.782 . . . . 0.0 110.45 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.269 7.1 tt0 -116.19 98.33 6.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 100.928 -3.73 . . . . 0.0 100.928 169.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.16 121.28 44.5 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.19 135.16 49.2 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 125.511 1.757 . . . . 0.0 106.681 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.411 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.7 mp -133.2 98.72 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.312 0 N-CA-C 101.461 -3.533 . . . . 0.0 101.461 -167.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t -118.37 7.94 12.07 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -116.77 125.54 51.78 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -168.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -97.05 115.67 27.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.411 ' CD1' HD13 ' A' ' 7' ' ' ILE . 90.2 m-85 -104.84 112.86 26.13 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -127.31 118.8 24.9 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -169.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.19 -165.11 19.76 Favored Glycine 1 CA--C 1.58 4.126 0 CA-C-O 114.482 -3.399 . . . . 0.0 115.911 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -86.57 161.48 9.42 Favored 'Trans proline' 0 C--N 1.394 2.927 1 CA-C-N 126.697 5.248 . . . . 0.0 113.928 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 117.91 1.46 Allowed Glycine 0 N--CA 1.479 1.511 0 CA-C-O 117.964 -1.464 . . . . 0.0 110.057 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.8 m -100.65 84.51 0.47 Allowed Pre-proline 0 CA--C 1.587 2.389 0 CA-C-O 117.038 -1.458 . . . . 0.0 112.909 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -82.21 173.78 10.54 Favored 'Trans proline' 0 C--N 1.389 2.684 0 C-N-CA 123.16 2.573 . . . . 0.0 112.898 168.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.288 9.0 t -95.43 157.27 15.97 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 123.547 0.739 . . . . 0.0 109.288 167.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.6 m -125.68 158.55 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 124.19 0.996 . . . . 0.0 112.363 -166.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -67.76 -176.24 0.26 Allowed Pre-proline 0 CA--C 1.599 2.844 0 N-CA-C 117.662 2.468 . . . . 0.0 117.662 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -77.51 124.84 7.25 Favored 'Trans proline' 0 C--N 1.399 3.235 0 C-N-CA 123.866 3.044 . . . . 0.0 110.816 172.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.85 140.61 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -143.34 108.45 4.98 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.268 1.3 tt -71.32 161.9 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 C-N-CA 127.12 2.168 . . . . 0.0 112.82 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -141.84 122.01 13.84 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 102.21 -3.255 . . . . 0.0 102.21 168.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.8 t -97.56 115.1 27.21 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 111.813 -2.449 . . . . 0.0 107.138 169.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.246 -0.883 . . . . 0.0 108.641 -169.36 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -142.15 124.66 15.76 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.3 1.04 . . . . 0.0 108.521 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -85.14 130.94 34.51 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 117.818 -1.087 . . . . 0.0 110.672 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.276 4.9 tt0 -114.52 95.18 5.13 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 171.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.79 122.38 47.68 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -106.97 135.0 49.28 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 125.575 1.797 . . . . 0.0 106.655 -169.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.51 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.6 mp -131.17 98.08 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.352 0 N-CA-C 100.722 -3.807 . . . . 0.0 100.722 -167.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t -119.69 6.88 10.98 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 169.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -116.6 125.37 51.73 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -168.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -96.98 116.91 30.04 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.51 ' CD1' HD13 ' A' ' 7' ' ' ILE . 83.9 m-85 -104.67 112.35 25.4 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -127.6 120.75 28.83 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -169.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.51 -163.58 24.79 Favored Glycine 1 CA--C 1.58 4.115 0 CA-C-O 114.521 -3.377 . . . . 0.0 116.29 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -89.98 160.86 4.94 Favored 'Trans proline' 0 C--N 1.395 2.98 1 CA-C-N 126.43 5.115 . . . . 0.0 114.455 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.14 110.44 0.69 Allowed Glycine 0 N--CA 1.483 1.797 0 CA-C-O 117.46 -1.745 . . . . 0.0 110.495 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.3 m -97.98 94.99 2.43 Favored Pre-proline 0 CA--C 1.588 2.427 0 CA-C-O 116.224 -1.846 . . . . 0.0 112.972 -169.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.29 175.65 9.49 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 123.327 2.684 . . . . 0.0 113.581 169.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -76.95 160.06 29.47 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.658 1.183 . . . . 0.0 112.128 168.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.5 m -135.49 151.5 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 123.264 0.625 . . . . 0.0 111.806 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.14 166.65 38.89 Favored Pre-proline 0 CA--C 1.586 2.361 0 CA-C-O 115.094 -2.384 . . . . 0.0 113.678 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.93 128.84 15.47 Favored 'Trans proline' 0 C--N 1.399 3.187 0 CA-C-N 126.82 3.471 . . . . 0.0 111.647 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.4 t -80.27 120.22 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 174.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.1 p -130.2 105.99 8.29 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.263 1.9 tt -67.69 162.6 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 CA-C-N 111.95 -2.386 . . . . 0.0 114.357 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -143.21 102.31 3.96 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 168.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.3 t -89.55 93.82 9.63 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 112.204 -2.271 . . . . 0.0 105.412 169.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.108 -165.544 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 CA--C 1.544 0.75 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -143.77 124.88 14.47 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -88.06 135.8 33.26 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 124.127 0.892 . . . . 0.0 110.498 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -117.99 98.87 6.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 101.076 -3.675 . . . . 0.0 101.076 170.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.53 124.05 51.48 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 m -107.91 133.32 52.43 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -169.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.437 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.9 mp -131.0 97.81 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.328 0 N-CA-C 100.925 -3.731 . . . . 0.0 100.925 -167.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -118.71 8.85 11.96 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -117.69 125.67 51.1 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -169.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -96.71 113.07 24.6 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.437 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.8 m-85 -102.84 117.5 34.76 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -134.93 120.95 19.85 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -168.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.41 -171.88 36.25 Favored Glycine 1 CA--C 1.581 4.159 0 CA-C-O 114.721 -3.266 . . . . 0.0 116.279 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -88.73 158.45 6.24 Favored 'Trans proline' 0 C--N 1.396 3.027 1 CA-C-N 126.364 5.082 . . . . 0.0 114.295 -177.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.76 106.58 0.63 Allowed Glycine 0 N--CA 1.484 1.873 0 CA-C-O 117.196 -1.891 . . . . 0.0 110.579 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.8 m -93.48 98.49 2.58 Favored Pre-proline 0 CA--C 1.588 2.438 0 CA-C-O 116.168 -1.872 . . . . 0.0 113.008 -169.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.01 173.44 12.71 Favored 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 123.401 2.734 . . . . 0.0 113.673 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.94 159.24 31.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.483 1.113 . . . . 0.0 112.371 168.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 11.0 m -133.98 152.84 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 CA-C-O 121.422 0.63 . . . . 0.0 112.695 -169.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.24 165.47 27.96 Favored Pre-proline 0 CA--C 1.581 2.15 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.97 108.26 2.55 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 123.148 2.565 . . . . 0.0 110.033 169.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.6 t -77.11 122.07 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.8 p -132.26 106.19 7.78 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.5 tt -69.33 160.78 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.835 0 CA-C-N 111.904 -2.407 . . . . 0.0 114.023 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -139.31 102.94 4.61 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 167.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 t -98.66 113.67 25.83 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 110.87 -2.877 . . . . 0.0 105.816 170.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.297 10.2 pt-20 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -167.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.8 127.41 21.7 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.345 1.058 . . . . 0.0 108.835 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -87.42 128.41 35.21 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 124.037 0.836 . . . . 0.0 110.096 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.25 8.2 tt0 -112.34 98.38 7.25 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 100.734 -3.802 . . . . 0.0 100.734 168.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.56 120.15 41.48 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -106.98 134.74 49.67 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 125.409 1.693 . . . . 0.0 106.523 -168.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.414 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.6 mp -132.97 98.57 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.294 0 N-CA-C 101.442 -3.54 . . . . 0.0 101.442 -167.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t -119.36 6.85 11.15 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -114.75 125.09 53.3 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -168.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.23 113.4 25.0 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.414 ' CD1' HD13 ' A' ' 7' ' ' ILE . 93.2 m-85 -103.81 115.03 29.72 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -131.17 120.23 23.01 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -168.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.5 -158.52 12.61 Favored Glycine 1 CA--C 1.579 4.049 0 CA-C-O 114.361 -3.466 . . . . 0.0 115.836 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -89.04 161.37 5.87 Favored 'Trans proline' 0 C--N 1.394 2.955 1 CA-C-N 126.719 5.259 . . . . 0.0 114.294 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.15 117.19 1.33 Allowed Glycine 0 N--CA 1.479 1.563 0 CA-C-O 117.965 -1.464 . . . . 0.0 110.277 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.4 m -100.96 85.82 0.62 Allowed Pre-proline 0 CA--C 1.588 2.412 0 CA-C-O 116.697 -1.62 . . . . 0.0 111.589 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -82.86 176.13 7.97 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.378 2.719 . . . . 0.0 113.73 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -74.63 158.01 34.39 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.72 1.208 . . . . 0.0 111.941 168.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.258 15.4 m -135.62 156.08 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 C-N-CA 122.93 0.492 . . . . 0.0 112.212 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -76.95 -179.29 1.17 Allowed Pre-proline 0 CA--C 1.593 2.598 0 CA-C-O 115.543 -2.17 . . . . 0.0 115.79 -170.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.08 114.25 3.99 Favored 'Trans proline' 0 C--N 1.404 3.469 0 C-N-CA 123.902 3.068 . . . . 0.0 110.251 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -77.7 135.03 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.9 p -141.41 108.81 5.55 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.274 1.2 tt -69.98 164.37 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 127.046 2.138 . . . . 0.0 113.256 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -140.83 114.89 9.15 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 101.734 -3.432 . . . . 0.0 101.734 167.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.5 t -97.44 111.84 23.93 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 111.579 -2.555 . . . . 0.0 106.292 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 N--CA 1.494 1.756 0 O-C-N 124.184 0.927 . . . . 0.0 109.172 -168.709 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -148.04 124.34 10.89 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -87.06 124.61 33.41 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.933 0.893 . . . . 0.0 109.773 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.258 8.9 tt0 -109.28 97.04 6.71 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 101.382 -3.562 . . . . 0.0 101.382 168.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.465 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.9 120.79 43.28 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 178.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -107.94 131.31 54.67 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 -169.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.489 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.2 mp -128.66 97.11 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.331 0 N-CA-C 100.463 -3.903 . . . . 0.0 100.463 -167.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 t -120.67 5.43 10.55 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -113.15 124.75 53.28 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -168.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.0 m -96.78 113.8 25.38 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -176.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.489 ' CD1' HD13 ' A' ' 7' ' ' ILE . 87.1 m-85 -104.09 115.2 30.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -131.19 120.98 24.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -168.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.51 -156.93 11.28 Favored Glycine 1 CA--C 1.58 4.143 0 CA-C-O 114.229 -3.54 . . . . 0.0 115.911 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.22 161.09 4.7 Favored 'Trans proline' 0 C--N 1.395 2.992 1 CA-C-N 126.799 5.299 . . . . 0.0 114.534 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.72 119.35 1.62 Allowed Glycine 0 N--CA 1.479 1.507 0 CA-C-O 118.034 -1.426 . . . . 0.0 110.33 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.2 t -98.1 87.49 0.55 Allowed Pre-proline 0 CA--C 1.591 2.524 0 CA-C-O 116.503 -1.713 . . . . 0.0 112.325 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.71 175.62 9.24 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 123.414 2.742 . . . . 0.0 113.426 169.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 p -77.62 158.24 29.87 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.638 1.175 . . . . 0.0 111.828 168.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.259 15.7 m -136.9 156.09 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 122.999 0.52 . . . . 0.0 112.23 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -76.89 -179.31 1.17 Allowed Pre-proline 0 CA--C 1.593 2.608 0 CA-C-O 115.631 -2.128 . . . . 0.0 115.742 -171.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.99 116.69 4.82 Favored 'Trans proline' 0 C--N 1.405 3.504 0 C-N-CA 123.97 3.114 . . . . 0.0 110.365 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.7 t -77.22 132.35 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -140.87 108.89 5.72 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.265 1.3 tt -69.84 160.89 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.836 0 C-N-CA 127.036 2.134 . . . . 0.0 113.353 -177.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -139.22 109.25 6.38 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 168.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.8 m -98.11 106.91 19.27 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 110.229 -3.168 . . . . 0.0 104.679 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.736 0 C-N-CA 124.307 1.043 . . . . 0.0 111.033 -167.246 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -147.86 125.46 11.77 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -83.55 122.79 29.03 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 117.82 -1.086 . . . . 0.0 109.988 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.265 8.4 tt0 -109.25 95.94 5.96 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 102.123 -3.288 . . . . 0.0 102.123 170.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.529 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -109.73 120.77 43.51 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.406 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.47 130.82 54.8 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 125.423 1.702 . . . . 0.0 106.648 -169.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.529 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.3 mp -135.88 96.18 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.185 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -167.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.7 p -78.46 -18.17 55.25 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 169.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -98.41 139.38 34.24 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 120.259 1.391 . . . . 0.0 111.155 -169.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.5 m -107.14 102.96 12.25 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 100.922 -3.733 . . . . 0.0 100.922 166.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -93.49 113.71 25.91 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -129.44 120.99 26.41 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -168.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.71 -160.81 18.88 Favored Glycine 1 CA--C 1.579 4.036 0 CA-C-O 114.522 -3.377 . . . . 0.0 116.022 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -86.74 163.37 9.17 Favored 'Trans proline' 0 C--N 1.393 2.911 1 CA-C-N 126.584 5.192 . . . . 0.0 114.023 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.18 119.87 1.79 Allowed Glycine 0 C--N 1.354 1.57 0 CA-C-O 118.01 -1.439 . . . . 0.0 110.019 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.6 t -97.86 87.87 0.57 Allowed Pre-proline 0 CA--C 1.591 2.526 0 CA-C-O 116.452 -1.737 . . . . 0.0 112.206 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -81.8 173.83 10.85 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.373 2.716 . . . . 0.0 113.504 169.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 p -79.44 158.78 27.25 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.578 1.151 . . . . 0.0 111.626 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.251 15.2 m -136.46 151.58 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.15 0.58 . . . . 0.0 111.492 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.67 166.71 40.66 Favored Pre-proline 0 CA--C 1.588 2.406 0 CA-C-O 114.949 -2.453 . . . . 0.0 114.043 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.09 130.29 17.48 Favored 'Trans proline' 0 C--N 1.4 3.275 0 CA-C-N 126.998 3.535 . . . . 0.0 111.627 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t -78.72 128.13 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 173.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -137.19 106.86 6.18 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.273 1.3 tt -69.24 165.55 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.955 0 CA-C-N 112.265 -2.243 . . . . 0.0 113.696 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -144.08 108.86 4.92 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 168.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 76.1 m -94.13 97.67 10.45 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 . . . . . 0 N--CA 1.491 1.615 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.808 -165.318 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -138.63 131.56 29.56 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.354 1.062 . . . . 0.0 109.058 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -85.74 136.24 33.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.644 0.778 . . . . 0.0 110.418 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.267 4.7 tt0 -120.97 98.9 6.21 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 169.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.6 122.79 47.59 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.25 135.67 48.37 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 125.671 1.857 . . . . 0.0 106.924 -169.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.431 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.6 mp -132.75 98.51 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.28 0 N-CA-C 101.271 -3.603 . . . . 0.0 101.271 -167.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 t -116.64 11.85 14.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 169.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -122.26 126.59 48.5 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -168.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -96.79 116.39 29.06 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.431 ' CD1' HD13 ' A' ' 7' ' ' ILE . 82.4 m-85 -105.06 113.57 27.25 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -128.58 122.49 31.14 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -169.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.05 -163.9 16.81 Favored Glycine 1 CA--C 1.58 4.151 0 CA-C-O 114.461 -3.41 . . . . 0.0 115.833 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -87.83 160.47 7.57 Favored 'Trans proline' 0 C--N 1.395 2.988 1 CA-C-N 126.709 5.254 . . . . 0.0 114.108 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.91 118.31 1.36 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-O 118.018 -1.435 . . . . 0.0 110.194 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -101.88 83.09 0.44 Allowed Pre-proline 0 CA--C 1.589 2.461 0 CA-C-O 117.239 -1.362 . . . . 0.0 113.263 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -84.92 172.83 8.53 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.105 2.537 . . . . 0.0 113.312 168.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.28 9.3 t -94.14 148.68 21.94 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 166.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.72 156.78 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 C-N-CA 123.343 0.657 . . . . 0.0 111.75 -165.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -8.24 145.09 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.272 0 N-CA-C 120.74 3.607 . . . . 0.0 120.74 169.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.93 116.57 4.63 Favored 'Trans proline' 0 C--N 1.396 3.051 0 CA-C-N 126.6 3.393 . . . . 0.0 109.557 168.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.83 118.87 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -125.39 106.31 9.72 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.269 1.3 tt -67.11 162.24 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 CA-C-N 112.087 -2.324 . . . . 0.0 113.322 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -140.59 124.09 16.93 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 102.264 -3.236 . . . . 0.0 102.264 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.4 t -97.43 116.08 28.96 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.776 -2.466 . . . . 0.0 107.477 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -169.485 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -147.61 125.55 12.01 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -85.63 126.93 34.3 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.89 0.876 . . . . 0.0 110.069 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.274 5.5 tt0 -111.4 97.13 6.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 101.484 -3.524 . . . . 0.0 101.484 169.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.444 ' CE2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -110.06 121.5 45.4 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 179.533 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -107.68 131.68 54.14 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -169.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.511 HD13 ' CD1' ' A' ' 12' ' ' PHE . 2.9 mp -127.94 97.23 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.38 0 N-CA-C 100.302 -3.962 . . . . 0.0 100.302 -167.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t -120.63 5.99 10.55 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 170.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -114.75 125.11 53.33 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -168.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -96.72 117.2 30.52 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.511 ' CD1' HD13 ' A' ' 7' ' ' ILE . 82.5 m-85 -105.79 113.46 27.02 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -127.8 120.29 27.53 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -169.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.21 -160.1 13.91 Favored Glycine 1 CA--C 1.58 4.125 0 CA-C-O 114.349 -3.473 . . . . 0.0 116.321 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -88.68 161.32 6.37 Favored 'Trans proline' 0 C--N 1.395 2.987 1 CA-C-N 126.632 5.216 . . . . 0.0 114.276 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.62 119.8 1.65 Allowed Glycine 0 N--CA 1.48 1.603 0 CA-C-O 118.008 -1.44 . . . . 0.0 110.133 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.3 t -98.53 86.27 0.47 Allowed Pre-proline 0 CA--C 1.591 2.554 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.001 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -81.08 178.06 7.24 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.174 2.583 . . . . 0.0 112.117 166.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.299 11.2 t -103.94 158.16 16.6 Favored 'General case' 0 N--CA 1.504 2.275 0 C-N-CA 123.868 0.867 . . . . 0.0 109.818 168.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.2 m -125.91 160.05 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.56 0 C-N-CA 124.506 1.122 . . . . 0.0 111.982 -166.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 164.73 56.18 Favored Pre-proline 0 CA--C 1.585 2.304 0 CA-C-O 115.278 -2.296 . . . . 0.0 114.675 177.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -64.05 129.88 25.75 Favored 'Trans proline' 0 C--N 1.4 3.257 0 CA-C-N 126.218 3.256 . . . . 0.0 113.002 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.0 t -77.2 135.62 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.4 p -142.8 108.96 5.23 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.264 1.4 tt -71.07 158.43 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 C-N-CA 127.033 2.133 . . . . 0.0 112.848 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -141.84 115.06 8.82 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 102.716 -3.068 . . . . 0.0 102.716 169.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 73.7 m -97.0 112.38 24.17 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 110.552 -3.022 . . . . 0.0 105.841 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.752 0 C-N-CA 124.18 0.992 . . . . 0.0 110.472 -167.853 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -139.5 128.11 23.11 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.348 1.059 . . . . 0.0 108.946 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -88.27 135.57 33.39 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 123.994 0.808 . . . . 0.0 110.471 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.266 4.2 tt0 -118.25 97.46 5.79 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 101.259 -3.608 . . . . 0.0 101.259 169.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.26 122.41 47.66 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.33 136.12 47.69 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 125.513 1.758 . . . . 0.0 106.818 -169.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.419 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.7 mp -133.71 98.78 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.314 0 N-CA-C 101.407 -3.553 . . . . 0.0 101.407 -167.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.7 t -117.97 8.65 12.59 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -118.19 125.84 51.0 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -168.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.8 m -97.14 116.78 29.97 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.419 ' CD1' HD13 ' A' ' 7' ' ' ILE . 87.9 m-85 -105.38 112.95 26.24 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -127.63 121.36 30.27 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -169.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.15 -156.79 11.48 Favored Glycine 1 CA--C 1.579 4.077 0 CA-C-O 114.309 -3.495 . . . . 0.0 115.989 177.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -91.02 160.73 3.91 Favored 'Trans proline' 0 C--N 1.395 3.016 1 CA-C-N 126.568 5.184 . . . . 0.0 114.628 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.66 115.49 0.97 Allowed Glycine 0 N--CA 1.481 1.634 0 CA-C-O 117.799 -1.556 . . . . 0.0 110.457 174.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.6 m -100.66 87.16 0.76 Allowed Pre-proline 0 CA--C 1.589 2.467 0 CA-C-O 116.676 -1.63 . . . . 0.0 111.663 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.61 173.94 10.08 Favored 'Trans proline' 0 C--N 1.391 2.781 0 C-N-CA 123.399 2.733 . . . . 0.0 113.887 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.71 156.17 38.19 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.536 1.134 . . . . 0.0 112.426 168.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.268 14.1 m -135.6 155.67 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.664 0.745 . . . . 0.0 112.813 -169.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -69.39 165.52 39.14 Favored Pre-proline 0 CA--C 1.58 2.112 0 CA-C-O 115.64 -2.124 . . . . 0.0 116.731 -171.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -68.6 102.72 0.88 Allowed 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 123.772 2.981 . . . . 0.0 109.858 168.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.9 129.03 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -139.11 108.88 6.26 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 123.794 1.759 . . . . 0.0 108.187 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.262 2.1 tt -70.11 162.91 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.826 0 CA-C-N 109.098 -3.683 . . . . 0.0 113.739 -174.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -140.83 111.0 6.63 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 167.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.2 t -96.1 112.41 24.15 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 111.615 -2.539 . . . . 0.0 106.338 172.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 124.207 0.942 . . . . 0.0 110.177 -168.361 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -142.76 125.45 15.92 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.296 1.038 . . . . 0.0 108.57 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -82.83 120.62 25.87 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 117.814 -1.089 . . . . 0.0 109.622 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.278 9.7 tt0 -106.53 95.92 6.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 102.249 -3.241 . . . . 0.0 102.249 169.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.452 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.49 118.77 37.59 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.636 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.73 131.76 54.09 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -169.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.452 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.1 mp -129.59 98.09 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.324 0 N-CA-C 100.919 -3.734 . . . . 0.0 100.919 -167.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -120.31 3.48 10.83 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 169.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -111.02 124.96 53.19 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -168.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -97.06 113.36 24.91 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.406 ' CD1' HD13 ' A' ' 7' ' ' ILE . 91.9 m-85 -104.25 114.36 28.54 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -130.09 120.07 24.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -168.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.0 -163.96 21.79 Favored Glycine 1 CA--C 1.579 4.083 0 CA-C-O 114.542 -3.365 . . . . 0.0 115.848 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -87.32 162.06 8.34 Favored 'Trans proline' 0 C--N 1.394 2.93 1 CA-C-N 126.668 5.234 . . . . 0.0 113.996 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.91 116.03 1.41 Allowed Glycine 0 N--CA 1.479 1.541 0 CA-C-O 118.07 -1.406 . . . . 0.0 110.228 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.0 m -103.63 84.16 0.74 Allowed Pre-proline 0 CA--C 1.587 2.395 0 CA-C-O 116.952 -1.499 . . . . 0.0 111.613 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -85.11 173.63 7.78 Favored 'Trans proline' 0 C--N 1.39 2.728 0 C-N-CA 123.247 2.632 . . . . 0.0 114.064 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 p -78.13 146.69 34.97 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.468 1.107 . . . . 0.0 110.216 167.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.259 30.9 m -139.47 152.65 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 O-C-N 123.6 0.562 . . . . 0.0 112.083 -172.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -17.3 146.61 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.263 0 CA-C-O 112.746 -3.502 . . . . 0.0 119.774 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.03 117.31 4.64 Favored 'Trans proline' 0 C--N 1.394 2.961 0 CA-C-N 126.667 3.417 . . . . 0.0 109.664 168.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.68 115.8 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.5 p -118.97 104.42 10.48 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.297 1.3 tt -66.79 165.7 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.857 0 CA-C-N 111.639 -2.528 . . . . 0.0 113.644 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -142.94 112.69 6.94 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 103.373 -2.825 . . . . 0.0 103.373 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.7 t -94.94 98.32 10.62 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 168.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 . . . . . 0 N--CA 1.493 1.705 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.241 -166.11 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -142.47 124.09 14.98 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.287 1.035 . . . . 0.0 108.286 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -83.49 121.66 27.49 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.822 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.293 9.9 tt0 -108.71 95.88 5.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 101.994 -3.335 . . . . 0.0 101.994 169.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.97 108.14 17.37 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -175.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -95.79 127.15 41.57 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 113.218 -1.81 . . . . 0.0 107.195 -167.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mm -118.6 87.28 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.108 0 N-CA-C 102.818 -3.03 . . . . 0.0 102.818 -167.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -89.19 -16.71 30.7 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 169.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.24 139.92 30.0 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.494 1.117 . . . . 0.0 110.458 -170.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -111.18 110.56 21.12 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 102.788 -3.041 . . . . 0.0 102.788 169.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -99.04 115.55 29.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -128.13 122.16 31.31 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -173.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.68 -160.14 17.18 Favored Glycine 1 CA--C 1.578 4.012 0 CA-C-O 114.496 -3.391 . . . . 0.0 115.659 176.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -86.97 162.68 8.86 Favored 'Trans proline' 0 C--N 1.392 2.837 1 CA-C-N 126.602 5.201 . . . . 0.0 113.952 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.43 115.38 1.49 Allowed Glycine 0 N--CA 1.48 1.608 0 CA-C-O 117.943 -1.476 . . . . 0.0 110.238 174.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.9 m -102.11 85.79 0.77 Allowed Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 116.721 -1.609 . . . . 0.0 111.247 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.34 172.98 11.11 Favored 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 123.333 2.688 . . . . 0.0 113.804 171.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -76.58 155.1 33.86 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.582 1.153 . . . . 0.0 111.885 168.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.272 18.0 m -137.93 154.75 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 C-N-CA 122.968 0.507 . . . . 0.0 112.004 -174.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 168.49 27.55 Favored Pre-proline 0 CA--C 1.588 2.423 0 CA-C-O 114.945 -2.455 . . . . 0.0 114.246 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.35 130.74 17.86 Favored 'Trans proline' 0 C--N 1.399 3.22 0 CA-C-N 126.878 3.492 . . . . 0.0 111.726 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.1 t -77.34 122.62 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 170.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.0 p -136.59 108.88 7.29 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.28 0.8 OUTLIER -68.92 166.1 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.878 0 C-N-CA 126.782 2.033 . . . . 0.0 113.89 -173.694 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -140.2 110.71 6.72 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 102.717 -3.068 . . . . 0.0 102.717 168.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.6 t -96.09 98.82 10.65 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 N--CA 1.492 1.67 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.332 -165.998 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -146.25 128.3 15.57 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -87.39 126.07 34.65 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.733 0.813 . . . . 0.0 109.993 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.253 8.6 tt0 -110.44 97.84 7.19 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 101.026 -3.694 . . . . 0.0 101.026 168.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.8 120.14 41.4 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.543 -2.392 . . . . 0.0 104.543 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -107.03 134.87 49.53 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 125.46 1.725 . . . . 0.0 106.552 -169.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.425 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.4 mp -132.48 98.25 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.27 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 -167.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m -120.66 3.41 10.66 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -111.0 125.23 53.51 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -168.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.24 113.42 25.03 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CD1' HD13 ' A' ' 7' ' ' ILE . 93.4 m-85 -103.74 114.82 29.36 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -130.85 120.44 23.68 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -168.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.08 -158.12 12.56 Favored Glycine 1 CA--C 1.579 4.067 0 CA-C-O 114.399 -3.445 . . . . 0.0 115.945 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -88.54 161.45 6.58 Favored 'Trans proline' 0 C--N 1.394 2.956 1 CA-C-N 126.61 5.205 . . . . 0.0 114.235 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.24 118.1 1.41 Allowed Glycine 0 N--CA 1.48 1.594 0 CA-C-O 117.96 -1.467 . . . . 0.0 110.162 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.4 m -100.81 85.73 0.6 Allowed Pre-proline 0 CA--C 1.587 2.396 0 CA-C-O 116.705 -1.617 . . . . 0.0 111.5 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.58 176.49 7.81 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 123.401 2.734 . . . . 0.0 113.66 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -75.38 158.74 32.3 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.717 1.207 . . . . 0.0 112.033 168.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.252 13.3 m -135.4 152.0 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 C-N-CA 123.15 0.58 . . . . 0.0 111.72 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 167.04 38.45 Favored Pre-proline 0 CA--C 1.586 2.357 0 CA-C-O 114.98 -2.438 . . . . 0.0 114.107 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.13 129.59 16.38 Favored 'Trans proline' 0 C--N 1.4 3.261 0 CA-C-N 126.968 3.524 . . . . 0.0 111.525 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.54 128.86 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 173.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.2 p -138.98 108.46 6.16 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.275 1.2 tt -69.03 163.78 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.913 0 C-N-CA 126.885 2.074 . . . . 0.0 113.257 -177.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -141.25 115.19 9.15 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 101.753 -3.425 . . . . 0.0 101.753 168.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.6 t -94.98 116.67 28.98 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 111.6 -2.545 . . . . 0.0 107.174 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.727 0 C-N-CA 124.03 0.932 . . . . 0.0 109.815 -168.457 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -140.62 124.24 17.03 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.268 1.027 . . . . 0.0 108.534 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -85.14 124.15 31.47 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.049 0.939 . . . . 0.0 109.408 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.279 8.5 tt0 -109.44 95.95 5.96 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 101.825 -3.398 . . . . 0.0 101.825 169.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.528 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -108.83 120.45 42.54 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 m -107.3 131.56 54.08 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 125.128 1.517 . . . . 0.0 106.98 -168.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.528 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.3 mp -136.53 96.0 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.211 0 N-CA-C 100.87 -3.752 . . . . 0.0 100.87 -167.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 t -80.13 -15.95 55.99 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 170.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -100.59 139.71 35.89 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 120.711 1.596 . . . . 0.0 110.99 -169.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 m -106.76 105.02 14.86 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 166.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -95.38 112.46 24.17 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -125.9 119.96 29.17 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -169.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.28 -164.62 21.06 Favored Glycine 1 CA--C 1.58 4.119 0 CA-C-O 114.495 -3.392 . . . . 0.0 116.055 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -87.14 161.44 8.59 Favored 'Trans proline' 0 C--N 1.394 2.958 1 CA-C-N 126.687 5.244 . . . . 0.0 113.998 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.48 118.34 1.48 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-O 118.078 -1.401 . . . . 0.0 110.242 174.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.7 t -99.32 86.09 0.51 Allowed Pre-proline 0 CA--C 1.588 2.416 0 CA-C-O 116.757 -1.592 . . . . 0.0 111.988 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -83.53 172.46 10.28 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 123.11 2.54 . . . . 0.0 113.458 169.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -80.3 146.29 31.69 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.244 1.017 . . . . 0.0 110.12 167.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.264 30.9 m -138.36 153.42 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 O-C-N 123.724 0.64 . . . . 0.0 112.031 -170.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -23.07 147.56 0.01 OUTLIER Pre-proline 0 CA--C 1.584 2.277 0 CA-C-O 112.937 -3.411 . . . . 0.0 119.378 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.26 116.92 4.68 Favored 'Trans proline' 0 C--N 1.394 2.945 0 CA-C-N 126.606 3.395 . . . . 0.0 109.647 168.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.1 t -78.45 114.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 104.177 -2.527 . . . . 0.0 104.177 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.5 p -118.75 104.47 10.62 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 1.3 tt -68.7 159.87 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.791 0 CA-C-N 111.64 -2.527 . . . . 0.0 113.244 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.7 ttm105 -139.32 108.6 6.1 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 168.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.9 m -94.81 97.16 9.83 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 110.072 -3.24 . . . . 0.0 106.02 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 N--CA 1.495 1.776 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.768 -168.059 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -139.52 128.04 22.98 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.321 1.048 . . . . 0.0 108.898 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -85.89 141.46 29.56 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.49 0.716 . . . . 0.0 111.129 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.268 4.8 tt0 -123.01 96.23 4.93 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 101.017 -3.697 . . . . 0.0 101.017 167.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.76 121.97 44.07 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -108.15 135.8 48.88 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 125.873 1.983 . . . . 0.0 106.819 -168.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.427 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mp -131.78 98.71 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.373 0 N-CA-C 100.986 -3.709 . . . . 0.0 100.986 -167.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.0 m -117.55 6.95 12.56 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 169.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -117.8 127.81 54.25 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -168.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 m -97.16 115.95 28.47 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.427 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.9 m-85 -104.25 114.9 29.46 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -128.47 119.61 25.25 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -170.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.8 171.04 39.33 Favored Glycine 1 CA--C 1.582 4.228 0 CA-C-O 115.059 -3.078 . . . . 0.0 116.948 -175.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.52 160.66 22.35 Favored 'Trans proline' 0 C--N 1.395 3.021 1 CA-C-N 125.624 4.712 . . . . 0.0 114.232 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.61 95.22 0.4 Allowed Glycine 0 N--CA 1.487 2.05 0 CA-C-O 117.315 -1.825 . . . . 0.0 111.308 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.255 4.7 p -102.8 92.05 3.26 Favored Pre-proline 0 CA--C 1.585 2.296 0 CA-C-O 116.507 -1.711 . . . . 0.0 114.403 -167.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.5 179.98 4.16 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 123.42 2.747 . . . . 0.0 113.898 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 p -68.33 148.39 50.81 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 125.114 1.366 . . . . 0.0 111.313 167.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 24.3 m -141.38 151.42 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.077 0.465 . . . . 0.0 112.02 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -12.03 145.61 0.0 OUTLIER Pre-proline 0 CA--C 1.583 2.236 0 N-CA-C 120.396 3.48 . . . . 0.0 120.396 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.56 117.6 4.61 Favored 'Trans proline' 0 C--N 1.395 2.987 0 CA-C-N 126.541 3.372 . . . . 0.0 109.406 168.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.1 t -79.24 107.34 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.0 p -112.75 101.34 9.44 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -172.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 tt -70.23 157.83 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.63 0 CA-C-N 111.113 -2.767 . . . . 0.0 113.596 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -136.14 106.36 6.38 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 167.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -95.59 109.35 21.6 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 111.062 -2.79 . . . . 0.0 106.127 170.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 124.629 1.206 . . . . 0.0 110.125 -168.052 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -138.96 129.89 26.42 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.297 1.039 . . . . 0.0 109.012 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -88.02 139.64 30.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.497 0.719 . . . . 0.0 110.801 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -122.55 99.92 6.66 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 101.478 -3.527 . . . . 0.0 101.478 167.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.72 122.5 47.96 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 178.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.63 133.23 52.38 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -169.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.449 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.0 mp -130.47 97.42 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.311 0 N-CA-C 100.595 -3.854 . . . . 0.0 100.595 -167.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.9 p -119.52 5.62 11.09 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 169.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -113.85 125.4 54.03 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -168.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -98.47 108.74 21.5 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.449 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.6 m-85 -102.04 112.46 25.12 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.75 124.95 30.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -168.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.02 -154.09 9.41 Favored Glycine 1 CA--C 1.58 4.133 0 CA-C-O 114.377 -3.457 . . . . 0.0 115.239 174.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -90.35 161.65 4.56 Favored 'Trans proline' 0 C--N 1.395 3.019 1 CA-C-N 126.474 5.137 . . . . 0.0 114.533 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.05 116.02 1.05 Allowed Glycine 0 N--CA 1.481 1.648 0 CA-C-O 117.897 -1.502 . . . . 0.0 110.317 174.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.4 m -101.36 86.1 0.71 Allowed Pre-proline 0 CA--C 1.588 2.426 0 CA-C-O 116.741 -1.6 . . . . 0.0 111.609 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.66 174.35 8.76 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 123.438 2.759 . . . . 0.0 113.9 172.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.98 155.83 39.44 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.598 1.159 . . . . 0.0 112.294 168.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 13.5 m -135.83 155.21 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -169.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -56.71 153.39 22.07 Favored Pre-proline 0 CA--C 1.583 2.22 0 CA-C-O 114.25 -2.786 . . . . 0.0 116.342 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -66.99 109.27 1.66 Allowed 'Trans proline' 0 C--N 1.397 3.103 0 CA-C-N 126.093 3.212 . . . . 0.0 109.967 168.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.74 126.24 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 p -136.44 107.42 6.7 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.265 2.6 tt -67.95 162.2 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 CA-C-N 112.099 -2.319 . . . . 0.0 113.713 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -138.98 112.54 8.28 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 167.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.4 t -96.33 111.57 23.61 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 111.48 -2.6 . . . . 0.0 106.247 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 124.282 0.989 . . . . 0.0 109.458 -168.328 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -141.19 125.54 17.57 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.268 1.027 . . . . 0.0 108.789 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -80.36 141.35 35.47 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 124.174 0.922 . . . . 0.0 111.439 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -124.32 98.9 5.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 100.525 -3.88 . . . . 0.0 100.525 168.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.48 122.43 47.26 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -106.83 134.87 49.31 Favored 'General case' 0 CA--C 1.55 0.981 0 O-C-N 125.653 1.846 . . . . 0.0 106.842 -169.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.494 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.7 mp -130.73 97.41 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.332 0 N-CA-C 100.532 -3.877 . . . . 0.0 100.532 -168.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -120.77 5.73 10.49 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 169.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -114.91 126.12 54.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -168.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -96.71 111.7 23.75 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.494 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.1 m-85 -103.0 119.1 38.25 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 -139.49 125.48 19.8 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.087 -167.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.81 -156.62 10.22 Favored Glycine 1 CA--C 1.581 4.165 0 CA-C-O 114.249 -3.528 . . . . 0.0 115.755 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -87.67 163.47 7.83 Favored 'Trans proline' 0 C--N 1.395 3.011 1 CA-C-N 126.721 5.261 . . . . 0.0 114.182 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.95 131.12 4.41 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.2 m -95.79 87.01 0.37 Allowed Pre-proline 0 CA--C 1.591 2.545 0 CA-C-O 116.767 -1.587 . . . . 0.0 110.337 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.14 169.62 17.37 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 123.428 2.752 . . . . 0.0 113.689 170.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.79 156.92 24.69 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.519 1.128 . . . . 0.0 111.202 168.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.251 15.6 m -136.78 151.42 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.113 0.565 . . . . 0.0 111.728 -175.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.47 164.54 44.81 Favored Pre-proline 0 CA--C 1.584 2.264 0 CA-C-O 115.339 -2.267 . . . . 0.0 114.186 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -63.33 126.59 18.07 Favored 'Trans proline' 0 C--N 1.4 3.241 0 CA-C-N 126.251 3.268 . . . . 0.0 112.654 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t -80.96 123.67 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.9 p -134.21 106.77 7.32 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 103.668 -2.716 . . . . 0.0 103.668 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 tt -69.87 162.15 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 127.368 2.267 . . . . 0.0 113.466 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.8 ttm-85 -144.07 111.6 6.02 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 102.506 -3.146 . . . . 0.0 102.506 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -100.33 108.76 20.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 111.732 -2.485 . . . . 0.0 105.477 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.493 1.722 0 O-C-N 124.479 1.112 . . . . 0.0 109.502 -168.454 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.34 128.05 40.6 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -84.73 126.33 33.31 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.116 0.966 . . . . 0.0 109.842 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.264 5.1 tt0 -121.22 92.05 3.66 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 171.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.27 130.99 55.15 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 171.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 m -108.2 128.03 54.35 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 112.479 -2.146 . . . . 0.0 106.625 -169.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.2 95.06 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.201 0 N-CA-C 100.428 -3.915 . . . . 0.0 100.428 -168.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.8 m -78.19 -18.96 54.82 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 169.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -99.02 138.57 35.93 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 120.55 1.523 . . . . 0.0 111.022 -169.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.7 m -106.12 104.0 13.61 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 100.994 -3.706 . . . . 0.0 100.994 166.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -92.17 98.3 11.44 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -113.32 121.27 43.88 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -170.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.73 -166.26 28.42 Favored Glycine 1 CA--C 1.58 4.104 0 CA-C-O 114.495 -3.392 . . . . 0.0 116.519 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -88.0 160.3 7.32 Favored 'Trans proline' 0 C--N 1.395 2.974 1 CA-C-N 126.737 5.269 . . . . 0.0 114.211 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.03 116.8 1.28 Allowed Glycine 0 N--CA 1.479 1.534 0 CA-C-O 118.194 -1.337 . . . . 0.0 110.602 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 t -97.03 90.67 0.82 Allowed Pre-proline 0 CA--C 1.587 2.392 0 CA-C-O 116.394 -1.765 . . . . 0.0 111.68 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.85 170.47 13.97 Favored 'Trans proline' 0 C--N 1.39 2.711 0 CA-C-N 124.287 2.567 . . . . 0.0 113.431 169.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -82.57 143.85 30.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.354 1.062 . . . . 0.0 109.806 168.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.302 19.0 m -140.53 161.56 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.052 0 CA-C-O 121.328 0.585 . . . . 0.0 111.896 -176.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.9 175.72 0.52 Allowed Pre-proline 0 CA--C 1.591 2.526 0 N-CA-C 118.786 2.884 . . . . 0.0 118.786 -168.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -80.9 122.73 4.41 Favored 'Trans proline' 0 C--N 1.404 3.471 0 CA-C-N 125.614 3.041 . . . . 0.0 110.635 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.7 t -78.71 115.86 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 174.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.4 p -125.44 106.34 9.74 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 tt -66.48 160.32 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.835 0 CA-C-N 111.956 -2.384 . . . . 0.0 113.049 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -136.85 107.97 6.77 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.2 m -94.92 109.55 21.54 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 109.764 -3.38 . . . . 0.0 105.425 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.737 0 C-N-CA 124.217 1.007 . . . . 0.0 111.033 -167.332 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -136.53 140.98 43.37 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.316 1.046 . . . . 0.0 110.086 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -87.63 143.99 26.9 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.564 0.746 . . . . 0.0 111.643 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -126.23 96.8 4.84 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 100.269 -3.975 . . . . 0.0 100.269 166.557 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.94 122.46 46.33 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.1 m -108.16 135.78 48.92 Favored 'General case' 0 CA--C 1.552 1.035 0 O-C-N 125.79 1.931 . . . . 0.0 106.685 -169.016 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.409 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.8 mp -132.23 98.94 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.329 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 -167.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m -117.69 8.49 12.8 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -118.53 127.26 53.45 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -168.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 m -97.51 112.49 24.32 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.409 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.1 m-85 -102.85 119.65 39.21 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.3 mtm-85 -138.25 123.01 18.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -168.233 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.92 177.15 42.31 Favored Glycine 1 CA--C 1.581 4.198 0 CA-C-O 115.054 -3.081 . . . . 0.0 116.555 -178.38 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.88 160.07 21.22 Favored 'Trans proline' 0 C--N 1.395 2.999 1 CA-C-N 126.019 4.91 . . . . 0.0 113.97 -175.639 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.94 96.66 0.4 Allowed Glycine 0 N--CA 1.487 2.074 0 CA-C-O 117.315 -1.825 . . . . 0.0 111.174 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.252 4.0 p -102.3 95.43 5.87 Favored Pre-proline 0 CA--C 1.584 2.275 0 CA-C-O 115.978 -1.963 . . . . 0.0 114.192 -167.326 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -85.54 179.51 3.9 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 123.442 2.761 . . . . 0.0 114.006 173.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 p -61.68 161.81 9.43 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 125.616 1.566 . . . . 0.0 113.857 169.322 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.252 14.2 m -135.29 154.27 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 C-N-CA 122.983 0.513 . . . . 0.0 112.229 178.308 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.259 50.7 pttt -75.14 -172.2 0.25 Allowed Pre-proline 0 CA--C 1.601 2.919 0 CA-C-O 114.688 -2.577 . . . . 0.0 116.46 -176.069 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.79 122.16 3.4 Favored 'Trans proline' 0 C--N 1.4 3.263 0 CA-C-N 126.539 3.371 . . . . 0.0 110.806 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.64 131.98 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 179.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -137.4 106.87 6.12 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 -177.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.53 162.91 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 CA-C-N 112.173 -2.285 . . . . 0.0 113.584 -178.52 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -137.93 108.63 6.62 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 101.87 -3.382 . . . . 0.0 101.87 166.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.1 t -98.07 109.34 22.11 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 111.558 -2.565 . . . . 0.0 105.673 171.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 124.601 1.188 . . . . 0.0 110.1 -167.824 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -139.57 137.46 35.4 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 124.4 1.08 . . . . 0.0 109.882 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -84.85 121.84 28.3 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 117.404 -1.284 . . . . 0.0 109.517 -179.037 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -109.17 98.56 7.98 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 170.261 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -110.93 120.26 41.8 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 179.897 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.4 m -107.38 130.71 54.77 Favored 'General case' 0 CA--C 1.554 1.108 0 O-C-N 125.314 1.634 . . . . 0.0 106.817 -168.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.492 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.3 mp -135.73 96.35 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.195 0 N-CA-C 100.522 -3.881 . . . . 0.0 100.522 -167.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.8 p -78.16 -19.07 54.72 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 169.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -98.6 140.66 32.49 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 120.443 1.474 . . . . 0.0 111.102 -169.656 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.0 m -107.02 100.19 9.7 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 101.058 -3.682 . . . . 0.0 101.058 167.227 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -94.14 110.72 22.42 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -175.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.46 116.59 20.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -167.817 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.98 -172.21 28.0 Favored Glycine 1 CA--C 1.583 4.286 0 CA-C-O 114.613 -3.326 . . . . 0.0 115.059 177.487 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -86.48 162.81 9.57 Favored 'Trans proline' 0 C--N 1.394 2.933 1 CA-C-N 126.892 5.346 . . . . 0.0 114.332 -175.657 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.32 113.81 1.38 Allowed Glycine 0 N--CA 1.481 1.649 0 CA-C-O 117.643 -1.643 . . . . 0.0 110.089 176.013 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.3 m -102.56 85.62 0.8 Allowed Pre-proline 0 CA--C 1.588 2.439 0 CA-C-O 117.021 -1.466 . . . . 0.0 111.942 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.02 173.41 9.07 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 123.258 2.638 . . . . 0.0 113.791 169.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -77.44 147.71 35.81 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.443 1.097 . . . . 0.0 110.358 167.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 31.2 m -139.08 152.21 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.828 0 O-C-N 123.556 0.535 . . . . 0.0 112.052 -173.173 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -17.45 146.57 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.265 0 CA-C-O 112.784 -3.484 . . . . 0.0 119.713 170.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.98 116.57 4.44 Favored 'Trans proline' 0 C--N 1.395 2.991 0 CA-C-N 126.614 3.398 . . . . 0.0 109.616 168.505 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.0 t -77.72 115.78 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 176.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.2 p -118.56 104.14 10.38 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 -174.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.282 1.3 tt -67.3 167.55 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 111.455 -2.611 . . . . 0.0 113.66 179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -144.65 112.19 6.14 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 168.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.4 t -95.82 98.05 10.14 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 168.315 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 N--CA 1.492 1.668 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.349 -165.963 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -139.46 125.64 20.04 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.264 1.026 . . . . 0.0 108.862 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -112.61 145.09 41.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 124.185 0.928 . . . . 0.0 112.201 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.27 3.2 tt0 -126.04 95.04 4.27 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 102.176 -3.268 . . . . 0.0 102.176 168.525 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -111.12 124.7 52.72 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.3 m -109.59 134.43 51.94 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 125.495 1.747 . . . . 0.0 106.528 -168.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.97 99.04 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.293 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 -167.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.5 m -115.68 9.66 15.29 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 169.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -120.64 127.51 52.15 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -168.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m -96.96 117.46 31.2 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 178.276 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -106.5 113.02 26.29 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -127.02 121.46 31.68 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -169.638 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.18 -160.31 13.28 Favored Glycine 1 CA--C 1.58 4.123 0 CA-C-O 114.466 -3.408 . . . . 0.0 116.297 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -90.71 156.86 4.21 Favored 'Trans proline' 0 C--N 1.397 3.096 1 CA-C-N 126.271 5.035 . . . . 0.0 114.487 -176.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.22 109.99 0.51 Allowed Glycine 0 N--CA 1.482 1.703 0 CA-C-O 117.954 -1.47 . . . . 0.0 111.261 174.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.323 1.3 p -108.38 82.37 1.6 Allowed Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 116.69 -1.624 . . . . 0.0 112.197 -171.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.84 -178.8 3.39 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 123.619 2.879 . . . . 0.0 113.684 172.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 p -61.79 158.31 16.09 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.446 1.498 . . . . 0.0 113.937 169.594 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.25 12.7 m -132.92 154.86 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.858 0 C-N-CA 123.358 0.663 . . . . 0.0 111.752 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 163.95 58.06 Favored Pre-proline 0 CA--C 1.583 2.248 0 CA-C-O 115.338 -2.267 . . . . 0.0 114.659 -179.447 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -64.81 128.35 20.72 Favored 'Trans proline' 0 C--N 1.4 3.245 0 CA-C-N 126.058 3.199 . . . . 0.0 112.661 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.25 130.1 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 175.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.2 p -139.14 108.51 6.13 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 102.907 -2.997 . . . . 0.0 102.907 -178.625 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 tt -70.06 163.2 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 C-N-CA 126.918 2.087 . . . . 0.0 113.685 -174.558 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -119.64 134.85 55.06 Favored 'General case' 0 CA--C 1.543 0.677 1 N-CA-C 97.397 -5.038 . . . . 0.0 97.397 163.205 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.0 t -106.17 65.0 0.68 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.689 1.233 . . . . 0.0 108.001 162.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.327 10.3 pt-20 . . . . . 0 N--CA 1.493 1.697 0 C-N-CA 126.08 1.752 . . . . 0.0 107.798 -170.061 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -146.29 128.28 15.52 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.15 128.24 35.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.542 0.737 . . . . 0.0 110.351 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.279 9.4 tt0 -112.92 96.83 6.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 101.216 -3.624 . . . . 0.0 101.216 168.555 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.4 109.93 19.84 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 -176.303 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 m -96.39 127.75 42.68 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.243 -167.221 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mm -119.12 86.82 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.112 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 -167.506 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.6 p -88.42 -16.06 33.87 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 168.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.52 139.41 30.56 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.582 1.153 . . . . 0.0 110.356 -170.148 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -110.93 110.47 21.06 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 102.782 -3.044 . . . . 0.0 102.782 169.059 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -98.94 115.75 29.6 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.31 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -128.22 122.61 32.19 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -173.028 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.53 -155.71 11.1 Favored Glycine 0 CA--C 1.578 3.982 0 CA-C-O 114.452 -3.416 . . . . 0.0 115.856 176.236 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -87.94 161.58 7.44 Favored 'Trans proline' 0 C--N 1.394 2.942 1 CA-C-N 126.393 5.096 . . . . 0.0 114.024 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.64 117.02 1.42 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-O 118.235 -1.314 . . . . 0.0 110.481 173.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.5 m -102.46 84.47 0.63 Allowed Pre-proline 0 CA--C 1.588 2.407 0 CA-C-O 116.766 -1.588 . . . . 0.0 111.129 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.91 174.07 9.73 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 123.399 2.732 . . . . 0.0 113.958 171.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.51 155.4 36.17 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.556 1.143 . . . . 0.0 112.05 168.61 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.268 13.4 m -137.08 156.63 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -169.512 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -63.64 165.59 11.67 Favored Pre-proline 0 CA--C 1.58 2.132 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.67 111.32 3.27 Favored 'Trans proline' 0 C--N 1.396 3.052 0 C-N-CA 123.149 2.566 . . . . 0.0 109.944 169.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -74.64 124.11 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 172.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -137.76 108.78 6.74 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 -178.287 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.264 1.1 tt -69.49 164.36 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 C-N-CA 126.91 2.084 . . . . 0.0 113.718 -174.712 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -139.35 113.76 9.03 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 167.019 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.4 t -95.78 115.91 28.12 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 111.606 -2.543 . . . . 0.0 106.943 171.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.493 1.686 0 C-N-CA 124.162 0.985 . . . . 0.0 110.098 -168.221 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -140.78 124.2 16.78 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.301 1.04 . . . . 0.0 108.4 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -86.16 128.07 34.83 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 124.088 0.868 . . . . 0.0 110.33 -179.405 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.259 7.1 tt0 -112.0 97.86 6.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 100.855 -3.757 . . . . 0.0 100.855 168.734 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.48 108.18 16.85 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -177.181 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 m -96.36 126.17 41.37 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 113.369 -1.741 . . . . 0.0 106.817 -167.213 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 mm -115.16 90.96 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.088 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 -166.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.7 m -125.64 4.74 7.5 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.495 169.719 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.74 119.52 36.95 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -169.245 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 m -96.58 120.81 37.6 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 -171.578 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -112.38 118.37 35.01 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -138.37 116.88 12.07 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -168.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.63 -155.34 9.92 Favored Glycine 1 CA--C 1.579 4.054 0 CA-C-O 114.345 -3.475 . . . . 0.0 115.373 178.472 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -88.12 161.63 7.17 Favored 'Trans proline' 0 C--N 1.394 2.935 1 CA-C-N 126.728 5.264 . . . . 0.0 114.131 -178.394 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.28 115.72 1.47 Allowed Glycine 0 N--CA 1.479 1.519 0 CA-C-O 118.058 -1.412 . . . . 0.0 110.443 174.357 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.2 m -101.56 85.7 0.68 Allowed Pre-proline 0 CA--C 1.587 2.376 0 CA-C-O 116.716 -1.611 . . . . 0.0 111.295 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.48 173.51 10.54 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 123.31 2.673 . . . . 0.0 113.827 171.046 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -75.48 155.3 36.35 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.557 1.143 . . . . 0.0 111.963 168.674 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.27 19.4 m -136.96 153.3 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 123.503 0.502 . . . . 0.0 111.98 -173.175 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.98 48.41 Favored Pre-proline 0 CA--C 1.585 2.292 0 CA-C-O 115.241 -2.314 . . . . 0.0 114.688 -179.441 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -63.68 130.21 27.29 Favored 'Trans proline' 0 C--N 1.4 3.249 0 CA-C-N 126.34 3.3 . . . . 0.0 113.006 177.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -77.99 122.7 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 171.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 p -137.36 109.18 7.08 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 0.9 OUTLIER -68.8 164.5 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 C-N-CA 126.84 2.056 . . . . 0.0 113.685 -174.959 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -141.03 113.11 7.84 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 167.131 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.1 t -97.81 114.15 26.12 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 111.524 -2.58 . . . . 0.0 106.411 170.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 124.055 0.847 . . . . 0.0 110.005 -168.695 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.93 139.75 38.1 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 124.265 1.026 . . . . 0.0 109.672 179.44 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -80.0 139.54 36.94 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 117.338 -1.315 . . . . 0.0 111.78 -177.067 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -121.22 97.58 5.58 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 102.503 -3.147 . . . . 0.0 102.503 168.697 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.58 119.63 39.8 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 -178.705 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -107.13 130.03 54.75 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 125.652 1.845 . . . . 0.0 106.174 -168.892 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.8 mp -126.03 97.6 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.335 0 N-CA-C 100.469 -3.901 . . . . 0.0 100.469 -167.871 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m -121.35 5.14 10.22 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.843 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -113.52 125.55 54.33 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -168.882 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -97.92 108.35 21.04 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 -173.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.471 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.5 m-85 -101.86 112.08 24.57 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -176.67 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.75 121.24 26.48 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -168.541 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.03 170.8 42.69 Favored Glycine 1 CA--C 1.581 4.218 0 CA-C-O 115.102 -3.054 . . . . 0.0 116.325 -177.705 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.46 162.76 22.07 Favored 'Trans proline' 0 C--N 1.394 2.938 1 CA-C-N 125.805 4.802 . . . . 0.0 114.153 -176.294 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.08 91.54 0.81 Allowed Glycine 0 N--CA 1.486 2.003 0 CA-C-O 117.379 -1.79 . . . . 0.0 110.38 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.9 m -85.7 102.49 2.63 Favored Pre-proline 0 CA--C 1.589 2.472 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -166.895 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -79.68 179.37 6.37 Favored 'Trans proline' 0 CA--C 1.58 2.796 0 C-N-CA 123.199 2.599 . . . . 0.0 112.158 166.709 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.303 9.9 t -105.24 155.97 18.57 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 123.841 0.856 . . . . 0.0 109.025 167.091 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.0 m -120.31 155.42 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 C-N-CA 124.22 1.008 . . . . 0.0 112.151 -165.695 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 179.79 1.58 Allowed Pre-proline 0 CA--C 1.6 2.869 0 CA-C-O 116.232 -1.842 . . . . 0.0 112.935 -179.342 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -75.23 125.6 9.28 Favored 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 123.654 2.903 . . . . 0.0 111.088 177.391 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.7 t -77.31 138.85 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.9 p -141.4 106.09 4.9 Favored 'General case' 0 CA--C 1.558 1.272 0 N-CA-C 104.54 -2.392 . . . . 0.0 104.54 -176.042 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.253 1.6 tt -72.91 159.95 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.741 0 C-N-CA 127.14 2.176 . . . . 0.0 113.653 -178.203 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -145.42 103.53 3.83 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 105.896 -1.891 . . . . 0.0 105.896 168.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.9 t -91.89 98.02 11.33 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 111.951 -2.386 . . . . 0.0 104.729 169.507 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 . . . . . 0 N--CA 1.492 1.647 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.983 -165.51 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -136.25 141.04 43.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 124.312 1.045 . . . . 0.0 110.148 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -88.75 142.84 27.33 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.559 0.744 . . . . 0.0 111.404 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.251 4.0 tt0 -125.49 96.93 4.98 Favored 'General case' 0 N--CA 1.487 1.387 1 N-CA-C 100.15 -4.018 . . . . 0.0 100.15 166.704 . . . . . . . . 3 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.89 124.2 50.02 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 m -106.56 132.26 52.77 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 125.576 1.797 . . . . 0.0 107.357 -168.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.8 mp -136.32 95.83 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.179 0 N-CA-C 100.998 -3.704 . . . . 0.0 100.998 -168.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.6 m -78.51 -17.92 55.52 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 169.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -101.73 141.25 34.87 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.612 1.551 . . . . 0.0 111.231 -169.55 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -104.51 102.84 12.46 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 165.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -92.42 115.23 27.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -178.916 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -131.54 122.32 25.93 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -168.261 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.22 172.21 42.76 Favored Glycine 1 CA--C 1.58 4.12 0 CA-C-O 115.139 -3.034 . . . . 0.0 116.542 -177.402 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.12 159.69 23.62 Favored 'Trans proline' 0 C--N 1.395 3.009 1 CA-C-N 125.896 4.848 . . . . 0.0 113.962 -175.838 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.99 97.11 0.39 Allowed Glycine 0 N--CA 1.488 2.103 0 CA-C-O 117.346 -1.808 . . . . 0.0 111.151 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.253 4.0 p -101.44 95.93 5.62 Favored Pre-proline 0 CA--C 1.583 2.241 0 CA-C-O 115.932 -1.985 . . . . 0.0 114.02 -167.459 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -84.03 178.52 5.27 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 123.497 2.798 . . . . 0.0 113.88 173.447 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -63.72 161.23 15.47 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 125.454 1.502 . . . . 0.0 114.095 169.792 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.3 m -134.1 152.78 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 C-N-CA 123.42 0.688 . . . . 0.0 111.682 -179.694 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.28 164.54 49.53 Favored Pre-proline 0 CA--C 1.585 2.289 0 CA-C-O 115.305 -2.283 . . . . 0.0 114.219 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -64.28 126.5 17.17 Favored 'Trans proline' 0 C--N 1.398 3.179 0 CA-C-N 126.203 3.251 . . . . 0.0 112.503 177.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.6 t -79.73 127.73 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 176.264 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.6 p -135.92 106.22 6.4 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 -176.394 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 tt -71.46 164.06 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.829 0 CA-C-N 111.983 -2.371 . . . . 0.0 113.54 -178.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -139.0 108.0 6.01 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 101.776 -3.416 . . . . 0.0 101.776 165.351 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.6 t -98.02 108.98 21.8 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 111.664 -2.517 . . . . 0.0 105.637 172.227 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 124.67 1.231 . . . . 0.0 110.164 -167.774 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -138.5 136.6 36.3 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.349 1.06 . . . . 0.0 109.664 179.646 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -87.65 142.02 28.16 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.45 0.7 . . . . 0.0 111.4 -178.01 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.254 4.2 tt0 -124.72 96.87 5.05 Favored 'General case' 0 N--CA 1.488 1.43 1 N-CA-C 100.185 -4.005 . . . . 0.0 100.185 166.639 . . . . . . . . 3 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.24 123.67 49.42 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -106.57 131.71 53.42 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 113.23 -1.805 . . . . 0.0 107.194 -168.482 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.24 95.9 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.172 0 N-CA-C 101.002 -3.703 . . . . 0.0 101.002 -168.507 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.7 m -78.57 -18.1 55.12 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 169.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -101.41 141.09 34.8 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 120.622 1.555 . . . . 0.0 111.247 -169.556 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -104.6 102.65 12.25 Favored 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 100.928 -3.731 . . . . 0.0 100.928 165.744 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -92.68 115.0 27.71 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 -178.764 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -131.22 122.03 25.83 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -168.29 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.2 171.8 42.61 Favored Glycine 1 CA--C 1.58 4.132 0 CA-C-O 115.102 -3.054 . . . . 0.0 116.694 -177.149 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.96 159.64 24.11 Favored 'Trans proline' 0 C--N 1.394 2.965 1 CA-C-N 125.775 4.787 . . . . 0.0 113.958 -175.884 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.8 96.89 0.38 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-O 117.324 -1.82 . . . . 0.0 111.107 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.253 3.8 p -101.44 95.97 5.66 Favored Pre-proline 0 CA--C 1.582 2.209 0 CA-C-O 115.893 -2.003 . . . . 0.0 114.048 -167.504 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -83.93 178.0 5.69 Favored 'Trans proline' 0 C--N 1.394 2.95 0 C-N-CA 123.479 2.786 . . . . 0.0 113.912 173.493 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -63.9 161.11 16.21 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 125.35 1.46 . . . . 0.0 114.062 169.818 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 m -134.84 152.55 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 123.353 0.661 . . . . 0.0 111.589 -179.636 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 164.73 49.69 Favored Pre-proline 0 CA--C 1.583 2.243 0 CA-C-O 115.341 -2.266 . . . . 0.0 114.225 179.644 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -64.34 126.09 16.34 Favored 'Trans proline' 0 C--N 1.399 3.226 0 CA-C-N 126.179 3.243 . . . . 0.0 112.373 177.331 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.4 t -79.48 127.82 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 176.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -137.42 106.03 5.85 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 123.724 1.726 . . . . 0.0 108.528 -178.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 tt -70.9 162.29 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 CA-C-N 109.109 -3.678 . . . . 0.0 113.663 -176.045 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -138.01 107.67 6.23 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 101.934 -3.358 . . . . 0.0 101.934 165.499 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -97.97 107.51 20.0 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 111.469 -2.605 . . . . 0.0 105.617 171.697 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 124.657 1.223 . . . . 0.0 109.947 -167.91 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -141.4 122.86 14.99 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -82.46 123.5 29.21 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 117.535 -1.222 . . . . 0.0 110.0 -175.92 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -108.66 95.96 6.01 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 170.532 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.527 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.56 119.24 38.86 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 179.346 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.0 m -107.52 130.15 54.89 Favored 'General case' 0 CA--C 1.554 1.132 0 O-C-N 125.323 1.639 . . . . 0.0 106.66 -168.913 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.527 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.3 mp -135.37 96.34 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.184 0 N-CA-C 100.572 -3.862 . . . . 0.0 100.572 -167.819 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.6 m -78.79 -19.06 53.07 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 169.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -96.58 139.71 32.27 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 120.621 1.555 . . . . 0.0 111.03 -169.677 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 m -107.93 99.86 9.27 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 101.098 -3.667 . . . . 0.0 101.098 167.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -94.11 110.93 22.61 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -176.029 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.27 116.82 20.45 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -167.805 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.01 -164.63 20.8 Favored Glycine 1 CA--C 1.582 4.231 0 CA-C-O 114.687 -3.285 . . . . 0.0 115.464 177.528 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -88.01 162.65 7.35 Favored 'Trans proline' 0 C--N 1.394 2.945 1 CA-C-N 126.554 5.177 . . . . 0.0 114.204 -177.075 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.82 114.95 1.55 Allowed Glycine 0 N--CA 1.48 1.569 0 CA-C-O 117.861 -1.522 . . . . 0.0 110.097 174.016 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.2 t -101.23 85.92 0.67 Allowed Pre-proline 0 CA--C 1.588 2.411 0 CA-C-O 116.864 -1.541 . . . . 0.0 112.432 -175.577 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.12 171.72 11.28 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 123.134 2.556 . . . . 0.0 113.33 168.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.81 147.13 31.92 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.195 0.998 . . . . 0.0 110.467 167.816 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.266 29.8 m -138.09 154.42 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 O-C-N 123.743 0.652 . . . . 0.0 111.934 -169.941 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -28.0 148.52 0.03 OUTLIER Pre-proline 0 CA--C 1.585 2.298 0 CA-C-O 113.145 -3.312 . . . . 0.0 118.884 174.759 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.74 116.83 4.72 Favored 'Trans proline' 0 C--N 1.395 3.014 0 CA-C-N 126.546 3.374 . . . . 0.0 109.828 168.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.9 t -80.23 112.58 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 103.84 -2.652 . . . . 0.0 103.84 177.472 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.6 p -115.37 102.42 9.82 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -173.225 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.263 1.7 tt -68.28 163.05 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-N 111.159 -2.746 . . . . 0.0 114.026 -179.173 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -145.14 106.23 4.17 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 167.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 81.2 m -92.43 91.35 7.6 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 111.362 -2.654 . . . . 0.0 104.769 172.426 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 . . . . . 0 N--CA 1.493 1.677 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.79 -165.383 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.2 p . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -140.44 123.9 16.96 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 118.056 -0.974 . . . . 0.0 108.783 178.154 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -89.81 135.86 33.38 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 124.391 1.057 . . . . 0.0 110.23 174.433 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.287 3.4 tt0 -119.32 95.71 4.91 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 102.626 -3.101 . . . . 0.0 102.626 169.889 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.38 123.71 50.15 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -176.787 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -105.75 134.22 49.23 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 125.489 1.743 . . . . 0.0 107.679 -168.515 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp -137.75 95.25 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 N-CA-C 100.961 -3.718 . . . . 0.0 100.961 -168.514 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.9 p -78.41 -16.66 57.37 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 169.705 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -103.41 141.54 35.79 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 120.173 1.351 . . . . 0.0 111.082 -169.533 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 m -105.05 105.74 15.92 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 100.995 -3.706 . . . . 0.0 100.995 166.2 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -93.5 110.44 22.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -122.45 116.6 24.24 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -169.883 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.89 164.97 36.76 Favored Glycine 1 CA--C 1.58 4.096 0 CA-C-O 114.975 -3.125 . . . . 0.0 116.693 -174.187 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.79 159.16 21.52 Favored 'Trans proline' 0 C--N 1.395 3.008 1 CA-C-N 125.739 4.77 . . . . 0.0 114.303 -174.173 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.72 95.17 0.41 Allowed Glycine 0 N--CA 1.487 2.071 0 CA-C-O 117.144 -1.92 . . . . 0.0 111.375 177.093 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.4 m -74.09 108.12 4.57 Favored Pre-proline 0 CA--C 1.586 2.358 0 CA-C-O 115.662 -2.113 . . . . 0.0 114.818 -167.314 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.73 169.44 18.22 Favored 'Trans proline' 0 C--N 1.39 2.727 0 CA-C-N 124.683 2.708 . . . . 0.0 113.663 169.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.88 149.88 26.07 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.127 0.971 . . . . 0.0 110.519 168.635 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.71 148.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 123.712 0.805 . . . . 0.0 111.491 -169.161 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 166.68 33.96 Favored Pre-proline 0 CA--C 1.586 2.345 0 CA-C-O 115.097 -2.383 . . . . 0.0 113.176 175.66 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.74 125.72 11.93 Favored 'Trans proline' 0 C--N 1.4 3.249 0 CA-C-N 127.032 3.547 . . . . 0.0 111.341 -177.967 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.64 129.14 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.625 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -136.53 107.28 6.6 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 123.767 1.746 . . . . 0.0 108.261 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 tt -70.88 160.12 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 CA-C-N 109.124 -3.671 . . . . 0.0 114.042 -172.843 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -135.45 94.73 3.15 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 166.593 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.0 t -93.17 117.55 30.2 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 111.16 -2.745 . . . . 0.0 106.596 170.094 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.29 14.3 pt-20 . . . . . 0 N--CA 1.497 1.911 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -166.8 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.97 130.24 33.35 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.159 0.983 . . . . 0.0 109.064 176.519 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -87.82 140.29 29.66 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.979 0.799 . . . . 0.0 110.333 174.32 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.54 100.94 6.89 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 101.916 -3.365 . . . . 0.0 101.916 169.018 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.433 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -113.97 123.75 50.49 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.411 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -107.08 131.33 54.23 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 125.38 1.675 . . . . 0.0 107.124 -168.825 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.433 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.5 mp -136.32 95.89 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.198 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 -168.187 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.6 m -78.78 -17.69 55.35 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 169.921 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -100.15 139.87 35.21 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 120.657 1.571 . . . . 0.0 111.054 -169.63 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.1 m -105.57 102.29 11.76 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 100.906 -3.739 . . . . 0.0 100.906 166.212 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -92.42 117.84 30.33 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -178.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -136.22 123.28 21.56 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -167.776 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.36 -156.53 12.57 Favored Glycine 1 CA--C 1.579 4.091 0 CA-C-O 114.501 -3.388 . . . . 0.0 115.698 176.573 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -88.95 161.93 5.98 Favored 'Trans proline' 0 C--N 1.395 2.984 1 CA-C-N 126.268 5.034 . . . . 0.0 114.339 -178.965 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.42 113.71 0.76 Allowed Glycine 0 N--CA 1.481 1.637 0 CA-C-O 117.656 -1.636 . . . . 0.0 110.597 173.358 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.4 m -98.78 89.3 0.84 Allowed Pre-proline 0 CA--C 1.587 2.401 0 CA-C-O 116.554 -1.688 . . . . 0.0 111.906 -175.448 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.04 172.72 12.66 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.298 2.665 . . . . 0.0 113.632 169.951 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.05 156.54 37.38 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.581 1.152 . . . . 0.0 112.394 168.786 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.26 13.3 m -134.45 154.64 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.841 0 O-C-N 123.685 0.615 . . . . 0.0 112.225 -170.347 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -64.94 164.59 20.54 Favored Pre-proline 0 CA--C 1.581 2.135 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 -178.418 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.58 107.98 2.43 Favored 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 123.199 2.6 . . . . 0.0 110.034 169.9 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.61 126.27 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 176.454 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.7 p -135.8 106.98 6.75 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 -176.333 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.253 1.9 tt -69.17 163.51 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.87 0 CA-C-N 111.932 -2.394 . . . . 0.0 113.465 -179.314 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -139.53 108.03 5.87 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 103.048 -2.945 . . . . 0.0 103.048 167.624 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 17.5 t -98.35 123.92 42.72 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 111.019 -2.809 . . . . 0.0 106.735 169.643 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.285 14.8 pt-20 . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -167.82 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -140.12 131.31 26.51 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.155 0.982 . . . . 0.0 109.697 179.395 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -84.08 135.65 34.32 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 124.543 1.152 . . . . 0.0 110.523 179.197 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.268 8.0 tt0 -119.81 99.14 6.46 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 100.999 -3.704 . . . . 0.0 100.999 170.285 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.479 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -108.69 123.62 49.27 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 177.077 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 m -107.84 131.09 54.86 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -169.442 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.482 HD13 ' CD1' ' A' ' 12' ' ' PHE . 2.9 mp -127.85 96.9 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.349 0 N-CA-C 100.42 -3.918 . . . . 0.0 100.42 -167.765 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m -120.35 7.17 10.66 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 170.101 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -115.83 125.27 52.46 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -169.065 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -95.97 116.4 28.88 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 -177.654 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.482 ' CD1' HD13 ' A' ' 7' ' ' ILE . 83.2 m-85 -105.57 113.89 27.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -128.34 117.54 21.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -169.828 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.22 -166.24 20.64 Favored Glycine 1 CA--C 1.582 4.266 0 CA-C-O 114.199 -3.556 . . . . 0.0 115.986 179.445 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -89.47 163.04 5.43 Favored 'Trans proline' 0 C--N 1.395 3.019 1 CA-C-N 127.293 5.547 . . . . 0.0 114.601 -177.816 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.27 128.32 4.08 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 m -98.48 84.17 0.33 Allowed Pre-proline 0 CA--C 1.591 2.557 0 CA-C-O 117.296 -1.335 . . . . 0.0 112.244 177.917 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -80.71 174.92 10.56 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.124 2.55 . . . . 0.0 112.482 167.761 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.299 8.8 t -106.47 153.8 21.76 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 167.735 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 m -121.96 159.79 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 C-N-CA 124.389 1.076 . . . . 0.0 111.958 -165.732 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 163.42 65.28 Favored Pre-proline 0 CA--C 1.585 2.321 0 CA-C-O 115.28 -2.295 . . . . 0.0 114.782 176.406 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -64.31 134.02 40.21 Favored 'Trans proline' 0 C--N 1.399 3.203 0 CA-C-N 126.162 3.236 . . . . 0.0 113.503 -179.532 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.3 t -77.04 133.53 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.676 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -142.53 108.44 5.16 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 103.428 -2.805 . . . . 0.0 103.428 -178.212 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.256 3.3 tt -70.93 160.92 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 C-N-CA 127.233 2.213 . . . . 0.0 113.027 -179.275 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -145.97 115.07 7.01 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 102.565 -3.124 . . . . 0.0 102.565 169.12 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.48 110.21 22.7 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 111.977 -2.374 . . . . 0.0 106.23 169.646 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 124.472 1.108 . . . . 0.0 109.389 -168.666 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.43 130.61 17.45 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.757 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -84.47 137.15 33.52 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.874 178.16 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.25 8.2 tt0 -121.05 99.61 6.6 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 100.965 -3.717 . . . . 0.0 100.965 169.038 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.24 122.92 46.4 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.093 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.29 136.14 47.6 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 125.67 1.856 . . . . 0.0 106.926 -169.267 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.469 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.2 mp -133.08 98.28 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.299 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 -167.829 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t -119.05 10.65 12.21 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 169.815 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -119.97 126.08 49.97 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -169.073 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 m -97.07 112.01 23.98 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -177.2 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.469 ' CD1' HD13 ' A' ' 7' ' ' ILE . 83.3 m-85 -103.38 118.62 37.18 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -178.921 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -139.57 124.82 18.95 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -168.013 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.54 -156.15 9.76 Favored Glycine 1 CA--C 1.578 4.022 0 CA-C-O 114.478 -3.401 . . . . 0.0 115.734 177.241 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.58 161.07 9.4 Favored 'Trans proline' 0 C--N 1.394 2.969 1 CA-C-N 126.429 5.114 . . . . 0.0 113.833 -178.421 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.91 118.51 1.37 Allowed Glycine 0 N--CA 1.479 1.516 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.093 176.571 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -100.2 84.56 0.45 Allowed Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 117.036 -1.459 . . . . 0.0 112.702 -179.021 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.99 172.29 12.1 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 123.116 2.544 . . . . 0.0 112.953 168.585 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.289 9.5 t -93.45 157.85 16.01 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 123.457 0.703 . . . . 0.0 109.281 167.775 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.5 m -126.61 158.97 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 C-N-CA 124.131 0.972 . . . . 0.0 112.244 -166.277 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -73.99 -176.07 0.47 Allowed Pre-proline 0 CA--C 1.609 3.226 0 CA-C-O 115.142 -2.361 . . . . 0.0 113.717 -179.495 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -84.02 129.54 4.65 Favored 'Trans proline' 0 C--N 1.394 2.955 0 CA-C-N 126.606 3.395 . . . . 0.0 111.476 -178.634 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.12 133.96 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 175.443 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.8 p -141.75 107.23 5.04 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 103.656 -2.72 . . . . 0.0 103.656 -176.619 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.266 1.4 tt -71.34 162.61 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 C-N-CA 127.255 2.222 . . . . 0.0 112.7 -179.077 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -142.65 123.94 14.67 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 169.019 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.8 t -95.31 123.76 38.99 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 111.789 -2.46 . . . . 0.0 108.391 169.536 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 . . . . . 0 N--CA 1.492 1.629 0 C-N-CA 124.176 0.991 . . . . 0.0 109.663 -169.269 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -147.52 127.28 13.44 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 178.696 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -86.4 140.45 29.99 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.118 0.567 . . . . 0.0 111.086 178.52 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.258 8.2 tt0 -124.56 96.46 4.91 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 100.665 -3.828 . . . . 0.0 100.665 166.785 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.99 123.33 46.65 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -177.016 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -107.77 135.72 48.71 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 125.853 1.97 . . . . 0.0 106.928 -169.143 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.438 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.6 mp -132.45 98.39 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.314 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 -167.956 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.5 m -118.5 8.64 12.11 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 169.825 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -118.36 126.9 53.06 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -168.852 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -97.01 112.41 24.18 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 -178.284 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.438 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.0 m-85 -103.59 119.26 38.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -179.671 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -138.57 120.43 15.39 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -168.485 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.11 178.75 42.18 Favored Glycine 1 CA--C 1.582 4.22 0 CA-C-O 115.054 -3.081 . . . . 0.0 116.866 -177.406 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.31 159.45 17.46 Favored 'Trans proline' 0 C--N 1.395 2.992 1 CA-C-N 125.877 4.839 . . . . 0.0 114.088 -174.994 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.03 96.37 0.41 Allowed Glycine 0 N--CA 1.488 2.127 0 CA-C-O 117.322 -1.821 . . . . 0.0 111.163 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.25 3.1 p -100.57 96.02 4.93 Favored Pre-proline 0 CA--C 1.583 2.234 0 CA-C-O 115.949 -1.977 . . . . 0.0 113.948 -167.414 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -83.5 178.81 5.38 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 123.516 2.81 . . . . 0.0 113.796 173.149 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 p -64.57 160.57 19.27 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.291 1.437 . . . . 0.0 113.817 169.554 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 m -134.29 152.23 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 123.334 0.654 . . . . 0.0 111.73 -178.262 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.71 164.09 48.58 Favored Pre-proline 0 CA--C 1.583 2.227 0 CA-C-O 115.336 -2.269 . . . . 0.0 114.213 178.952 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -63.74 126.87 18.32 Favored 'Trans proline' 0 C--N 1.399 3.223 0 CA-C-N 126.216 3.256 . . . . 0.0 112.686 178.575 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t -81.01 124.6 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 176.648 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.4 p -133.81 105.85 7.01 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -176.72 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.4 tt -71.58 160.98 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.775 0 CA-C-N 112.009 -2.36 . . . . 0.0 113.471 -177.411 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -136.45 105.21 5.85 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 102.392 -3.188 . . . . 0.0 102.392 165.409 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.4 t -94.9 112.97 24.65 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 111.258 -2.701 . . . . 0.0 106.102 173.239 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 124.621 1.201 . . . . 0.0 111.228 -167.428 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -140.47 125.94 18.96 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.292 1.037 . . . . 0.0 108.767 179.722 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -88.2 139.92 30.01 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 124.005 0.816 . . . . 0.0 111.184 179.211 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -123.56 98.52 5.87 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 101.996 -3.335 . . . . 0.0 101.996 168.356 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.47 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -112.05 122.68 48.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 178.747 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -106.96 130.66 54.58 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 125.353 1.658 . . . . 0.0 107.029 -168.718 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.47 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.4 mp -136.12 96.22 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.182 0 N-CA-C 100.635 -3.839 . . . . 0.0 100.635 -168.271 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.8 p -77.97 -18.87 55.5 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 169.84 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -100.31 141.14 33.57 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.417 1.462 . . . . 0.0 111.068 -169.607 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.8 m -106.09 100.46 10.0 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 166.926 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -93.46 109.9 21.48 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 -175.599 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.93 118.5 25.54 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -168.146 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.9 169.02 40.61 Favored Glycine 1 CA--C 1.582 4.22 0 CA-C-O 115.097 -3.057 . . . . 0.0 116.35 -176.343 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.45 160.89 22.53 Favored 'Trans proline' 0 C--N 1.395 2.987 1 CA-C-N 125.834 4.817 . . . . 0.0 114.29 -174.092 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.36 95.8 0.37 Allowed Glycine 0 N--CA 1.487 2.062 0 CA-C-O 116.921 -2.044 . . . . 0.0 111.465 178.017 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.8 m -78.98 106.59 4.59 Favored Pre-proline 0 CA--C 1.587 2.368 0 CA-C-O 115.755 -2.069 . . . . 0.0 113.943 -167.639 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -80.07 171.38 15.29 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 123.428 2.752 . . . . 0.0 113.828 170.7 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.82 153.69 28.95 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.358 1.063 . . . . 0.0 110.746 168.008 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.25 11.4 m -129.55 152.21 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 123.211 0.604 . . . . 0.0 112.497 -168.845 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.13 165.63 31.47 Favored Pre-proline 0 CA--C 1.581 2.16 0 CA-C-O 115.814 -2.041 . . . . 0.0 116.332 -179.611 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.69 106.91 2.2 Favored 'Trans proline' 0 C--N 1.395 3.017 0 C-N-CA 123.12 2.547 . . . . 0.0 109.958 169.73 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.3 t -76.79 122.86 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 176.936 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 p -131.7 106.27 8.04 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 -176.482 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 tt -69.66 162.16 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.827 0 CA-C-N 111.863 -2.426 . . . . 0.0 113.871 -179.071 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -138.17 102.31 4.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 166.162 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.0 t -96.1 105.14 17.14 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 111.138 -2.755 . . . . 0.0 105.818 171.776 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 N--CA 1.491 1.597 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.582 -167.677 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.6 p . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -141.29 124.22 16.23 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 124.285 1.034 . . . . 0.0 108.481 179.72 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -84.57 129.7 34.82 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 117.83 -1.081 . . . . 0.0 110.574 -177.207 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.276 5.3 tt0 -114.55 94.44 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 102.639 -3.097 . . . . 0.0 102.639 172.685 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.491 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -108.19 123.31 48.55 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.473 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 m -108.08 132.53 53.47 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -169.736 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.491 HD11 ' CD2' ' A' ' 5' ' ' TYR . 3.6 mp -129.82 97.8 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.351 0 N-CA-C 100.602 -3.851 . . . . 0.0 100.602 -167.661 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 94.7 p -118.72 3.91 11.63 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 169.8 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -113.57 125.67 54.44 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -168.768 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -97.12 116.41 29.28 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 -179.709 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.436 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.3 m-85 -104.23 112.92 26.13 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -128.2 119.42 25.18 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -169.961 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.58 -161.71 20.48 Favored Glycine 1 CA--C 1.579 4.078 0 CA-C-O 114.362 -3.466 . . . . 0.0 115.821 177.663 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.8 160.96 4.12 Favored 'Trans proline' 0 C--N 1.394 2.928 1 CA-C-N 126.748 5.274 . . . . 0.0 114.533 -179.458 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.31 113.51 0.87 Allowed Glycine 0 N--CA 1.482 1.719 0 CA-C-O 117.576 -1.68 . . . . 0.0 110.489 172.671 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -96.1 94.89 1.69 Allowed Pre-proline 0 CA--C 1.591 2.525 0 CA-C-O 116.211 -1.852 . . . . 0.0 113.628 -170.996 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -82.11 174.79 9.75 Favored 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 123.309 2.673 . . . . 0.0 113.624 169.283 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.94 158.89 27.92 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.431 1.093 . . . . 0.0 111.958 168.351 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.253 10.5 m -135.98 153.73 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -169.74 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -62.3 158.69 45.54 Favored Pre-proline 0 CA--C 1.587 2.366 0 CA-C-O 114.613 -2.613 . . . . 0.0 115.823 179.216 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.82 108.95 2.4 Favored 'Trans proline' 0 C--N 1.398 3.134 0 CA-C-N 126.105 3.216 . . . . 0.0 109.783 168.764 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.3 t -75.14 121.93 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 174.5 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 p -132.08 105.52 7.44 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 -174.672 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.267 2.6 tt -67.74 161.91 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.828 0 CA-C-N 111.65 -2.523 . . . . 0.0 114.446 -178.753 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -143.44 100.69 3.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 124.664 2.173 . . . . 0.0 106.49 167.852 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.7 m -94.89 91.95 6.67 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 110.792 -2.913 . . . . 0.0 104.128 173.571 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 N--CA 1.493 1.721 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.53 -165.161 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -142.24 132.59 24.99 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.346 1.059 . . . . 0.0 109.17 -179.774 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -83.13 135.2 34.9 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 117.343 -1.313 . . . . 0.0 111.211 -178.551 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -120.58 96.89 5.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 102.368 -3.197 . . . . 0.0 102.368 167.918 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.26 122.76 46.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.038 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -107.0 131.35 54.16 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 125.73 1.894 . . . . 0.0 107.068 -168.559 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.93 96.33 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.17 0 N-CA-C 100.521 -3.881 . . . . 0.0 100.521 -168.435 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.6 p -78.28 -19.06 54.42 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 169.789 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -99.54 141.31 32.5 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 120.401 1.455 . . . . 0.0 111.297 -169.614 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 m -105.94 101.64 11.13 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 101.004 -3.702 . . . . 0.0 101.004 166.762 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -94.36 110.32 22.1 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 -176.248 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.03 121.34 29.52 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -168.342 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.61 171.8 42.85 Favored Glycine 1 CA--C 1.581 4.175 0 CA-C-O 115.16 -3.022 . . . . 0.0 116.45 -177.549 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.21 160.39 23.29 Favored 'Trans proline' 0 C--N 1.396 3.031 1 CA-C-N 125.767 4.784 . . . . 0.0 114.064 -175.565 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.78 95.46 0.62 Allowed Glycine 0 N--CA 1.486 1.986 0 CA-C-O 117.603 -1.665 . . . . 0.0 110.863 -179.503 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.257 4.7 p -105.2 90.75 4.01 Favored Pre-proline 0 CA--C 1.583 2.248 0 CA-C-O 116.474 -1.727 . . . . 0.0 113.432 -167.645 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -83.73 178.6 5.39 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 123.409 2.74 . . . . 0.0 113.721 171.847 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 p -69.33 146.98 51.73 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.89 1.276 . . . . 0.0 111.871 168.911 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.31 30.8 m -138.94 168.56 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.112 0 CA-C-O 121.455 0.645 . . . . 0.0 111.607 -179.335 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.08 161.98 3.29 Favored Pre-proline 0 CA--C 1.58 2.1 0 N-CA-C 118.863 2.912 . . . . 0.0 118.863 -170.146 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.32 114.88 4.09 Favored 'Trans proline' 0 C--N 1.396 3.031 0 C-N-CA 123.111 2.541 . . . . 0.0 110.227 169.886 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.9 t -78.36 112.58 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 176.275 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.7 p -117.07 101.93 8.89 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -172.732 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.47 163.74 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 CA-C-N 111.023 -2.808 . . . . 0.0 113.934 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -140.18 105.53 5.06 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 166.968 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.13 97.29 10.19 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 169.023 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.492 1.671 0 CA-C-N 113.71 -1.587 . . . . 0.0 111.424 -165.491 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -138.87 129.1 25.54 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.332 1.053 . . . . 0.0 108.929 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -86.13 133.15 33.89 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.665 179.829 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -116.69 100.12 7.6 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 100.888 -3.745 . . . . 0.0 100.888 168.865 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.77 123.15 49.64 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 177.69 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -107.51 133.23 52.29 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 125.303 1.627 . . . . 0.0 106.633 -169.213 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.485 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.6 mp -130.38 97.4 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.317 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -167.686 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -119.59 8.01 11.19 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 169.931 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -116.71 125.4 51.65 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -169.053 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 m -96.28 113.34 24.93 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -177.976 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.485 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.8 m-85 -103.16 115.76 31.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -179.493 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -132.5 120.91 22.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -168.686 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.6 -162.19 16.28 Favored Glycine 1 CA--C 1.581 4.157 0 CA-C-O 114.496 -3.391 . . . . 0.0 115.887 178.47 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -87.61 161.53 7.92 Favored 'Trans proline' 0 C--N 1.395 3.004 1 CA-C-N 126.617 5.209 . . . . 0.0 114.062 -178.084 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.33 117.84 1.41 Allowed Glycine 0 N--CA 1.48 1.598 0 CA-C-O 117.932 -1.482 . . . . 0.0 110.044 176.929 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.5 m -100.72 84.6 0.48 Allowed Pre-proline 0 CA--C 1.588 2.408 0 CA-C-O 116.979 -1.486 . . . . 0.0 112.957 -177.304 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.99 174.11 10.44 Favored 'Trans proline' 0 C--N 1.389 2.701 0 C-N-CA 123.17 2.58 . . . . 0.0 112.923 168.559 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.288 9.6 t -95.57 157.72 15.77 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 123.619 0.768 . . . . 0.0 109.406 167.886 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 m -125.93 159.43 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 124.306 1.042 . . . . 0.0 112.069 -166.445 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -73.58 -176.2 0.46 Allowed Pre-proline 0 CA--C 1.609 3.22 0 CA-C-O 115.096 -2.383 . . . . 0.0 113.843 -179.111 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -83.66 129.84 4.99 Favored 'Trans proline' 0 C--N 1.394 2.956 0 CA-C-N 126.685 3.423 . . . . 0.0 111.579 -178.482 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.8 t -76.53 134.52 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 174.901 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.5 p -142.73 108.07 5.02 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 -176.799 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.272 1.8 tt -70.8 161.64 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 C-N-CA 127.248 2.219 . . . . 0.0 112.711 -179.049 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -141.79 121.21 13.2 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 102.348 -3.204 . . . . 0.0 102.348 169.409 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.8 t -97.0 116.04 28.51 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 111.601 -2.545 . . . . 0.0 107.208 169.497 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.267 -0.873 . . . . 0.0 108.828 -169.367 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.28 124.61 19.14 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.164 0.986 . . . . 0.0 108.779 178.863 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -85.55 127.9 34.58 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 124.395 1.059 . . . . 0.0 110.252 -179.071 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.252 9.1 tt0 -109.9 97.68 7.15 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 169.127 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.67 122.08 45.98 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 177.545 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 m -108.17 130.46 55.13 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -169.248 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.5 HD13 ' CD1' ' A' ' 12' ' ' PHE . 2.6 mp -127.67 96.81 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.336 0 N-CA-C 100.291 -3.966 . . . . 0.0 100.291 -167.602 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.2 m -121.71 3.83 10.07 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 170.197 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -111.86 124.35 52.17 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -168.884 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -96.25 113.61 25.22 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -176.471 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.5 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.0 m-85 -103.72 114.38 28.6 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 -179.544 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -131.25 119.66 22.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 -169.029 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.58 -161.37 19.87 Favored Glycine 1 CA--C 1.58 4.101 0 CA-C-O 114.379 -3.456 . . . . 0.0 116.134 178.455 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -90.66 160.53 4.26 Favored 'Trans proline' 0 C--N 1.394 2.964 1 CA-C-N 126.768 5.284 . . . . 0.0 114.595 -178.477 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.17 113.62 0.73 Allowed Glycine 0 N--CA 1.481 1.681 0 CA-C-O 117.451 -1.749 . . . . 0.0 110.615 173.614 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.7 t -94.28 95.18 1.31 Allowed Pre-proline 0 CA--C 1.589 2.458 0 CA-C-O 116.132 -1.89 . . . . 0.0 113.471 -173.294 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -81.02 174.35 10.97 Favored 'Trans proline' 0 C--N 1.392 2.839 0 CA-C-N 124.559 2.664 . . . . 0.0 113.225 168.806 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -79.12 157.65 27.91 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.412 1.085 . . . . 0.0 111.508 168.403 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.262 16.5 m -135.07 152.58 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 C-N-CA 123.118 0.567 . . . . 0.0 111.559 -177.905 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 167.56 34.62 Favored Pre-proline 0 CA--C 1.588 2.411 0 CA-C-O 115.006 -2.426 . . . . 0.0 114.032 179.331 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.3 129.19 16.62 Favored 'Trans proline' 0 C--N 1.4 3.237 0 CA-C-N 126.883 3.494 . . . . 0.0 111.572 177.861 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.3 t -78.93 125.86 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 171.993 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -139.77 111.29 7.18 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 123.682 1.706 . . . . 0.0 107.722 177.763 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.255 1.8 tt -70.76 158.98 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 CA-C-N 109.26 -3.609 . . . . 0.0 113.632 -172.441 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -139.78 103.93 4.78 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 167.905 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.7 m -97.57 98.48 9.94 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 109.879 -3.328 . . . . 0.0 105.01 175.307 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.493 1.715 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.282 -167.418 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.6 t . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -135.91 140.95 44.45 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 124.272 1.029 . . . . 0.0 110.191 179.049 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -86.37 136.92 32.94 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.645 0.778 . . . . 0.0 110.226 174.173 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.253 4.3 tt0 -123.55 100.31 6.74 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 101.352 -3.573 . . . . 0.0 101.352 170.099 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.15 124.41 51.42 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 179.127 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -106.51 132.07 52.94 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 125.406 1.691 . . . . 0.0 107.465 -168.536 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp -136.47 94.95 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.583 2.224 0 N-CA-C 100.761 -3.792 . . . . 0.0 100.761 -168.325 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.7 p -78.16 -17.31 56.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 169.76 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -101.31 140.65 35.31 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 120.342 1.428 . . . . 0.0 110.985 -169.612 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m -105.03 102.95 12.42 Favored 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 100.939 -3.726 . . . . 0.0 100.939 166.137 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -92.47 116.57 29.1 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 -179.38 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -132.39 119.42 20.66 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -168.186 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.89 -169.37 25.13 Favored Glycine 1 CA--C 1.582 4.26 0 CA-C-O 114.482 -3.399 . . . . 0.0 115.585 179.04 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -86.83 160.96 9.03 Favored 'Trans proline' 0 C--N 1.394 2.957 1 CA-C-N 126.898 5.349 . . . . 0.0 114.186 -176.27 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.33 117.71 1.4 Allowed Glycine 0 N--CA 1.479 1.552 0 CA-C-O 117.83 -1.539 . . . . 0.0 110.084 177.68 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.8 m -100.65 83.93 0.43 Allowed Pre-proline 0 CA--C 1.589 2.48 0 CA-C-O 117.275 -1.345 . . . . 0.0 113.717 -177.623 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.31 171.53 10.03 Favored 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 123.123 2.548 . . . . 0.0 113.117 168.157 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.282 9.5 t -93.98 149.43 21.24 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.669 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.62 156.66 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.644 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.788 -165.616 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -7.69 145.01 0.0 OUTLIER Pre-proline 0 CA--C 1.585 2.296 0 N-CA-C 120.752 3.612 . . . . 0.0 120.752 169.405 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.92 115.37 4.27 Favored 'Trans proline' 0 C--N 1.395 3.02 0 CA-C-N 126.571 3.382 . . . . 0.0 109.464 168.533 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -77.25 122.27 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 174.508 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.8 p -127.23 107.31 9.89 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 -178.498 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 1.3 tt -65.1 162.69 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 C-N-CA 127.456 2.302 . . . . 0.0 113.349 177.806 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -139.18 118.56 12.83 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 102.918 -2.993 . . . . 0.0 102.918 169.805 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 14.3 t -100.79 128.97 46.62 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.001 -2.818 . . . . 0.0 107.474 168.422 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.283 14.8 pt-20 . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -168.729 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -136.17 137.49 40.98 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 124.183 0.993 . . . . 0.0 110.422 -179.364 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -92.75 135.21 34.31 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.189 0.93 . . . . 0.0 110.215 -178.08 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -115.83 99.82 7.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 100.87 -3.752 . . . . 0.0 100.87 169.318 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.43 122.65 46.44 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -179.922 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.44 134.53 50.35 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 125.652 1.845 . . . . 0.0 106.485 -169.132 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.426 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mp -131.35 98.52 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.301 0 N-CA-C 101.136 -3.653 . . . . 0.0 101.136 -167.842 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 t -117.81 9.64 13.01 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 169.861 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -119.21 126.5 51.69 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -168.904 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m -97.1 113.45 25.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 -179.293 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.426 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.6 m-85 -103.43 116.07 31.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -179.657 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -133.22 122.73 24.39 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -168.622 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.86 -178.17 40.73 Favored Glycine 1 CA--C 1.58 4.149 0 CA-C-O 114.977 -3.124 . . . . 0.0 116.529 -179.632 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -84.28 158.75 13.03 Favored 'Trans proline' 0 C--N 1.395 3.005 1 CA-C-N 125.929 4.865 . . . . 0.0 113.798 -177.418 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.18 107.33 0.42 Allowed Glycine 0 N--CA 1.483 1.789 0 CA-C-O 116.902 -2.054 . . . . 0.0 110.828 177.071 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.3 m -90.54 98.82 1.65 Allowed Pre-proline 0 CA--C 1.587 2.381 0 CA-C-O 116.121 -1.895 . . . . 0.0 112.4 -169.645 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.79 170.14 18.54 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 123.43 2.754 . . . . 0.0 113.688 169.911 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.16 149.24 29.2 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.078 0.951 . . . . 0.0 111.083 169.388 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.5 m -104.06 147.11 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 124.049 0.939 . . . . 0.0 112.241 -168.064 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.64 163.03 51.18 Favored Pre-proline 0 CA--C 1.588 2.417 0 CA-C-O 115.159 -2.353 . . . . 0.0 112.205 168.95 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.62 140.24 35.61 Favored 'Trans proline' 0 C--N 1.396 3.058 0 CA-C-N 126.948 3.517 . . . . 0.0 113.678 -169.571 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.8 t -143.41 129.21 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 N-CA-C 101.164 -3.643 . . . . 0.0 101.164 -176.542 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.6 p -129.96 105.12 7.76 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -177.442 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 tt -72.15 161.79 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 112.25 -2.25 . . . . 0.0 113.861 -177.851 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -142.46 104.48 4.41 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 165.835 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.1 t -95.97 108.82 21.25 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 111.58 -2.554 . . . . 0.0 105.923 171.365 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 124.619 1.199 . . . . 0.0 110.598 -167.609 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -139.11 128.29 23.96 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.331 1.053 . . . . 0.0 108.966 179.698 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -87.52 133.8 33.71 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.964 0.79 . . . . 0.0 110.177 179.785 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.98 102.02 8.72 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 101.325 -3.583 . . . . 0.0 101.325 168.257 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.493 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -112.21 121.22 44.31 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 178.036 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -107.17 130.91 54.65 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 125.128 1.517 . . . . 0.0 107.037 -168.767 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.4 mp -135.76 95.65 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.176 0 N-CA-C 100.743 -3.799 . . . . 0.0 100.743 -167.928 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.1 t -79.23 -16.71 56.08 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 170.069 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -99.73 139.57 35.2 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 120.737 1.608 . . . . 0.0 110.971 -169.571 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.2 m -106.11 102.35 11.78 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 100.962 -3.718 . . . . 0.0 100.962 166.483 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -93.27 116.67 29.23 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 -179.559 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -132.82 121.94 23.71 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -167.838 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.4 -162.57 19.47 Favored Glycine 1 CA--C 1.58 4.108 0 CA-C-O 114.675 -3.291 . . . . 0.0 115.822 178.009 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -86.22 161.92 9.94 Favored 'Trans proline' 0 C--N 1.394 2.93 1 CA-C-N 126.354 5.077 . . . . 0.0 113.868 -177.832 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.61 117.22 1.22 Allowed Glycine 0 N--CA 1.479 1.52 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.295 174.292 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -101.7 84.58 0.56 Allowed Pre-proline 0 CA--C 1.588 2.416 0 CA-C-O 116.913 -1.518 . . . . 0.0 111.621 -179.169 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.18 174.03 7.43 Favored 'Trans proline' 0 C--N 1.39 2.733 0 C-N-CA 123.253 2.635 . . . . 0.0 114.116 171.2 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 p -77.95 147.11 35.11 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.484 1.113 . . . . 0.0 110.056 167.223 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 30.1 m -139.64 151.66 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 123.526 0.516 . . . . 0.0 112.07 -174.2 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -14.46 146.18 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.272 0 CA-C-O 112.685 -3.531 . . . . 0.0 119.939 169.904 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.14 116.8 4.46 Favored 'Trans proline' 0 C--N 1.394 2.969 0 CA-C-N 126.624 3.401 . . . . 0.0 109.473 168.413 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t -76.87 117.5 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 175.428 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 p -121.85 105.35 10.28 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 -175.756 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.27 1.5 tt -68.11 163.75 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 CA-C-N 111.774 -2.466 . . . . 0.0 113.202 -179.797 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -139.75 118.04 12.03 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 168.697 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.2 t -97.6 114.52 26.46 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 111.416 -2.629 . . . . 0.0 106.776 169.499 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.493 1.72 0 C-N-CA 123.825 0.85 . . . . 0.0 109.052 -169.039 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -139.81 127.45 21.74 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.31 1.044 . . . . 0.0 108.766 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -85.66 130.15 34.64 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.733 0.813 . . . . 0.0 110.259 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.269 7.2 tt0 -114.39 98.28 6.82 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 101.152 -3.647 . . . . 0.0 101.152 169.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.11 120.97 43.63 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -106.95 135.38 48.6 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 125.54 1.775 . . . . 0.0 106.588 -169.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mp . . . . . 0 CA--C 1.584 2.278 0 N-CA-C 101.382 -3.562 . . . . 0.0 101.382 -167.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -116.45 125.71 52.38 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -168.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.09 115.96 28.44 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.424 ' CD1' HD13 ' A' ' 7' ' ' ILE . 91.3 m-85 -105.22 112.94 26.25 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -127.33 119.07 25.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 -169.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.37 -163.12 16.7 Favored Glycine 1 CA--C 1.58 4.119 0 CA-C-O 114.475 -3.403 . . . . 0.0 115.999 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -87.45 161.53 8.14 Favored 'Trans proline' 0 C--N 1.394 2.969 1 CA-C-N 126.679 5.239 . . . . 0.0 114.076 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.53 118.48 1.51 Allowed Glycine 0 N--CA 1.48 1.575 0 CA-C-O 118.021 -1.433 . . . . 0.0 110.018 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.0 m -100.74 84.46 0.47 Allowed Pre-proline 0 CA--C 1.588 2.421 0 CA-C-O 117.001 -1.476 . . . . 0.0 112.965 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -81.92 176.66 8.09 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 123.231 2.621 . . . . 0.0 112.725 168.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.29 10.0 t -98.96 157.54 16.25 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 123.791 0.836 . . . . 0.0 109.568 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 m -123.81 159.69 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 C-N-CA 124.487 1.115 . . . . 0.0 111.981 -166.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 164.2 58.8 Favored Pre-proline 0 CA--C 1.584 2.278 0 CA-C-O 115.252 -2.309 . . . . 0.0 114.686 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 C--N 1.399 3.23 0 CA-C-N 126.239 3.264 . . . . 0.0 112.945 179.576 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.8 t . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -142.58 108.31 5.12 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.263 1.3 tt -71.62 160.37 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.843 0 C-N-CA 126.972 2.109 . . . . 0.0 112.75 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -141.82 120.0 12.18 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 102.21 -3.256 . . . . 0.0 102.21 169.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.1 t -97.28 115.09 27.01 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.103 169.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 124.084 0.865 . . . . 0.0 109.126 -169.311 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -146.45 127.98 15.07 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -87.56 125.95 34.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.805 0.842 . . . . 0.0 109.804 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.271 8.3 tt0 -110.37 96.9 6.5 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 101.34 -3.578 . . . . 0.0 101.34 168.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.96 120.5 42.6 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.16 135.72 48.22 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 125.514 1.759 . . . . 0.0 106.615 -169.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mp . . . . . 0 CA--C 1.584 2.276 0 N-CA-C 101.372 -3.566 . . . . 0.0 101.372 -167.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -114.87 125.42 53.64 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.27 116.25 29.14 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.421 ' CD1' HD13 ' A' ' 7' ' ' ILE . 93.0 m-85 -105.78 112.94 26.21 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -127.36 120.67 29.05 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -169.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.75 -158.6 12.9 Favored Glycine 1 CA--C 1.579 4.04 0 CA-C-O 114.368 -3.462 . . . . 0.0 116.132 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -88.42 161.2 6.74 Favored 'Trans proline' 0 C--N 1.395 2.989 1 CA-C-N 126.571 5.186 . . . . 0.0 114.212 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.02 118.39 1.39 Allowed Glycine 0 N--CA 1.479 1.559 0 CA-C-O 117.981 -1.455 . . . . 0.0 110.197 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.9 m -100.69 85.71 0.59 Allowed Pre-proline 0 CA--C 1.588 2.417 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.456 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -82.4 175.45 8.94 Favored 'Trans proline' 0 C--N 1.391 2.81 0 C-N-CA 123.444 2.763 . . . . 0.0 113.739 170.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -75.71 158.13 32.7 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.727 1.211 . . . . 0.0 112.018 168.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 13.3 m -135.46 152.87 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.185 0.594 . . . . 0.0 111.609 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 167.79 32.1 Favored Pre-proline 0 CA--C 1.586 2.341 0 CA-C-O 114.998 -2.43 . . . . 0.0 113.939 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.4 3.263 0 CA-C-N 126.961 3.522 . . . . 0.0 111.349 178.88 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.501 2.077 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -140.69 109.64 6.08 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 123.3 1.524 . . . . 0.0 107.827 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.273 1.1 tt -70.54 163.4 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 109.686 -3.416 . . . . 0.0 113.192 -173.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -141.43 115.21 9.09 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 168.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.8 t -94.67 116.51 28.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 111.582 -2.553 . . . . 0.0 107.242 170.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 N--CA 1.494 1.729 0 C-N-CA 123.988 0.915 . . . . 0.0 109.774 -168.517 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -140.04 125.23 18.74 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.292 1.037 . . . . 0.0 108.58 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.35 126.08 34.09 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 124.12 0.888 . . . . 0.0 110.11 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.266 9.0 tt0 -110.76 98.91 7.94 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 100.932 -3.729 . . . . 0.0 100.932 168.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.85 107.99 16.47 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 103.763 -2.681 . . . . 0.0 103.763 -176.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -97.25 126.72 42.64 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 125.466 1.729 . . . . 0.0 106.856 -167.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mm . . . . . 0 CA--C 1.577 2.006 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 -167.137 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.2 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -94.38 127.17 40.1 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.353 1.061 . . . . 0.0 108.59 -169.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -100.8 111.28 23.47 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -103.54 119.11 38.24 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -135.62 119.19 17.0 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -170.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.04 -158.11 13.4 Favored Glycine 1 CA--C 1.579 4.048 0 CA-C-O 114.401 -3.444 . . . . 0.0 115.713 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -87.14 161.92 8.6 Favored 'Trans proline' 0 C--N 1.393 2.901 1 CA-C-N 126.597 5.198 . . . . 0.0 114.016 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.87 116.08 1.4 Allowed Glycine 0 N--CA 1.48 1.568 0 CA-C-O 118.106 -1.385 . . . . 0.0 110.381 174.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.4 m -101.46 85.78 0.68 Allowed Pre-proline 0 CA--C 1.587 2.371 0 CA-C-O 116.697 -1.62 . . . . 0.0 111.102 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -82.37 173.01 11.06 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 123.252 2.635 . . . . 0.0 113.771 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -75.61 154.78 36.45 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.575 1.15 . . . . 0.0 111.948 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.272 18.0 m -137.17 154.0 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 O-C-N 123.5 0.5 . . . . 0.0 111.856 -173.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 168.08 30.83 Favored Pre-proline 0 CA--C 1.588 2.423 0 CA-C-O 114.91 -2.471 . . . . 0.0 114.187 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 C--N 1.399 3.236 0 CA-C-N 126.982 3.529 . . . . 0.0 111.84 177.388 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.1 t . . . . . 0 N--CA 1.503 2.187 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.8 p -136.26 109.17 7.61 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 102.42 -3.178 . . . . 0.0 102.42 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.259 0.8 OUTLIER -68.79 162.33 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.858 0 C-N-CA 126.745 2.018 . . . . 0.0 113.488 -174.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -138.07 113.85 9.8 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 167.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.8 t -97.96 111.48 23.77 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.139 170.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 124.231 0.957 . . . . 0.0 109.572 -168.605 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.04 129.11 25.21 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.338 1.055 . . . . 0.0 108.92 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -85.84 131.38 34.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.654 0.782 . . . . 0.0 110.45 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.269 7.1 tt0 -116.19 98.33 6.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 100.928 -3.73 . . . . 0.0 100.928 169.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.16 121.28 44.5 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.19 135.16 49.2 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 125.511 1.757 . . . . 0.0 106.681 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.411 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.7 mp . . . . . 0 CA--C 1.585 2.312 0 N-CA-C 101.461 -3.533 . . . . 0.0 101.461 -167.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -116.77 125.54 51.78 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -168.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -97.05 115.67 27.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.411 ' CD1' HD13 ' A' ' 7' ' ' ILE . 90.2 m-85 -104.84 112.86 26.13 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -127.31 118.8 24.9 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -169.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.19 -165.11 19.76 Favored Glycine 1 CA--C 1.58 4.126 0 CA-C-O 114.482 -3.399 . . . . 0.0 115.911 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -86.57 161.48 9.42 Favored 'Trans proline' 0 C--N 1.394 2.927 1 CA-C-N 126.697 5.248 . . . . 0.0 113.928 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 117.91 1.46 Allowed Glycine 0 N--CA 1.479 1.511 0 CA-C-O 117.964 -1.464 . . . . 0.0 110.057 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.8 m -100.65 84.51 0.47 Allowed Pre-proline 0 CA--C 1.587 2.389 0 CA-C-O 117.038 -1.458 . . . . 0.0 112.909 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -82.21 173.78 10.54 Favored 'Trans proline' 0 C--N 1.389 2.684 0 C-N-CA 123.16 2.573 . . . . 0.0 112.898 168.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.288 9.0 t -95.43 157.27 15.97 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 123.547 0.739 . . . . 0.0 109.288 167.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.6 m -125.68 158.55 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 124.19 0.996 . . . . 0.0 112.363 -166.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -67.76 -176.24 0.26 Allowed Pre-proline 0 CA--C 1.599 2.844 0 N-CA-C 117.662 2.468 . . . . 0.0 117.662 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 C--N 1.399 3.235 0 C-N-CA 123.866 3.044 . . . . 0.0 110.816 172.74 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -143.34 108.45 4.98 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.268 1.3 tt -71.32 161.9 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 C-N-CA 127.12 2.168 . . . . 0.0 112.82 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -141.84 122.01 13.84 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 102.21 -3.255 . . . . 0.0 102.21 168.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.8 t -97.56 115.1 27.21 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 111.813 -2.449 . . . . 0.0 107.138 169.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.246 -0.883 . . . . 0.0 108.641 -169.36 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -142.15 124.66 15.76 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.3 1.04 . . . . 0.0 108.521 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -85.14 130.94 34.51 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 117.818 -1.087 . . . . 0.0 110.672 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.276 4.9 tt0 -114.52 95.18 5.13 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 171.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.79 122.38 47.68 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -106.97 135.0 49.28 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 125.575 1.797 . . . . 0.0 106.655 -169.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.51 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.6 mp . . . . . 0 CA--C 1.586 2.352 0 N-CA-C 100.722 -3.807 . . . . 0.0 100.722 -167.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -116.6 125.37 51.73 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -168.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -96.98 116.91 30.04 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.51 ' CD1' HD13 ' A' ' 7' ' ' ILE . 83.9 m-85 -104.67 112.35 25.4 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -127.6 120.75 28.83 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -169.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.51 -163.58 24.79 Favored Glycine 1 CA--C 1.58 4.115 0 CA-C-O 114.521 -3.377 . . . . 0.0 116.29 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -89.98 160.86 4.94 Favored 'Trans proline' 0 C--N 1.395 2.98 1 CA-C-N 126.43 5.115 . . . . 0.0 114.455 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.14 110.44 0.69 Allowed Glycine 0 N--CA 1.483 1.797 0 CA-C-O 117.46 -1.745 . . . . 0.0 110.495 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.3 m -97.98 94.99 2.43 Favored Pre-proline 0 CA--C 1.588 2.427 0 CA-C-O 116.224 -1.846 . . . . 0.0 112.972 -169.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.29 175.65 9.49 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 123.327 2.684 . . . . 0.0 113.581 169.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -76.95 160.06 29.47 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.658 1.183 . . . . 0.0 112.128 168.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.5 m -135.49 151.5 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 123.264 0.625 . . . . 0.0 111.806 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.14 166.65 38.89 Favored Pre-proline 0 CA--C 1.586 2.361 0 CA-C-O 115.094 -2.384 . . . . 0.0 113.678 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 C--N 1.399 3.187 0 CA-C-N 126.82 3.471 . . . . 0.0 111.647 178.794 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.4 t . . . . . 0 N--CA 1.502 2.132 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.1 p -130.2 105.99 8.29 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.263 1.9 tt -67.69 162.6 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 CA-C-N 111.95 -2.386 . . . . 0.0 114.357 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -143.21 102.31 3.96 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 168.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.3 t -89.55 93.82 9.63 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 112.204 -2.271 . . . . 0.0 105.412 169.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.108 -165.544 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 CA--C 1.544 0.75 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -143.77 124.88 14.47 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -88.06 135.8 33.26 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 124.127 0.892 . . . . 0.0 110.498 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -117.99 98.87 6.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 101.076 -3.675 . . . . 0.0 101.076 170.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.53 124.05 51.48 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 m -107.91 133.32 52.43 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -169.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.437 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.9 mp . . . . . 0 CA--C 1.586 2.328 0 N-CA-C 100.925 -3.731 . . . . 0.0 100.925 -167.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -117.69 125.67 51.1 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -169.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -96.71 113.07 24.6 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.437 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.8 m-85 -102.84 117.5 34.76 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -134.93 120.95 19.85 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -168.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.41 -171.88 36.25 Favored Glycine 1 CA--C 1.581 4.159 0 CA-C-O 114.721 -3.266 . . . . 0.0 116.279 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -88.73 158.45 6.24 Favored 'Trans proline' 0 C--N 1.396 3.027 1 CA-C-N 126.364 5.082 . . . . 0.0 114.295 -177.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.76 106.58 0.63 Allowed Glycine 0 N--CA 1.484 1.873 0 CA-C-O 117.196 -1.891 . . . . 0.0 110.579 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.8 m -93.48 98.49 2.58 Favored Pre-proline 0 CA--C 1.588 2.438 0 CA-C-O 116.168 -1.872 . . . . 0.0 113.008 -169.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.01 173.44 12.71 Favored 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 123.401 2.734 . . . . 0.0 113.673 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.94 159.24 31.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.483 1.113 . . . . 0.0 112.371 168.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 11.0 m -133.98 152.84 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 CA-C-O 121.422 0.63 . . . . 0.0 112.695 -169.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.24 165.47 27.96 Favored Pre-proline 0 CA--C 1.581 2.15 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--N 1.396 3.034 0 C-N-CA 123.148 2.565 . . . . 0.0 110.033 169.658 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.6 t . . . . . 0 N--CA 1.504 2.264 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.8 p -132.26 106.19 7.78 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.5 tt -69.33 160.78 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.835 0 CA-C-N 111.904 -2.407 . . . . 0.0 114.023 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -139.31 102.94 4.61 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 167.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 t -98.66 113.67 25.83 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 110.87 -2.877 . . . . 0.0 105.816 170.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.297 10.2 pt-20 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -167.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.8 127.41 21.7 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.345 1.058 . . . . 0.0 108.835 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -87.42 128.41 35.21 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 124.037 0.836 . . . . 0.0 110.096 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.25 8.2 tt0 -112.34 98.38 7.25 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 100.734 -3.802 . . . . 0.0 100.734 168.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.56 120.15 41.48 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -106.98 134.74 49.67 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 125.409 1.693 . . . . 0.0 106.523 -168.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.414 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.6 mp . . . . . 0 CA--C 1.585 2.294 0 N-CA-C 101.442 -3.54 . . . . 0.0 101.442 -167.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -114.75 125.09 53.3 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -168.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.23 113.4 25.0 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.414 ' CD1' HD13 ' A' ' 7' ' ' ILE . 93.2 m-85 -103.81 115.03 29.72 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -131.17 120.23 23.01 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -168.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.5 -158.52 12.61 Favored Glycine 1 CA--C 1.579 4.049 0 CA-C-O 114.361 -3.466 . . . . 0.0 115.836 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -89.04 161.37 5.87 Favored 'Trans proline' 0 C--N 1.394 2.955 1 CA-C-N 126.719 5.259 . . . . 0.0 114.294 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.15 117.19 1.33 Allowed Glycine 0 N--CA 1.479 1.563 0 CA-C-O 117.965 -1.464 . . . . 0.0 110.277 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.4 m -100.96 85.82 0.62 Allowed Pre-proline 0 CA--C 1.588 2.412 0 CA-C-O 116.697 -1.62 . . . . 0.0 111.589 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -82.86 176.13 7.97 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.378 2.719 . . . . 0.0 113.73 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -74.63 158.01 34.39 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.72 1.208 . . . . 0.0 111.941 168.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.258 15.4 m -135.62 156.08 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 C-N-CA 122.93 0.492 . . . . 0.0 112.212 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -76.95 -179.29 1.17 Allowed Pre-proline 0 CA--C 1.593 2.598 0 CA-C-O 115.543 -2.17 . . . . 0.0 115.79 -170.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 C--N 1.404 3.469 0 C-N-CA 123.902 3.068 . . . . 0.0 110.251 170.692 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.502 2.126 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.9 p -141.41 108.81 5.55 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.274 1.2 tt -69.98 164.37 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 127.046 2.138 . . . . 0.0 113.256 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -140.83 114.89 9.15 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 101.734 -3.432 . . . . 0.0 101.734 167.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.5 t -97.44 111.84 23.93 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 111.579 -2.555 . . . . 0.0 106.292 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 N--CA 1.494 1.756 0 O-C-N 124.184 0.927 . . . . 0.0 109.172 -168.709 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -148.04 124.34 10.89 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -87.06 124.61 33.41 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.933 0.893 . . . . 0.0 109.773 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.258 8.9 tt0 -109.28 97.04 6.71 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 101.382 -3.562 . . . . 0.0 101.382 168.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.465 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.9 120.79 43.28 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 178.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -107.94 131.31 54.67 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 -169.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.489 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.2 mp . . . . . 0 CA--C 1.586 2.331 0 N-CA-C 100.463 -3.903 . . . . 0.0 100.463 -167.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -113.15 124.75 53.28 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -168.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.0 m -96.78 113.8 25.38 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -176.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.489 ' CD1' HD13 ' A' ' 7' ' ' ILE . 87.1 m-85 -104.09 115.2 30.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -131.19 120.98 24.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -168.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.51 -156.93 11.28 Favored Glycine 1 CA--C 1.58 4.143 0 CA-C-O 114.229 -3.54 . . . . 0.0 115.911 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.22 161.09 4.7 Favored 'Trans proline' 0 C--N 1.395 2.992 1 CA-C-N 126.799 5.299 . . . . 0.0 114.534 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.72 119.35 1.62 Allowed Glycine 0 N--CA 1.479 1.507 0 CA-C-O 118.034 -1.426 . . . . 0.0 110.33 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.2 t -98.1 87.49 0.55 Allowed Pre-proline 0 CA--C 1.591 2.524 0 CA-C-O 116.503 -1.713 . . . . 0.0 112.325 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.71 175.62 9.24 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 123.414 2.742 . . . . 0.0 113.426 169.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 p -77.62 158.24 29.87 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.638 1.175 . . . . 0.0 111.828 168.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.259 15.7 m -136.9 156.09 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 122.999 0.52 . . . . 0.0 112.23 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -76.89 -179.31 1.17 Allowed Pre-proline 0 CA--C 1.593 2.608 0 CA-C-O 115.631 -2.128 . . . . 0.0 115.742 -171.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo . . . . . 0 C--N 1.405 3.504 0 C-N-CA 123.97 3.114 . . . . 0.0 110.365 171.191 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 N--CA 1.503 2.187 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -140.87 108.89 5.72 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.265 1.3 tt -69.84 160.89 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.836 0 C-N-CA 127.036 2.134 . . . . 0.0 113.353 -177.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -139.22 109.25 6.38 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 168.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.8 m -98.11 106.91 19.27 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 110.229 -3.168 . . . . 0.0 104.679 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.736 0 C-N-CA 124.307 1.043 . . . . 0.0 111.033 -167.246 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -147.86 125.46 11.77 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -83.55 122.79 29.03 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 117.82 -1.086 . . . . 0.0 109.988 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.265 8.4 tt0 -109.25 95.94 5.96 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 102.123 -3.288 . . . . 0.0 102.123 170.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.529 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -109.73 120.77 43.51 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.47 130.82 54.8 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 125.423 1.702 . . . . 0.0 106.648 -169.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.529 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.3 mp . . . . . 0 CA--C 1.582 2.185 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -167.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.7 p . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -98.41 139.38 34.24 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 120.259 1.391 . . . . 0.0 111.155 -169.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.5 m -107.14 102.96 12.25 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 100.922 -3.733 . . . . 0.0 100.922 166.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -93.49 113.71 25.91 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -129.44 120.99 26.41 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -168.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.71 -160.81 18.88 Favored Glycine 1 CA--C 1.579 4.036 0 CA-C-O 114.522 -3.377 . . . . 0.0 116.022 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -86.74 163.37 9.17 Favored 'Trans proline' 0 C--N 1.393 2.911 1 CA-C-N 126.584 5.192 . . . . 0.0 114.023 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.18 119.87 1.79 Allowed Glycine 0 C--N 1.354 1.57 0 CA-C-O 118.01 -1.439 . . . . 0.0 110.019 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.6 t -97.86 87.87 0.57 Allowed Pre-proline 0 CA--C 1.591 2.526 0 CA-C-O 116.452 -1.737 . . . . 0.0 112.206 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -81.8 173.83 10.85 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.373 2.716 . . . . 0.0 113.504 169.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 p -79.44 158.78 27.25 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.578 1.151 . . . . 0.0 111.626 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.251 15.2 m -136.46 151.58 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.15 0.58 . . . . 0.0 111.492 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.67 166.71 40.66 Favored Pre-proline 0 CA--C 1.588 2.406 0 CA-C-O 114.949 -2.453 . . . . 0.0 114.043 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 C--N 1.4 3.275 0 CA-C-N 126.998 3.535 . . . . 0.0 111.627 -177.585 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -137.19 106.86 6.18 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.273 1.3 tt -69.24 165.55 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.955 0 CA-C-N 112.265 -2.243 . . . . 0.0 113.696 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -144.08 108.86 4.92 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 168.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 76.1 m -94.13 97.67 10.45 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 . . . . . 0 N--CA 1.491 1.615 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.808 -165.318 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -138.63 131.56 29.56 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.354 1.062 . . . . 0.0 109.058 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -85.74 136.24 33.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.644 0.778 . . . . 0.0 110.418 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.267 4.7 tt0 -120.97 98.9 6.21 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 169.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.6 122.79 47.59 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.25 135.67 48.37 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 125.671 1.857 . . . . 0.0 106.924 -169.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.431 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.6 mp . . . . . 0 CA--C 1.584 2.28 0 N-CA-C 101.271 -3.603 . . . . 0.0 101.271 -167.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -122.26 126.59 48.5 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -168.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -96.79 116.39 29.06 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.431 ' CD1' HD13 ' A' ' 7' ' ' ILE . 82.4 m-85 -105.06 113.57 27.25 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -128.58 122.49 31.14 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -169.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.05 -163.9 16.81 Favored Glycine 1 CA--C 1.58 4.151 0 CA-C-O 114.461 -3.41 . . . . 0.0 115.833 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -87.83 160.47 7.57 Favored 'Trans proline' 0 C--N 1.395 2.988 1 CA-C-N 126.709 5.254 . . . . 0.0 114.108 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.91 118.31 1.36 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-O 118.018 -1.435 . . . . 0.0 110.194 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -101.88 83.09 0.44 Allowed Pre-proline 0 CA--C 1.589 2.461 0 CA-C-O 117.239 -1.362 . . . . 0.0 113.263 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -84.92 172.83 8.53 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.105 2.537 . . . . 0.0 113.312 168.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.28 9.3 t -94.14 148.68 21.94 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 166.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.72 156.78 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 C-N-CA 123.343 0.657 . . . . 0.0 111.75 -165.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -8.24 145.09 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.272 0 N-CA-C 120.74 3.607 . . . . 0.0 120.74 169.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--N 1.396 3.051 0 CA-C-N 126.6 3.393 . . . . 0.0 109.557 168.599 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -125.39 106.31 9.72 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.269 1.3 tt -67.11 162.24 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 CA-C-N 112.087 -2.324 . . . . 0.0 113.322 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -140.59 124.09 16.93 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 102.264 -3.236 . . . . 0.0 102.264 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.4 t -97.43 116.08 28.96 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.776 -2.466 . . . . 0.0 107.477 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -169.485 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -147.61 125.55 12.01 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -85.63 126.93 34.3 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.89 0.876 . . . . 0.0 110.069 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.274 5.5 tt0 -111.4 97.13 6.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 101.484 -3.524 . . . . 0.0 101.484 169.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.444 ' CE2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -110.06 121.5 45.4 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 179.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -107.68 131.68 54.14 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -169.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.511 HD13 ' CD1' ' A' ' 12' ' ' PHE . 2.9 mp . . . . . 0 CA--C 1.587 2.38 0 N-CA-C 100.302 -3.962 . . . . 0.0 100.302 -167.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -114.75 125.11 53.33 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -168.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -96.72 117.2 30.52 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.511 ' CD1' HD13 ' A' ' 7' ' ' ILE . 82.5 m-85 -105.79 113.46 27.02 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -127.8 120.29 27.53 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -169.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.21 -160.1 13.91 Favored Glycine 1 CA--C 1.58 4.125 0 CA-C-O 114.349 -3.473 . . . . 0.0 116.321 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -88.68 161.32 6.37 Favored 'Trans proline' 0 C--N 1.395 2.987 1 CA-C-N 126.632 5.216 . . . . 0.0 114.276 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.62 119.8 1.65 Allowed Glycine 0 N--CA 1.48 1.603 0 CA-C-O 118.008 -1.44 . . . . 0.0 110.133 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.3 t -98.53 86.27 0.47 Allowed Pre-proline 0 CA--C 1.591 2.554 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.001 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -81.08 178.06 7.24 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.174 2.583 . . . . 0.0 112.117 166.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.299 11.2 t -103.94 158.16 16.6 Favored 'General case' 0 N--CA 1.504 2.275 0 C-N-CA 123.868 0.867 . . . . 0.0 109.818 168.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.2 m -125.91 160.05 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.56 0 C-N-CA 124.506 1.122 . . . . 0.0 111.982 -166.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 164.73 56.18 Favored Pre-proline 0 CA--C 1.585 2.304 0 CA-C-O 115.278 -2.296 . . . . 0.0 114.675 177.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--N 1.4 3.257 0 CA-C-N 126.218 3.256 . . . . 0.0 113.002 178.231 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 N--CA 1.501 2.099 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.4 p -142.8 108.96 5.23 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.264 1.4 tt -71.07 158.43 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 C-N-CA 127.033 2.133 . . . . 0.0 112.848 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -141.84 115.06 8.82 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 102.716 -3.068 . . . . 0.0 102.716 169.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 73.7 m -97.0 112.38 24.17 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 110.552 -3.022 . . . . 0.0 105.841 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.752 0 C-N-CA 124.18 0.992 . . . . 0.0 110.472 -167.853 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -139.5 128.11 23.11 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.348 1.059 . . . . 0.0 108.946 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -88.27 135.57 33.39 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 123.994 0.808 . . . . 0.0 110.471 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.266 4.2 tt0 -118.25 97.46 5.79 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 101.259 -3.608 . . . . 0.0 101.259 169.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.26 122.41 47.66 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.33 136.12 47.69 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 125.513 1.758 . . . . 0.0 106.818 -169.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.419 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.7 mp . . . . . 0 CA--C 1.585 2.314 0 N-CA-C 101.407 -3.553 . . . . 0.0 101.407 -167.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -118.19 125.84 51.0 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -168.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.8 m -97.14 116.78 29.97 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.419 ' CD1' HD13 ' A' ' 7' ' ' ILE . 87.9 m-85 -105.38 112.95 26.24 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -127.63 121.36 30.27 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -169.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.15 -156.79 11.48 Favored Glycine 1 CA--C 1.579 4.077 0 CA-C-O 114.309 -3.495 . . . . 0.0 115.989 177.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -91.02 160.73 3.91 Favored 'Trans proline' 0 C--N 1.395 3.016 1 CA-C-N 126.568 5.184 . . . . 0.0 114.628 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.66 115.49 0.97 Allowed Glycine 0 N--CA 1.481 1.634 0 CA-C-O 117.799 -1.556 . . . . 0.0 110.457 174.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.6 m -100.66 87.16 0.76 Allowed Pre-proline 0 CA--C 1.589 2.467 0 CA-C-O 116.676 -1.63 . . . . 0.0 111.663 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.61 173.94 10.08 Favored 'Trans proline' 0 C--N 1.391 2.781 0 C-N-CA 123.399 2.733 . . . . 0.0 113.887 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.71 156.17 38.19 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.536 1.134 . . . . 0.0 112.426 168.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.268 14.1 m -135.6 155.67 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.664 0.745 . . . . 0.0 112.813 -169.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -69.39 165.52 39.14 Favored Pre-proline 0 CA--C 1.58 2.112 0 CA-C-O 115.64 -2.124 . . . . 0.0 116.731 -171.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo . . . . . 0 C--N 1.396 3.039 0 C-N-CA 123.772 2.981 . . . . 0.0 109.858 168.994 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.502 2.172 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -139.11 108.88 6.26 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 123.794 1.759 . . . . 0.0 108.187 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.262 2.1 tt -70.11 162.91 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.826 0 CA-C-N 109.098 -3.683 . . . . 0.0 113.739 -174.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -140.83 111.0 6.63 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 167.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.2 t -96.1 112.41 24.15 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 111.615 -2.539 . . . . 0.0 106.338 172.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 124.207 0.942 . . . . 0.0 110.177 -168.361 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -142.76 125.45 15.92 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.296 1.038 . . . . 0.0 108.57 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -82.83 120.62 25.87 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 117.814 -1.089 . . . . 0.0 109.622 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.278 9.7 tt0 -106.53 95.92 6.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 102.249 -3.241 . . . . 0.0 102.249 169.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.452 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.49 118.77 37.59 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.73 131.76 54.09 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -169.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.452 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.1 mp . . . . . 0 CA--C 1.585 2.324 0 N-CA-C 100.919 -3.734 . . . . 0.0 100.919 -167.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -111.02 124.96 53.19 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -168.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -97.06 113.36 24.91 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.406 ' CD1' HD13 ' A' ' 7' ' ' ILE . 91.9 m-85 -104.25 114.36 28.54 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -130.09 120.07 24.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -168.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.0 -163.96 21.79 Favored Glycine 1 CA--C 1.579 4.083 0 CA-C-O 114.542 -3.365 . . . . 0.0 115.848 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -87.32 162.06 8.34 Favored 'Trans proline' 0 C--N 1.394 2.93 1 CA-C-N 126.668 5.234 . . . . 0.0 113.996 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.91 116.03 1.41 Allowed Glycine 0 N--CA 1.479 1.541 0 CA-C-O 118.07 -1.406 . . . . 0.0 110.228 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.0 m -103.63 84.16 0.74 Allowed Pre-proline 0 CA--C 1.587 2.395 0 CA-C-O 116.952 -1.499 . . . . 0.0 111.613 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -85.11 173.63 7.78 Favored 'Trans proline' 0 C--N 1.39 2.728 0 C-N-CA 123.247 2.632 . . . . 0.0 114.064 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 p -78.13 146.69 34.97 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.468 1.107 . . . . 0.0 110.216 167.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.259 30.9 m -139.47 152.65 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 O-C-N 123.6 0.562 . . . . 0.0 112.083 -172.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -17.3 146.61 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.263 0 CA-C-O 112.746 -3.502 . . . . 0.0 119.774 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 C--N 1.394 2.961 0 CA-C-N 126.667 3.417 . . . . 0.0 109.664 168.498 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.502 2.159 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.5 p -118.97 104.42 10.48 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.297 1.3 tt -66.79 165.7 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.857 0 CA-C-N 111.639 -2.528 . . . . 0.0 113.644 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -142.94 112.69 6.94 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 103.373 -2.825 . . . . 0.0 103.373 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.7 t -94.94 98.32 10.62 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 168.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 . . . . . 0 N--CA 1.493 1.705 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.241 -166.11 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -142.47 124.09 14.98 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.287 1.035 . . . . 0.0 108.286 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -83.49 121.66 27.49 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.822 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.293 9.9 tt0 -108.71 95.88 5.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 101.994 -3.335 . . . . 0.0 101.994 169.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.97 108.14 17.37 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -175.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -95.79 127.15 41.57 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 113.218 -1.81 . . . . 0.0 107.195 -167.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mm . . . . . 0 CA--C 1.58 2.108 0 N-CA-C 102.818 -3.03 . . . . 0.0 102.818 -167.491 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.24 139.92 30.0 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.494 1.117 . . . . 0.0 110.458 -170.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -111.18 110.56 21.12 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 102.788 -3.041 . . . . 0.0 102.788 169.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -99.04 115.55 29.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -128.13 122.16 31.31 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -173.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.68 -160.14 17.18 Favored Glycine 1 CA--C 1.578 4.012 0 CA-C-O 114.496 -3.391 . . . . 0.0 115.659 176.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -86.97 162.68 8.86 Favored 'Trans proline' 0 C--N 1.392 2.837 1 CA-C-N 126.602 5.201 . . . . 0.0 113.952 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.43 115.38 1.49 Allowed Glycine 0 N--CA 1.48 1.608 0 CA-C-O 117.943 -1.476 . . . . 0.0 110.238 174.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.9 m -102.11 85.79 0.77 Allowed Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 116.721 -1.609 . . . . 0.0 111.247 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.34 172.98 11.11 Favored 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 123.333 2.688 . . . . 0.0 113.804 171.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -76.58 155.1 33.86 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.582 1.153 . . . . 0.0 111.885 168.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.272 18.0 m -137.93 154.75 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 C-N-CA 122.968 0.507 . . . . 0.0 112.004 -174.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 168.49 27.55 Favored Pre-proline 0 CA--C 1.588 2.423 0 CA-C-O 114.945 -2.455 . . . . 0.0 114.246 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo . . . . . 0 C--N 1.399 3.22 0 CA-C-N 126.878 3.492 . . . . 0.0 111.726 176.139 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.504 2.246 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.0 p -136.59 108.88 7.29 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.28 0.8 OUTLIER -68.92 166.1 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.878 0 C-N-CA 126.782 2.033 . . . . 0.0 113.89 -173.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -140.2 110.71 6.72 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 102.717 -3.068 . . . . 0.0 102.717 168.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.6 t -96.09 98.82 10.65 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 N--CA 1.492 1.67 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.332 -165.998 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -146.25 128.3 15.57 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -87.39 126.07 34.65 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.733 0.813 . . . . 0.0 109.993 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.253 8.6 tt0 -110.44 97.84 7.19 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 101.026 -3.694 . . . . 0.0 101.026 168.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.8 120.14 41.4 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.543 -2.392 . . . . 0.0 104.543 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -107.03 134.87 49.53 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 125.46 1.725 . . . . 0.0 106.552 -169.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.425 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.4 mp . . . . . 0 CA--C 1.584 2.27 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 -167.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -111.0 125.23 53.51 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -168.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.24 113.42 25.03 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CD1' HD13 ' A' ' 7' ' ' ILE . 93.4 m-85 -103.74 114.82 29.36 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -130.85 120.44 23.68 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -168.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.08 -158.12 12.56 Favored Glycine 1 CA--C 1.579 4.067 0 CA-C-O 114.399 -3.445 . . . . 0.0 115.945 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -88.54 161.45 6.58 Favored 'Trans proline' 0 C--N 1.394 2.956 1 CA-C-N 126.61 5.205 . . . . 0.0 114.235 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.24 118.1 1.41 Allowed Glycine 0 N--CA 1.48 1.594 0 CA-C-O 117.96 -1.467 . . . . 0.0 110.162 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.4 m -100.81 85.73 0.6 Allowed Pre-proline 0 CA--C 1.587 2.396 0 CA-C-O 116.705 -1.617 . . . . 0.0 111.5 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.58 176.49 7.81 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 123.401 2.734 . . . . 0.0 113.66 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -75.38 158.74 32.3 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.717 1.207 . . . . 0.0 112.033 168.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.252 13.3 m -135.4 152.0 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 C-N-CA 123.15 0.58 . . . . 0.0 111.72 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 167.04 38.45 Favored Pre-proline 0 CA--C 1.586 2.357 0 CA-C-O 114.98 -2.438 . . . . 0.0 114.107 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 C--N 1.4 3.261 0 CA-C-N 126.968 3.524 . . . . 0.0 111.525 -177.816 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.2 p -138.98 108.46 6.16 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.275 1.2 tt -69.03 163.78 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.913 0 C-N-CA 126.885 2.074 . . . . 0.0 113.257 -177.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -141.25 115.19 9.15 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 101.753 -3.425 . . . . 0.0 101.753 168.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.6 t -94.98 116.67 28.98 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 111.6 -2.545 . . . . 0.0 107.174 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.727 0 C-N-CA 124.03 0.932 . . . . 0.0 109.815 -168.457 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -140.62 124.24 17.03 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.268 1.027 . . . . 0.0 108.534 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -85.14 124.15 31.47 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.049 0.939 . . . . 0.0 109.408 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.279 8.5 tt0 -109.44 95.95 5.96 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 101.825 -3.398 . . . . 0.0 101.825 169.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.528 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -108.83 120.45 42.54 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 m -107.3 131.56 54.08 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 125.128 1.517 . . . . 0.0 106.98 -168.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.528 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.3 mp . . . . . 0 CA--C 1.582 2.211 0 N-CA-C 100.87 -3.752 . . . . 0.0 100.87 -167.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 t . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -100.59 139.71 35.89 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 120.711 1.596 . . . . 0.0 110.99 -169.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 m -106.76 105.02 14.86 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 166.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -95.38 112.46 24.17 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -125.9 119.96 29.17 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -169.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.28 -164.62 21.06 Favored Glycine 1 CA--C 1.58 4.119 0 CA-C-O 114.495 -3.392 . . . . 0.0 116.055 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -87.14 161.44 8.59 Favored 'Trans proline' 0 C--N 1.394 2.958 1 CA-C-N 126.687 5.244 . . . . 0.0 113.998 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.48 118.34 1.48 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-O 118.078 -1.401 . . . . 0.0 110.242 174.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.7 t -99.32 86.09 0.51 Allowed Pre-proline 0 CA--C 1.588 2.416 0 CA-C-O 116.757 -1.592 . . . . 0.0 111.988 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -83.53 172.46 10.28 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 123.11 2.54 . . . . 0.0 113.458 169.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -80.3 146.29 31.69 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.244 1.017 . . . . 0.0 110.12 167.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.264 30.9 m -138.36 153.42 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 O-C-N 123.724 0.64 . . . . 0.0 112.031 -170.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -23.07 147.56 0.01 OUTLIER Pre-proline 0 CA--C 1.584 2.277 0 CA-C-O 112.937 -3.411 . . . . 0.0 119.378 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 C--N 1.394 2.945 0 CA-C-N 126.606 3.395 . . . . 0.0 109.647 168.676 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.1 t . . . . . 0 N--CA 1.501 2.116 0 N-CA-C 104.177 -2.527 . . . . 0.0 104.177 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.5 p -118.75 104.47 10.62 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 1.3 tt -68.7 159.87 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.791 0 CA-C-N 111.64 -2.527 . . . . 0.0 113.244 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.7 ttm105 -139.32 108.6 6.1 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 168.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.9 m -94.81 97.16 9.83 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 110.072 -3.24 . . . . 0.0 106.02 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 N--CA 1.495 1.776 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.768 -168.059 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -139.52 128.04 22.98 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.321 1.048 . . . . 0.0 108.898 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -85.89 141.46 29.56 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.49 0.716 . . . . 0.0 111.129 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.268 4.8 tt0 -123.01 96.23 4.93 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 101.017 -3.697 . . . . 0.0 101.017 167.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.76 121.97 44.07 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -108.15 135.8 48.88 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 125.873 1.983 . . . . 0.0 106.819 -168.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.427 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mp . . . . . 0 CA--C 1.587 2.373 0 N-CA-C 100.986 -3.709 . . . . 0.0 100.986 -167.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.0 m . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -117.8 127.81 54.25 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -168.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 m -97.16 115.95 28.47 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.427 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.9 m-85 -104.25 114.9 29.46 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -128.47 119.61 25.25 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -170.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.8 171.04 39.33 Favored Glycine 1 CA--C 1.582 4.228 0 CA-C-O 115.059 -3.078 . . . . 0.0 116.948 -175.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.52 160.66 22.35 Favored 'Trans proline' 0 C--N 1.395 3.021 1 CA-C-N 125.624 4.712 . . . . 0.0 114.232 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.61 95.22 0.4 Allowed Glycine 0 N--CA 1.487 2.05 0 CA-C-O 117.315 -1.825 . . . . 0.0 111.308 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.255 4.7 p -102.8 92.05 3.26 Favored Pre-proline 0 CA--C 1.585 2.296 0 CA-C-O 116.507 -1.711 . . . . 0.0 114.403 -167.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.5 179.98 4.16 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 123.42 2.747 . . . . 0.0 113.898 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 p -68.33 148.39 50.81 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 125.114 1.366 . . . . 0.0 111.313 167.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 24.3 m -141.38 151.42 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.077 0.465 . . . . 0.0 112.02 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -12.03 145.61 0.0 OUTLIER Pre-proline 0 CA--C 1.583 2.236 0 N-CA-C 120.396 3.48 . . . . 0.0 120.396 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 C--N 1.395 2.987 0 CA-C-N 126.541 3.372 . . . . 0.0 109.406 168.178 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.1 t . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.0 p -112.75 101.34 9.44 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -172.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 tt -70.23 157.83 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.63 0 CA-C-N 111.113 -2.767 . . . . 0.0 113.596 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -136.14 106.36 6.38 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 167.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -95.59 109.35 21.6 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 111.062 -2.79 . . . . 0.0 106.127 170.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 124.629 1.206 . . . . 0.0 110.125 -168.052 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -138.96 129.89 26.42 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.297 1.039 . . . . 0.0 109.012 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -88.02 139.64 30.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.497 0.719 . . . . 0.0 110.801 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -122.55 99.92 6.66 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 101.478 -3.527 . . . . 0.0 101.478 167.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.72 122.5 47.96 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 178.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.63 133.23 52.38 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -169.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.449 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.0 mp . . . . . 0 CA--C 1.585 2.311 0 N-CA-C 100.595 -3.854 . . . . 0.0 100.595 -167.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.9 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -113.85 125.4 54.03 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -168.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -98.47 108.74 21.5 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.449 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.6 m-85 -102.04 112.46 25.12 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.75 124.95 30.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -168.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.02 -154.09 9.41 Favored Glycine 1 CA--C 1.58 4.133 0 CA-C-O 114.377 -3.457 . . . . 0.0 115.239 174.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -90.35 161.65 4.56 Favored 'Trans proline' 0 C--N 1.395 3.019 1 CA-C-N 126.474 5.137 . . . . 0.0 114.533 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.05 116.02 1.05 Allowed Glycine 0 N--CA 1.481 1.648 0 CA-C-O 117.897 -1.502 . . . . 0.0 110.317 174.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.4 m -101.36 86.1 0.71 Allowed Pre-proline 0 CA--C 1.588 2.426 0 CA-C-O 116.741 -1.6 . . . . 0.0 111.609 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.66 174.35 8.76 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 123.438 2.759 . . . . 0.0 113.9 172.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.98 155.83 39.44 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.598 1.159 . . . . 0.0 112.294 168.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 13.5 m -135.83 155.21 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -169.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -56.71 153.39 22.07 Favored Pre-proline 0 CA--C 1.583 2.22 0 CA-C-O 114.25 -2.786 . . . . 0.0 116.342 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo . . . . . 0 C--N 1.397 3.103 0 CA-C-N 126.093 3.212 . . . . 0.0 109.967 168.796 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.505 2.298 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 p -136.44 107.42 6.7 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.265 2.6 tt -67.95 162.2 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 CA-C-N 112.099 -2.319 . . . . 0.0 113.713 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -138.98 112.54 8.28 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 167.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.4 t -96.33 111.57 23.61 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 111.48 -2.6 . . . . 0.0 106.247 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 124.282 0.989 . . . . 0.0 109.458 -168.328 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -141.19 125.54 17.57 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.268 1.027 . . . . 0.0 108.789 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -80.36 141.35 35.47 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 124.174 0.922 . . . . 0.0 111.439 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -124.32 98.9 5.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 100.525 -3.88 . . . . 0.0 100.525 168.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.48 122.43 47.26 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -106.83 134.87 49.31 Favored 'General case' 0 CA--C 1.55 0.981 0 O-C-N 125.653 1.846 . . . . 0.0 106.842 -169.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.494 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.7 mp . . . . . 0 CA--C 1.586 2.332 0 N-CA-C 100.532 -3.877 . . . . 0.0 100.532 -168.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -114.91 126.12 54.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -168.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -96.71 111.7 23.75 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.494 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.1 m-85 -103.0 119.1 38.25 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 -139.49 125.48 19.8 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.087 -167.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.81 -156.62 10.22 Favored Glycine 1 CA--C 1.581 4.165 0 CA-C-O 114.249 -3.528 . . . . 0.0 115.755 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -87.67 163.47 7.83 Favored 'Trans proline' 0 C--N 1.395 3.011 1 CA-C-N 126.721 5.261 . . . . 0.0 114.182 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.95 131.12 4.41 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.2 m -95.79 87.01 0.37 Allowed Pre-proline 0 CA--C 1.591 2.545 0 CA-C-O 116.767 -1.587 . . . . 0.0 110.337 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.14 169.62 17.37 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 123.428 2.752 . . . . 0.0 113.689 170.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.79 156.92 24.69 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.519 1.128 . . . . 0.0 111.202 168.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.251 15.6 m -136.78 151.42 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.113 0.565 . . . . 0.0 111.728 -175.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.47 164.54 44.81 Favored Pre-proline 0 CA--C 1.584 2.264 0 CA-C-O 115.339 -2.267 . . . . 0.0 114.186 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--N 1.4 3.241 0 CA-C-N 126.251 3.268 . . . . 0.0 112.654 177.856 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.5 2.031 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.9 p -134.21 106.77 7.32 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 103.668 -2.716 . . . . 0.0 103.668 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 tt -69.87 162.15 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 127.368 2.267 . . . . 0.0 113.466 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.8 ttm-85 -144.07 111.6 6.02 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 102.506 -3.146 . . . . 0.0 102.506 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -100.33 108.76 20.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 111.732 -2.485 . . . . 0.0 105.477 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.493 1.722 0 O-C-N 124.479 1.112 . . . . 0.0 109.502 -168.454 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.34 128.05 40.6 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -84.73 126.33 33.31 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.116 0.966 . . . . 0.0 109.842 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.264 5.1 tt0 -121.22 92.05 3.66 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 171.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.27 130.99 55.15 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 171.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 m -108.2 128.03 54.35 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 112.479 -2.146 . . . . 0.0 106.625 -169.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 CA--C 1.582 2.201 0 N-CA-C 100.428 -3.915 . . . . 0.0 100.428 -168.56 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.8 m . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -99.02 138.57 35.93 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 120.55 1.523 . . . . 0.0 111.022 -169.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.7 m -106.12 104.0 13.61 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 100.994 -3.706 . . . . 0.0 100.994 166.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -92.17 98.3 11.44 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -113.32 121.27 43.88 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -170.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.73 -166.26 28.42 Favored Glycine 1 CA--C 1.58 4.104 0 CA-C-O 114.495 -3.392 . . . . 0.0 116.519 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -88.0 160.3 7.32 Favored 'Trans proline' 0 C--N 1.395 2.974 1 CA-C-N 126.737 5.269 . . . . 0.0 114.211 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.03 116.8 1.28 Allowed Glycine 0 N--CA 1.479 1.534 0 CA-C-O 118.194 -1.337 . . . . 0.0 110.602 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 t -97.03 90.67 0.82 Allowed Pre-proline 0 CA--C 1.587 2.392 0 CA-C-O 116.394 -1.765 . . . . 0.0 111.68 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.85 170.47 13.97 Favored 'Trans proline' 0 C--N 1.39 2.711 0 CA-C-N 124.287 2.567 . . . . 0.0 113.431 169.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -82.57 143.85 30.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.354 1.062 . . . . 0.0 109.806 168.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.302 19.0 m -140.53 161.56 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.052 0 CA-C-O 121.328 0.585 . . . . 0.0 111.896 -176.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.9 175.72 0.52 Allowed Pre-proline 0 CA--C 1.591 2.526 0 N-CA-C 118.786 2.884 . . . . 0.0 118.786 -168.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo . . . . . 0 C--N 1.404 3.471 0 CA-C-N 125.614 3.041 . . . . 0.0 110.635 173.254 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 N--CA 1.499 1.993 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.4 p -125.44 106.34 9.74 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 tt -66.48 160.32 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.835 0 CA-C-N 111.956 -2.384 . . . . 0.0 113.049 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -136.85 107.97 6.77 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.2 m -94.92 109.55 21.54 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 109.764 -3.38 . . . . 0.0 105.425 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.737 0 C-N-CA 124.217 1.007 . . . . 0.0 111.033 -167.332 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -136.53 140.98 43.37 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.316 1.046 . . . . 0.0 110.086 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -87.63 143.99 26.9 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.564 0.746 . . . . 0.0 111.643 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -126.23 96.8 4.84 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 100.269 -3.975 . . . . 0.0 100.269 166.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.94 122.46 46.33 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.1 m -108.16 135.78 48.92 Favored 'General case' 0 CA--C 1.552 1.035 0 O-C-N 125.79 1.931 . . . . 0.0 106.685 -169.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.409 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.8 mp . . . . . 0 CA--C 1.586 2.329 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 -167.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -118.53 127.26 53.45 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -168.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 m -97.51 112.49 24.32 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.409 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.1 m-85 -102.85 119.65 39.21 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.3 mtm-85 -138.25 123.01 18.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -168.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.92 177.15 42.31 Favored Glycine 1 CA--C 1.581 4.198 0 CA-C-O 115.054 -3.081 . . . . 0.0 116.555 -178.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.88 160.07 21.22 Favored 'Trans proline' 0 C--N 1.395 2.999 1 CA-C-N 126.019 4.91 . . . . 0.0 113.97 -175.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.94 96.66 0.4 Allowed Glycine 0 N--CA 1.487 2.074 0 CA-C-O 117.315 -1.825 . . . . 0.0 111.174 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.252 4.0 p -102.3 95.43 5.87 Favored Pre-proline 0 CA--C 1.584 2.275 0 CA-C-O 115.978 -1.963 . . . . 0.0 114.192 -167.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -85.54 179.51 3.9 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 123.442 2.761 . . . . 0.0 114.006 173.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 p -61.68 161.81 9.43 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 125.616 1.566 . . . . 0.0 113.857 169.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.252 14.2 m -135.29 154.27 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 C-N-CA 122.983 0.513 . . . . 0.0 112.229 178.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.259 50.7 pttt -75.14 -172.2 0.25 Allowed Pre-proline 0 CA--C 1.601 2.919 0 CA-C-O 114.688 -2.577 . . . . 0.0 116.46 -176.069 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 C--N 1.4 3.263 0 CA-C-N 126.539 3.371 . . . . 0.0 110.806 173.993 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.5 2.03 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -137.4 106.87 6.12 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 -177.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.53 162.91 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 CA-C-N 112.173 -2.285 . . . . 0.0 113.584 -178.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -137.93 108.63 6.62 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 101.87 -3.382 . . . . 0.0 101.87 166.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.1 t -98.07 109.34 22.11 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 111.558 -2.565 . . . . 0.0 105.673 171.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 124.601 1.188 . . . . 0.0 110.1 -167.824 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -139.57 137.46 35.4 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 124.4 1.08 . . . . 0.0 109.882 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -84.85 121.84 28.3 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 117.404 -1.284 . . . . 0.0 109.517 -179.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -109.17 98.56 7.98 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 170.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -110.93 120.26 41.8 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 179.897 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.4 m -107.38 130.71 54.77 Favored 'General case' 0 CA--C 1.554 1.108 0 O-C-N 125.314 1.634 . . . . 0.0 106.817 -168.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.492 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.3 mp . . . . . 0 CA--C 1.582 2.195 0 N-CA-C 100.522 -3.881 . . . . 0.0 100.522 -167.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -98.6 140.66 32.49 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 120.443 1.474 . . . . 0.0 111.102 -169.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.0 m -107.02 100.19 9.7 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 101.058 -3.682 . . . . 0.0 101.058 167.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -94.14 110.72 22.42 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -175.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.46 116.59 20.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -167.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.98 -172.21 28.0 Favored Glycine 1 CA--C 1.583 4.286 0 CA-C-O 114.613 -3.326 . . . . 0.0 115.059 177.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -86.48 162.81 9.57 Favored 'Trans proline' 0 C--N 1.394 2.933 1 CA-C-N 126.892 5.346 . . . . 0.0 114.332 -175.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.32 113.81 1.38 Allowed Glycine 0 N--CA 1.481 1.649 0 CA-C-O 117.643 -1.643 . . . . 0.0 110.089 176.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.3 m -102.56 85.62 0.8 Allowed Pre-proline 0 CA--C 1.588 2.439 0 CA-C-O 117.021 -1.466 . . . . 0.0 111.942 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.02 173.41 9.07 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 123.258 2.638 . . . . 0.0 113.791 169.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -77.44 147.71 35.81 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.443 1.097 . . . . 0.0 110.358 167.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 31.2 m -139.08 152.21 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.828 0 O-C-N 123.556 0.535 . . . . 0.0 112.052 -173.173 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -17.45 146.57 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.265 0 CA-C-O 112.784 -3.484 . . . . 0.0 119.713 170.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 C--N 1.395 2.991 0 CA-C-N 126.614 3.398 . . . . 0.0 109.616 168.505 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.0 t . . . . . 0 N--CA 1.502 2.156 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.2 p -118.56 104.14 10.38 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 -174.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.282 1.3 tt -67.3 167.55 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 111.455 -2.611 . . . . 0.0 113.66 179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -144.65 112.19 6.14 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 168.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.4 t -95.82 98.05 10.14 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 168.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 N--CA 1.492 1.668 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.349 -165.963 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -139.46 125.64 20.04 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.264 1.026 . . . . 0.0 108.862 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -112.61 145.09 41.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 124.185 0.928 . . . . 0.0 112.201 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.27 3.2 tt0 -126.04 95.04 4.27 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 102.176 -3.268 . . . . 0.0 102.176 168.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -111.12 124.7 52.72 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.3 m -109.59 134.43 51.94 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 125.495 1.747 . . . . 0.0 106.528 -168.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 CA--C 1.585 2.293 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 -167.852 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -120.64 127.51 52.15 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -168.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m -96.96 117.46 31.2 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 178.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -106.5 113.02 26.29 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -127.02 121.46 31.68 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -169.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.18 -160.31 13.28 Favored Glycine 1 CA--C 1.58 4.123 0 CA-C-O 114.466 -3.408 . . . . 0.0 116.297 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -90.71 156.86 4.21 Favored 'Trans proline' 0 C--N 1.397 3.096 1 CA-C-N 126.271 5.035 . . . . 0.0 114.487 -176.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.22 109.99 0.51 Allowed Glycine 0 N--CA 1.482 1.703 0 CA-C-O 117.954 -1.47 . . . . 0.0 111.261 174.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.323 1.3 p -108.38 82.37 1.6 Allowed Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 116.69 -1.624 . . . . 0.0 112.197 -171.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.84 -178.8 3.39 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 123.619 2.879 . . . . 0.0 113.684 172.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 p -61.79 158.31 16.09 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.446 1.498 . . . . 0.0 113.937 169.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.25 12.7 m -132.92 154.86 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.858 0 C-N-CA 123.358 0.663 . . . . 0.0 111.752 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 163.95 58.06 Favored Pre-proline 0 CA--C 1.583 2.248 0 CA-C-O 115.338 -2.267 . . . . 0.0 114.659 -179.447 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo . . . . . 0 C--N 1.4 3.245 0 CA-C-N 126.058 3.199 . . . . 0.0 112.661 179.845 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.2 p -139.14 108.51 6.13 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 102.907 -2.997 . . . . 0.0 102.907 -178.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 tt -70.06 163.2 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 C-N-CA 126.918 2.087 . . . . 0.0 113.685 -174.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -119.64 134.85 55.06 Favored 'General case' 0 CA--C 1.543 0.677 1 N-CA-C 97.397 -5.038 . . . . 0.0 97.397 163.205 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.0 t -106.17 65.0 0.68 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.689 1.233 . . . . 0.0 108.001 162.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.327 10.3 pt-20 . . . . . 0 N--CA 1.493 1.697 0 C-N-CA 126.08 1.752 . . . . 0.0 107.798 -170.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -146.29 128.28 15.52 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.15 128.24 35.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.542 0.737 . . . . 0.0 110.351 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.279 9.4 tt0 -112.92 96.83 6.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 101.216 -3.624 . . . . 0.0 101.216 168.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.4 109.93 19.84 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 -176.303 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 m -96.39 127.75 42.68 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.243 -167.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mm . . . . . 0 CA--C 1.58 2.112 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 -167.506 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.52 139.41 30.56 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.582 1.153 . . . . 0.0 110.356 -170.148 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -110.93 110.47 21.06 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 102.782 -3.044 . . . . 0.0 102.782 169.059 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -98.94 115.75 29.6 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.31 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -128.22 122.61 32.19 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -173.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.53 -155.71 11.1 Favored Glycine 0 CA--C 1.578 3.982 0 CA-C-O 114.452 -3.416 . . . . 0.0 115.856 176.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -87.94 161.58 7.44 Favored 'Trans proline' 0 C--N 1.394 2.942 1 CA-C-N 126.393 5.096 . . . . 0.0 114.024 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.64 117.02 1.42 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-O 118.235 -1.314 . . . . 0.0 110.481 173.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.5 m -102.46 84.47 0.63 Allowed Pre-proline 0 CA--C 1.588 2.407 0 CA-C-O 116.766 -1.588 . . . . 0.0 111.129 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.91 174.07 9.73 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 123.399 2.732 . . . . 0.0 113.958 171.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.51 155.4 36.17 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.556 1.143 . . . . 0.0 112.05 168.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.268 13.4 m -137.08 156.63 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -169.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -63.64 165.59 11.67 Favored Pre-proline 0 CA--C 1.58 2.132 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--N 1.396 3.052 0 C-N-CA 123.149 2.566 . . . . 0.0 109.944 169.53 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t . . . . . 0 N--CA 1.506 2.353 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -137.76 108.78 6.74 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 -178.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.264 1.1 tt -69.49 164.36 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 C-N-CA 126.91 2.084 . . . . 0.0 113.718 -174.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -139.35 113.76 9.03 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 167.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.4 t -95.78 115.91 28.12 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 111.606 -2.543 . . . . 0.0 106.943 171.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.493 1.686 0 C-N-CA 124.162 0.985 . . . . 0.0 110.098 -168.221 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -140.78 124.2 16.78 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.301 1.04 . . . . 0.0 108.4 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -86.16 128.07 34.83 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 124.088 0.868 . . . . 0.0 110.33 -179.405 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.259 7.1 tt0 -112.0 97.86 6.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 100.855 -3.757 . . . . 0.0 100.855 168.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.48 108.18 16.85 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -177.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 m -96.36 126.17 41.37 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 113.369 -1.741 . . . . 0.0 106.817 -167.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 mm . . . . . 0 CA--C 1.579 2.088 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 -166.897 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.74 119.52 36.95 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -169.245 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 m -96.58 120.81 37.6 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 -171.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -112.38 118.37 35.01 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -138.37 116.88 12.07 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -168.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.63 -155.34 9.92 Favored Glycine 1 CA--C 1.579 4.054 0 CA-C-O 114.345 -3.475 . . . . 0.0 115.373 178.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -88.12 161.63 7.17 Favored 'Trans proline' 0 C--N 1.394 2.935 1 CA-C-N 126.728 5.264 . . . . 0.0 114.131 -178.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.28 115.72 1.47 Allowed Glycine 0 N--CA 1.479 1.519 0 CA-C-O 118.058 -1.412 . . . . 0.0 110.443 174.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.2 m -101.56 85.7 0.68 Allowed Pre-proline 0 CA--C 1.587 2.376 0 CA-C-O 116.716 -1.611 . . . . 0.0 111.295 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.48 173.51 10.54 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 123.31 2.673 . . . . 0.0 113.827 171.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -75.48 155.3 36.35 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.557 1.143 . . . . 0.0 111.963 168.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.27 19.4 m -136.96 153.3 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 123.503 0.502 . . . . 0.0 111.98 -173.175 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.98 48.41 Favored Pre-proline 0 CA--C 1.585 2.292 0 CA-C-O 115.241 -2.314 . . . . 0.0 114.688 -179.441 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo . . . . . 0 C--N 1.4 3.249 0 CA-C-N 126.34 3.3 . . . . 0.0 113.006 177.916 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t . . . . . 0 N--CA 1.503 2.191 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 p -137.36 109.18 7.08 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 0.9 OUTLIER -68.8 164.5 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 C-N-CA 126.84 2.056 . . . . 0.0 113.685 -174.959 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -141.03 113.11 7.84 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 167.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.1 t -97.81 114.15 26.12 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 111.524 -2.58 . . . . 0.0 106.411 170.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 124.055 0.847 . . . . 0.0 110.005 -168.695 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.93 139.75 38.1 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 124.265 1.026 . . . . 0.0 109.672 179.44 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -80.0 139.54 36.94 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 117.338 -1.315 . . . . 0.0 111.78 -177.067 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -121.22 97.58 5.58 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 102.503 -3.147 . . . . 0.0 102.503 168.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.58 119.63 39.8 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 -178.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -107.13 130.03 54.75 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 125.652 1.845 . . . . 0.0 106.174 -168.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.8 mp . . . . . 0 CA--C 1.586 2.335 0 N-CA-C 100.469 -3.901 . . . . 0.0 100.469 -167.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -113.52 125.55 54.33 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -168.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -97.92 108.35 21.04 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 -173.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.471 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.5 m-85 -101.86 112.08 24.57 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -176.67 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.75 121.24 26.48 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -168.541 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.03 170.8 42.69 Favored Glycine 1 CA--C 1.581 4.218 0 CA-C-O 115.102 -3.054 . . . . 0.0 116.325 -177.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.46 162.76 22.07 Favored 'Trans proline' 0 C--N 1.394 2.938 1 CA-C-N 125.805 4.802 . . . . 0.0 114.153 -176.294 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.08 91.54 0.81 Allowed Glycine 0 N--CA 1.486 2.003 0 CA-C-O 117.379 -1.79 . . . . 0.0 110.38 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.9 m -85.7 102.49 2.63 Favored Pre-proline 0 CA--C 1.589 2.472 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -166.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -79.68 179.37 6.37 Favored 'Trans proline' 0 CA--C 1.58 2.796 0 C-N-CA 123.199 2.599 . . . . 0.0 112.158 166.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.303 9.9 t -105.24 155.97 18.57 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 123.841 0.856 . . . . 0.0 109.025 167.091 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.0 m -120.31 155.42 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 C-N-CA 124.22 1.008 . . . . 0.0 112.151 -165.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 179.79 1.58 Allowed Pre-proline 0 CA--C 1.6 2.869 0 CA-C-O 116.232 -1.842 . . . . 0.0 112.935 -179.342 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo . . . . . 0 C--N 1.394 2.951 0 C-N-CA 123.654 2.903 . . . . 0.0 111.088 177.391 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.501 2.108 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.9 p -141.4 106.09 4.9 Favored 'General case' 0 CA--C 1.558 1.272 0 N-CA-C 104.54 -2.392 . . . . 0.0 104.54 -176.042 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.253 1.6 tt -72.91 159.95 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.741 0 C-N-CA 127.14 2.176 . . . . 0.0 113.653 -178.203 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -145.42 103.53 3.83 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 105.896 -1.891 . . . . 0.0 105.896 168.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.9 t -91.89 98.02 11.33 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 111.951 -2.386 . . . . 0.0 104.729 169.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 . . . . . 0 N--CA 1.492 1.647 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.983 -165.51 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -136.25 141.04 43.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 124.312 1.045 . . . . 0.0 110.148 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -88.75 142.84 27.33 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.559 0.744 . . . . 0.0 111.404 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.251 4.0 tt0 -125.49 96.93 4.98 Favored 'General case' 0 N--CA 1.487 1.387 1 N-CA-C 100.15 -4.018 . . . . 0.0 100.15 166.704 . . . . . . . . 3 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.89 124.2 50.02 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 m -106.56 132.26 52.77 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 125.576 1.797 . . . . 0.0 107.357 -168.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.582 2.179 0 N-CA-C 100.998 -3.704 . . . . 0.0 100.998 -168.679 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -101.73 141.25 34.87 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.612 1.551 . . . . 0.0 111.231 -169.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -104.51 102.84 12.46 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 165.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -92.42 115.23 27.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -178.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -131.54 122.32 25.93 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -168.261 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.22 172.21 42.76 Favored Glycine 1 CA--C 1.58 4.12 0 CA-C-O 115.139 -3.034 . . . . 0.0 116.542 -177.402 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.12 159.69 23.62 Favored 'Trans proline' 0 C--N 1.395 3.009 1 CA-C-N 125.896 4.848 . . . . 0.0 113.962 -175.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.99 97.11 0.39 Allowed Glycine 0 N--CA 1.488 2.103 0 CA-C-O 117.346 -1.808 . . . . 0.0 111.151 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.253 4.0 p -101.44 95.93 5.62 Favored Pre-proline 0 CA--C 1.583 2.241 0 CA-C-O 115.932 -1.985 . . . . 0.0 114.02 -167.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -84.03 178.52 5.27 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 123.497 2.798 . . . . 0.0 113.88 173.447 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -63.72 161.23 15.47 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 125.454 1.502 . . . . 0.0 114.095 169.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.3 m -134.1 152.78 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 C-N-CA 123.42 0.688 . . . . 0.0 111.682 -179.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.28 164.54 49.53 Favored Pre-proline 0 CA--C 1.585 2.289 0 CA-C-O 115.305 -2.283 . . . . 0.0 114.219 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo . . . . . 0 C--N 1.398 3.179 0 CA-C-N 126.203 3.251 . . . . 0.0 112.503 177.626 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.6 t . . . . . 0 N--CA 1.502 2.146 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.6 p -135.92 106.22 6.4 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 -176.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 tt -71.46 164.06 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.829 0 CA-C-N 111.983 -2.371 . . . . 0.0 113.54 -178.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -139.0 108.0 6.01 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 101.776 -3.416 . . . . 0.0 101.776 165.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.6 t -98.02 108.98 21.8 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 111.664 -2.517 . . . . 0.0 105.637 172.227 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 124.67 1.231 . . . . 0.0 110.164 -167.774 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -138.5 136.6 36.3 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.349 1.06 . . . . 0.0 109.664 179.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -87.65 142.02 28.16 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.45 0.7 . . . . 0.0 111.4 -178.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.254 4.2 tt0 -124.72 96.87 5.05 Favored 'General case' 0 N--CA 1.488 1.43 1 N-CA-C 100.185 -4.005 . . . . 0.0 100.185 166.639 . . . . . . . . 3 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.24 123.67 49.42 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -106.57 131.71 53.42 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 113.23 -1.805 . . . . 0.0 107.194 -168.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.581 2.172 0 N-CA-C 101.002 -3.703 . . . . 0.0 101.002 -168.507 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.7 m . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -101.41 141.09 34.8 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 120.622 1.555 . . . . 0.0 111.247 -169.556 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -104.6 102.65 12.25 Favored 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 100.928 -3.731 . . . . 0.0 100.928 165.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -92.68 115.0 27.71 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 -178.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -131.22 122.03 25.83 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -168.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.2 171.8 42.61 Favored Glycine 1 CA--C 1.58 4.132 0 CA-C-O 115.102 -3.054 . . . . 0.0 116.694 -177.149 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.96 159.64 24.11 Favored 'Trans proline' 0 C--N 1.394 2.965 1 CA-C-N 125.775 4.787 . . . . 0.0 113.958 -175.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.8 96.89 0.38 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-O 117.324 -1.82 . . . . 0.0 111.107 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.253 3.8 p -101.44 95.97 5.66 Favored Pre-proline 0 CA--C 1.582 2.209 0 CA-C-O 115.893 -2.003 . . . . 0.0 114.048 -167.504 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -83.93 178.0 5.69 Favored 'Trans proline' 0 C--N 1.394 2.95 0 C-N-CA 123.479 2.786 . . . . 0.0 113.912 173.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -63.9 161.11 16.21 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 125.35 1.46 . . . . 0.0 114.062 169.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 m -134.84 152.55 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 123.353 0.661 . . . . 0.0 111.589 -179.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 164.73 49.69 Favored Pre-proline 0 CA--C 1.583 2.243 0 CA-C-O 115.341 -2.266 . . . . 0.0 114.225 179.644 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo . . . . . 0 C--N 1.399 3.226 0 CA-C-N 126.179 3.243 . . . . 0.0 112.373 177.331 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 N--CA 1.502 2.151 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -137.42 106.03 5.85 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 123.724 1.726 . . . . 0.0 108.528 -178.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 tt -70.9 162.29 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 CA-C-N 109.109 -3.678 . . . . 0.0 113.663 -176.045 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -138.01 107.67 6.23 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 101.934 -3.358 . . . . 0.0 101.934 165.499 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -97.97 107.51 20.0 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 111.469 -2.605 . . . . 0.0 105.617 171.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 124.657 1.223 . . . . 0.0 109.947 -167.91 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -141.4 122.86 14.99 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -82.46 123.5 29.21 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 117.535 -1.222 . . . . 0.0 110.0 -175.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -108.66 95.96 6.01 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 170.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.527 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.56 119.24 38.86 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 179.346 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.0 m -107.52 130.15 54.89 Favored 'General case' 0 CA--C 1.554 1.132 0 O-C-N 125.323 1.639 . . . . 0.0 106.66 -168.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.527 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.3 mp . . . . . 0 CA--C 1.582 2.184 0 N-CA-C 100.572 -3.862 . . . . 0.0 100.572 -167.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -96.58 139.71 32.27 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 120.621 1.555 . . . . 0.0 111.03 -169.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 m -107.93 99.86 9.27 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 101.098 -3.667 . . . . 0.0 101.098 167.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -94.11 110.93 22.61 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -176.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.27 116.82 20.45 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -167.805 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.01 -164.63 20.8 Favored Glycine 1 CA--C 1.582 4.231 0 CA-C-O 114.687 -3.285 . . . . 0.0 115.464 177.528 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -88.01 162.65 7.35 Favored 'Trans proline' 0 C--N 1.394 2.945 1 CA-C-N 126.554 5.177 . . . . 0.0 114.204 -177.075 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.82 114.95 1.55 Allowed Glycine 0 N--CA 1.48 1.569 0 CA-C-O 117.861 -1.522 . . . . 0.0 110.097 174.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.2 t -101.23 85.92 0.67 Allowed Pre-proline 0 CA--C 1.588 2.411 0 CA-C-O 116.864 -1.541 . . . . 0.0 112.432 -175.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.12 171.72 11.28 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 123.134 2.556 . . . . 0.0 113.33 168.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.81 147.13 31.92 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.195 0.998 . . . . 0.0 110.467 167.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.266 29.8 m -138.09 154.42 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 O-C-N 123.743 0.652 . . . . 0.0 111.934 -169.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -28.0 148.52 0.03 OUTLIER Pre-proline 0 CA--C 1.585 2.298 0 CA-C-O 113.145 -3.312 . . . . 0.0 118.884 174.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 C--N 1.395 3.014 0 CA-C-N 126.546 3.374 . . . . 0.0 109.828 168.98 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 N--CA 1.502 2.136 0 N-CA-C 103.84 -2.652 . . . . 0.0 103.84 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.6 p -115.37 102.42 9.82 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -173.225 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.263 1.7 tt -68.28 163.05 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-N 111.159 -2.746 . . . . 0.0 114.026 -179.173 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -145.14 106.23 4.17 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 167.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 81.2 m -92.43 91.35 7.6 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 111.362 -2.654 . . . . 0.0 104.769 172.426 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 . . . . . 0 N--CA 1.493 1.677 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.79 -165.383 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.2 p . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -140.44 123.9 16.96 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 118.056 -0.974 . . . . 0.0 108.783 178.154 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -89.81 135.86 33.38 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 124.391 1.057 . . . . 0.0 110.23 174.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.287 3.4 tt0 -119.32 95.71 4.91 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 102.626 -3.101 . . . . 0.0 102.626 169.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.38 123.71 50.15 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -176.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -105.75 134.22 49.23 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 125.489 1.743 . . . . 0.0 107.679 -168.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 CA--C 1.583 2.22 0 N-CA-C 100.961 -3.718 . . . . 0.0 100.961 -168.514 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -103.41 141.54 35.79 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 120.173 1.351 . . . . 0.0 111.082 -169.533 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 m -105.05 105.74 15.92 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 100.995 -3.706 . . . . 0.0 100.995 166.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -93.5 110.44 22.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -122.45 116.6 24.24 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -169.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.89 164.97 36.76 Favored Glycine 1 CA--C 1.58 4.096 0 CA-C-O 114.975 -3.125 . . . . 0.0 116.693 -174.187 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.79 159.16 21.52 Favored 'Trans proline' 0 C--N 1.395 3.008 1 CA-C-N 125.739 4.77 . . . . 0.0 114.303 -174.173 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.72 95.17 0.41 Allowed Glycine 0 N--CA 1.487 2.071 0 CA-C-O 117.144 -1.92 . . . . 0.0 111.375 177.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.4 m -74.09 108.12 4.57 Favored Pre-proline 0 CA--C 1.586 2.358 0 CA-C-O 115.662 -2.113 . . . . 0.0 114.818 -167.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.73 169.44 18.22 Favored 'Trans proline' 0 C--N 1.39 2.727 0 CA-C-N 124.683 2.708 . . . . 0.0 113.663 169.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.88 149.88 26.07 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.127 0.971 . . . . 0.0 110.519 168.635 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.71 148.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 123.712 0.805 . . . . 0.0 111.491 -169.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 166.68 33.96 Favored Pre-proline 0 CA--C 1.586 2.345 0 CA-C-O 115.097 -2.383 . . . . 0.0 113.176 175.66 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--N 1.4 3.249 0 CA-C-N 127.032 3.547 . . . . 0.0 111.341 -177.967 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -136.53 107.28 6.6 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 123.767 1.746 . . . . 0.0 108.261 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 tt -70.88 160.12 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 CA-C-N 109.124 -3.671 . . . . 0.0 114.042 -172.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -135.45 94.73 3.15 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 166.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.0 t -93.17 117.55 30.2 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 111.16 -2.745 . . . . 0.0 106.596 170.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.29 14.3 pt-20 . . . . . 0 N--CA 1.497 1.911 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -166.8 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.97 130.24 33.35 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.159 0.983 . . . . 0.0 109.064 176.519 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -87.82 140.29 29.66 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.979 0.799 . . . . 0.0 110.333 174.32 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.54 100.94 6.89 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 101.916 -3.365 . . . . 0.0 101.916 169.018 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.433 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -113.97 123.75 50.49 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.411 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -107.08 131.33 54.23 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 125.38 1.675 . . . . 0.0 107.124 -168.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.433 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.5 mp . . . . . 0 CA--C 1.582 2.198 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 -168.187 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -100.15 139.87 35.21 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 120.657 1.571 . . . . 0.0 111.054 -169.63 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.1 m -105.57 102.29 11.76 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 100.906 -3.739 . . . . 0.0 100.906 166.212 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -92.42 117.84 30.33 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -178.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -136.22 123.28 21.56 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -167.776 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.36 -156.53 12.57 Favored Glycine 1 CA--C 1.579 4.091 0 CA-C-O 114.501 -3.388 . . . . 0.0 115.698 176.573 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -88.95 161.93 5.98 Favored 'Trans proline' 0 C--N 1.395 2.984 1 CA-C-N 126.268 5.034 . . . . 0.0 114.339 -178.965 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.42 113.71 0.76 Allowed Glycine 0 N--CA 1.481 1.637 0 CA-C-O 117.656 -1.636 . . . . 0.0 110.597 173.358 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.4 m -98.78 89.3 0.84 Allowed Pre-proline 0 CA--C 1.587 2.401 0 CA-C-O 116.554 -1.688 . . . . 0.0 111.906 -175.448 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.04 172.72 12.66 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.298 2.665 . . . . 0.0 113.632 169.951 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.05 156.54 37.38 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.581 1.152 . . . . 0.0 112.394 168.786 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.26 13.3 m -134.45 154.64 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.841 0 O-C-N 123.685 0.615 . . . . 0.0 112.225 -170.347 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -64.94 164.59 20.54 Favored Pre-proline 0 CA--C 1.581 2.135 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 -178.418 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--N 1.396 3.05 0 C-N-CA 123.199 2.6 . . . . 0.0 110.034 169.9 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.504 2.241 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.7 p -135.8 106.98 6.75 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 -176.333 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.253 1.9 tt -69.17 163.51 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.87 0 CA-C-N 111.932 -2.394 . . . . 0.0 113.465 -179.314 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -139.53 108.03 5.87 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 103.048 -2.945 . . . . 0.0 103.048 167.624 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 17.5 t -98.35 123.92 42.72 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 111.019 -2.809 . . . . 0.0 106.735 169.643 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.285 14.8 pt-20 . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -167.82 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -140.12 131.31 26.51 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.155 0.982 . . . . 0.0 109.697 179.395 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -84.08 135.65 34.32 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 124.543 1.152 . . . . 0.0 110.523 179.197 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.268 8.0 tt0 -119.81 99.14 6.46 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 100.999 -3.704 . . . . 0.0 100.999 170.285 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.479 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -108.69 123.62 49.27 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 177.077 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 m -107.84 131.09 54.86 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -169.442 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.482 HD13 ' CD1' ' A' ' 12' ' ' PHE . 2.9 mp . . . . . 0 CA--C 1.586 2.349 0 N-CA-C 100.42 -3.918 . . . . 0.0 100.42 -167.765 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -115.83 125.27 52.46 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -169.065 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -95.97 116.4 28.88 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 -177.654 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.482 ' CD1' HD13 ' A' ' 7' ' ' ILE . 83.2 m-85 -105.57 113.89 27.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -128.34 117.54 21.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -169.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.22 -166.24 20.64 Favored Glycine 1 CA--C 1.582 4.266 0 CA-C-O 114.199 -3.556 . . . . 0.0 115.986 179.445 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -89.47 163.04 5.43 Favored 'Trans proline' 0 C--N 1.395 3.019 1 CA-C-N 127.293 5.547 . . . . 0.0 114.601 -177.816 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.27 128.32 4.08 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 m -98.48 84.17 0.33 Allowed Pre-proline 0 CA--C 1.591 2.557 0 CA-C-O 117.296 -1.335 . . . . 0.0 112.244 177.917 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -80.71 174.92 10.56 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.124 2.55 . . . . 0.0 112.482 167.761 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.299 8.8 t -106.47 153.8 21.76 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 167.735 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 m -121.96 159.79 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 C-N-CA 124.389 1.076 . . . . 0.0 111.958 -165.732 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 163.42 65.28 Favored Pre-proline 0 CA--C 1.585 2.321 0 CA-C-O 115.28 -2.295 . . . . 0.0 114.782 176.406 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo . . . . . 0 C--N 1.399 3.203 0 CA-C-N 126.162 3.236 . . . . 0.0 113.503 -179.532 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.3 t . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -142.53 108.44 5.16 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 103.428 -2.805 . . . . 0.0 103.428 -178.212 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.256 3.3 tt -70.93 160.92 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 C-N-CA 127.233 2.213 . . . . 0.0 113.027 -179.275 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -145.97 115.07 7.01 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 102.565 -3.124 . . . . 0.0 102.565 169.12 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.48 110.21 22.7 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 111.977 -2.374 . . . . 0.0 106.23 169.646 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 124.472 1.108 . . . . 0.0 109.389 -168.666 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.43 130.61 17.45 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.757 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -84.47 137.15 33.52 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.874 178.16 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.25 8.2 tt0 -121.05 99.61 6.6 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 100.965 -3.717 . . . . 0.0 100.965 169.038 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.24 122.92 46.4 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.093 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.29 136.14 47.6 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 125.67 1.856 . . . . 0.0 106.926 -169.267 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.469 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.2 mp . . . . . 0 CA--C 1.585 2.299 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 -167.829 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -119.97 126.08 49.97 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -169.073 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 m -97.07 112.01 23.98 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -177.2 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.469 ' CD1' HD13 ' A' ' 7' ' ' ILE . 83.3 m-85 -103.38 118.62 37.18 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -178.921 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -139.57 124.82 18.95 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -168.013 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.54 -156.15 9.76 Favored Glycine 1 CA--C 1.578 4.022 0 CA-C-O 114.478 -3.401 . . . . 0.0 115.734 177.241 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.58 161.07 9.4 Favored 'Trans proline' 0 C--N 1.394 2.969 1 CA-C-N 126.429 5.114 . . . . 0.0 113.833 -178.421 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.91 118.51 1.37 Allowed Glycine 0 N--CA 1.479 1.516 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.093 176.571 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -100.2 84.56 0.45 Allowed Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 117.036 -1.459 . . . . 0.0 112.702 -179.021 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.99 172.29 12.1 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 123.116 2.544 . . . . 0.0 112.953 168.585 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.289 9.5 t -93.45 157.85 16.01 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 123.457 0.703 . . . . 0.0 109.281 167.775 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.5 m -126.61 158.97 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 C-N-CA 124.131 0.972 . . . . 0.0 112.244 -166.277 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -73.99 -176.07 0.47 Allowed Pre-proline 0 CA--C 1.609 3.226 0 CA-C-O 115.142 -2.361 . . . . 0.0 113.717 -179.495 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--N 1.394 2.955 0 CA-C-N 126.606 3.395 . . . . 0.0 111.476 -178.634 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 N--CA 1.502 2.126 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.8 p -141.75 107.23 5.04 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 103.656 -2.72 . . . . 0.0 103.656 -176.619 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.266 1.4 tt -71.34 162.61 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 C-N-CA 127.255 2.222 . . . . 0.0 112.7 -179.077 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -142.65 123.94 14.67 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 169.019 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.8 t -95.31 123.76 38.99 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 111.789 -2.46 . . . . 0.0 108.391 169.536 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 . . . . . 0 N--CA 1.492 1.629 0 C-N-CA 124.176 0.991 . . . . 0.0 109.663 -169.269 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -147.52 127.28 13.44 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 178.696 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -86.4 140.45 29.99 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.118 0.567 . . . . 0.0 111.086 178.52 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.258 8.2 tt0 -124.56 96.46 4.91 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 100.665 -3.828 . . . . 0.0 100.665 166.785 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.99 123.33 46.65 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -177.016 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -107.77 135.72 48.71 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 125.853 1.97 . . . . 0.0 106.928 -169.143 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.438 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.6 mp . . . . . 0 CA--C 1.585 2.314 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 -167.956 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -118.36 126.9 53.06 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -168.852 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -97.01 112.41 24.18 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 -178.284 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.438 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.0 m-85 -103.59 119.26 38.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -179.671 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -138.57 120.43 15.39 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -168.485 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.11 178.75 42.18 Favored Glycine 1 CA--C 1.582 4.22 0 CA-C-O 115.054 -3.081 . . . . 0.0 116.866 -177.406 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.31 159.45 17.46 Favored 'Trans proline' 0 C--N 1.395 2.992 1 CA-C-N 125.877 4.839 . . . . 0.0 114.088 -174.994 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.03 96.37 0.41 Allowed Glycine 0 N--CA 1.488 2.127 0 CA-C-O 117.322 -1.821 . . . . 0.0 111.163 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.25 3.1 p -100.57 96.02 4.93 Favored Pre-proline 0 CA--C 1.583 2.234 0 CA-C-O 115.949 -1.977 . . . . 0.0 113.948 -167.414 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -83.5 178.81 5.38 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 123.516 2.81 . . . . 0.0 113.796 173.149 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 p -64.57 160.57 19.27 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.291 1.437 . . . . 0.0 113.817 169.554 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 m -134.29 152.23 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 123.334 0.654 . . . . 0.0 111.73 -178.262 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.71 164.09 48.58 Favored Pre-proline 0 CA--C 1.583 2.227 0 CA-C-O 115.336 -2.269 . . . . 0.0 114.213 178.952 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 C--N 1.399 3.223 0 CA-C-N 126.216 3.256 . . . . 0.0 112.686 178.575 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.499 2.024 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.4 p -133.81 105.85 7.01 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -176.72 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.4 tt -71.58 160.98 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.775 0 CA-C-N 112.009 -2.36 . . . . 0.0 113.471 -177.411 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -136.45 105.21 5.85 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 102.392 -3.188 . . . . 0.0 102.392 165.409 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.4 t -94.9 112.97 24.65 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 111.258 -2.701 . . . . 0.0 106.102 173.239 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 124.621 1.201 . . . . 0.0 111.228 -167.428 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -140.47 125.94 18.96 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.292 1.037 . . . . 0.0 108.767 179.722 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -88.2 139.92 30.01 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 124.005 0.816 . . . . 0.0 111.184 179.211 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -123.56 98.52 5.87 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 101.996 -3.335 . . . . 0.0 101.996 168.356 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.47 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -112.05 122.68 48.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 178.747 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -106.96 130.66 54.58 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 125.353 1.658 . . . . 0.0 107.029 -168.718 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.47 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.4 mp . . . . . 0 CA--C 1.582 2.182 0 N-CA-C 100.635 -3.839 . . . . 0.0 100.635 -168.271 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -100.31 141.14 33.57 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.417 1.462 . . . . 0.0 111.068 -169.607 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.8 m -106.09 100.46 10.0 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 166.926 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -93.46 109.9 21.48 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 -175.599 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.93 118.5 25.54 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -168.146 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.9 169.02 40.61 Favored Glycine 1 CA--C 1.582 4.22 0 CA-C-O 115.097 -3.057 . . . . 0.0 116.35 -176.343 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.45 160.89 22.53 Favored 'Trans proline' 0 C--N 1.395 2.987 1 CA-C-N 125.834 4.817 . . . . 0.0 114.29 -174.092 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.36 95.8 0.37 Allowed Glycine 0 N--CA 1.487 2.062 0 CA-C-O 116.921 -2.044 . . . . 0.0 111.465 178.017 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.8 m -78.98 106.59 4.59 Favored Pre-proline 0 CA--C 1.587 2.368 0 CA-C-O 115.755 -2.069 . . . . 0.0 113.943 -167.639 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -80.07 171.38 15.29 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 123.428 2.752 . . . . 0.0 113.828 170.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.82 153.69 28.95 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.358 1.063 . . . . 0.0 110.746 168.008 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.25 11.4 m -129.55 152.21 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 123.211 0.604 . . . . 0.0 112.497 -168.845 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.13 165.63 31.47 Favored Pre-proline 0 CA--C 1.581 2.16 0 CA-C-O 115.814 -2.041 . . . . 0.0 116.332 -179.611 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 C--N 1.395 3.017 0 C-N-CA 123.12 2.547 . . . . 0.0 109.958 169.73 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.3 t . . . . . 0 N--CA 1.504 2.234 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 p -131.7 106.27 8.04 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 -176.482 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 tt -69.66 162.16 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.827 0 CA-C-N 111.863 -2.426 . . . . 0.0 113.871 -179.071 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -138.17 102.31 4.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 166.162 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.0 t -96.1 105.14 17.14 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 111.138 -2.755 . . . . 0.0 105.818 171.776 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 N--CA 1.491 1.597 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.582 -167.677 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.6 p . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -141.29 124.22 16.23 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 124.285 1.034 . . . . 0.0 108.481 179.72 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -84.57 129.7 34.82 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 117.83 -1.081 . . . . 0.0 110.574 -177.207 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.276 5.3 tt0 -114.55 94.44 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 102.639 -3.097 . . . . 0.0 102.639 172.685 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.491 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -108.19 123.31 48.55 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.473 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 m -108.08 132.53 53.47 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -169.736 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.491 HD11 ' CD2' ' A' ' 5' ' ' TYR . 3.6 mp . . . . . 0 CA--C 1.586 2.351 0 N-CA-C 100.602 -3.851 . . . . 0.0 100.602 -167.661 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 94.7 p . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -113.57 125.67 54.44 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -168.768 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -97.12 116.41 29.28 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 -179.709 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.436 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.3 m-85 -104.23 112.92 26.13 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -128.2 119.42 25.18 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -169.961 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.58 -161.71 20.48 Favored Glycine 1 CA--C 1.579 4.078 0 CA-C-O 114.362 -3.466 . . . . 0.0 115.821 177.663 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.8 160.96 4.12 Favored 'Trans proline' 0 C--N 1.394 2.928 1 CA-C-N 126.748 5.274 . . . . 0.0 114.533 -179.458 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.31 113.51 0.87 Allowed Glycine 0 N--CA 1.482 1.719 0 CA-C-O 117.576 -1.68 . . . . 0.0 110.489 172.671 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -96.1 94.89 1.69 Allowed Pre-proline 0 CA--C 1.591 2.525 0 CA-C-O 116.211 -1.852 . . . . 0.0 113.628 -170.996 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -82.11 174.79 9.75 Favored 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 123.309 2.673 . . . . 0.0 113.624 169.283 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.94 158.89 27.92 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.431 1.093 . . . . 0.0 111.958 168.351 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.253 10.5 m -135.98 153.73 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -169.74 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -62.3 158.69 45.54 Favored Pre-proline 0 CA--C 1.587 2.366 0 CA-C-O 114.613 -2.613 . . . . 0.0 115.823 179.216 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 C--N 1.398 3.134 0 CA-C-N 126.105 3.216 . . . . 0.0 109.783 168.764 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.505 2.316 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 p -132.08 105.52 7.44 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 -174.672 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.267 2.6 tt -67.74 161.91 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.828 0 CA-C-N 111.65 -2.523 . . . . 0.0 114.446 -178.753 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -143.44 100.69 3.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 124.664 2.173 . . . . 0.0 106.49 167.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.7 m -94.89 91.95 6.67 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 110.792 -2.913 . . . . 0.0 104.128 173.571 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 N--CA 1.493 1.721 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.53 -165.161 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -142.24 132.59 24.99 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.346 1.059 . . . . 0.0 109.17 -179.774 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -83.13 135.2 34.9 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 117.343 -1.313 . . . . 0.0 111.211 -178.551 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -120.58 96.89 5.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 102.368 -3.197 . . . . 0.0 102.368 167.918 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.26 122.76 46.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.038 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -107.0 131.35 54.16 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 125.73 1.894 . . . . 0.0 107.068 -168.559 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 CA--C 1.581 2.17 0 N-CA-C 100.521 -3.881 . . . . 0.0 100.521 -168.435 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.6 p . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -99.54 141.31 32.5 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 120.401 1.455 . . . . 0.0 111.297 -169.614 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 m -105.94 101.64 11.13 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 101.004 -3.702 . . . . 0.0 101.004 166.762 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -94.36 110.32 22.1 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 -176.248 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.03 121.34 29.52 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -168.342 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.61 171.8 42.85 Favored Glycine 1 CA--C 1.581 4.175 0 CA-C-O 115.16 -3.022 . . . . 0.0 116.45 -177.549 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.21 160.39 23.29 Favored 'Trans proline' 0 C--N 1.396 3.031 1 CA-C-N 125.767 4.784 . . . . 0.0 114.064 -175.565 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.78 95.46 0.62 Allowed Glycine 0 N--CA 1.486 1.986 0 CA-C-O 117.603 -1.665 . . . . 0.0 110.863 -179.503 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.257 4.7 p -105.2 90.75 4.01 Favored Pre-proline 0 CA--C 1.583 2.248 0 CA-C-O 116.474 -1.727 . . . . 0.0 113.432 -167.645 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -83.73 178.6 5.39 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 123.409 2.74 . . . . 0.0 113.721 171.847 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 p -69.33 146.98 51.73 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.89 1.276 . . . . 0.0 111.871 168.911 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.31 30.8 m -138.94 168.56 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.112 0 CA-C-O 121.455 0.645 . . . . 0.0 111.607 -179.335 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.08 161.98 3.29 Favored Pre-proline 0 CA--C 1.58 2.1 0 N-CA-C 118.863 2.912 . . . . 0.0 118.863 -170.146 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 C--N 1.396 3.031 0 C-N-CA 123.111 2.541 . . . . 0.0 110.227 169.886 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.9 t . . . . . 0 N--CA 1.503 2.175 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.7 p -117.07 101.93 8.89 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -172.732 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.47 163.74 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 CA-C-N 111.023 -2.808 . . . . 0.0 113.934 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -140.18 105.53 5.06 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 166.968 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.13 97.29 10.19 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 169.023 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.492 1.671 0 CA-C-N 113.71 -1.587 . . . . 0.0 111.424 -165.491 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -138.87 129.1 25.54 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.332 1.053 . . . . 0.0 108.929 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -86.13 133.15 33.89 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.665 179.829 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -116.69 100.12 7.6 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 100.888 -3.745 . . . . 0.0 100.888 168.865 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.77 123.15 49.64 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 177.69 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -107.51 133.23 52.29 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 125.303 1.627 . . . . 0.0 106.633 -169.213 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.485 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.6 mp . . . . . 0 CA--C 1.585 2.317 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -167.686 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -116.71 125.4 51.65 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -169.053 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 m -96.28 113.34 24.93 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -177.976 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.485 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.8 m-85 -103.16 115.76 31.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -179.493 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -132.5 120.91 22.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -168.686 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.6 -162.19 16.28 Favored Glycine 1 CA--C 1.581 4.157 0 CA-C-O 114.496 -3.391 . . . . 0.0 115.887 178.47 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -87.61 161.53 7.92 Favored 'Trans proline' 0 C--N 1.395 3.004 1 CA-C-N 126.617 5.209 . . . . 0.0 114.062 -178.084 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.33 117.84 1.41 Allowed Glycine 0 N--CA 1.48 1.598 0 CA-C-O 117.932 -1.482 . . . . 0.0 110.044 176.929 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.5 m -100.72 84.6 0.48 Allowed Pre-proline 0 CA--C 1.588 2.408 0 CA-C-O 116.979 -1.486 . . . . 0.0 112.957 -177.304 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.99 174.11 10.44 Favored 'Trans proline' 0 C--N 1.389 2.701 0 C-N-CA 123.17 2.58 . . . . 0.0 112.923 168.559 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.288 9.6 t -95.57 157.72 15.77 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 123.619 0.768 . . . . 0.0 109.406 167.886 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 m -125.93 159.43 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 124.306 1.042 . . . . 0.0 112.069 -166.445 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -73.58 -176.2 0.46 Allowed Pre-proline 0 CA--C 1.609 3.22 0 CA-C-O 115.096 -2.383 . . . . 0.0 113.843 -179.111 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 C--N 1.394 2.956 0 CA-C-N 126.685 3.423 . . . . 0.0 111.579 -178.482 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.8 t . . . . . 0 N--CA 1.503 2.186 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.5 p -142.73 108.07 5.02 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 -176.799 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.272 1.8 tt -70.8 161.64 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 C-N-CA 127.248 2.219 . . . . 0.0 112.711 -179.049 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -141.79 121.21 13.2 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 102.348 -3.204 . . . . 0.0 102.348 169.409 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.8 t -97.0 116.04 28.51 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 111.601 -2.545 . . . . 0.0 107.208 169.497 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.267 -0.873 . . . . 0.0 108.828 -169.367 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.28 124.61 19.14 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.164 0.986 . . . . 0.0 108.779 178.863 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -85.55 127.9 34.58 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 124.395 1.059 . . . . 0.0 110.252 -179.071 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.252 9.1 tt0 -109.9 97.68 7.15 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 169.127 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.67 122.08 45.98 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 177.545 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 m -108.17 130.46 55.13 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -169.248 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.5 HD13 ' CD1' ' A' ' 12' ' ' PHE . 2.6 mp . . . . . 0 CA--C 1.586 2.336 0 N-CA-C 100.291 -3.966 . . . . 0.0 100.291 -167.602 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -111.86 124.35 52.17 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -168.884 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -96.25 113.61 25.22 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -176.471 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.5 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.0 m-85 -103.72 114.38 28.6 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 -179.544 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -131.25 119.66 22.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 -169.029 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.58 -161.37 19.87 Favored Glycine 1 CA--C 1.58 4.101 0 CA-C-O 114.379 -3.456 . . . . 0.0 116.134 178.455 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -90.66 160.53 4.26 Favored 'Trans proline' 0 C--N 1.394 2.964 1 CA-C-N 126.768 5.284 . . . . 0.0 114.595 -178.477 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.17 113.62 0.73 Allowed Glycine 0 N--CA 1.481 1.681 0 CA-C-O 117.451 -1.749 . . . . 0.0 110.615 173.614 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.7 t -94.28 95.18 1.31 Allowed Pre-proline 0 CA--C 1.589 2.458 0 CA-C-O 116.132 -1.89 . . . . 0.0 113.471 -173.294 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -81.02 174.35 10.97 Favored 'Trans proline' 0 C--N 1.392 2.839 0 CA-C-N 124.559 2.664 . . . . 0.0 113.225 168.806 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -79.12 157.65 27.91 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.412 1.085 . . . . 0.0 111.508 168.403 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.262 16.5 m -135.07 152.58 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 C-N-CA 123.118 0.567 . . . . 0.0 111.559 -177.905 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 167.56 34.62 Favored Pre-proline 0 CA--C 1.588 2.411 0 CA-C-O 115.006 -2.426 . . . . 0.0 114.032 179.331 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.4 3.237 0 CA-C-N 126.883 3.494 . . . . 0.0 111.572 177.861 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.3 t . . . . . 0 N--CA 1.502 2.167 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -139.77 111.29 7.18 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 123.682 1.706 . . . . 0.0 107.722 177.763 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.255 1.8 tt -70.76 158.98 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 CA-C-N 109.26 -3.609 . . . . 0.0 113.632 -172.441 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -139.78 103.93 4.78 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 167.905 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.7 m -97.57 98.48 9.94 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 109.879 -3.328 . . . . 0.0 105.01 175.307 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.493 1.715 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.282 -167.418 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.6 t . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -135.91 140.95 44.45 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 124.272 1.029 . . . . 0.0 110.191 179.049 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -86.37 136.92 32.94 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.645 0.778 . . . . 0.0 110.226 174.173 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.253 4.3 tt0 -123.55 100.31 6.74 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 101.352 -3.573 . . . . 0.0 101.352 170.099 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.15 124.41 51.42 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 179.127 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -106.51 132.07 52.94 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 125.406 1.691 . . . . 0.0 107.465 -168.536 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 CA--C 1.583 2.224 0 N-CA-C 100.761 -3.792 . . . . 0.0 100.761 -168.325 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.7 p . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -101.31 140.65 35.31 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 120.342 1.428 . . . . 0.0 110.985 -169.612 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m -105.03 102.95 12.42 Favored 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 100.939 -3.726 . . . . 0.0 100.939 166.137 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -92.47 116.57 29.1 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 -179.38 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -132.39 119.42 20.66 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -168.186 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.89 -169.37 25.13 Favored Glycine 1 CA--C 1.582 4.26 0 CA-C-O 114.482 -3.399 . . . . 0.0 115.585 179.04 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -86.83 160.96 9.03 Favored 'Trans proline' 0 C--N 1.394 2.957 1 CA-C-N 126.898 5.349 . . . . 0.0 114.186 -176.27 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.33 117.71 1.4 Allowed Glycine 0 N--CA 1.479 1.552 0 CA-C-O 117.83 -1.539 . . . . 0.0 110.084 177.68 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.8 m -100.65 83.93 0.43 Allowed Pre-proline 0 CA--C 1.589 2.48 0 CA-C-O 117.275 -1.345 . . . . 0.0 113.717 -177.623 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.31 171.53 10.03 Favored 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 123.123 2.548 . . . . 0.0 113.117 168.157 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.282 9.5 t -93.98 149.43 21.24 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.669 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.62 156.66 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.644 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.788 -165.616 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -7.69 145.01 0.0 OUTLIER Pre-proline 0 CA--C 1.585 2.296 0 N-CA-C 120.752 3.612 . . . . 0.0 120.752 169.405 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--N 1.395 3.02 0 CA-C-N 126.571 3.382 . . . . 0.0 109.464 168.533 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t . . . . . 0 N--CA 1.502 2.141 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.8 p -127.23 107.31 9.89 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 -178.498 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 1.3 tt -65.1 162.69 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 C-N-CA 127.456 2.302 . . . . 0.0 113.349 177.806 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -139.18 118.56 12.83 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 102.918 -2.993 . . . . 0.0 102.918 169.805 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 14.3 t -100.79 128.97 46.62 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.001 -2.818 . . . . 0.0 107.474 168.422 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.283 14.8 pt-20 . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -168.729 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -136.17 137.49 40.98 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 124.183 0.993 . . . . 0.0 110.422 -179.364 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -92.75 135.21 34.31 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.189 0.93 . . . . 0.0 110.215 -178.08 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -115.83 99.82 7.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 100.87 -3.752 . . . . 0.0 100.87 169.318 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.43 122.65 46.44 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -179.922 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.44 134.53 50.35 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 125.652 1.845 . . . . 0.0 106.485 -169.132 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.426 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mp . . . . . 0 CA--C 1.585 2.301 0 N-CA-C 101.136 -3.653 . . . . 0.0 101.136 -167.842 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -119.21 126.5 51.69 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -168.904 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m -97.1 113.45 25.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 -179.293 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.426 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.6 m-85 -103.43 116.07 31.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -179.657 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -133.22 122.73 24.39 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -168.622 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.86 -178.17 40.73 Favored Glycine 1 CA--C 1.58 4.149 0 CA-C-O 114.977 -3.124 . . . . 0.0 116.529 -179.632 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -84.28 158.75 13.03 Favored 'Trans proline' 0 C--N 1.395 3.005 1 CA-C-N 125.929 4.865 . . . . 0.0 113.798 -177.418 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.18 107.33 0.42 Allowed Glycine 0 N--CA 1.483 1.789 0 CA-C-O 116.902 -2.054 . . . . 0.0 110.828 177.071 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.3 m -90.54 98.82 1.65 Allowed Pre-proline 0 CA--C 1.587 2.381 0 CA-C-O 116.121 -1.895 . . . . 0.0 112.4 -169.645 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.79 170.14 18.54 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 123.43 2.754 . . . . 0.0 113.688 169.911 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.16 149.24 29.2 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.078 0.951 . . . . 0.0 111.083 169.388 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.5 m -104.06 147.11 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 124.049 0.939 . . . . 0.0 112.241 -168.064 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.64 163.03 51.18 Favored Pre-proline 0 CA--C 1.588 2.417 0 CA-C-O 115.159 -2.353 . . . . 0.0 112.205 168.95 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.396 3.058 0 CA-C-N 126.948 3.517 . . . . 0.0 113.678 -169.571 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.8 t . . . . . 0 CA--C 1.569 1.701 0 N-CA-C 101.164 -3.643 . . . . 0.0 101.164 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.6 p -129.96 105.12 7.76 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -177.442 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 tt -72.15 161.79 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 112.25 -2.25 . . . . 0.0 113.861 -177.851 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -142.46 104.48 4.41 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 165.835 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.1 t -95.97 108.82 21.25 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 111.58 -2.554 . . . . 0.0 105.923 171.365 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 124.619 1.199 . . . . 0.0 110.598 -167.609 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -139.11 128.29 23.96 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.331 1.053 . . . . 0.0 108.966 179.698 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -87.52 133.8 33.71 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.964 0.79 . . . . 0.0 110.177 179.785 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.98 102.02 8.72 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 101.325 -3.583 . . . . 0.0 101.325 168.257 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.493 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -112.21 121.22 44.31 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 178.036 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -107.17 130.91 54.65 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 125.128 1.517 . . . . 0.0 107.037 -168.767 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.4 mp . . . . . 0 CA--C 1.582 2.176 0 N-CA-C 100.743 -3.799 . . . . 0.0 100.743 -167.928 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -99.73 139.57 35.2 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 120.737 1.608 . . . . 0.0 110.971 -169.571 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.2 m -106.11 102.35 11.78 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 100.962 -3.718 . . . . 0.0 100.962 166.483 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -93.27 116.67 29.23 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 -179.559 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -132.82 121.94 23.71 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -167.838 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.4 -162.57 19.47 Favored Glycine 1 CA--C 1.58 4.108 0 CA-C-O 114.675 -3.291 . . . . 0.0 115.822 178.009 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -86.22 161.92 9.94 Favored 'Trans proline' 0 C--N 1.394 2.93 1 CA-C-N 126.354 5.077 . . . . 0.0 113.868 -177.832 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.61 117.22 1.22 Allowed Glycine 0 N--CA 1.479 1.52 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.295 174.292 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -101.7 84.58 0.56 Allowed Pre-proline 0 CA--C 1.588 2.416 0 CA-C-O 116.913 -1.518 . . . . 0.0 111.621 -179.169 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.18 174.03 7.43 Favored 'Trans proline' 0 C--N 1.39 2.733 0 C-N-CA 123.253 2.635 . . . . 0.0 114.116 171.2 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 p -77.95 147.11 35.11 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.484 1.113 . . . . 0.0 110.056 167.223 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 30.1 m -139.64 151.66 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 123.526 0.516 . . . . 0.0 112.07 -174.2 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -14.46 146.18 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.272 0 CA-C-O 112.685 -3.531 . . . . 0.0 119.939 169.904 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 C--N 1.394 2.969 0 CA-C-N 126.624 3.401 . . . . 0.0 109.473 168.413 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.502 2.149 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 p -121.85 105.35 10.28 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 -175.756 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.27 1.5 tt -68.11 163.75 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 CA-C-N 111.774 -2.466 . . . . 0.0 113.202 -179.797 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -139.75 118.04 12.03 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 168.697 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.2 t -97.6 114.52 26.46 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 111.416 -2.629 . . . . 0.0 106.776 169.499 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.493 1.72 0 C-N-CA 123.825 0.85 . . . . 0.0 109.052 -169.039 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -139.81 127.45 21.74 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.31 1.044 . . . . 0.0 108.766 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -85.66 130.15 34.64 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.733 0.813 . . . . 0.0 110.259 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.269 7.2 tt0 -114.39 98.28 6.82 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 101.152 -3.647 . . . . 0.0 101.152 169.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.11 120.97 43.63 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -106.95 135.38 48.6 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 125.54 1.775 . . . . 0.0 106.588 -169.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mp -133.17 98.69 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.278 0 N-CA-C 101.382 -3.562 . . . . 0.0 101.382 -167.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t -118.66 7.5 11.72 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -116.45 125.71 52.38 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -168.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.09 115.96 28.44 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.424 ' CD1' HD13 ' A' ' 7' ' ' ILE . 91.3 m-85 -105.22 112.94 26.25 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -127.33 119.07 25.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 -169.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.37 -163.12 16.7 Favored Glycine 1 CA--C 1.58 4.119 0 CA-C-O 114.475 -3.403 . . . . 0.0 115.999 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -87.45 161.53 8.14 Favored 'Trans proline' 0 C--N 1.394 2.969 1 CA-C-N 126.679 5.239 . . . . 0.0 114.076 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.53 118.48 1.51 Allowed Glycine 0 N--CA 1.48 1.575 0 CA-C-O 118.021 -1.433 . . . . 0.0 110.018 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.0 m -100.74 84.46 0.47 Allowed Pre-proline 0 CA--C 1.588 2.421 0 CA-C-O 117.001 -1.476 . . . . 0.0 112.965 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -81.92 176.66 8.09 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 123.231 2.621 . . . . 0.0 112.725 168.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.29 10.0 t -98.96 157.54 16.25 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 123.791 0.836 . . . . 0.0 109.568 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 m -123.81 159.69 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 C-N-CA 124.487 1.115 . . . . 0.0 111.981 -166.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 164.2 58.8 Favored Pre-proline 0 CA--C 1.584 2.278 0 CA-C-O 115.252 -2.309 . . . . 0.0 114.686 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -63.85 129.02 23.45 Favored 'Trans proline' 0 C--N 1.399 3.23 0 CA-C-N 126.239 3.264 . . . . 0.0 112.945 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.8 t -78.08 138.41 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -142.58 108.31 5.12 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.263 1.3 tt -71.62 160.37 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.843 0 C-N-CA 126.972 2.109 . . . . 0.0 112.75 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -141.82 120.0 12.18 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 102.21 -3.256 . . . . 0.0 102.21 169.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.1 t -97.28 115.09 27.01 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.103 169.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 124.084 0.865 . . . . 0.0 109.126 -169.311 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -146.45 127.98 15.07 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -87.56 125.95 34.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.805 0.842 . . . . 0.0 109.804 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.271 8.3 tt0 -110.37 96.9 6.5 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 101.34 -3.578 . . . . 0.0 101.34 168.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.96 120.5 42.6 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.16 135.72 48.22 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 125.514 1.759 . . . . 0.0 106.615 -169.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mp -133.56 98.65 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.276 0 N-CA-C 101.372 -3.566 . . . . 0.0 101.372 -167.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.6 t -119.24 6.38 11.22 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -114.87 125.42 53.64 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.27 116.25 29.14 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.421 ' CD1' HD13 ' A' ' 7' ' ' ILE . 93.0 m-85 -105.78 112.94 26.21 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -127.36 120.67 29.05 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -169.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.75 -158.6 12.9 Favored Glycine 1 CA--C 1.579 4.04 0 CA-C-O 114.368 -3.462 . . . . 0.0 116.132 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -88.42 161.2 6.74 Favored 'Trans proline' 0 C--N 1.395 2.989 1 CA-C-N 126.571 5.186 . . . . 0.0 114.212 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.02 118.39 1.39 Allowed Glycine 0 N--CA 1.479 1.559 0 CA-C-O 117.981 -1.455 . . . . 0.0 110.197 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.9 m -100.69 85.71 0.59 Allowed Pre-proline 0 CA--C 1.588 2.417 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.456 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -82.4 175.45 8.94 Favored 'Trans proline' 0 C--N 1.391 2.81 0 C-N-CA 123.444 2.763 . . . . 0.0 113.739 170.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -75.71 158.13 32.7 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.727 1.211 . . . . 0.0 112.018 168.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 13.3 m -135.46 152.87 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.185 0.594 . . . . 0.0 111.609 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 167.79 32.1 Favored Pre-proline 0 CA--C 1.586 2.341 0 CA-C-O 114.998 -2.43 . . . . 0.0 113.939 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.84 126.59 13.43 Favored 'Trans proline' 0 C--N 1.4 3.263 0 CA-C-N 126.961 3.522 . . . . 0.0 111.349 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.67 130.01 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 174.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -140.69 109.64 6.08 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 123.3 1.524 . . . . 0.0 107.827 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.273 1.1 tt -70.54 163.4 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 109.686 -3.416 . . . . 0.0 113.192 -173.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -141.43 115.21 9.09 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 168.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.8 t -94.67 116.51 28.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 111.582 -2.553 . . . . 0.0 107.242 170.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 N--CA 1.494 1.729 0 C-N-CA 123.988 0.915 . . . . 0.0 109.774 -168.517 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -140.04 125.23 18.74 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.292 1.037 . . . . 0.0 108.58 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.35 126.08 34.09 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 124.12 0.888 . . . . 0.0 110.11 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.266 9.0 tt0 -110.76 98.91 7.94 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 100.932 -3.729 . . . . 0.0 100.932 168.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.85 107.99 16.47 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 103.763 -2.681 . . . . 0.0 103.763 -176.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -97.25 126.72 42.64 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 125.466 1.729 . . . . 0.0 106.856 -167.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mm -113.43 88.9 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 -167.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.2 p -121.54 -6.86 9.2 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.588 -1.187 . . . . 0.0 114.098 169.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -94.38 127.17 40.1 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.353 1.061 . . . . 0.0 108.59 -169.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -100.8 111.28 23.47 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -103.54 119.11 38.24 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -135.62 119.19 17.0 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -170.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.04 -158.11 13.4 Favored Glycine 1 CA--C 1.579 4.048 0 CA-C-O 114.401 -3.444 . . . . 0.0 115.713 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -87.14 161.92 8.6 Favored 'Trans proline' 0 C--N 1.393 2.901 1 CA-C-N 126.597 5.198 . . . . 0.0 114.016 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.87 116.08 1.4 Allowed Glycine 0 N--CA 1.48 1.568 0 CA-C-O 118.106 -1.385 . . . . 0.0 110.381 174.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.4 m -101.46 85.78 0.68 Allowed Pre-proline 0 CA--C 1.587 2.371 0 CA-C-O 116.697 -1.62 . . . . 0.0 111.102 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -82.37 173.01 11.06 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 123.252 2.635 . . . . 0.0 113.771 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -75.61 154.78 36.45 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.575 1.15 . . . . 0.0 111.948 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.272 18.0 m -137.17 154.0 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 O-C-N 123.5 0.5 . . . . 0.0 111.856 -173.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 168.08 30.83 Favored Pre-proline 0 CA--C 1.588 2.423 0 CA-C-O 114.91 -2.471 . . . . 0.0 114.187 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.2 130.78 18.09 Favored 'Trans proline' 0 C--N 1.399 3.236 0 CA-C-N 126.982 3.529 . . . . 0.0 111.84 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.1 t -77.21 121.99 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 170.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.8 p -136.26 109.17 7.61 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 102.42 -3.178 . . . . 0.0 102.42 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.259 0.8 OUTLIER -68.79 162.33 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.858 0 C-N-CA 126.745 2.018 . . . . 0.0 113.488 -174.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -138.07 113.85 9.8 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 167.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.8 t -97.96 111.48 23.77 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.139 170.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 124.231 0.957 . . . . 0.0 109.572 -168.605 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.04 129.11 25.21 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.338 1.055 . . . . 0.0 108.92 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -85.84 131.38 34.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.654 0.782 . . . . 0.0 110.45 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.269 7.1 tt0 -116.19 98.33 6.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 100.928 -3.73 . . . . 0.0 100.928 169.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.16 121.28 44.5 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.19 135.16 49.2 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 125.511 1.757 . . . . 0.0 106.681 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.411 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.7 mp -133.2 98.72 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.312 0 N-CA-C 101.461 -3.533 . . . . 0.0 101.461 -167.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t -118.37 7.94 12.07 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -116.77 125.54 51.78 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -168.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -97.05 115.67 27.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.411 ' CD1' HD13 ' A' ' 7' ' ' ILE . 90.2 m-85 -104.84 112.86 26.13 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -127.31 118.8 24.9 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -169.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.19 -165.11 19.76 Favored Glycine 1 CA--C 1.58 4.126 0 CA-C-O 114.482 -3.399 . . . . 0.0 115.911 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -86.57 161.48 9.42 Favored 'Trans proline' 0 C--N 1.394 2.927 1 CA-C-N 126.697 5.248 . . . . 0.0 113.928 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 117.91 1.46 Allowed Glycine 0 N--CA 1.479 1.511 0 CA-C-O 117.964 -1.464 . . . . 0.0 110.057 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.8 m -100.65 84.51 0.47 Allowed Pre-proline 0 CA--C 1.587 2.389 0 CA-C-O 117.038 -1.458 . . . . 0.0 112.909 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -82.21 173.78 10.54 Favored 'Trans proline' 0 C--N 1.389 2.684 0 C-N-CA 123.16 2.573 . . . . 0.0 112.898 168.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.288 9.0 t -95.43 157.27 15.97 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 123.547 0.739 . . . . 0.0 109.288 167.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.6 m -125.68 158.55 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 124.19 0.996 . . . . 0.0 112.363 -166.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -67.76 -176.24 0.26 Allowed Pre-proline 0 CA--C 1.599 2.844 0 N-CA-C 117.662 2.468 . . . . 0.0 117.662 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -77.51 124.84 7.25 Favored 'Trans proline' 0 C--N 1.399 3.235 0 C-N-CA 123.866 3.044 . . . . 0.0 110.816 172.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.85 140.61 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -143.34 108.45 4.98 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.268 1.3 tt -71.32 161.9 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 C-N-CA 127.12 2.168 . . . . 0.0 112.82 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -141.84 122.01 13.84 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 102.21 -3.255 . . . . 0.0 102.21 168.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.8 t -97.56 115.1 27.21 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 111.813 -2.449 . . . . 0.0 107.138 169.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.246 -0.883 . . . . 0.0 108.641 -169.36 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -142.15 124.66 15.76 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.3 1.04 . . . . 0.0 108.521 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -85.14 130.94 34.51 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 117.818 -1.087 . . . . 0.0 110.672 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.276 4.9 tt0 -114.52 95.18 5.13 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 171.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.79 122.38 47.68 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -106.97 135.0 49.28 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 125.575 1.797 . . . . 0.0 106.655 -169.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.51 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.6 mp -131.17 98.08 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.352 0 N-CA-C 100.722 -3.807 . . . . 0.0 100.722 -167.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t -119.69 6.88 10.98 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 169.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -116.6 125.37 51.73 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -168.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -96.98 116.91 30.04 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.51 ' CD1' HD13 ' A' ' 7' ' ' ILE . 83.9 m-85 -104.67 112.35 25.4 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -127.6 120.75 28.83 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -169.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.51 -163.58 24.79 Favored Glycine 1 CA--C 1.58 4.115 0 CA-C-O 114.521 -3.377 . . . . 0.0 116.29 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -89.98 160.86 4.94 Favored 'Trans proline' 0 C--N 1.395 2.98 1 CA-C-N 126.43 5.115 . . . . 0.0 114.455 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.14 110.44 0.69 Allowed Glycine 0 N--CA 1.483 1.797 0 CA-C-O 117.46 -1.745 . . . . 0.0 110.495 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.3 m -97.98 94.99 2.43 Favored Pre-proline 0 CA--C 1.588 2.427 0 CA-C-O 116.224 -1.846 . . . . 0.0 112.972 -169.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.29 175.65 9.49 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 123.327 2.684 . . . . 0.0 113.581 169.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -76.95 160.06 29.47 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.658 1.183 . . . . 0.0 112.128 168.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.5 m -135.49 151.5 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 123.264 0.625 . . . . 0.0 111.806 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.14 166.65 38.89 Favored Pre-proline 0 CA--C 1.586 2.361 0 CA-C-O 115.094 -2.384 . . . . 0.0 113.678 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.93 128.84 15.47 Favored 'Trans proline' 0 C--N 1.399 3.187 0 CA-C-N 126.82 3.471 . . . . 0.0 111.647 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.4 t -80.27 120.22 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 174.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.1 p -130.2 105.99 8.29 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.263 1.9 tt -67.69 162.6 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 CA-C-N 111.95 -2.386 . . . . 0.0 114.357 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -143.21 102.31 3.96 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 168.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.3 t -89.55 93.82 9.63 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 112.204 -2.271 . . . . 0.0 105.412 169.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.108 -165.544 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 CA--C 1.544 0.75 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -143.77 124.88 14.47 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -88.06 135.8 33.26 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 124.127 0.892 . . . . 0.0 110.498 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -117.99 98.87 6.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 101.076 -3.675 . . . . 0.0 101.076 170.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.53 124.05 51.48 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 m -107.91 133.32 52.43 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -169.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.437 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.9 mp -131.0 97.81 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.328 0 N-CA-C 100.925 -3.731 . . . . 0.0 100.925 -167.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -118.71 8.85 11.96 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -117.69 125.67 51.1 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -169.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -96.71 113.07 24.6 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.437 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.8 m-85 -102.84 117.5 34.76 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -134.93 120.95 19.85 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -168.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.41 -171.88 36.25 Favored Glycine 1 CA--C 1.581 4.159 0 CA-C-O 114.721 -3.266 . . . . 0.0 116.279 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -88.73 158.45 6.24 Favored 'Trans proline' 0 C--N 1.396 3.027 1 CA-C-N 126.364 5.082 . . . . 0.0 114.295 -177.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.76 106.58 0.63 Allowed Glycine 0 N--CA 1.484 1.873 0 CA-C-O 117.196 -1.891 . . . . 0.0 110.579 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.8 m -93.48 98.49 2.58 Favored Pre-proline 0 CA--C 1.588 2.438 0 CA-C-O 116.168 -1.872 . . . . 0.0 113.008 -169.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.01 173.44 12.71 Favored 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 123.401 2.734 . . . . 0.0 113.673 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.94 159.24 31.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.483 1.113 . . . . 0.0 112.371 168.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 11.0 m -133.98 152.84 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 CA-C-O 121.422 0.63 . . . . 0.0 112.695 -169.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.24 165.47 27.96 Favored Pre-proline 0 CA--C 1.581 2.15 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.97 108.26 2.55 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 123.148 2.565 . . . . 0.0 110.033 169.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.6 t -77.11 122.07 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.8 p -132.26 106.19 7.78 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.5 tt -69.33 160.78 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.835 0 CA-C-N 111.904 -2.407 . . . . 0.0 114.023 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -139.31 102.94 4.61 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 167.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 t -98.66 113.67 25.83 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 110.87 -2.877 . . . . 0.0 105.816 170.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.297 10.2 pt-20 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -167.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.8 127.41 21.7 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.345 1.058 . . . . 0.0 108.835 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -87.42 128.41 35.21 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 124.037 0.836 . . . . 0.0 110.096 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.25 8.2 tt0 -112.34 98.38 7.25 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 100.734 -3.802 . . . . 0.0 100.734 168.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.56 120.15 41.48 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -106.98 134.74 49.67 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 125.409 1.693 . . . . 0.0 106.523 -168.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.414 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.6 mp -132.97 98.57 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.294 0 N-CA-C 101.442 -3.54 . . . . 0.0 101.442 -167.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t -119.36 6.85 11.15 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -114.75 125.09 53.3 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -168.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.23 113.4 25.0 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.414 ' CD1' HD13 ' A' ' 7' ' ' ILE . 93.2 m-85 -103.81 115.03 29.72 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -131.17 120.23 23.01 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -168.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.5 -158.52 12.61 Favored Glycine 1 CA--C 1.579 4.049 0 CA-C-O 114.361 -3.466 . . . . 0.0 115.836 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -89.04 161.37 5.87 Favored 'Trans proline' 0 C--N 1.394 2.955 1 CA-C-N 126.719 5.259 . . . . 0.0 114.294 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.15 117.19 1.33 Allowed Glycine 0 N--CA 1.479 1.563 0 CA-C-O 117.965 -1.464 . . . . 0.0 110.277 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.4 m -100.96 85.82 0.62 Allowed Pre-proline 0 CA--C 1.588 2.412 0 CA-C-O 116.697 -1.62 . . . . 0.0 111.589 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -82.86 176.13 7.97 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.378 2.719 . . . . 0.0 113.73 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -74.63 158.01 34.39 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.72 1.208 . . . . 0.0 111.941 168.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.258 15.4 m -135.62 156.08 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 C-N-CA 122.93 0.492 . . . . 0.0 112.212 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -76.95 -179.29 1.17 Allowed Pre-proline 0 CA--C 1.593 2.598 0 CA-C-O 115.543 -2.17 . . . . 0.0 115.79 -170.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.08 114.25 3.99 Favored 'Trans proline' 0 C--N 1.404 3.469 0 C-N-CA 123.902 3.068 . . . . 0.0 110.251 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -77.7 135.03 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.9 p -141.41 108.81 5.55 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.274 1.2 tt -69.98 164.37 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 127.046 2.138 . . . . 0.0 113.256 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -140.83 114.89 9.15 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 101.734 -3.432 . . . . 0.0 101.734 167.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.5 t -97.44 111.84 23.93 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 111.579 -2.555 . . . . 0.0 106.292 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 N--CA 1.494 1.756 0 O-C-N 124.184 0.927 . . . . 0.0 109.172 -168.709 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -148.04 124.34 10.89 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -87.06 124.61 33.41 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.933 0.893 . . . . 0.0 109.773 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.258 8.9 tt0 -109.28 97.04 6.71 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 101.382 -3.562 . . . . 0.0 101.382 168.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.465 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.9 120.79 43.28 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 178.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -107.94 131.31 54.67 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 -169.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.489 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.2 mp -128.66 97.11 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.331 0 N-CA-C 100.463 -3.903 . . . . 0.0 100.463 -167.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 t -120.67 5.43 10.55 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -113.15 124.75 53.28 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -168.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.0 m -96.78 113.8 25.38 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -176.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.489 ' CD1' HD13 ' A' ' 7' ' ' ILE . 87.1 m-85 -104.09 115.2 30.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -131.19 120.98 24.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -168.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.51 -156.93 11.28 Favored Glycine 1 CA--C 1.58 4.143 0 CA-C-O 114.229 -3.54 . . . . 0.0 115.911 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.22 161.09 4.7 Favored 'Trans proline' 0 C--N 1.395 2.992 1 CA-C-N 126.799 5.299 . . . . 0.0 114.534 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.72 119.35 1.62 Allowed Glycine 0 N--CA 1.479 1.507 0 CA-C-O 118.034 -1.426 . . . . 0.0 110.33 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.2 t -98.1 87.49 0.55 Allowed Pre-proline 0 CA--C 1.591 2.524 0 CA-C-O 116.503 -1.713 . . . . 0.0 112.325 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.71 175.62 9.24 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 123.414 2.742 . . . . 0.0 113.426 169.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 p -77.62 158.24 29.87 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.638 1.175 . . . . 0.0 111.828 168.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.259 15.7 m -136.9 156.09 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 122.999 0.52 . . . . 0.0 112.23 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -76.89 -179.31 1.17 Allowed Pre-proline 0 CA--C 1.593 2.608 0 CA-C-O 115.631 -2.128 . . . . 0.0 115.742 -171.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.99 116.69 4.82 Favored 'Trans proline' 0 C--N 1.405 3.504 0 C-N-CA 123.97 3.114 . . . . 0.0 110.365 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.7 t -77.22 132.35 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -140.87 108.89 5.72 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.265 1.3 tt -69.84 160.89 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.836 0 C-N-CA 127.036 2.134 . . . . 0.0 113.353 -177.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -139.22 109.25 6.38 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 168.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.8 m -98.11 106.91 19.27 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 110.229 -3.168 . . . . 0.0 104.679 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.736 0 C-N-CA 124.307 1.043 . . . . 0.0 111.033 -167.246 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -147.86 125.46 11.77 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -83.55 122.79 29.03 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 117.82 -1.086 . . . . 0.0 109.988 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.265 8.4 tt0 -109.25 95.94 5.96 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 102.123 -3.288 . . . . 0.0 102.123 170.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.529 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -109.73 120.77 43.51 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.47 130.82 54.8 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 125.423 1.702 . . . . 0.0 106.648 -169.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.529 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.3 mp -135.88 96.18 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.185 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -167.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.7 p -78.46 -18.17 55.25 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 169.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -98.41 139.38 34.24 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 120.259 1.391 . . . . 0.0 111.155 -169.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.5 m -107.14 102.96 12.25 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 100.922 -3.733 . . . . 0.0 100.922 166.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -93.49 113.71 25.91 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -129.44 120.99 26.41 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -168.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.71 -160.81 18.88 Favored Glycine 1 CA--C 1.579 4.036 0 CA-C-O 114.522 -3.377 . . . . 0.0 116.022 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -86.74 163.37 9.17 Favored 'Trans proline' 0 C--N 1.393 2.911 1 CA-C-N 126.584 5.192 . . . . 0.0 114.023 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.18 119.87 1.79 Allowed Glycine 0 C--N 1.354 1.57 0 CA-C-O 118.01 -1.439 . . . . 0.0 110.019 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.6 t -97.86 87.87 0.57 Allowed Pre-proline 0 CA--C 1.591 2.526 0 CA-C-O 116.452 -1.737 . . . . 0.0 112.206 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -81.8 173.83 10.85 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.373 2.716 . . . . 0.0 113.504 169.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 p -79.44 158.78 27.25 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.578 1.151 . . . . 0.0 111.626 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.251 15.2 m -136.46 151.58 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.15 0.58 . . . . 0.0 111.492 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.67 166.71 40.66 Favored Pre-proline 0 CA--C 1.588 2.406 0 CA-C-O 114.949 -2.453 . . . . 0.0 114.043 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.09 130.29 17.48 Favored 'Trans proline' 0 C--N 1.4 3.275 0 CA-C-N 126.998 3.535 . . . . 0.0 111.627 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t -78.72 128.13 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 173.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -137.19 106.86 6.18 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.273 1.3 tt -69.24 165.55 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.955 0 CA-C-N 112.265 -2.243 . . . . 0.0 113.696 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -144.08 108.86 4.92 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 168.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 76.1 m -94.13 97.67 10.45 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 . . . . . 0 N--CA 1.491 1.615 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.808 -165.318 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -138.63 131.56 29.56 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.354 1.062 . . . . 0.0 109.058 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -85.74 136.24 33.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.644 0.778 . . . . 0.0 110.418 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.267 4.7 tt0 -120.97 98.9 6.21 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 169.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.6 122.79 47.59 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.25 135.67 48.37 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 125.671 1.857 . . . . 0.0 106.924 -169.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.431 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.6 mp -132.75 98.51 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.28 0 N-CA-C 101.271 -3.603 . . . . 0.0 101.271 -167.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 t -116.64 11.85 14.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 169.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -122.26 126.59 48.5 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -168.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -96.79 116.39 29.06 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.431 ' CD1' HD13 ' A' ' 7' ' ' ILE . 82.4 m-85 -105.06 113.57 27.25 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -128.58 122.49 31.14 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -169.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.05 -163.9 16.81 Favored Glycine 1 CA--C 1.58 4.151 0 CA-C-O 114.461 -3.41 . . . . 0.0 115.833 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -87.83 160.47 7.57 Favored 'Trans proline' 0 C--N 1.395 2.988 1 CA-C-N 126.709 5.254 . . . . 0.0 114.108 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.91 118.31 1.36 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-O 118.018 -1.435 . . . . 0.0 110.194 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -101.88 83.09 0.44 Allowed Pre-proline 0 CA--C 1.589 2.461 0 CA-C-O 117.239 -1.362 . . . . 0.0 113.263 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -84.92 172.83 8.53 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.105 2.537 . . . . 0.0 113.312 168.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.28 9.3 t -94.14 148.68 21.94 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 166.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.72 156.78 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 C-N-CA 123.343 0.657 . . . . 0.0 111.75 -165.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -8.24 145.09 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.272 0 N-CA-C 120.74 3.607 . . . . 0.0 120.74 169.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.93 116.57 4.63 Favored 'Trans proline' 0 C--N 1.396 3.051 0 CA-C-N 126.6 3.393 . . . . 0.0 109.557 168.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.83 118.87 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -125.39 106.31 9.72 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.269 1.3 tt -67.11 162.24 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 CA-C-N 112.087 -2.324 . . . . 0.0 113.322 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -140.59 124.09 16.93 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 102.264 -3.236 . . . . 0.0 102.264 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.4 t -97.43 116.08 28.96 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.776 -2.466 . . . . 0.0 107.477 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -169.485 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -147.61 125.55 12.01 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -85.63 126.93 34.3 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.89 0.876 . . . . 0.0 110.069 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.274 5.5 tt0 -111.4 97.13 6.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 101.484 -3.524 . . . . 0.0 101.484 169.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.444 ' CE2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -110.06 121.5 45.4 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 179.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -107.68 131.68 54.14 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -169.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.511 HD13 ' CD1' ' A' ' 12' ' ' PHE . 2.9 mp -127.94 97.23 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.38 0 N-CA-C 100.302 -3.962 . . . . 0.0 100.302 -167.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.5 t -120.63 5.99 10.55 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 170.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -114.75 125.11 53.33 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -168.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -96.72 117.2 30.52 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.511 ' CD1' HD13 ' A' ' 7' ' ' ILE . 82.5 m-85 -105.79 113.46 27.02 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -127.8 120.29 27.53 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -169.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.21 -160.1 13.91 Favored Glycine 1 CA--C 1.58 4.125 0 CA-C-O 114.349 -3.473 . . . . 0.0 116.321 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -88.68 161.32 6.37 Favored 'Trans proline' 0 C--N 1.395 2.987 1 CA-C-N 126.632 5.216 . . . . 0.0 114.276 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.62 119.8 1.65 Allowed Glycine 0 N--CA 1.48 1.603 0 CA-C-O 118.008 -1.44 . . . . 0.0 110.133 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.3 t -98.53 86.27 0.47 Allowed Pre-proline 0 CA--C 1.591 2.554 0 CA-C-O 116.569 -1.681 . . . . 0.0 113.001 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -81.08 178.06 7.24 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.174 2.583 . . . . 0.0 112.117 166.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.299 11.2 t -103.94 158.16 16.6 Favored 'General case' 0 N--CA 1.504 2.275 0 C-N-CA 123.868 0.867 . . . . 0.0 109.818 168.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.2 m -125.91 160.05 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.56 0 C-N-CA 124.506 1.122 . . . . 0.0 111.982 -166.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 164.73 56.18 Favored Pre-proline 0 CA--C 1.585 2.304 0 CA-C-O 115.278 -2.296 . . . . 0.0 114.675 177.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -64.05 129.88 25.75 Favored 'Trans proline' 0 C--N 1.4 3.257 0 CA-C-N 126.218 3.256 . . . . 0.0 113.002 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.0 t -77.2 135.62 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.4 p -142.8 108.96 5.23 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.264 1.4 tt -71.07 158.43 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 C-N-CA 127.033 2.133 . . . . 0.0 112.848 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -141.84 115.06 8.82 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 102.716 -3.068 . . . . 0.0 102.716 169.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 73.7 m -97.0 112.38 24.17 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 110.552 -3.022 . . . . 0.0 105.841 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.752 0 C-N-CA 124.18 0.992 . . . . 0.0 110.472 -167.853 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -139.5 128.11 23.11 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.348 1.059 . . . . 0.0 108.946 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -88.27 135.57 33.39 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 123.994 0.808 . . . . 0.0 110.471 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.266 4.2 tt0 -118.25 97.46 5.79 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 101.259 -3.608 . . . . 0.0 101.259 169.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.26 122.41 47.66 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -107.33 136.12 47.69 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 125.513 1.758 . . . . 0.0 106.818 -169.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.419 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.7 mp -133.71 98.78 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.314 0 N-CA-C 101.407 -3.553 . . . . 0.0 101.407 -167.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.7 t -117.97 8.65 12.59 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -118.19 125.84 51.0 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -168.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.8 m -97.14 116.78 29.97 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.419 ' CD1' HD13 ' A' ' 7' ' ' ILE . 87.9 m-85 -105.38 112.95 26.24 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -127.63 121.36 30.27 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -169.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.15 -156.79 11.48 Favored Glycine 1 CA--C 1.579 4.077 0 CA-C-O 114.309 -3.495 . . . . 0.0 115.989 177.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -91.02 160.73 3.91 Favored 'Trans proline' 0 C--N 1.395 3.016 1 CA-C-N 126.568 5.184 . . . . 0.0 114.628 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.66 115.49 0.97 Allowed Glycine 0 N--CA 1.481 1.634 0 CA-C-O 117.799 -1.556 . . . . 0.0 110.457 174.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.6 m -100.66 87.16 0.76 Allowed Pre-proline 0 CA--C 1.589 2.467 0 CA-C-O 116.676 -1.63 . . . . 0.0 111.663 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.61 173.94 10.08 Favored 'Trans proline' 0 C--N 1.391 2.781 0 C-N-CA 123.399 2.733 . . . . 0.0 113.887 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.71 156.17 38.19 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.536 1.134 . . . . 0.0 112.426 168.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.268 14.1 m -135.6 155.67 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.664 0.745 . . . . 0.0 112.813 -169.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -69.39 165.52 39.14 Favored Pre-proline 0 CA--C 1.58 2.112 0 CA-C-O 115.64 -2.124 . . . . 0.0 116.731 -171.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -68.6 102.72 0.88 Allowed 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 123.772 2.981 . . . . 0.0 109.858 168.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.9 129.03 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -139.11 108.88 6.26 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 123.794 1.759 . . . . 0.0 108.187 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.262 2.1 tt -70.11 162.91 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.826 0 CA-C-N 109.098 -3.683 . . . . 0.0 113.739 -174.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -140.83 111.0 6.63 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 167.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.2 t -96.1 112.41 24.15 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 111.615 -2.539 . . . . 0.0 106.338 172.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 124.207 0.942 . . . . 0.0 110.177 -168.361 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -142.76 125.45 15.92 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.296 1.038 . . . . 0.0 108.57 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -82.83 120.62 25.87 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 117.814 -1.089 . . . . 0.0 109.622 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.278 9.7 tt0 -106.53 95.92 6.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 102.249 -3.241 . . . . 0.0 102.249 169.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.452 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.49 118.77 37.59 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.73 131.76 54.09 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -169.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.452 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.1 mp -129.59 98.09 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.324 0 N-CA-C 100.919 -3.734 . . . . 0.0 100.919 -167.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -120.31 3.48 10.83 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 169.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -111.02 124.96 53.19 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -168.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -97.06 113.36 24.91 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.406 ' CD1' HD13 ' A' ' 7' ' ' ILE . 91.9 m-85 -104.25 114.36 28.54 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -130.09 120.07 24.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -168.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.0 -163.96 21.79 Favored Glycine 1 CA--C 1.579 4.083 0 CA-C-O 114.542 -3.365 . . . . 0.0 115.848 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -87.32 162.06 8.34 Favored 'Trans proline' 0 C--N 1.394 2.93 1 CA-C-N 126.668 5.234 . . . . 0.0 113.996 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.91 116.03 1.41 Allowed Glycine 0 N--CA 1.479 1.541 0 CA-C-O 118.07 -1.406 . . . . 0.0 110.228 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.0 m -103.63 84.16 0.74 Allowed Pre-proline 0 CA--C 1.587 2.395 0 CA-C-O 116.952 -1.499 . . . . 0.0 111.613 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -85.11 173.63 7.78 Favored 'Trans proline' 0 C--N 1.39 2.728 0 C-N-CA 123.247 2.632 . . . . 0.0 114.064 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 p -78.13 146.69 34.97 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.468 1.107 . . . . 0.0 110.216 167.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.259 30.9 m -139.47 152.65 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 O-C-N 123.6 0.562 . . . . 0.0 112.083 -172.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -17.3 146.61 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.263 0 CA-C-O 112.746 -3.502 . . . . 0.0 119.774 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.03 117.31 4.64 Favored 'Trans proline' 0 C--N 1.394 2.961 0 CA-C-N 126.667 3.417 . . . . 0.0 109.664 168.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.68 115.8 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.5 p -118.97 104.42 10.48 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.297 1.3 tt -66.79 165.7 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.857 0 CA-C-N 111.639 -2.528 . . . . 0.0 113.644 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -142.94 112.69 6.94 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 103.373 -2.825 . . . . 0.0 103.373 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.7 t -94.94 98.32 10.62 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 168.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 . . . . . 0 N--CA 1.493 1.705 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.241 -166.11 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -142.47 124.09 14.98 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.287 1.035 . . . . 0.0 108.286 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -83.49 121.66 27.49 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.822 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.293 9.9 tt0 -108.71 95.88 5.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 101.994 -3.335 . . . . 0.0 101.994 169.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.97 108.14 17.37 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -175.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -95.79 127.15 41.57 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 113.218 -1.81 . . . . 0.0 107.195 -167.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mm -118.6 87.28 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.108 0 N-CA-C 102.818 -3.03 . . . . 0.0 102.818 -167.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -89.19 -16.71 30.7 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 169.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.24 139.92 30.0 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.494 1.117 . . . . 0.0 110.458 -170.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -111.18 110.56 21.12 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 102.788 -3.041 . . . . 0.0 102.788 169.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -99.04 115.55 29.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -128.13 122.16 31.31 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -173.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.68 -160.14 17.18 Favored Glycine 1 CA--C 1.578 4.012 0 CA-C-O 114.496 -3.391 . . . . 0.0 115.659 176.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -86.97 162.68 8.86 Favored 'Trans proline' 0 C--N 1.392 2.837 1 CA-C-N 126.602 5.201 . . . . 0.0 113.952 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.43 115.38 1.49 Allowed Glycine 0 N--CA 1.48 1.608 0 CA-C-O 117.943 -1.476 . . . . 0.0 110.238 174.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.9 m -102.11 85.79 0.77 Allowed Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 116.721 -1.609 . . . . 0.0 111.247 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.34 172.98 11.11 Favored 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 123.333 2.688 . . . . 0.0 113.804 171.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -76.58 155.1 33.86 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.582 1.153 . . . . 0.0 111.885 168.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.272 18.0 m -137.93 154.75 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 C-N-CA 122.968 0.507 . . . . 0.0 112.004 -174.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 168.49 27.55 Favored Pre-proline 0 CA--C 1.588 2.423 0 CA-C-O 114.945 -2.455 . . . . 0.0 114.246 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.35 130.74 17.86 Favored 'Trans proline' 0 C--N 1.399 3.22 0 CA-C-N 126.878 3.492 . . . . 0.0 111.726 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.1 t -77.34 122.62 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 170.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.0 p -136.59 108.88 7.29 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.28 0.8 OUTLIER -68.92 166.1 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.878 0 C-N-CA 126.782 2.033 . . . . 0.0 113.89 -173.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -140.2 110.71 6.72 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 102.717 -3.068 . . . . 0.0 102.717 168.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.6 t -96.09 98.82 10.65 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 N--CA 1.492 1.67 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.332 -165.998 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -146.25 128.3 15.57 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -87.39 126.07 34.65 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.733 0.813 . . . . 0.0 109.993 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.253 8.6 tt0 -110.44 97.84 7.19 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 101.026 -3.694 . . . . 0.0 101.026 168.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.8 120.14 41.4 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.543 -2.392 . . . . 0.0 104.543 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -107.03 134.87 49.53 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 125.46 1.725 . . . . 0.0 106.552 -169.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.425 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.4 mp -132.48 98.25 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.27 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 -167.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m -120.66 3.41 10.66 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -111.0 125.23 53.51 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -168.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -97.24 113.42 25.03 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CD1' HD13 ' A' ' 7' ' ' ILE . 93.4 m-85 -103.74 114.82 29.36 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -130.85 120.44 23.68 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -168.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.08 -158.12 12.56 Favored Glycine 1 CA--C 1.579 4.067 0 CA-C-O 114.399 -3.445 . . . . 0.0 115.945 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -88.54 161.45 6.58 Favored 'Trans proline' 0 C--N 1.394 2.956 1 CA-C-N 126.61 5.205 . . . . 0.0 114.235 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.24 118.1 1.41 Allowed Glycine 0 N--CA 1.48 1.594 0 CA-C-O 117.96 -1.467 . . . . 0.0 110.162 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.4 m -100.81 85.73 0.6 Allowed Pre-proline 0 CA--C 1.587 2.396 0 CA-C-O 116.705 -1.617 . . . . 0.0 111.5 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.58 176.49 7.81 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 123.401 2.734 . . . . 0.0 113.66 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -75.38 158.74 32.3 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.717 1.207 . . . . 0.0 112.033 168.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.252 13.3 m -135.4 152.0 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 C-N-CA 123.15 0.58 . . . . 0.0 111.72 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 167.04 38.45 Favored Pre-proline 0 CA--C 1.586 2.357 0 CA-C-O 114.98 -2.438 . . . . 0.0 114.107 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.13 129.59 16.38 Favored 'Trans proline' 0 C--N 1.4 3.261 0 CA-C-N 126.968 3.524 . . . . 0.0 111.525 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.54 128.86 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 173.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.2 p -138.98 108.46 6.16 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.275 1.2 tt -69.03 163.78 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.913 0 C-N-CA 126.885 2.074 . . . . 0.0 113.257 -177.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -141.25 115.19 9.15 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 101.753 -3.425 . . . . 0.0 101.753 168.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.6 t -94.98 116.67 28.98 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 111.6 -2.545 . . . . 0.0 107.174 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.727 0 C-N-CA 124.03 0.932 . . . . 0.0 109.815 -168.457 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -140.62 124.24 17.03 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.268 1.027 . . . . 0.0 108.534 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -85.14 124.15 31.47 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.049 0.939 . . . . 0.0 109.408 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.279 8.5 tt0 -109.44 95.95 5.96 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 101.825 -3.398 . . . . 0.0 101.825 169.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.528 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -108.83 120.45 42.54 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 m -107.3 131.56 54.08 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 125.128 1.517 . . . . 0.0 106.98 -168.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.528 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.3 mp -136.53 96.0 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.211 0 N-CA-C 100.87 -3.752 . . . . 0.0 100.87 -167.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 t -80.13 -15.95 55.99 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 170.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -100.59 139.71 35.89 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 120.711 1.596 . . . . 0.0 110.99 -169.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 m -106.76 105.02 14.86 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 166.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -95.38 112.46 24.17 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -125.9 119.96 29.17 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -169.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.28 -164.62 21.06 Favored Glycine 1 CA--C 1.58 4.119 0 CA-C-O 114.495 -3.392 . . . . 0.0 116.055 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -87.14 161.44 8.59 Favored 'Trans proline' 0 C--N 1.394 2.958 1 CA-C-N 126.687 5.244 . . . . 0.0 113.998 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.48 118.34 1.48 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-O 118.078 -1.401 . . . . 0.0 110.242 174.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.7 t -99.32 86.09 0.51 Allowed Pre-proline 0 CA--C 1.588 2.416 0 CA-C-O 116.757 -1.592 . . . . 0.0 111.988 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -83.53 172.46 10.28 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 123.11 2.54 . . . . 0.0 113.458 169.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -80.3 146.29 31.69 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.244 1.017 . . . . 0.0 110.12 167.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.264 30.9 m -138.36 153.42 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 O-C-N 123.724 0.64 . . . . 0.0 112.031 -170.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -23.07 147.56 0.01 OUTLIER Pre-proline 0 CA--C 1.584 2.277 0 CA-C-O 112.937 -3.411 . . . . 0.0 119.378 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.26 116.92 4.68 Favored 'Trans proline' 0 C--N 1.394 2.945 0 CA-C-N 126.606 3.395 . . . . 0.0 109.647 168.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.1 t -78.45 114.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 104.177 -2.527 . . . . 0.0 104.177 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.5 p -118.75 104.47 10.62 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 1.3 tt -68.7 159.87 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.791 0 CA-C-N 111.64 -2.527 . . . . 0.0 113.244 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.7 ttm105 -139.32 108.6 6.1 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 168.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.9 m -94.81 97.16 9.83 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 110.072 -3.24 . . . . 0.0 106.02 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 N--CA 1.495 1.776 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.768 -168.059 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -139.52 128.04 22.98 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.321 1.048 . . . . 0.0 108.898 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -85.89 141.46 29.56 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.49 0.716 . . . . 0.0 111.129 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.268 4.8 tt0 -123.01 96.23 4.93 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 101.017 -3.697 . . . . 0.0 101.017 167.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.76 121.97 44.07 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -108.15 135.8 48.88 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 125.873 1.983 . . . . 0.0 106.819 -168.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.427 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mp -131.78 98.71 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.373 0 N-CA-C 100.986 -3.709 . . . . 0.0 100.986 -167.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.0 m -117.55 6.95 12.56 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 169.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -117.8 127.81 54.25 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -168.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 m -97.16 115.95 28.47 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.427 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.9 m-85 -104.25 114.9 29.46 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -128.47 119.61 25.25 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -170.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.8 171.04 39.33 Favored Glycine 1 CA--C 1.582 4.228 0 CA-C-O 115.059 -3.078 . . . . 0.0 116.948 -175.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.52 160.66 22.35 Favored 'Trans proline' 0 C--N 1.395 3.021 1 CA-C-N 125.624 4.712 . . . . 0.0 114.232 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.61 95.22 0.4 Allowed Glycine 0 N--CA 1.487 2.05 0 CA-C-O 117.315 -1.825 . . . . 0.0 111.308 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.255 4.7 p -102.8 92.05 3.26 Favored Pre-proline 0 CA--C 1.585 2.296 0 CA-C-O 116.507 -1.711 . . . . 0.0 114.403 -167.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.5 179.98 4.16 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 123.42 2.747 . . . . 0.0 113.898 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 p -68.33 148.39 50.81 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 125.114 1.366 . . . . 0.0 111.313 167.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 24.3 m -141.38 151.42 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.077 0.465 . . . . 0.0 112.02 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -12.03 145.61 0.0 OUTLIER Pre-proline 0 CA--C 1.583 2.236 0 N-CA-C 120.396 3.48 . . . . 0.0 120.396 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.56 117.6 4.61 Favored 'Trans proline' 0 C--N 1.395 2.987 0 CA-C-N 126.541 3.372 . . . . 0.0 109.406 168.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.1 t -79.24 107.34 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.0 p -112.75 101.34 9.44 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -172.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 tt -70.23 157.83 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.63 0 CA-C-N 111.113 -2.767 . . . . 0.0 113.596 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -136.14 106.36 6.38 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 167.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -95.59 109.35 21.6 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 111.062 -2.79 . . . . 0.0 106.127 170.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 124.629 1.206 . . . . 0.0 110.125 -168.052 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -138.96 129.89 26.42 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.297 1.039 . . . . 0.0 109.012 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -88.02 139.64 30.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.497 0.719 . . . . 0.0 110.801 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -122.55 99.92 6.66 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 101.478 -3.527 . . . . 0.0 101.478 167.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.72 122.5 47.96 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 178.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.63 133.23 52.38 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -169.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.449 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.0 mp -130.47 97.42 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.311 0 N-CA-C 100.595 -3.854 . . . . 0.0 100.595 -167.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.9 p -119.52 5.62 11.09 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 169.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -113.85 125.4 54.03 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -168.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -98.47 108.74 21.5 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.449 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.6 m-85 -102.04 112.46 25.12 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.75 124.95 30.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -168.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.02 -154.09 9.41 Favored Glycine 1 CA--C 1.58 4.133 0 CA-C-O 114.377 -3.457 . . . . 0.0 115.239 174.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -90.35 161.65 4.56 Favored 'Trans proline' 0 C--N 1.395 3.019 1 CA-C-N 126.474 5.137 . . . . 0.0 114.533 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.05 116.02 1.05 Allowed Glycine 0 N--CA 1.481 1.648 0 CA-C-O 117.897 -1.502 . . . . 0.0 110.317 174.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.4 m -101.36 86.1 0.71 Allowed Pre-proline 0 CA--C 1.588 2.426 0 CA-C-O 116.741 -1.6 . . . . 0.0 111.609 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.66 174.35 8.76 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 123.438 2.759 . . . . 0.0 113.9 172.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.98 155.83 39.44 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.598 1.159 . . . . 0.0 112.294 168.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 13.5 m -135.83 155.21 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -169.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -56.71 153.39 22.07 Favored Pre-proline 0 CA--C 1.583 2.22 0 CA-C-O 114.25 -2.786 . . . . 0.0 116.342 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -66.99 109.27 1.66 Allowed 'Trans proline' 0 C--N 1.397 3.103 0 CA-C-N 126.093 3.212 . . . . 0.0 109.967 168.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.74 126.24 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 p -136.44 107.42 6.7 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.265 2.6 tt -67.95 162.2 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 CA-C-N 112.099 -2.319 . . . . 0.0 113.713 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -138.98 112.54 8.28 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 167.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.4 t -96.33 111.57 23.61 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 111.48 -2.6 . . . . 0.0 106.247 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 124.282 0.989 . . . . 0.0 109.458 -168.328 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -141.19 125.54 17.57 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.268 1.027 . . . . 0.0 108.789 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -80.36 141.35 35.47 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 124.174 0.922 . . . . 0.0 111.439 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -124.32 98.9 5.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 100.525 -3.88 . . . . 0.0 100.525 168.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.48 122.43 47.26 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -106.83 134.87 49.31 Favored 'General case' 0 CA--C 1.55 0.981 0 O-C-N 125.653 1.846 . . . . 0.0 106.842 -169.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.494 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.7 mp -130.73 97.41 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.332 0 N-CA-C 100.532 -3.877 . . . . 0.0 100.532 -168.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -120.77 5.73 10.49 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 169.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -114.91 126.12 54.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -168.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -96.71 111.7 23.75 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.494 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.1 m-85 -103.0 119.1 38.25 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 -139.49 125.48 19.8 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.087 -167.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.81 -156.62 10.22 Favored Glycine 1 CA--C 1.581 4.165 0 CA-C-O 114.249 -3.528 . . . . 0.0 115.755 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -87.67 163.47 7.83 Favored 'Trans proline' 0 C--N 1.395 3.011 1 CA-C-N 126.721 5.261 . . . . 0.0 114.182 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.95 131.12 4.41 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.2 m -95.79 87.01 0.37 Allowed Pre-proline 0 CA--C 1.591 2.545 0 CA-C-O 116.767 -1.587 . . . . 0.0 110.337 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.14 169.62 17.37 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 123.428 2.752 . . . . 0.0 113.689 170.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.79 156.92 24.69 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.519 1.128 . . . . 0.0 111.202 168.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.251 15.6 m -136.78 151.42 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.113 0.565 . . . . 0.0 111.728 -175.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.47 164.54 44.81 Favored Pre-proline 0 CA--C 1.584 2.264 0 CA-C-O 115.339 -2.267 . . . . 0.0 114.186 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -63.33 126.59 18.07 Favored 'Trans proline' 0 C--N 1.4 3.241 0 CA-C-N 126.251 3.268 . . . . 0.0 112.654 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t -80.96 123.67 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.9 p -134.21 106.77 7.32 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 103.668 -2.716 . . . . 0.0 103.668 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 tt -69.87 162.15 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 127.368 2.267 . . . . 0.0 113.466 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.8 ttm-85 -144.07 111.6 6.02 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 102.506 -3.146 . . . . 0.0 102.506 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -100.33 108.76 20.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 111.732 -2.485 . . . . 0.0 105.477 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.493 1.722 0 O-C-N 124.479 1.112 . . . . 0.0 109.502 -168.454 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.34 128.05 40.6 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -84.73 126.33 33.31 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.116 0.966 . . . . 0.0 109.842 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.264 5.1 tt0 -121.22 92.05 3.66 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 171.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.27 130.99 55.15 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 171.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 m -108.2 128.03 54.35 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 112.479 -2.146 . . . . 0.0 106.625 -169.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.2 95.06 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.201 0 N-CA-C 100.428 -3.915 . . . . 0.0 100.428 -168.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.8 m -78.19 -18.96 54.82 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 169.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -99.02 138.57 35.93 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 120.55 1.523 . . . . 0.0 111.022 -169.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.7 m -106.12 104.0 13.61 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 100.994 -3.706 . . . . 0.0 100.994 166.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -92.17 98.3 11.44 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -113.32 121.27 43.88 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -170.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.73 -166.26 28.42 Favored Glycine 1 CA--C 1.58 4.104 0 CA-C-O 114.495 -3.392 . . . . 0.0 116.519 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -88.0 160.3 7.32 Favored 'Trans proline' 0 C--N 1.395 2.974 1 CA-C-N 126.737 5.269 . . . . 0.0 114.211 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.03 116.8 1.28 Allowed Glycine 0 N--CA 1.479 1.534 0 CA-C-O 118.194 -1.337 . . . . 0.0 110.602 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 t -97.03 90.67 0.82 Allowed Pre-proline 0 CA--C 1.587 2.392 0 CA-C-O 116.394 -1.765 . . . . 0.0 111.68 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.85 170.47 13.97 Favored 'Trans proline' 0 C--N 1.39 2.711 0 CA-C-N 124.287 2.567 . . . . 0.0 113.431 169.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -82.57 143.85 30.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.354 1.062 . . . . 0.0 109.806 168.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.302 19.0 m -140.53 161.56 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.052 0 CA-C-O 121.328 0.585 . . . . 0.0 111.896 -176.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.9 175.72 0.52 Allowed Pre-proline 0 CA--C 1.591 2.526 0 N-CA-C 118.786 2.884 . . . . 0.0 118.786 -168.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -80.9 122.73 4.41 Favored 'Trans proline' 0 C--N 1.404 3.471 0 CA-C-N 125.614 3.041 . . . . 0.0 110.635 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.7 t -78.71 115.86 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 174.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.4 p -125.44 106.34 9.74 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 tt -66.48 160.32 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.835 0 CA-C-N 111.956 -2.384 . . . . 0.0 113.049 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -136.85 107.97 6.77 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.2 m -94.92 109.55 21.54 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 109.764 -3.38 . . . . 0.0 105.425 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.737 0 C-N-CA 124.217 1.007 . . . . 0.0 111.033 -167.332 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -136.53 140.98 43.37 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.316 1.046 . . . . 0.0 110.086 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -87.63 143.99 26.9 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.564 0.746 . . . . 0.0 111.643 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -126.23 96.8 4.84 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 100.269 -3.975 . . . . 0.0 100.269 166.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.94 122.46 46.33 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.1 m -108.16 135.78 48.92 Favored 'General case' 0 CA--C 1.552 1.035 0 O-C-N 125.79 1.931 . . . . 0.0 106.685 -169.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.409 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.8 mp -132.23 98.94 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.329 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 -167.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m -117.69 8.49 12.8 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -118.53 127.26 53.45 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -168.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 m -97.51 112.49 24.32 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.409 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.1 m-85 -102.85 119.65 39.21 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.3 mtm-85 -138.25 123.01 18.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -168.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.92 177.15 42.31 Favored Glycine 1 CA--C 1.581 4.198 0 CA-C-O 115.054 -3.081 . . . . 0.0 116.555 -178.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.88 160.07 21.22 Favored 'Trans proline' 0 C--N 1.395 2.999 1 CA-C-N 126.019 4.91 . . . . 0.0 113.97 -175.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.94 96.66 0.4 Allowed Glycine 0 N--CA 1.487 2.074 0 CA-C-O 117.315 -1.825 . . . . 0.0 111.174 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.252 4.0 p -102.3 95.43 5.87 Favored Pre-proline 0 CA--C 1.584 2.275 0 CA-C-O 115.978 -1.963 . . . . 0.0 114.192 -167.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -85.54 179.51 3.9 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 123.442 2.761 . . . . 0.0 114.006 173.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 p -61.68 161.81 9.43 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 125.616 1.566 . . . . 0.0 113.857 169.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.252 14.2 m -135.29 154.27 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 C-N-CA 122.983 0.513 . . . . 0.0 112.229 178.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.259 50.7 pttt -75.14 -172.2 0.25 Allowed Pre-proline 0 CA--C 1.601 2.919 0 CA-C-O 114.688 -2.577 . . . . 0.0 116.46 -176.069 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.79 122.16 3.4 Favored 'Trans proline' 0 C--N 1.4 3.263 0 CA-C-N 126.539 3.371 . . . . 0.0 110.806 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.64 131.98 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 179.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -137.4 106.87 6.12 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 -177.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.53 162.91 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 CA-C-N 112.173 -2.285 . . . . 0.0 113.584 -178.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -137.93 108.63 6.62 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 101.87 -3.382 . . . . 0.0 101.87 166.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.1 t -98.07 109.34 22.11 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 111.558 -2.565 . . . . 0.0 105.673 171.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 124.601 1.188 . . . . 0.0 110.1 -167.824 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -139.57 137.46 35.4 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 124.4 1.08 . . . . 0.0 109.882 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -84.85 121.84 28.3 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 117.404 -1.284 . . . . 0.0 109.517 -179.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -109.17 98.56 7.98 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 170.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -110.93 120.26 41.8 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 179.897 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.4 m -107.38 130.71 54.77 Favored 'General case' 0 CA--C 1.554 1.108 0 O-C-N 125.314 1.634 . . . . 0.0 106.817 -168.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.492 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.3 mp -135.73 96.35 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.195 0 N-CA-C 100.522 -3.881 . . . . 0.0 100.522 -167.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.8 p -78.16 -19.07 54.72 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 169.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -98.6 140.66 32.49 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 120.443 1.474 . . . . 0.0 111.102 -169.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.0 m -107.02 100.19 9.7 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 101.058 -3.682 . . . . 0.0 101.058 167.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -94.14 110.72 22.42 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -175.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.46 116.59 20.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -167.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.98 -172.21 28.0 Favored Glycine 1 CA--C 1.583 4.286 0 CA-C-O 114.613 -3.326 . . . . 0.0 115.059 177.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -86.48 162.81 9.57 Favored 'Trans proline' 0 C--N 1.394 2.933 1 CA-C-N 126.892 5.346 . . . . 0.0 114.332 -175.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.32 113.81 1.38 Allowed Glycine 0 N--CA 1.481 1.649 0 CA-C-O 117.643 -1.643 . . . . 0.0 110.089 176.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.3 m -102.56 85.62 0.8 Allowed Pre-proline 0 CA--C 1.588 2.439 0 CA-C-O 117.021 -1.466 . . . . 0.0 111.942 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.02 173.41 9.07 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 123.258 2.638 . . . . 0.0 113.791 169.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 p -77.44 147.71 35.81 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.443 1.097 . . . . 0.0 110.358 167.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 31.2 m -139.08 152.21 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.828 0 O-C-N 123.556 0.535 . . . . 0.0 112.052 -173.173 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -17.45 146.57 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.265 0 CA-C-O 112.784 -3.484 . . . . 0.0 119.713 170.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.98 116.57 4.44 Favored 'Trans proline' 0 C--N 1.395 2.991 0 CA-C-N 126.614 3.398 . . . . 0.0 109.616 168.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.0 t -77.72 115.78 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 176.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.2 p -118.56 104.14 10.38 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 -174.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.282 1.3 tt -67.3 167.55 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 111.455 -2.611 . . . . 0.0 113.66 179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -144.65 112.19 6.14 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 168.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.4 t -95.82 98.05 10.14 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 168.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 N--CA 1.492 1.668 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.349 -165.963 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -139.46 125.64 20.04 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.264 1.026 . . . . 0.0 108.862 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -112.61 145.09 41.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 124.185 0.928 . . . . 0.0 112.201 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.27 3.2 tt0 -126.04 95.04 4.27 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 102.176 -3.268 . . . . 0.0 102.176 168.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -111.12 124.7 52.72 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.3 m -109.59 134.43 51.94 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 125.495 1.747 . . . . 0.0 106.528 -168.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.97 99.04 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.293 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 -167.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.5 m -115.68 9.66 15.29 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 169.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -120.64 127.51 52.15 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -168.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m -96.96 117.46 31.2 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 178.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -106.5 113.02 26.29 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -127.02 121.46 31.68 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -169.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.18 -160.31 13.28 Favored Glycine 1 CA--C 1.58 4.123 0 CA-C-O 114.466 -3.408 . . . . 0.0 116.297 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -90.71 156.86 4.21 Favored 'Trans proline' 0 C--N 1.397 3.096 1 CA-C-N 126.271 5.035 . . . . 0.0 114.487 -176.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.22 109.99 0.51 Allowed Glycine 0 N--CA 1.482 1.703 0 CA-C-O 117.954 -1.47 . . . . 0.0 111.261 174.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.323 1.3 p -108.38 82.37 1.6 Allowed Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 116.69 -1.624 . . . . 0.0 112.197 -171.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.84 -178.8 3.39 Favored 'Trans proline' 0 C--N 1.393 2.908 0 C-N-CA 123.619 2.879 . . . . 0.0 113.684 172.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 p -61.79 158.31 16.09 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.446 1.498 . . . . 0.0 113.937 169.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.25 12.7 m -132.92 154.86 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.858 0 C-N-CA 123.358 0.663 . . . . 0.0 111.752 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 163.95 58.06 Favored Pre-proline 0 CA--C 1.583 2.248 0 CA-C-O 115.338 -2.267 . . . . 0.0 114.659 -179.447 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -64.81 128.35 20.72 Favored 'Trans proline' 0 C--N 1.4 3.245 0 CA-C-N 126.058 3.199 . . . . 0.0 112.661 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.25 130.1 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 175.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.2 p -139.14 108.51 6.13 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 102.907 -2.997 . . . . 0.0 102.907 -178.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 tt -70.06 163.2 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 C-N-CA 126.918 2.087 . . . . 0.0 113.685 -174.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -119.64 134.85 55.06 Favored 'General case' 0 CA--C 1.543 0.677 1 N-CA-C 97.397 -5.038 . . . . 0.0 97.397 163.205 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.0 t -106.17 65.0 0.68 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.689 1.233 . . . . 0.0 108.001 162.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.327 10.3 pt-20 . . . . . 0 N--CA 1.493 1.697 0 C-N-CA 126.08 1.752 . . . . 0.0 107.798 -170.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -146.29 128.28 15.52 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.15 128.24 35.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.542 0.737 . . . . 0.0 110.351 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.279 9.4 tt0 -112.92 96.83 6.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 101.216 -3.624 . . . . 0.0 101.216 168.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.4 109.93 19.84 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 -176.303 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 m -96.39 127.75 42.68 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.243 -167.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mm -119.12 86.82 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.112 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 -167.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.6 p -88.42 -16.06 33.87 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 168.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.52 139.41 30.56 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.582 1.153 . . . . 0.0 110.356 -170.148 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -110.93 110.47 21.06 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 102.782 -3.044 . . . . 0.0 102.782 169.059 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -98.94 115.75 29.6 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.31 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -128.22 122.61 32.19 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -173.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.53 -155.71 11.1 Favored Glycine 0 CA--C 1.578 3.982 0 CA-C-O 114.452 -3.416 . . . . 0.0 115.856 176.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -87.94 161.58 7.44 Favored 'Trans proline' 0 C--N 1.394 2.942 1 CA-C-N 126.393 5.096 . . . . 0.0 114.024 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.64 117.02 1.42 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-O 118.235 -1.314 . . . . 0.0 110.481 173.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.5 m -102.46 84.47 0.63 Allowed Pre-proline 0 CA--C 1.588 2.407 0 CA-C-O 116.766 -1.588 . . . . 0.0 111.129 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.91 174.07 9.73 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 123.399 2.732 . . . . 0.0 113.958 171.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.51 155.4 36.17 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.556 1.143 . . . . 0.0 112.05 168.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.268 13.4 m -137.08 156.63 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -169.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -63.64 165.59 11.67 Favored Pre-proline 0 CA--C 1.58 2.132 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.67 111.32 3.27 Favored 'Trans proline' 0 C--N 1.396 3.052 0 C-N-CA 123.149 2.566 . . . . 0.0 109.944 169.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -74.64 124.11 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 172.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -137.76 108.78 6.74 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 -178.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.264 1.1 tt -69.49 164.36 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 C-N-CA 126.91 2.084 . . . . 0.0 113.718 -174.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -139.35 113.76 9.03 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 167.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.4 t -95.78 115.91 28.12 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 111.606 -2.543 . . . . 0.0 106.943 171.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.493 1.686 0 C-N-CA 124.162 0.985 . . . . 0.0 110.098 -168.221 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -140.78 124.2 16.78 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.301 1.04 . . . . 0.0 108.4 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -86.16 128.07 34.83 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 124.088 0.868 . . . . 0.0 110.33 -179.405 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.259 7.1 tt0 -112.0 97.86 6.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 100.855 -3.757 . . . . 0.0 100.855 168.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.48 108.18 16.85 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -177.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 m -96.36 126.17 41.37 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 113.369 -1.741 . . . . 0.0 106.817 -167.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 mm -115.16 90.96 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.088 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 -166.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.7 m -125.64 4.74 7.5 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.495 169.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.74 119.52 36.95 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -169.245 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 m -96.58 120.81 37.6 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 -171.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -112.38 118.37 35.01 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -138.37 116.88 12.07 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -168.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.63 -155.34 9.92 Favored Glycine 1 CA--C 1.579 4.054 0 CA-C-O 114.345 -3.475 . . . . 0.0 115.373 178.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -88.12 161.63 7.17 Favored 'Trans proline' 0 C--N 1.394 2.935 1 CA-C-N 126.728 5.264 . . . . 0.0 114.131 -178.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.28 115.72 1.47 Allowed Glycine 0 N--CA 1.479 1.519 0 CA-C-O 118.058 -1.412 . . . . 0.0 110.443 174.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.2 m -101.56 85.7 0.68 Allowed Pre-proline 0 CA--C 1.587 2.376 0 CA-C-O 116.716 -1.611 . . . . 0.0 111.295 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.48 173.51 10.54 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 123.31 2.673 . . . . 0.0 113.827 171.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 p -75.48 155.3 36.35 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.557 1.143 . . . . 0.0 111.963 168.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.27 19.4 m -136.96 153.3 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 123.503 0.502 . . . . 0.0 111.98 -173.175 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.98 48.41 Favored Pre-proline 0 CA--C 1.585 2.292 0 CA-C-O 115.241 -2.314 . . . . 0.0 114.688 -179.441 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -63.68 130.21 27.29 Favored 'Trans proline' 0 C--N 1.4 3.249 0 CA-C-N 126.34 3.3 . . . . 0.0 113.006 177.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -77.99 122.7 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 171.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 p -137.36 109.18 7.08 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 0.9 OUTLIER -68.8 164.5 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 C-N-CA 126.84 2.056 . . . . 0.0 113.685 -174.959 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -141.03 113.11 7.84 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 167.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.1 t -97.81 114.15 26.12 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 111.524 -2.58 . . . . 0.0 106.411 170.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 124.055 0.847 . . . . 0.0 110.005 -168.695 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.93 139.75 38.1 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 124.265 1.026 . . . . 0.0 109.672 179.44 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -80.0 139.54 36.94 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 117.338 -1.315 . . . . 0.0 111.78 -177.067 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -121.22 97.58 5.58 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 102.503 -3.147 . . . . 0.0 102.503 168.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.58 119.63 39.8 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 -178.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -107.13 130.03 54.75 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 125.652 1.845 . . . . 0.0 106.174 -168.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.8 mp -126.03 97.6 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.335 0 N-CA-C 100.469 -3.901 . . . . 0.0 100.469 -167.871 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m -121.35 5.14 10.22 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -113.52 125.55 54.33 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -168.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -97.92 108.35 21.04 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 -173.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.471 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.5 m-85 -101.86 112.08 24.57 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -176.67 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.75 121.24 26.48 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -168.541 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.03 170.8 42.69 Favored Glycine 1 CA--C 1.581 4.218 0 CA-C-O 115.102 -3.054 . . . . 0.0 116.325 -177.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.46 162.76 22.07 Favored 'Trans proline' 0 C--N 1.394 2.938 1 CA-C-N 125.805 4.802 . . . . 0.0 114.153 -176.294 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.08 91.54 0.81 Allowed Glycine 0 N--CA 1.486 2.003 0 CA-C-O 117.379 -1.79 . . . . 0.0 110.38 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.9 m -85.7 102.49 2.63 Favored Pre-proline 0 CA--C 1.589 2.472 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -166.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -79.68 179.37 6.37 Favored 'Trans proline' 0 CA--C 1.58 2.796 0 C-N-CA 123.199 2.599 . . . . 0.0 112.158 166.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.303 9.9 t -105.24 155.97 18.57 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 123.841 0.856 . . . . 0.0 109.025 167.091 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.0 m -120.31 155.42 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 C-N-CA 124.22 1.008 . . . . 0.0 112.151 -165.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 179.79 1.58 Allowed Pre-proline 0 CA--C 1.6 2.869 0 CA-C-O 116.232 -1.842 . . . . 0.0 112.935 -179.342 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -75.23 125.6 9.28 Favored 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 123.654 2.903 . . . . 0.0 111.088 177.391 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.7 t -77.31 138.85 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.9 p -141.4 106.09 4.9 Favored 'General case' 0 CA--C 1.558 1.272 0 N-CA-C 104.54 -2.392 . . . . 0.0 104.54 -176.042 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.253 1.6 tt -72.91 159.95 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.741 0 C-N-CA 127.14 2.176 . . . . 0.0 113.653 -178.203 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -145.42 103.53 3.83 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 105.896 -1.891 . . . . 0.0 105.896 168.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.9 t -91.89 98.02 11.33 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 111.951 -2.386 . . . . 0.0 104.729 169.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 . . . . . 0 N--CA 1.492 1.647 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.983 -165.51 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -136.25 141.04 43.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 124.312 1.045 . . . . 0.0 110.148 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -88.75 142.84 27.33 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.559 0.744 . . . . 0.0 111.404 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.251 4.0 tt0 -125.49 96.93 4.98 Favored 'General case' 0 N--CA 1.487 1.387 1 N-CA-C 100.15 -4.018 . . . . 0.0 100.15 166.704 . . . . . . . . 3 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.89 124.2 50.02 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 m -106.56 132.26 52.77 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 125.576 1.797 . . . . 0.0 107.357 -168.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.8 mp -136.32 95.83 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.179 0 N-CA-C 100.998 -3.704 . . . . 0.0 100.998 -168.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.6 m -78.51 -17.92 55.52 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 169.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -101.73 141.25 34.87 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.612 1.551 . . . . 0.0 111.231 -169.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -104.51 102.84 12.46 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 165.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -92.42 115.23 27.91 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -178.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -131.54 122.32 25.93 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -168.261 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.22 172.21 42.76 Favored Glycine 1 CA--C 1.58 4.12 0 CA-C-O 115.139 -3.034 . . . . 0.0 116.542 -177.402 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.12 159.69 23.62 Favored 'Trans proline' 0 C--N 1.395 3.009 1 CA-C-N 125.896 4.848 . . . . 0.0 113.962 -175.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.99 97.11 0.39 Allowed Glycine 0 N--CA 1.488 2.103 0 CA-C-O 117.346 -1.808 . . . . 0.0 111.151 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.253 4.0 p -101.44 95.93 5.62 Favored Pre-proline 0 CA--C 1.583 2.241 0 CA-C-O 115.932 -1.985 . . . . 0.0 114.02 -167.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -84.03 178.52 5.27 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 123.497 2.798 . . . . 0.0 113.88 173.447 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -63.72 161.23 15.47 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 125.454 1.502 . . . . 0.0 114.095 169.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.3 m -134.1 152.78 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 C-N-CA 123.42 0.688 . . . . 0.0 111.682 -179.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.28 164.54 49.53 Favored Pre-proline 0 CA--C 1.585 2.289 0 CA-C-O 115.305 -2.283 . . . . 0.0 114.219 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -64.28 126.5 17.17 Favored 'Trans proline' 0 C--N 1.398 3.179 0 CA-C-N 126.203 3.251 . . . . 0.0 112.503 177.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.6 t -79.73 127.73 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 176.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.6 p -135.92 106.22 6.4 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 -176.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 tt -71.46 164.06 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.829 0 CA-C-N 111.983 -2.371 . . . . 0.0 113.54 -178.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -139.0 108.0 6.01 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 101.776 -3.416 . . . . 0.0 101.776 165.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.6 t -98.02 108.98 21.8 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 111.664 -2.517 . . . . 0.0 105.637 172.227 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 124.67 1.231 . . . . 0.0 110.164 -167.774 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -138.5 136.6 36.3 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.349 1.06 . . . . 0.0 109.664 179.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -87.65 142.02 28.16 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.45 0.7 . . . . 0.0 111.4 -178.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.254 4.2 tt0 -124.72 96.87 5.05 Favored 'General case' 0 N--CA 1.488 1.43 1 N-CA-C 100.185 -4.005 . . . . 0.0 100.185 166.639 . . . . . . . . 3 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.24 123.67 49.42 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -106.57 131.71 53.42 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 113.23 -1.805 . . . . 0.0 107.194 -168.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.24 95.9 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.172 0 N-CA-C 101.002 -3.703 . . . . 0.0 101.002 -168.507 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.7 m -78.57 -18.1 55.12 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 169.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -101.41 141.09 34.8 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 120.622 1.555 . . . . 0.0 111.247 -169.556 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -104.6 102.65 12.25 Favored 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 100.928 -3.731 . . . . 0.0 100.928 165.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -92.68 115.0 27.71 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 -178.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -131.22 122.03 25.83 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -168.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.2 171.8 42.61 Favored Glycine 1 CA--C 1.58 4.132 0 CA-C-O 115.102 -3.054 . . . . 0.0 116.694 -177.149 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.96 159.64 24.11 Favored 'Trans proline' 0 C--N 1.394 2.965 1 CA-C-N 125.775 4.787 . . . . 0.0 113.958 -175.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.8 96.89 0.38 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-O 117.324 -1.82 . . . . 0.0 111.107 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.253 3.8 p -101.44 95.97 5.66 Favored Pre-proline 0 CA--C 1.582 2.209 0 CA-C-O 115.893 -2.003 . . . . 0.0 114.048 -167.504 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -83.93 178.0 5.69 Favored 'Trans proline' 0 C--N 1.394 2.95 0 C-N-CA 123.479 2.786 . . . . 0.0 113.912 173.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -63.9 161.11 16.21 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 125.35 1.46 . . . . 0.0 114.062 169.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 m -134.84 152.55 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 123.353 0.661 . . . . 0.0 111.589 -179.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 164.73 49.69 Favored Pre-proline 0 CA--C 1.583 2.243 0 CA-C-O 115.341 -2.266 . . . . 0.0 114.225 179.644 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -64.34 126.09 16.34 Favored 'Trans proline' 0 C--N 1.399 3.226 0 CA-C-N 126.179 3.243 . . . . 0.0 112.373 177.331 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.4 t -79.48 127.82 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 176.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -137.42 106.03 5.85 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 123.724 1.726 . . . . 0.0 108.528 -178.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 tt -70.9 162.29 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 CA-C-N 109.109 -3.678 . . . . 0.0 113.663 -176.045 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -138.01 107.67 6.23 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 101.934 -3.358 . . . . 0.0 101.934 165.499 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -97.97 107.51 20.0 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 111.469 -2.605 . . . . 0.0 105.617 171.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 124.657 1.223 . . . . 0.0 109.947 -167.91 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -141.4 122.86 14.99 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -82.46 123.5 29.21 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 117.535 -1.222 . . . . 0.0 110.0 -175.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -108.66 95.96 6.01 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 170.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.527 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.56 119.24 38.86 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 179.346 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.0 m -107.52 130.15 54.89 Favored 'General case' 0 CA--C 1.554 1.132 0 O-C-N 125.323 1.639 . . . . 0.0 106.66 -168.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.527 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.3 mp -135.37 96.34 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.184 0 N-CA-C 100.572 -3.862 . . . . 0.0 100.572 -167.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.6 m -78.79 -19.06 53.07 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 169.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -96.58 139.71 32.27 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 120.621 1.555 . . . . 0.0 111.03 -169.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 m -107.93 99.86 9.27 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 101.098 -3.667 . . . . 0.0 101.098 167.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -94.11 110.93 22.61 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -176.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.27 116.82 20.45 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -167.805 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.01 -164.63 20.8 Favored Glycine 1 CA--C 1.582 4.231 0 CA-C-O 114.687 -3.285 . . . . 0.0 115.464 177.528 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -88.01 162.65 7.35 Favored 'Trans proline' 0 C--N 1.394 2.945 1 CA-C-N 126.554 5.177 . . . . 0.0 114.204 -177.075 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.82 114.95 1.55 Allowed Glycine 0 N--CA 1.48 1.569 0 CA-C-O 117.861 -1.522 . . . . 0.0 110.097 174.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.2 t -101.23 85.92 0.67 Allowed Pre-proline 0 CA--C 1.588 2.411 0 CA-C-O 116.864 -1.541 . . . . 0.0 112.432 -175.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.12 171.72 11.28 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 123.134 2.556 . . . . 0.0 113.33 168.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.81 147.13 31.92 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.195 0.998 . . . . 0.0 110.467 167.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.266 29.8 m -138.09 154.42 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 O-C-N 123.743 0.652 . . . . 0.0 111.934 -169.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -28.0 148.52 0.03 OUTLIER Pre-proline 0 CA--C 1.585 2.298 0 CA-C-O 113.145 -3.312 . . . . 0.0 118.884 174.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.74 116.83 4.72 Favored 'Trans proline' 0 C--N 1.395 3.014 0 CA-C-N 126.546 3.374 . . . . 0.0 109.828 168.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.9 t -80.23 112.58 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 103.84 -2.652 . . . . 0.0 103.84 177.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.6 p -115.37 102.42 9.82 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -173.225 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.263 1.7 tt -68.28 163.05 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-N 111.159 -2.746 . . . . 0.0 114.026 -179.173 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -145.14 106.23 4.17 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 167.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 81.2 m -92.43 91.35 7.6 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 111.362 -2.654 . . . . 0.0 104.769 172.426 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 . . . . . 0 N--CA 1.493 1.677 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.79 -165.383 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.2 p . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -140.44 123.9 16.96 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 118.056 -0.974 . . . . 0.0 108.783 178.154 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -89.81 135.86 33.38 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 124.391 1.057 . . . . 0.0 110.23 174.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.287 3.4 tt0 -119.32 95.71 4.91 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 102.626 -3.101 . . . . 0.0 102.626 169.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.38 123.71 50.15 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -176.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -105.75 134.22 49.23 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 125.489 1.743 . . . . 0.0 107.679 -168.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp -137.75 95.25 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 N-CA-C 100.961 -3.718 . . . . 0.0 100.961 -168.514 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.9 p -78.41 -16.66 57.37 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 169.705 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -103.41 141.54 35.79 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 120.173 1.351 . . . . 0.0 111.082 -169.533 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 m -105.05 105.74 15.92 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 100.995 -3.706 . . . . 0.0 100.995 166.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -93.5 110.44 22.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -122.45 116.6 24.24 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -169.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.89 164.97 36.76 Favored Glycine 1 CA--C 1.58 4.096 0 CA-C-O 114.975 -3.125 . . . . 0.0 116.693 -174.187 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.79 159.16 21.52 Favored 'Trans proline' 0 C--N 1.395 3.008 1 CA-C-N 125.739 4.77 . . . . 0.0 114.303 -174.173 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.72 95.17 0.41 Allowed Glycine 0 N--CA 1.487 2.071 0 CA-C-O 117.144 -1.92 . . . . 0.0 111.375 177.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.4 m -74.09 108.12 4.57 Favored Pre-proline 0 CA--C 1.586 2.358 0 CA-C-O 115.662 -2.113 . . . . 0.0 114.818 -167.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.73 169.44 18.22 Favored 'Trans proline' 0 C--N 1.39 2.727 0 CA-C-N 124.683 2.708 . . . . 0.0 113.663 169.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.88 149.88 26.07 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.127 0.971 . . . . 0.0 110.519 168.635 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.71 148.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 123.712 0.805 . . . . 0.0 111.491 -169.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 166.68 33.96 Favored Pre-proline 0 CA--C 1.586 2.345 0 CA-C-O 115.097 -2.383 . . . . 0.0 113.176 175.66 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.74 125.72 11.93 Favored 'Trans proline' 0 C--N 1.4 3.249 0 CA-C-N 127.032 3.547 . . . . 0.0 111.341 -177.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.64 129.14 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.625 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -136.53 107.28 6.6 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 123.767 1.746 . . . . 0.0 108.261 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 tt -70.88 160.12 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 CA-C-N 109.124 -3.671 . . . . 0.0 114.042 -172.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -135.45 94.73 3.15 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 166.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.0 t -93.17 117.55 30.2 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 111.16 -2.745 . . . . 0.0 106.596 170.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.29 14.3 pt-20 . . . . . 0 N--CA 1.497 1.911 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -166.8 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.97 130.24 33.35 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.159 0.983 . . . . 0.0 109.064 176.519 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -87.82 140.29 29.66 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.979 0.799 . . . . 0.0 110.333 174.32 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.54 100.94 6.89 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 101.916 -3.365 . . . . 0.0 101.916 169.018 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.433 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -113.97 123.75 50.49 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.411 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -107.08 131.33 54.23 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 125.38 1.675 . . . . 0.0 107.124 -168.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.433 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.5 mp -136.32 95.89 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.198 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 -168.187 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.6 m -78.78 -17.69 55.35 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 169.921 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -100.15 139.87 35.21 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 120.657 1.571 . . . . 0.0 111.054 -169.63 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.1 m -105.57 102.29 11.76 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 100.906 -3.739 . . . . 0.0 100.906 166.212 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -92.42 117.84 30.33 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -178.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -136.22 123.28 21.56 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -167.776 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.36 -156.53 12.57 Favored Glycine 1 CA--C 1.579 4.091 0 CA-C-O 114.501 -3.388 . . . . 0.0 115.698 176.573 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -88.95 161.93 5.98 Favored 'Trans proline' 0 C--N 1.395 2.984 1 CA-C-N 126.268 5.034 . . . . 0.0 114.339 -178.965 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.42 113.71 0.76 Allowed Glycine 0 N--CA 1.481 1.637 0 CA-C-O 117.656 -1.636 . . . . 0.0 110.597 173.358 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.4 m -98.78 89.3 0.84 Allowed Pre-proline 0 CA--C 1.587 2.401 0 CA-C-O 116.554 -1.688 . . . . 0.0 111.906 -175.448 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.04 172.72 12.66 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.298 2.665 . . . . 0.0 113.632 169.951 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.05 156.54 37.38 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.581 1.152 . . . . 0.0 112.394 168.786 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.26 13.3 m -134.45 154.64 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.841 0 O-C-N 123.685 0.615 . . . . 0.0 112.225 -170.347 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -64.94 164.59 20.54 Favored Pre-proline 0 CA--C 1.581 2.135 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 -178.418 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.58 107.98 2.43 Favored 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 123.199 2.6 . . . . 0.0 110.034 169.9 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.61 126.27 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 176.454 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.7 p -135.8 106.98 6.75 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 -176.333 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.253 1.9 tt -69.17 163.51 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.87 0 CA-C-N 111.932 -2.394 . . . . 0.0 113.465 -179.314 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -139.53 108.03 5.87 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 103.048 -2.945 . . . . 0.0 103.048 167.624 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 17.5 t -98.35 123.92 42.72 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 111.019 -2.809 . . . . 0.0 106.735 169.643 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.285 14.8 pt-20 . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -167.82 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -140.12 131.31 26.51 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.155 0.982 . . . . 0.0 109.697 179.395 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -84.08 135.65 34.32 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 124.543 1.152 . . . . 0.0 110.523 179.197 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.268 8.0 tt0 -119.81 99.14 6.46 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 100.999 -3.704 . . . . 0.0 100.999 170.285 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.479 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -108.69 123.62 49.27 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 177.077 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 m -107.84 131.09 54.86 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -169.442 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.482 HD13 ' CD1' ' A' ' 12' ' ' PHE . 2.9 mp -127.85 96.9 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.349 0 N-CA-C 100.42 -3.918 . . . . 0.0 100.42 -167.765 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m -120.35 7.17 10.66 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 170.101 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -115.83 125.27 52.46 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -169.065 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -95.97 116.4 28.88 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 -177.654 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.482 ' CD1' HD13 ' A' ' 7' ' ' ILE . 83.2 m-85 -105.57 113.89 27.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -128.34 117.54 21.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -169.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.22 -166.24 20.64 Favored Glycine 1 CA--C 1.582 4.266 0 CA-C-O 114.199 -3.556 . . . . 0.0 115.986 179.445 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -89.47 163.04 5.43 Favored 'Trans proline' 0 C--N 1.395 3.019 1 CA-C-N 127.293 5.547 . . . . 0.0 114.601 -177.816 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.27 128.32 4.08 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 m -98.48 84.17 0.33 Allowed Pre-proline 0 CA--C 1.591 2.557 0 CA-C-O 117.296 -1.335 . . . . 0.0 112.244 177.917 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -80.71 174.92 10.56 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.124 2.55 . . . . 0.0 112.482 167.761 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.299 8.8 t -106.47 153.8 21.76 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 167.735 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 m -121.96 159.79 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 C-N-CA 124.389 1.076 . . . . 0.0 111.958 -165.732 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 163.42 65.28 Favored Pre-proline 0 CA--C 1.585 2.321 0 CA-C-O 115.28 -2.295 . . . . 0.0 114.782 176.406 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -64.31 134.02 40.21 Favored 'Trans proline' 0 C--N 1.399 3.203 0 CA-C-N 126.162 3.236 . . . . 0.0 113.503 -179.532 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.3 t -77.04 133.53 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.676 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -142.53 108.44 5.16 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 103.428 -2.805 . . . . 0.0 103.428 -178.212 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.256 3.3 tt -70.93 160.92 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 C-N-CA 127.233 2.213 . . . . 0.0 113.027 -179.275 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -145.97 115.07 7.01 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 102.565 -3.124 . . . . 0.0 102.565 169.12 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.48 110.21 22.7 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 111.977 -2.374 . . . . 0.0 106.23 169.646 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 124.472 1.108 . . . . 0.0 109.389 -168.666 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.43 130.61 17.45 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.757 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -84.47 137.15 33.52 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.874 178.16 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.25 8.2 tt0 -121.05 99.61 6.6 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 100.965 -3.717 . . . . 0.0 100.965 169.038 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.24 122.92 46.4 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.093 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -107.29 136.14 47.6 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 125.67 1.856 . . . . 0.0 106.926 -169.267 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.469 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.2 mp -133.08 98.28 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.299 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 -167.829 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.1 t -119.05 10.65 12.21 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 169.815 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -119.97 126.08 49.97 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -169.073 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 m -97.07 112.01 23.98 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -177.2 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.469 ' CD1' HD13 ' A' ' 7' ' ' ILE . 83.3 m-85 -103.38 118.62 37.18 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -178.921 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -139.57 124.82 18.95 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -168.013 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.54 -156.15 9.76 Favored Glycine 1 CA--C 1.578 4.022 0 CA-C-O 114.478 -3.401 . . . . 0.0 115.734 177.241 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.58 161.07 9.4 Favored 'Trans proline' 0 C--N 1.394 2.969 1 CA-C-N 126.429 5.114 . . . . 0.0 113.833 -178.421 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.91 118.51 1.37 Allowed Glycine 0 N--CA 1.479 1.516 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.093 176.571 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -100.2 84.56 0.45 Allowed Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 117.036 -1.459 . . . . 0.0 112.702 -179.021 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.99 172.29 12.1 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 123.116 2.544 . . . . 0.0 112.953 168.585 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.289 9.5 t -93.45 157.85 16.01 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 123.457 0.703 . . . . 0.0 109.281 167.775 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.5 m -126.61 158.97 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 C-N-CA 124.131 0.972 . . . . 0.0 112.244 -166.277 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -73.99 -176.07 0.47 Allowed Pre-proline 0 CA--C 1.609 3.226 0 CA-C-O 115.142 -2.361 . . . . 0.0 113.717 -179.495 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -84.02 129.54 4.65 Favored 'Trans proline' 0 C--N 1.394 2.955 0 CA-C-N 126.606 3.395 . . . . 0.0 111.476 -178.634 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.12 133.96 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 175.443 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.8 p -141.75 107.23 5.04 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 103.656 -2.72 . . . . 0.0 103.656 -176.619 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.266 1.4 tt -71.34 162.61 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 C-N-CA 127.255 2.222 . . . . 0.0 112.7 -179.077 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -142.65 123.94 14.67 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 169.019 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.8 t -95.31 123.76 38.99 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 111.789 -2.46 . . . . 0.0 108.391 169.536 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 . . . . . 0 N--CA 1.492 1.629 0 C-N-CA 124.176 0.991 . . . . 0.0 109.663 -169.269 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -147.52 127.28 13.44 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 178.696 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -86.4 140.45 29.99 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.118 0.567 . . . . 0.0 111.086 178.52 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.258 8.2 tt0 -124.56 96.46 4.91 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 100.665 -3.828 . . . . 0.0 100.665 166.785 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.99 123.33 46.65 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -177.016 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -107.77 135.72 48.71 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 125.853 1.97 . . . . 0.0 106.928 -169.143 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.438 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.6 mp -132.45 98.39 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.314 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 -167.956 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.5 m -118.5 8.64 12.11 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 169.825 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -118.36 126.9 53.06 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -168.852 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -97.01 112.41 24.18 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 -178.284 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.438 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.0 m-85 -103.59 119.26 38.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -179.671 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -138.57 120.43 15.39 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -168.485 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.11 178.75 42.18 Favored Glycine 1 CA--C 1.582 4.22 0 CA-C-O 115.054 -3.081 . . . . 0.0 116.866 -177.406 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.31 159.45 17.46 Favored 'Trans proline' 0 C--N 1.395 2.992 1 CA-C-N 125.877 4.839 . . . . 0.0 114.088 -174.994 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.03 96.37 0.41 Allowed Glycine 0 N--CA 1.488 2.127 0 CA-C-O 117.322 -1.821 . . . . 0.0 111.163 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.25 3.1 p -100.57 96.02 4.93 Favored Pre-proline 0 CA--C 1.583 2.234 0 CA-C-O 115.949 -1.977 . . . . 0.0 113.948 -167.414 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -83.5 178.81 5.38 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 123.516 2.81 . . . . 0.0 113.796 173.149 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 p -64.57 160.57 19.27 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.291 1.437 . . . . 0.0 113.817 169.554 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 m -134.29 152.23 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 123.334 0.654 . . . . 0.0 111.73 -178.262 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.71 164.09 48.58 Favored Pre-proline 0 CA--C 1.583 2.227 0 CA-C-O 115.336 -2.269 . . . . 0.0 114.213 178.952 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -63.74 126.87 18.32 Favored 'Trans proline' 0 C--N 1.399 3.223 0 CA-C-N 126.216 3.256 . . . . 0.0 112.686 178.575 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t -81.01 124.6 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 176.648 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.4 p -133.81 105.85 7.01 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 -176.72 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.4 tt -71.58 160.98 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.775 0 CA-C-N 112.009 -2.36 . . . . 0.0 113.471 -177.411 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -136.45 105.21 5.85 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 102.392 -3.188 . . . . 0.0 102.392 165.409 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.4 t -94.9 112.97 24.65 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 111.258 -2.701 . . . . 0.0 106.102 173.239 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 124.621 1.201 . . . . 0.0 111.228 -167.428 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -140.47 125.94 18.96 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.292 1.037 . . . . 0.0 108.767 179.722 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -88.2 139.92 30.01 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 124.005 0.816 . . . . 0.0 111.184 179.211 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -123.56 98.52 5.87 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 101.996 -3.335 . . . . 0.0 101.996 168.356 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.47 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -112.05 122.68 48.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 178.747 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -106.96 130.66 54.58 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 125.353 1.658 . . . . 0.0 107.029 -168.718 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.47 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.4 mp -136.12 96.22 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.182 0 N-CA-C 100.635 -3.839 . . . . 0.0 100.635 -168.271 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.8 p -77.97 -18.87 55.5 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 169.84 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -100.31 141.14 33.57 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.417 1.462 . . . . 0.0 111.068 -169.607 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.8 m -106.09 100.46 10.0 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 166.926 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -93.46 109.9 21.48 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 -175.599 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.93 118.5 25.54 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -168.146 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.9 169.02 40.61 Favored Glycine 1 CA--C 1.582 4.22 0 CA-C-O 115.097 -3.057 . . . . 0.0 116.35 -176.343 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.45 160.89 22.53 Favored 'Trans proline' 0 C--N 1.395 2.987 1 CA-C-N 125.834 4.817 . . . . 0.0 114.29 -174.092 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.36 95.8 0.37 Allowed Glycine 0 N--CA 1.487 2.062 0 CA-C-O 116.921 -2.044 . . . . 0.0 111.465 178.017 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.8 m -78.98 106.59 4.59 Favored Pre-proline 0 CA--C 1.587 2.368 0 CA-C-O 115.755 -2.069 . . . . 0.0 113.943 -167.639 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -80.07 171.38 15.29 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 123.428 2.752 . . . . 0.0 113.828 170.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.82 153.69 28.95 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.358 1.063 . . . . 0.0 110.746 168.008 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.25 11.4 m -129.55 152.21 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 123.211 0.604 . . . . 0.0 112.497 -168.845 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.13 165.63 31.47 Favored Pre-proline 0 CA--C 1.581 2.16 0 CA-C-O 115.814 -2.041 . . . . 0.0 116.332 -179.611 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.69 106.91 2.2 Favored 'Trans proline' 0 C--N 1.395 3.017 0 C-N-CA 123.12 2.547 . . . . 0.0 109.958 169.73 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.3 t -76.79 122.86 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 176.936 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 p -131.7 106.27 8.04 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 -176.482 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 tt -69.66 162.16 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.827 0 CA-C-N 111.863 -2.426 . . . . 0.0 113.871 -179.071 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -138.17 102.31 4.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 166.162 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.0 t -96.1 105.14 17.14 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 111.138 -2.755 . . . . 0.0 105.818 171.776 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 N--CA 1.491 1.597 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.582 -167.677 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.6 p . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -141.29 124.22 16.23 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 124.285 1.034 . . . . 0.0 108.481 179.72 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -84.57 129.7 34.82 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 117.83 -1.081 . . . . 0.0 110.574 -177.207 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.276 5.3 tt0 -114.55 94.44 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 102.639 -3.097 . . . . 0.0 102.639 172.685 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.491 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -108.19 123.31 48.55 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.473 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 m -108.08 132.53 53.47 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -169.736 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.491 HD11 ' CD2' ' A' ' 5' ' ' TYR . 3.6 mp -129.82 97.8 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.351 0 N-CA-C 100.602 -3.851 . . . . 0.0 100.602 -167.661 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 94.7 p -118.72 3.91 11.63 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 169.8 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -113.57 125.67 54.44 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -168.768 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -97.12 116.41 29.28 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 -179.709 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.436 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.3 m-85 -104.23 112.92 26.13 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -128.2 119.42 25.18 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -169.961 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.58 -161.71 20.48 Favored Glycine 1 CA--C 1.579 4.078 0 CA-C-O 114.362 -3.466 . . . . 0.0 115.821 177.663 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.8 160.96 4.12 Favored 'Trans proline' 0 C--N 1.394 2.928 1 CA-C-N 126.748 5.274 . . . . 0.0 114.533 -179.458 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.31 113.51 0.87 Allowed Glycine 0 N--CA 1.482 1.719 0 CA-C-O 117.576 -1.68 . . . . 0.0 110.489 172.671 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -96.1 94.89 1.69 Allowed Pre-proline 0 CA--C 1.591 2.525 0 CA-C-O 116.211 -1.852 . . . . 0.0 113.628 -170.996 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -82.11 174.79 9.75 Favored 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 123.309 2.673 . . . . 0.0 113.624 169.283 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.94 158.89 27.92 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.431 1.093 . . . . 0.0 111.958 168.351 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.253 10.5 m -135.98 153.73 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -169.74 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -62.3 158.69 45.54 Favored Pre-proline 0 CA--C 1.587 2.366 0 CA-C-O 114.613 -2.613 . . . . 0.0 115.823 179.216 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.82 108.95 2.4 Favored 'Trans proline' 0 C--N 1.398 3.134 0 CA-C-N 126.105 3.216 . . . . 0.0 109.783 168.764 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.3 t -75.14 121.93 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 174.5 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 p -132.08 105.52 7.44 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 -174.672 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.267 2.6 tt -67.74 161.91 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.828 0 CA-C-N 111.65 -2.523 . . . . 0.0 114.446 -178.753 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -143.44 100.69 3.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 124.664 2.173 . . . . 0.0 106.49 167.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.7 m -94.89 91.95 6.67 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 110.792 -2.913 . . . . 0.0 104.128 173.571 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 N--CA 1.493 1.721 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.53 -165.161 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -142.24 132.59 24.99 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.346 1.059 . . . . 0.0 109.17 -179.774 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -83.13 135.2 34.9 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 117.343 -1.313 . . . . 0.0 111.211 -178.551 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -120.58 96.89 5.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 102.368 -3.197 . . . . 0.0 102.368 167.918 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.26 122.76 46.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.038 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 m -107.0 131.35 54.16 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 125.73 1.894 . . . . 0.0 107.068 -168.559 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.93 96.33 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.17 0 N-CA-C 100.521 -3.881 . . . . 0.0 100.521 -168.435 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.6 p -78.28 -19.06 54.42 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 169.789 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -99.54 141.31 32.5 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 120.401 1.455 . . . . 0.0 111.297 -169.614 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.4 m -105.94 101.64 11.13 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 101.004 -3.702 . . . . 0.0 101.004 166.762 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -94.36 110.32 22.1 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 -176.248 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.03 121.34 29.52 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -168.342 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.61 171.8 42.85 Favored Glycine 1 CA--C 1.581 4.175 0 CA-C-O 115.16 -3.022 . . . . 0.0 116.45 -177.549 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.21 160.39 23.29 Favored 'Trans proline' 0 C--N 1.396 3.031 1 CA-C-N 125.767 4.784 . . . . 0.0 114.064 -175.565 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.78 95.46 0.62 Allowed Glycine 0 N--CA 1.486 1.986 0 CA-C-O 117.603 -1.665 . . . . 0.0 110.863 -179.503 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.257 4.7 p -105.2 90.75 4.01 Favored Pre-proline 0 CA--C 1.583 2.248 0 CA-C-O 116.474 -1.727 . . . . 0.0 113.432 -167.645 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -83.73 178.6 5.39 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 123.409 2.74 . . . . 0.0 113.721 171.847 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 p -69.33 146.98 51.73 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.89 1.276 . . . . 0.0 111.871 168.911 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.31 30.8 m -138.94 168.56 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.112 0 CA-C-O 121.455 0.645 . . . . 0.0 111.607 -179.335 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.08 161.98 3.29 Favored Pre-proline 0 CA--C 1.58 2.1 0 N-CA-C 118.863 2.912 . . . . 0.0 118.863 -170.146 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.32 114.88 4.09 Favored 'Trans proline' 0 C--N 1.396 3.031 0 C-N-CA 123.111 2.541 . . . . 0.0 110.227 169.886 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.9 t -78.36 112.58 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 176.275 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.7 p -117.07 101.93 8.89 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -172.732 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.47 163.74 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 CA-C-N 111.023 -2.808 . . . . 0.0 113.934 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -140.18 105.53 5.06 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 166.968 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.13 97.29 10.19 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 169.023 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.492 1.671 0 CA-C-N 113.71 -1.587 . . . . 0.0 111.424 -165.491 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -138.87 129.1 25.54 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.332 1.053 . . . . 0.0 108.929 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -86.13 133.15 33.89 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.665 179.829 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -116.69 100.12 7.6 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 100.888 -3.745 . . . . 0.0 100.888 168.865 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.77 123.15 49.64 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 177.69 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -107.51 133.23 52.29 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 125.303 1.627 . . . . 0.0 106.633 -169.213 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.485 HD13 ' CD1' ' A' ' 12' ' ' PHE . 3.6 mp -130.38 97.4 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.317 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -167.686 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -119.59 8.01 11.19 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 169.931 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -116.71 125.4 51.65 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -169.053 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 m -96.28 113.34 24.93 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -177.976 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.485 ' CD1' HD13 ' A' ' 7' ' ' ILE . 84.8 m-85 -103.16 115.76 31.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -179.493 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -132.5 120.91 22.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -168.686 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.6 -162.19 16.28 Favored Glycine 1 CA--C 1.581 4.157 0 CA-C-O 114.496 -3.391 . . . . 0.0 115.887 178.47 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -87.61 161.53 7.92 Favored 'Trans proline' 0 C--N 1.395 3.004 1 CA-C-N 126.617 5.209 . . . . 0.0 114.062 -178.084 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.33 117.84 1.41 Allowed Glycine 0 N--CA 1.48 1.598 0 CA-C-O 117.932 -1.482 . . . . 0.0 110.044 176.929 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.5 m -100.72 84.6 0.48 Allowed Pre-proline 0 CA--C 1.588 2.408 0 CA-C-O 116.979 -1.486 . . . . 0.0 112.957 -177.304 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.99 174.11 10.44 Favored 'Trans proline' 0 C--N 1.389 2.701 0 C-N-CA 123.17 2.58 . . . . 0.0 112.923 168.559 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.288 9.6 t -95.57 157.72 15.77 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 123.619 0.768 . . . . 0.0 109.406 167.886 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 m -125.93 159.43 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 124.306 1.042 . . . . 0.0 112.069 -166.445 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -73.58 -176.2 0.46 Allowed Pre-proline 0 CA--C 1.609 3.22 0 CA-C-O 115.096 -2.383 . . . . 0.0 113.843 -179.111 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -83.66 129.84 4.99 Favored 'Trans proline' 0 C--N 1.394 2.956 0 CA-C-N 126.685 3.423 . . . . 0.0 111.579 -178.482 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.8 t -76.53 134.52 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 174.901 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.5 p -142.73 108.07 5.02 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 -176.799 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.272 1.8 tt -70.8 161.64 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 C-N-CA 127.248 2.219 . . . . 0.0 112.711 -179.049 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -141.79 121.21 13.2 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 102.348 -3.204 . . . . 0.0 102.348 169.409 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.8 t -97.0 116.04 28.51 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 111.601 -2.545 . . . . 0.0 107.208 169.497 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.267 -0.873 . . . . 0.0 108.828 -169.367 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.28 124.61 19.14 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.164 0.986 . . . . 0.0 108.779 178.863 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -85.55 127.9 34.58 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 124.395 1.059 . . . . 0.0 110.252 -179.071 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.252 9.1 tt0 -109.9 97.68 7.15 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 169.127 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.67 122.08 45.98 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 177.545 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 m -108.17 130.46 55.13 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -169.248 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.5 HD13 ' CD1' ' A' ' 12' ' ' PHE . 2.6 mp -127.67 96.81 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.336 0 N-CA-C 100.291 -3.966 . . . . 0.0 100.291 -167.602 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.2 m -121.71 3.83 10.07 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 170.197 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -111.86 124.35 52.17 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -168.884 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -96.25 113.61 25.22 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -176.471 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.5 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.0 m-85 -103.72 114.38 28.6 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 -179.544 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -131.25 119.66 22.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 -169.029 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.58 -161.37 19.87 Favored Glycine 1 CA--C 1.58 4.101 0 CA-C-O 114.379 -3.456 . . . . 0.0 116.134 178.455 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -90.66 160.53 4.26 Favored 'Trans proline' 0 C--N 1.394 2.964 1 CA-C-N 126.768 5.284 . . . . 0.0 114.595 -178.477 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.17 113.62 0.73 Allowed Glycine 0 N--CA 1.481 1.681 0 CA-C-O 117.451 -1.749 . . . . 0.0 110.615 173.614 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.7 t -94.28 95.18 1.31 Allowed Pre-proline 0 CA--C 1.589 2.458 0 CA-C-O 116.132 -1.89 . . . . 0.0 113.471 -173.294 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -81.02 174.35 10.97 Favored 'Trans proline' 0 C--N 1.392 2.839 0 CA-C-N 124.559 2.664 . . . . 0.0 113.225 168.806 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -79.12 157.65 27.91 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.412 1.085 . . . . 0.0 111.508 168.403 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.262 16.5 m -135.07 152.58 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 C-N-CA 123.118 0.567 . . . . 0.0 111.559 -177.905 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 167.56 34.62 Favored Pre-proline 0 CA--C 1.588 2.411 0 CA-C-O 115.006 -2.426 . . . . 0.0 114.032 179.331 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.3 129.19 16.62 Favored 'Trans proline' 0 C--N 1.4 3.237 0 CA-C-N 126.883 3.494 . . . . 0.0 111.572 177.861 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.3 t -78.93 125.86 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 171.993 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.0 t -139.77 111.29 7.18 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 123.682 1.706 . . . . 0.0 107.722 177.763 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.255 1.8 tt -70.76 158.98 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 CA-C-N 109.26 -3.609 . . . . 0.0 113.632 -172.441 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -139.78 103.93 4.78 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 167.905 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.7 m -97.57 98.48 9.94 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 109.879 -3.328 . . . . 0.0 105.01 175.307 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.493 1.715 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.282 -167.418 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.6 t . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -135.91 140.95 44.45 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 124.272 1.029 . . . . 0.0 110.191 179.049 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -86.37 136.92 32.94 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.645 0.778 . . . . 0.0 110.226 174.173 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.253 4.3 tt0 -123.55 100.31 6.74 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 101.352 -3.573 . . . . 0.0 101.352 170.099 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.15 124.41 51.42 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 179.127 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -106.51 132.07 52.94 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 125.406 1.691 . . . . 0.0 107.465 -168.536 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp -136.47 94.95 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.583 2.224 0 N-CA-C 100.761 -3.792 . . . . 0.0 100.761 -168.325 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.7 p -78.16 -17.31 56.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 169.76 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -101.31 140.65 35.31 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 120.342 1.428 . . . . 0.0 110.985 -169.612 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m -105.03 102.95 12.42 Favored 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 100.939 -3.726 . . . . 0.0 100.939 166.137 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -92.47 116.57 29.1 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 -179.38 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -132.39 119.42 20.66 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -168.186 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.89 -169.37 25.13 Favored Glycine 1 CA--C 1.582 4.26 0 CA-C-O 114.482 -3.399 . . . . 0.0 115.585 179.04 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -86.83 160.96 9.03 Favored 'Trans proline' 0 C--N 1.394 2.957 1 CA-C-N 126.898 5.349 . . . . 0.0 114.186 -176.27 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.33 117.71 1.4 Allowed Glycine 0 N--CA 1.479 1.552 0 CA-C-O 117.83 -1.539 . . . . 0.0 110.084 177.68 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.8 m -100.65 83.93 0.43 Allowed Pre-proline 0 CA--C 1.589 2.48 0 CA-C-O 117.275 -1.345 . . . . 0.0 113.717 -177.623 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.31 171.53 10.03 Favored 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 123.123 2.548 . . . . 0.0 113.117 168.157 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.282 9.5 t -93.98 149.43 21.24 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.669 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.62 156.66 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.644 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.788 -165.616 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -7.69 145.01 0.0 OUTLIER Pre-proline 0 CA--C 1.585 2.296 0 N-CA-C 120.752 3.612 . . . . 0.0 120.752 169.405 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.92 115.37 4.27 Favored 'Trans proline' 0 C--N 1.395 3.02 0 CA-C-N 126.571 3.382 . . . . 0.0 109.464 168.533 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -77.25 122.27 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 174.508 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.8 p -127.23 107.31 9.89 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 -178.498 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.26 1.3 tt -65.1 162.69 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 C-N-CA 127.456 2.302 . . . . 0.0 113.349 177.806 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -139.18 118.56 12.83 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 102.918 -2.993 . . . . 0.0 102.918 169.805 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 14.3 t -100.79 128.97 46.62 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.001 -2.818 . . . . 0.0 107.474 168.422 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.283 14.8 pt-20 . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -168.729 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -136.17 137.49 40.98 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 124.183 0.993 . . . . 0.0 110.422 -179.364 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -92.75 135.21 34.31 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.189 0.93 . . . . 0.0 110.215 -178.08 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -115.83 99.82 7.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 100.87 -3.752 . . . . 0.0 100.87 169.318 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.43 122.65 46.44 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -179.922 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -107.44 134.53 50.35 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 125.652 1.845 . . . . 0.0 106.485 -169.132 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.426 HD13 ' CD1' ' A' ' 12' ' ' PHE . 4.5 mp -131.35 98.52 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.301 0 N-CA-C 101.136 -3.653 . . . . 0.0 101.136 -167.842 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 t -117.81 9.64 13.01 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 169.861 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -119.21 126.5 51.69 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -168.904 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m -97.1 113.45 25.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 -179.293 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.426 ' CD1' HD13 ' A' ' 7' ' ' ILE . 85.6 m-85 -103.43 116.07 31.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -179.657 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -133.22 122.73 24.39 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -168.622 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.86 -178.17 40.73 Favored Glycine 1 CA--C 1.58 4.149 0 CA-C-O 114.977 -3.124 . . . . 0.0 116.529 -179.632 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -84.28 158.75 13.03 Favored 'Trans proline' 0 C--N 1.395 3.005 1 CA-C-N 125.929 4.865 . . . . 0.0 113.798 -177.418 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.18 107.33 0.42 Allowed Glycine 0 N--CA 1.483 1.789 0 CA-C-O 116.902 -2.054 . . . . 0.0 110.828 177.071 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.3 m -90.54 98.82 1.65 Allowed Pre-proline 0 CA--C 1.587 2.381 0 CA-C-O 116.121 -1.895 . . . . 0.0 112.4 -169.645 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.79 170.14 18.54 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 123.43 2.754 . . . . 0.0 113.688 169.911 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.16 149.24 29.2 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.078 0.951 . . . . 0.0 111.083 169.388 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.5 m -104.06 147.11 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 124.049 0.939 . . . . 0.0 112.241 -168.064 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.64 163.03 51.18 Favored Pre-proline 0 CA--C 1.588 2.417 0 CA-C-O 115.159 -2.353 . . . . 0.0 112.205 168.95 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.62 140.24 35.61 Favored 'Trans proline' 0 C--N 1.396 3.058 0 CA-C-N 126.948 3.517 . . . . 0.0 113.678 -169.571 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.8 t -143.41 129.21 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 N-CA-C 101.164 -3.643 . . . . 0.0 101.164 -176.542 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.6 p -129.96 105.12 7.76 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -177.442 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 tt -72.15 161.79 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 112.25 -2.25 . . . . 0.0 113.861 -177.851 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -142.46 104.48 4.41 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 165.835 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.1 t -95.97 108.82 21.25 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 111.58 -2.554 . . . . 0.0 105.923 171.365 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 124.619 1.199 . . . . 0.0 110.598 -167.609 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -139.11 128.29 23.96 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.331 1.053 . . . . 0.0 108.966 179.698 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -87.52 133.8 33.71 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.964 0.79 . . . . 0.0 110.177 179.785 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.98 102.02 8.72 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 101.325 -3.583 . . . . 0.0 101.325 168.257 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.493 ' CD2' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -112.21 121.22 44.31 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 178.036 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -107.17 130.91 54.65 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 125.128 1.517 . . . . 0.0 107.037 -168.767 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 5' ' ' TYR . 4.4 mp -135.76 95.65 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.176 0 N-CA-C 100.743 -3.799 . . . . 0.0 100.743 -167.928 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.1 t -79.23 -16.71 56.08 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 170.069 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -99.73 139.57 35.2 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 120.737 1.608 . . . . 0.0 110.971 -169.571 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.2 m -106.11 102.35 11.78 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 100.962 -3.718 . . . . 0.0 100.962 166.483 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -93.27 116.67 29.23 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 -179.559 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -132.82 121.94 23.71 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -167.838 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.4 -162.57 19.47 Favored Glycine 1 CA--C 1.58 4.108 0 CA-C-O 114.675 -3.291 . . . . 0.0 115.822 178.009 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -86.22 161.92 9.94 Favored 'Trans proline' 0 C--N 1.394 2.93 1 CA-C-N 126.354 5.077 . . . . 0.0 113.868 -177.832 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.61 117.22 1.22 Allowed Glycine 0 N--CA 1.479 1.52 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.295 174.292 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -101.7 84.58 0.56 Allowed Pre-proline 0 CA--C 1.588 2.416 0 CA-C-O 116.913 -1.518 . . . . 0.0 111.621 -179.169 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.18 174.03 7.43 Favored 'Trans proline' 0 C--N 1.39 2.733 0 C-N-CA 123.253 2.635 . . . . 0.0 114.116 171.2 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 p -77.95 147.11 35.11 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.484 1.113 . . . . 0.0 110.056 167.223 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.263 30.1 m -139.64 151.66 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 123.526 0.516 . . . . 0.0 112.07 -174.2 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -14.46 146.18 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.272 0 CA-C-O 112.685 -3.531 . . . . 0.0 119.939 169.904 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.14 116.8 4.46 Favored 'Trans proline' 0 C--N 1.394 2.969 0 CA-C-N 126.624 3.401 . . . . 0.0 109.473 168.413 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t -76.87 117.5 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 175.428 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 p -121.85 105.35 10.28 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 -175.756 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.27 1.5 tt -68.11 163.75 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 CA-C-N 111.774 -2.466 . . . . 0.0 113.202 -179.797 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -139.75 118.04 12.03 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 168.697 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.2 t -97.6 114.52 26.46 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 111.416 -2.629 . . . . 0.0 106.776 169.499 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.493 1.72 0 C-N-CA 123.825 0.85 . . . . 0.0 109.052 -169.039 . . . . . . . . 0 0 . 1 stop_ save_